id	sid	tid	token	lemma	pos
ecj-12463	1	1	hrev_master	hrev_master	NOUN
ecj-12463	2	1	[	[	X
ecj-12463	2	2	page	page	NOUN
ecj-12463	2	3	49	49	NUM
ecj-12463	2	4	]	]	PUNCT
ecj-12463	3	1	[	[	X
ecj-12463	3	2	emergency	emergency	NOUN
ecj-12463	3	3	care	care	NOUN
ecj-12463	3	4	journal	journal	PROPN
ecj-12463	3	5	2024	2024	NUM
ecj-12463	3	6	;	;	PUNCT
ecj-12463	3	7	20:12463	20:12463	NUM
ecj-12463	3	8	]	]	X
ecj-12463	3	9	emergency	emergency	NOUN
ecj-12463	3	10	care	care	NOUN
ecj-12463	3	11	journal	journal	PROPN
ecj-12463	3	12	2024	2024	NUM
ecj-12463	3	13	volume	volume	NOUN
ecj-12463	3	14	20:12463	20:12463	NUM
ecj-12463	3	15	abstract	abstract	ADJ
ecj-12463	3	16	chest	chest	NOUN
ecj-12463	3	17	pain	pain	NOUN
ecj-12463	3	18	is	be	AUX
ecj-12463	3	19	one	one	NUM
ecj-12463	3	20	of	of	ADP
ecj-12463	3	21	the	the	DET
ecj-12463	3	22	most	most	ADV
ecj-12463	3	23	prevalent	prevalent	ADJ
ecj-12463	3	24	causes	cause	NOUN
ecj-12463	3	25	of	of	ADP
ecj-12463	3	26	emergency	emergency	NOUN
ecj-12463	3	27	department	department	NOUN
ecj-12463	3	28	(	(	PUNCT
ecj-12463	3	29	ed	ed	NOUN
ecj-12463	3	30	)	)	PUNCT
ecj-12463	3	31	admission	admission	NOUN
ecj-12463	3	32	and	and	CCONJ
ecj-12463	3	33	could	could	AUX
ecj-12463	3	34	be	be	AUX
ecj-12463	3	35	a	a	DET
ecj-12463	3	36	presenting	present	VERB
ecj-12463	3	37	symptom	symptom	NOUN
ecj-12463	3	38	of	of	ADP
ecj-12463	3	39	acute	acute	ADJ
ecj-12463	3	40	coronary	coronary	ADJ
ecj-12463	3	41	syndrome	syndrome	NOUN
ecj-12463	3	42	(	(	PUNCT
ecj-12463	3	43	acs	acs	PROPN
ecj-12463	3	44	)	)	PUNCT
ecj-12463	3	45	.	.	PUNCT
ecj-12463	4	1	the	the	DET
ecj-12463	4	2	aim	aim	NOUN
ecj-12463	4	3	of	of	ADP
ecj-12463	4	4	this	this	DET
ecj-12463	4	5	review	review	NOUN
ecj-12463	4	6	was	be	AUX
ecj-12463	4	7	to	to	PART
ecj-12463	4	8	provide	provide	VERB
ecj-12463	4	9	an	an	DET
ecj-12463	4	10	overview	overview	NOUN
ecj-12463	4	11	of	of	ADP
ecj-12463	4	12	the	the	DET
ecj-12463	4	13	research	research	NOUN
ecj-12463	4	14	about	about	ADP
ecj-12463	4	15	troponin	troponin	ADJ
ecj-12463	4	16	and	and	CCONJ
ecj-12463	4	17	its	its	PRON
ecj-12463	4	18	limitations	limitation	NOUN
ecj-12463	4	19	and	and	CCONJ
ecj-12463	4	20	new	new	ADJ
ecj-12463	4	21	biomarkers	biomarker	NOUN
ecj-12463	4	22	used	use	VERB
ecj-12463	4	23	in	in	ADP
ecj-12463	4	24	patients	patient	NOUN
ecj-12463	4	25	with	with	ADP
ecj-12463	4	26	cardiovascular	cardiovascular	ADJ
ecj-12463	4	27	diseases	disease	NOUN
ecj-12463	4	28	,	,	PUNCT
ecj-12463	4	29	with	with	ADP
ecj-12463	4	30	a	a	DET
ecj-12463	4	31	special	special	ADJ
ecj-12463	4	32	focus	focus	NOUN
ecj-12463	4	33	on	on	ADP
ecj-12463	4	34	soluble	soluble	ADJ
ecj-12463	4	35	suppression	suppression	NOUN
ecj-12463	4	36	of	of	ADP
ecj-12463	4	37	tumorigenicity	tumorigenicity	NOUN
ecj-12463	4	38	2	2	NUM
ecj-12463	4	39	(	(	PUNCT
ecj-12463	4	40	sst2	sst2	NOUN
ecj-12463	4	41	)	)	PUNCT
ecj-12463	4	42	and	and	CCONJ
ecj-12463	4	43	soluble	soluble	ADJ
ecj-12463	4	44	urokinase	urokinase	NOUN
ecj-12463	4	45	plasminogen	plasminogen	NOUN
ecj-12463	4	46	activator	activator	NOUN
ecj-12463	4	47	receptor	receptor	NOUN
ecj-12463	4	48	(	(	PUNCT
ecj-12463	4	49	supar	supar	NOUN
ecj-12463	4	50	)	)	PUNCT
ecj-12463	4	51	.	.	PUNCT
ecj-12463	5	1	in	in	ADP
ecj-12463	5	2	january	january	PROPN
ecj-12463	5	3	2024	2024	NUM
ecj-12463	5	4	,	,	PUNCT
ecj-12463	5	5	a	a	DET
ecj-12463	5	6	pubmed	pubmed	NOUN
ecj-12463	5	7	and	and	CCONJ
ecj-12463	5	8	reviews	review	NOUN
ecj-12463	5	9	in	in	ADP
ecj-12463	5	10	cardiovascular	cardiovascular	ADJ
ecj-12463	5	11	medicine	medicine	NOUN
ecj-12463	5	12	(	(	PUNCT
ecj-12463	5	13	rcm	rcm	PROPN
ecj-12463	5	14	)	)	PUNCT
ecj-12463	5	15	search	search	NOUN
ecj-12463	5	16	was	be	AUX
ecj-12463	5	17	carried	carry	VERB
ecj-12463	5	18	out	out	ADP
ecj-12463	5	19	to	to	PART
ecj-12463	5	20	identify	identify	VERB
ecj-12463	5	21	all	all	DET
ecj-12463	5	22	relevant	relevant	ADJ
ecj-12463	5	23	papers	paper	NOUN
ecj-12463	5	24	in	in	ADP
ecj-12463	5	25	the	the	DET
ecj-12463	5	26	past	past	ADJ
ecj-12463	5	27	five	five	NUM
ecj-12463	5	28	years	year	NOUN
ecj-12463	5	29	.	.	PUNCT
ecj-12463	6	1	80	80	NUM
ecj-12463	6	2	articles	article	NOUN
ecj-12463	6	3	were	be	AUX
ecj-12463	6	4	included	include	VERB
ecj-12463	6	5	in	in	ADP
ecj-12463	6	6	the	the	DET
ecj-12463	6	7	final	final	ADJ
ecj-12463	6	8	review	review	NOUN
ecj-12463	6	9	.	.	PUNCT
ecj-12463	7	1	sst2	sst2	PROPN
ecj-12463	7	2	and	and	CCONJ
ecj-12463	7	3	supar	supar	NOUN
ecj-12463	7	4	are	be	AUX
ecj-12463	7	5	involved	involve	VERB
ecj-12463	7	6	in	in	ADP
ecj-12463	7	7	both	both	CCONJ
ecj-12463	7	8	acute	acute	ADJ
ecj-12463	7	9	and	and	CCONJ
ecj-12463	7	10	chronic	chronic	ADJ
ecj-12463	7	11	cardiovascular	cardiovascular	ADJ
ecj-12463	7	12	disease	disease	NOUN
ecj-12463	7	13	and	and	CCONJ
ecj-12463	7	14	can	can	AUX
ecj-12463	7	15	predict	predict	VERB
ecj-12463	7	16	the	the	DET
ecj-12463	7	17	risk	risk	NOUN
ecj-12463	7	18	of	of	ADP
ecj-12463	7	19	adverse	adverse	ADJ
ecj-12463	7	20	events	event	NOUN
ecj-12463	7	21	.	.	PUNCT
ecj-12463	8	1	sst2	sst2	NOUN
ecj-12463	8	2	and	and	CCONJ
ecj-12463	8	3	supar	supar	PROPN
ecj-12463	8	4	are	be	AUX
ecj-12463	8	5	promising	promise	VERB
ecj-12463	8	6	biomarkers	biomarker	NOUN
ecj-12463	8	7	that	that	SCONJ
ecj-12463	8	8	,	,	PUNCT
ecj-12463	8	9	in	in	ADP
ecj-12463	8	10	combination	combination	NOUN
ecj-12463	8	11	with	with	ADP
ecj-12463	8	12	troponin	troponin	ADJ
ecj-12463	8	13	,	,	PUNCT
ecj-12463	8	14	could	could	AUX
ecj-12463	8	15	help	help	VERB
ecj-12463	8	16	in	in	ADP
ecj-12463	8	17	the	the	DET
ecj-12463	8	18	management	management	NOUN
ecj-12463	8	19	of	of	ADP
ecj-12463	8	20	patients	patient	NOUN
ecj-12463	8	21	with	with	ADP
ecj-12463	8	22	chest	chest	NOUN
ecj-12463	8	23	pain	pain	NOUN
ecj-12463	8	24	in	in	ADP
ecj-12463	8	25	the	the	DET
ecj-12463	8	26	ed	ed	NOUN
ecj-12463	8	27	.	.	PUNCT
ecj-12463	9	1	further	further	ADJ
ecj-12463	9	2	studies	study	NOUN
ecj-12463	9	3	are	be	AUX
ecj-12463	9	4	needed	need	VERB
ecj-12463	9	5	to	to	PART
ecj-12463	9	6	validate	validate	VERB
ecj-12463	9	7	their	their	PRON
ecj-12463	9	8	role	role	NOUN
ecj-12463	9	9	in	in	ADP
ecj-12463	9	10	management	management	NOUN
ecj-12463	9	11	of	of	ADP
ecj-12463	9	12	acs	acs	PROPN
ecj-12463	9	13	in	in	ADP
ecj-12463	9	14	this	this	DET
ecj-12463	9	15	specific	specific	ADJ
ecj-12463	9	16	setting	setting	NOUN
ecj-12463	9	17	.	.	PUNCT
ecj-12463	10	1	introduction	introduction	NOUN
ecj-12463	10	2	chest	chest	NOUN
ecj-12463	10	3	pain	pain	NOUN
ecj-12463	10	4	is	be	AUX
ecj-12463	10	5	one	one	NUM
ecj-12463	10	6	of	of	ADP
ecj-12463	10	7	the	the	DET
ecj-12463	10	8	most	most	ADV
ecj-12463	10	9	frequent	frequent	ADJ
ecj-12463	10	10	symptoms	symptom	NOUN
ecj-12463	10	11	of	of	ADP
ecj-12463	10	12	admission	admission	NOUN
ecj-12463	10	13	to	to	ADP
ecj-12463	10	14	the	the	DET
ecj-12463	10	15	emergency	emergency	NOUN
ecj-12463	10	16	department	department	NOUN
ecj-12463	10	17	(	(	PUNCT
ecj-12463	10	18	ed	ed	NOUN
ecj-12463	10	19	)	)	PUNCT
ecj-12463	10	20	.	.	PUNCT
ecj-12463	11	1	it	it	PRON
ecj-12463	11	2	represents	represent	VERB
ecj-12463	11	3	a	a	DET
ecj-12463	11	4	continuous	continuous	ADJ
ecj-12463	11	5	defiance	defiance	NOUN
ecj-12463	11	6	in	in	ADP
ecj-12463	11	7	emergency	emergency	NOUN
ecj-12463	11	8	departments	department	NOUN
ecj-12463	11	9	,	,	PUNCT
ecj-12463	11	10	which	which	PRON
ecj-12463	11	11	requires	require	VERB
ecj-12463	11	12	an	an	DET
ecj-12463	11	13	accurate	accurate	ADJ
ecj-12463	11	14	assessment	assessment	NOUN
ecj-12463	11	15	in	in	ADP
ecj-12463	11	16	order	order	NOUN
ecj-12463	11	17	to	to	PART
ecj-12463	11	18	identify	identify	VERB
ecj-12463	11	19	serious	serious	ADJ
ecj-12463	11	20	conditions	condition	NOUN
ecj-12463	11	21	that	that	PRON
ecj-12463	11	22	are	be	AUX
ecj-12463	11	23	potentially	potentially	ADV
ecj-12463	11	24	deadly	deadly	ADJ
ecj-12463	11	25	and	and	CCONJ
ecj-12463	11	26	predict	predict	VERB
ecj-12463	11	27	associated	associated	ADJ
ecj-12463	11	28	risks	risk	NOUN
ecj-12463	11	29	.	.	PUNCT
ecj-12463	12	1	cardiovascular	cardiovascular	ADJ
ecj-12463	12	2	disease	disease	NOUN
ecj-12463	12	3	(	(	PUNCT
ecj-12463	12	4	cvd	cvd	PROPN
ecj-12463	12	5	)	)	PUNCT
ecj-12463	12	6	can	can	AUX
ecj-12463	12	7	present	present	VERB
ecj-12463	12	8	with	with	ADP
ecj-12463	12	9	different	different	ADJ
ecj-12463	12	10	manifestations	manifestation	NOUN
ecj-12463	12	11	,	,	PUNCT
ecj-12463	12	12	of	of	ADP
ecj-12463	12	13	which	which	PRON
ecj-12463	12	14	chest	chest	NOUN
ecj-12463	12	15	pain	pain	NOUN
ecj-12463	12	16	represents	represent	VERB
ecj-12463	12	17	the	the	DET
ecj-12463	12	18	most	most	ADV
ecj-12463	12	19	frequent	frequent	ADJ
ecj-12463	12	20	symptom	symptom	NOUN
ecj-12463	12	21	.	.	PUNCT
ecj-12463	13	1	although	although	SCONJ
ecj-12463	13	2	sometimes	sometimes	ADV
ecj-12463	13	3	it	it	PRON
ecj-12463	13	4	is	be	AUX
ecj-12463	13	5	not	not	PART
ecj-12463	13	6	related	relate	VERB
ecj-12463	13	7	to	to	ADP
ecj-12463	13	8	acute	acute	ADJ
ecj-12463	13	9	syndromes	syndrome	NOUN
ecj-12463	13	10	that	that	PRON
ecj-12463	13	11	require	require	VERB
ecj-12463	13	12	immediate	immediate	ADJ
ecj-12463	13	13	treatment	treatment	NOUN
ecj-12463	13	14	,	,	PUNCT
ecj-12463	13	15	other	other	ADJ
ecj-12463	13	16	times	time	NOUN
ecj-12463	13	17	it	it	PRON
ecj-12463	13	18	indicates	indicate	VERB
ecj-12463	13	19	acute	acute	ADJ
ecj-12463	13	20	situations	situation	NOUN
ecj-12463	13	21	such	such	ADJ
ecj-12463	13	22	as	as	ADP
ecj-12463	13	23	acute	acute	ADJ
ecj-12463	13	24	coronary	coronary	ADJ
ecj-12463	13	25	syndrome	syndrome	NOUN
ecj-12463	13	26	(	(	PUNCT
ecj-12463	13	27	acs	acs	PROPN
ecj-12463	13	28	)	)	PUNCT
ecj-12463	13	29	which	which	PRON
ecj-12463	13	30	can	can	AUX
ecj-12463	13	31	endanger	endanger	VERB
ecj-12463	13	32	the	the	DET
ecj-12463	13	33	patient	patient	NOUN
ecj-12463	13	34	’s	’s	PART
ecj-12463	13	35	life	life	NOUN
ecj-12463	13	36	.	.	PUNCT
ecj-12463	14	1	cvd	cvd	PROPN
ecj-12463	14	2	is	be	AUX
ecj-12463	14	3	a	a	DET
ecj-12463	14	4	major	major	ADJ
ecj-12463	14	5	disease	disease	NOUN
ecj-12463	14	6	globally	globally	ADV
ecj-12463	14	7	and	and	CCONJ
ecj-12463	14	8	the	the	DET
ecj-12463	14	9	leading	lead	VERB
ecj-12463	14	10	cause	cause	NOUN
ecj-12463	14	11	of	of	ADP
ecj-12463	14	12	death	death	NOUN
ecj-12463	14	13	and	and	CCONJ
ecj-12463	14	14	disability	disability	NOUN
ecj-12463	14	15	worldwide.1	worldwide.1	ADP
ecj-12463	14	16	cvd	cvd	PROPN
ecj-12463	14	17	is	be	AUX
ecj-12463	14	18	typically	typically	ADV
ecj-12463	14	19	diagnosed	diagnose	VERB
ecj-12463	14	20	based	base	VERB
ecj-12463	14	21	on	on	ADP
ecj-12463	14	22	history	history	NOUN
ecj-12463	14	23	,	,	PUNCT
ecj-12463	14	24	clinical	clinical	ADJ
ecj-12463	14	25	examination	examination	NOUN
ecj-12463	14	26	,	,	PUNCT
ecj-12463	14	27	risk	risk	NOUN
ecj-12463	14	28	factors	factor	NOUN
ecj-12463	14	29	,	,	PUNCT
ecj-12463	14	30	ecg	ecg	PROPN
ecj-12463	14	31	tracing	tracing	PROPN
ecj-12463	14	32	,	,	PUNCT
ecj-12463	14	33	and	and	CCONJ
ecj-12463	14	34	laboratory	laboratory	NOUN
ecj-12463	14	35	criteria	criterion	NOUN
ecj-12463	14	36	.	.	PUNCT
ecj-12463	15	1	chest	chest	NOUN
ecj-12463	15	2	pain	pain	NOUN
ecj-12463	15	3	is	be	AUX
ecj-12463	15	4	a	a	DET
ecj-12463	15	5	symptom	symptom	NOUN
ecj-12463	15	6	of	of	ADP
ecj-12463	15	7	acs	acs	PROPN
ecj-12463	15	8	,	,	PUNCT
ecj-12463	15	9	but	but	CCONJ
ecj-12463	15	10	also	also	ADV
ecj-12463	15	11	of	of	ADP
ecj-12463	15	12	other	other	ADJ
ecj-12463	15	13	cardiothoracic	cardiothoracic	NOUN
ecj-12463	15	14	situations	situation	NOUN
ecj-12463	15	15	as	as	ADV
ecj-12463	15	16	well	well	ADV
ecj-12463	15	17	as	as	ADP
ecj-12463	15	18	manifestations	manifestation	NOUN
ecj-12463	15	19	of	of	ADP
ecj-12463	15	20	non	non	ADJ
ecj-12463	15	21	cardiothoracic	cardiothoracic	NOUN
ecj-12463	15	22	syndromes	syndrome	NOUN
ecj-12463	15	23	.	.	PUNCT
ecj-12463	16	1	the	the	DET
ecj-12463	16	2	risks	risk	NOUN
ecj-12463	16	3	of	of	ADP
ecj-12463	16	4	misdiagnosis	misdiagnosis	NOUN
ecj-12463	16	5	are	be	AUX
ecj-12463	16	6	high	high	ADJ
ecj-12463	16	7	.	.	PUNCT
ecj-12463	17	1	in	in	ADP
ecj-12463	17	2	spite	spite	NOUN
ecj-12463	17	3	of	of	ADP
ecj-12463	17	4	recent	recent	ADJ
ecj-12463	17	5	efforts	effort	NOUN
ecj-12463	17	6	to	to	PART
ecj-12463	17	7	develop	develop	VERB
ecj-12463	17	8	a	a	DET
ecj-12463	17	9	model	model	NOUN
ecj-12463	17	10	that	that	PRON
ecj-12463	17	11	could	could	AUX
ecj-12463	17	12	help	help	VERB
ecj-12463	17	13	in	in	ADP
ecj-12463	17	14	estimating	estimate	VERB
ecj-12463	17	15	the	the	DET
ecj-12463	17	16	cardiovascular	cardiovascular	ADJ
ecj-12463	17	17	risk	risk	NOUN
ecj-12463	17	18	in	in	ADP
ecj-12463	17	19	patients	patient	NOUN
ecj-12463	17	20	presenting	present	VERB
ecj-12463	17	21	to	to	ADP
ecj-12463	17	22	the	the	DET
ecj-12463	17	23	emergency	emergency	NOUN
ecj-12463	17	24	room	room	NOUN
ecj-12463	17	25	with	with	ADP
ecj-12463	17	26	chest	chest	NOUN
ecj-12463	17	27	pain	pain	NOUN
ecj-12463	17	28	,	,	PUNCT
ecj-12463	17	29	we	we	PRON
ecj-12463	17	30	are	be	AUX
ecj-12463	17	31	still	still	ADV
ecj-12463	17	32	unable	unable	ADJ
ecj-12463	17	33	to	to	PART
ecj-12463	17	34	rely	rely	VERB
ecj-12463	17	35	on	on	ADP
ecj-12463	17	36	trustworthy	trustworthy	ADJ
ecj-12463	17	37	instruments	instrument	NOUN
ecj-12463	17	38	to	to	PART
ecj-12463	17	39	estimate	estimate	VERB
ecj-12463	17	40	the	the	DET
ecj-12463	17	41	risk	risk	NOUN
ecj-12463	17	42	of	of	ADP
ecj-12463	17	43	acute	acute	ADJ
ecj-12463	17	44	coronary	coronary	ADJ
ecj-12463	17	45	syndromes	syndrome	NOUN
ecj-12463	17	46	in	in	ADP
ecj-12463	17	47	all	all	DET
ecj-12463	17	48	patients.2	patients.2	NOUN
ecj-12463	17	49	according	accord	VERB
ecj-12463	17	50	to	to	ADP
ecj-12463	17	51	the	the	DET
ecj-12463	17	52	centers	center	NOUN
ecj-12463	17	53	for	for	ADP
ecj-12463	17	54	disease	disease	NOUN
ecj-12463	17	55	control	control	NOUN
ecj-12463	17	56	and	and	CCONJ
ecj-12463	17	57	prevention	prevention	NOUN
ecj-12463	17	58	,	,	PUNCT
ecj-12463	17	59	about	about	ADV
ecj-12463	17	60	130	130	NUM
ecj-12463	17	61	million	million	NUM
ecj-12463	17	62	patients	patient	NOUN
ecj-12463	17	63	visit	visit	VERB
ecj-12463	17	64	the	the	DET
ecj-12463	17	65	ed	ed	NOUN
ecj-12463	17	66	in	in	ADP
ecj-12463	17	67	the	the	DET
ecj-12463	17	68	united	united	PROPN
ecj-12463	17	69	states	states	PROPN
ecj-12463	17	70	per	per	ADP
ecj-12463	17	71	year	year	NOUN
ecj-12463	17	72	,	,	PUNCT
ecj-12463	17	73	and	and	CCONJ
ecj-12463	17	74	of	of	ADP
ecj-12463	17	75	these	these	PRON
ecj-12463	17	76	the	the	DET
ecj-12463	17	77	31	31	NUM
ecj-12463	17	78	%	%	NOUN
ecj-12463	17	79	admitted	admit	VERB
ecj-12463	17	80	to	to	ADP
ecj-12463	17	81	the	the	DET
ecj-12463	17	82	ed	ed	NOUN
ecj-12463	17	83	with	with	ADP
ecj-12463	17	84	initially	initially	ADV
ecj-12463	17	85	normal	normal	ADJ
ecj-12463	17	86	vital	vital	ADJ
ecj-12463	17	87	signs	sign	NOUN
ecj-12463	17	88	show	show	VERB
ecj-12463	17	89	deterioration	deterioration	NOUN
ecj-12463	17	90	in	in	ADP
ecj-12463	17	91	the	the	DET
ecj-12463	17	92	first	first	ADJ
ecj-12463	17	93	24	24	NUM
ecj-12463	17	94	hours.3	hours.3	PROPN
ecj-12463	17	95	despite	despite	SCONJ
ecj-12463	17	96	the	the	DET
ecj-12463	17	97	attempt	attempt	NOUN
ecj-12463	17	98	to	to	PART
ecj-12463	17	99	build	build	VERB
ecj-12463	17	100	standardized	standardized	ADJ
ecj-12463	17	101	models	model	NOUN
ecj-12463	17	102	for	for	ADP
ecj-12463	17	103	the	the	DET
ecj-12463	17	104	correct	correct	ADJ
ecj-12463	17	105	management	management	NOUN
ecj-12463	17	106	of	of	ADP
ecj-12463	17	107	patients	patient	NOUN
ecj-12463	17	108	with	with	ADP
ecj-12463	17	109	chest	chest	NOUN
ecj-12463	17	110	pain	pain	NOUN
ecj-12463	17	111	in	in	ADP
ecj-12463	17	112	the	the	DET
ecj-12463	17	113	short	short	ADJ
ecj-12463	17	114	and	and	CCONJ
ecj-12463	17	115	long	long	ADJ
ecj-12463	17	116	term	term	NOUN
ecj-12463	17	117	,	,	PUNCT
ecj-12463	17	118	there	there	PRON
ecj-12463	17	119	are	be	VERB
ecj-12463	17	120	no	no	DET
ecj-12463	17	121	ideal	ideal	ADJ
ecj-12463	17	122	criteria	criterion	NOUN
ecj-12463	17	123	for	for	ADP
ecj-12463	17	124	determining	determine	VERB
ecj-12463	17	125	the	the	DET
ecj-12463	17	126	cardiovascular	cardiovascular	ADJ
ecj-12463	17	127	risk	risk	NOUN
ecj-12463	17	128	of	of	ADP
ecj-12463	17	129	patients	patient	NOUN
ecj-12463	17	130	who	who	PRON
ecj-12463	17	131	present	present	VERB
ecj-12463	17	132	with	with	ADP
ecj-12463	17	133	chest	chest	NOUN
ecj-12463	17	134	pain	pain	NOUN
ecj-12463	17	135	at	at	ADP
ecj-12463	17	136	the	the	DET
ecj-12463	17	137	ed	ed	NOUN
ecj-12463	17	138	.	.	PUNCT
ecj-12463	18	1	because	because	SCONJ
ecj-12463	18	2	of	of	ADP
ecj-12463	18	3	this	this	PRON
ecj-12463	18	4	,	,	PUNCT
ecj-12463	18	5	it	it	PRON
ecj-12463	18	6	is	be	AUX
ecj-12463	18	7	crucial	crucial	ADJ
ecj-12463	18	8	to	to	PART
ecj-12463	18	9	identify	identify	VERB
ecj-12463	18	10	markers	marker	NOUN
ecj-12463	18	11	that	that	PRON
ecj-12463	18	12	help	help	VERB
ecj-12463	18	13	ed	ed	NOUN
ecj-12463	18	14	physicians	physician	NOUN
ecj-12463	18	15	diagnose	diagnose	VERB
ecj-12463	18	16	and	and	CCONJ
ecj-12463	18	17	treat	treat	VERB
ecj-12463	18	18	these	these	DET
ecj-12463	18	19	conditions	condition	NOUN
ecj-12463	18	20	accurately	accurately	ADV
ecj-12463	18	21	for	for	ADP
ecj-12463	18	22	both	both	CCONJ
ecj-12463	18	23	immediate	immediate	ADJ
ecj-12463	18	24	diagnosis	diagnosis	NOUN
ecj-12463	18	25	and	and	CCONJ
ecj-12463	18	26	accurate	accurate	ADJ
ecj-12463	18	27	longand	longand	NOUN
ecj-12463	18	28	short	short	ADJ
ecj-12463	18	29	-	-	PUNCT
ecj-12463	18	30	term	term	NOUN
ecj-12463	18	31	risk	risk	NOUN
ecj-12463	18	32	assessment	assessment	NOUN
ecj-12463	18	33	,	,	PUNCT
ecj-12463	18	34	as	as	ADV
ecj-12463	18	35	well	well	ADV
ecj-12463	18	36	as	as	ADP
ecj-12463	18	37	for	for	ADP
ecj-12463	18	38	guiding	guide	VERB
ecj-12463	18	39	patients	patient	NOUN
ecj-12463	18	40	to	to	ADP
ecj-12463	18	41	the	the	DET
ecj-12463	18	42	appropriate	appropriate	ADJ
ecj-12463	18	43	follow	follow	NOUN
ecj-12463	18	44	-	-	PUNCT
ecj-12463	18	45	up	up	NOUN
ecj-12463	18	46	.	.	PUNCT
ecj-12463	19	1	thanks	thank	NOUN
ecj-12463	19	2	to	to	ADP
ecj-12463	19	3	its	its	PRON
ecj-12463	19	4	high	high	ADJ
ecj-12463	19	5	specificity	specificity	NOUN
ecj-12463	19	6	and	and	CCONJ
ecj-12463	19	7	sensitivity	sensitivity	NOUN
ecj-12463	19	8	,	,	PUNCT
ecj-12463	19	9	troponin	troponin	PROPN
ecj-12463	19	10	,	,	PUNCT
ecj-12463	19	11	a	a	DET
ecj-12463	19	12	reference	reference	NOUN
ecj-12463	19	13	biomarker	biomarker	NOUN
ecj-12463	19	14	for	for	ADP
ecj-12463	19	15	myocardial	myocardial	ADJ
ecj-12463	19	16	damage	damage	NOUN
ecj-12463	19	17	,	,	PUNCT
ecj-12463	19	18	is	be	AUX
ecj-12463	19	19	nearly	nearly	ADV
ecj-12463	19	20	always	always	ADV
ecj-12463	19	21	employed	employ	VERB
ecj-12463	19	22	to	to	PART
ecj-12463	19	23	diagnose	diagnose	VERB
ecj-12463	19	24	acute	acute	ADJ
ecj-12463	19	25	myocardial	myocardial	ADJ
ecj-12463	19	26	infarction	infarction	NOUN
ecj-12463	19	27	(	(	PUNCT
ecj-12463	19	28	ami	ami	NOUN
ecj-12463	19	29	)	)	PUNCT
ecj-12463	19	30	since	since	SCONJ
ecj-12463	19	31	it	it	PRON
ecj-12463	19	32	represents	represent	VERB
ecj-12463	19	33	the	the	DET
ecj-12463	19	34	main	main	ADJ
ecj-12463	19	35	biomarker	biomarker	NOUN
ecj-12463	19	36	in	in	ADP
ecj-12463	19	37	the	the	DET
ecj-12463	19	38	management	management	NOUN
ecj-12463	19	39	of	of	ADP
ecj-12463	19	40	patient	patient	NOUN
ecj-12463	19	41	with	with	ADP
ecj-12463	19	42	chest	chest	NOUN
ecj-12463	19	43	pain	pain	NOUN
ecj-12463	19	44	in	in	ADP
ecj-12463	19	45	ed	ed	NOUN
ecj-12463	19	46	,	,	PUNCT
ecj-12463	19	47	which	which	PRON
ecj-12463	19	48	can	can	AUX
ecj-12463	19	49	be	be	AUX
ecj-12463	19	50	measured	measure	VERB
ecj-12463	19	51	in	in	ADP
ecj-12463	19	52	its	its	PRON
ecj-12463	19	53	two	two	NUM
ecj-12463	19	54	isoforms	isoform	NOUN
ecj-12463	19	55	tni	tni	NOUN
ecj-12463	19	56	and	and	CCONJ
ecj-12463	19	57	tnt	tnt	PROPN
ecj-12463	19	58	.	.	PUNCT
ecj-12463	20	1	since	since	SCONJ
ecj-12463	20	2	the	the	DET
ecj-12463	20	3	plasma	plasma	NOUN
ecj-12463	20	4	levels	level	NOUN
ecj-12463	20	5	of	of	ADP
ecj-12463	20	6	these	these	DET
ecj-12463	20	7	two	two	NUM
ecj-12463	20	8	molecules	molecule	NOUN
ecj-12463	20	9	can	can	AUX
ecj-12463	20	10	rise	rise	VERB
ecj-12463	20	11	in	in	ADP
ecj-12463	20	12	a	a	DET
ecj-12463	20	13	variety	variety	NOUN
ecj-12463	20	14	of	of	ADP
ecj-12463	20	15	illnesses	illness	NOUN
ecj-12463	20	16	,	,	PUNCT
ecj-12463	20	17	including	include	VERB
ecj-12463	20	18	heart	heart	NOUN
ecj-12463	20	19	failure	failure	NOUN
ecj-12463	20	20	,	,	PUNCT
ecj-12463	20	21	chronic	chronic	ADJ
ecj-12463	20	22	kidney	kidney	NOUN
ecj-12463	20	23	disease	disease	NOUN
ecj-12463	20	24	,	,	PUNCT
ecj-12463	20	25	sepsis	sepsis	NOUN
ecj-12463	20	26	,	,	PUNCT
ecj-12463	20	27	and	and	CCONJ
ecj-12463	20	28	many	many	ADJ
ecj-12463	20	29	others	other	NOUN
ecj-12463	20	30	,	,	PUNCT
ecj-12463	20	31	doscorrespondence	doscorrespondence	NOUN
ecj-12463	20	32	:	:	PUNCT
ecj-12463	20	33	andrea	andrea	PROPN
ecj-12463	20	34	piccioni	piccioni	PROPN
ecj-12463	20	35	,	,	PUNCT
ecj-12463	20	36	department	department	NOUN
ecj-12463	20	37	of	of	ADP
ecj-12463	20	38	emergency	emergency	NOUN
ecj-12463	20	39	medicine	medicine	NOUN
ecj-12463	20	40	,	,	PUNCT
ecj-12463	20	41	gemelli	gemelli	NOUN
ecj-12463	20	42	hospital	hospital	NOUN
ecj-12463	20	43	,	,	PUNCT
ecj-12463	20	44	catholic	catholic	PROPN
ecj-12463	20	45	university	university	PROPN
ecj-12463	20	46	of	of	ADP
ecj-12463	20	47	rome	rome	PROPN
ecj-12463	20	48	,	,	PUNCT
ecj-12463	20	49	00168	00168	NUM
ecj-12463	20	50	rome	rome	PROPN
ecj-12463	20	51	,	,	PUNCT
ecj-12463	20	52	italy	italy	PROPN
ecj-12463	20	53	.	.	PUNCT
ecj-12463	21	1	e	e	X
ecj-12463	21	2	-	-	NOUN
ecj-12463	21	3	mail	mail	NOUN
ecj-12463	21	4	:	:	PUNCT
ecj-12463	21	5	andrea.piccioni@policlinicogemelli.it	andrea.piccioni@policlinicogemelli.it	PROPN
ecj-12463	21	6	key	key	ADJ
ecj-12463	21	7	words	word	NOUN
ecj-12463	21	8	:	:	PUNCT
ecj-12463	21	9	chest	chest	NOUN
ecj-12463	21	10	pain	pain	NOUN
ecj-12463	21	11	;	;	PUNCT
ecj-12463	21	12	acute	acute	ADJ
ecj-12463	21	13	coronary	coronary	ADJ
ecj-12463	21	14	syndrome	syndrome	NOUN
ecj-12463	21	15	;	;	PUNCT
ecj-12463	21	16	biomarkers	biomarker	NOUN
ecj-12463	21	17	;	;	PUNCT
ecj-12463	21	18	high	high	ADJ
ecj-12463	21	19	sensitivity	sensitivity	NOUN
ecj-12463	21	20	troponin	troponin	ADJ
ecj-12463	21	21	;	;	PUNCT
ecj-12463	21	22	supar	supar	NOUN
ecj-12463	21	23	;	;	PUNCT
ecj-12463	21	24	sst2	sst2	NOUN
ecj-12463	21	25	.	.	PUNCT
ecj-12463	22	1	conflict	conflict	NOUN
ecj-12463	22	2	of	of	ADP
ecj-12463	22	3	interest	interest	NOUN
ecj-12463	22	4	:	:	PUNCT
ecj-12463	22	5	the	the	DET
ecj-12463	22	6	authors	author	NOUN
ecj-12463	22	7	declare	declare	VERB
ecj-12463	22	8	no	no	DET
ecj-12463	22	9	potential	potential	ADJ
ecj-12463	22	10	conflict	conflict	NOUN
ecj-12463	22	11	of	of	ADP
ecj-12463	22	12	interest	interest	NOUN
ecj-12463	22	13	,	,	PUNCT
ecj-12463	22	14	and	and	CCONJ
ecj-12463	22	15	all	all	DET
ecj-12463	22	16	authors	author	NOUN
ecj-12463	22	17	confirm	confirm	VERB
ecj-12463	22	18	accuracy	accuracy	NOUN
ecj-12463	22	19	.	.	PUNCT
ecj-12463	23	1	ethics	ethic	NOUN
ecj-12463	23	2	approval	approval	NOUN
ecj-12463	23	3	:	:	PUNCT
ecj-12463	23	4	not	not	PART
ecj-12463	23	5	applicable	applicable	ADJ
ecj-12463	23	6	.	.	PUNCT
ecj-12463	24	1	informed	inform	VERB
ecj-12463	24	2	consent	consent	NOUN
ecj-12463	24	3	and	and	CCONJ
ecj-12463	24	4	patient	patient	ADJ
ecj-12463	24	5	consent	consent	NOUN
ecj-12463	24	6	for	for	ADP
ecj-12463	24	7	publication	publication	NOUN
ecj-12463	24	8	:	:	PUNCT
ecj-12463	24	9	not	not	PART
ecj-12463	24	10	applicable	applicable	ADJ
ecj-12463	24	11	.	.	PUNCT
ecj-12463	24	12	received	receive	VERB
ecj-12463	24	13	:	:	PUNCT
ecj-12463	24	14	8	8	NUM
ecj-12463	24	15	march	march	NOUN
ecj-12463	24	16	2024	2024	NUM
ecj-12463	24	17	.	.	PUNCT
ecj-12463	25	1	accepted	accept	VERB
ecj-12463	25	2	:	:	PUNCT
ecj-12463	25	3	4	4	NUM
ecj-12463	25	4	june	june	PROPN
ecj-12463	25	5	2024	2024	NUM
ecj-12463	25	6	.	.	PUNCT
ecj-12463	26	1	early	early	ADJ
ecj-12463	26	2	view	view	NOUN
ecj-12463	26	3	:	:	PUNCT
ecj-12463	26	4	18	18	NUM
ecj-12463	26	5	june	june	PROPN
ecj-12463	26	6	2024	2024	NUM
ecj-12463	26	7	.	.	PUNCT
ecj-12463	27	1	this	this	DET
ecj-12463	27	2	work	work	NOUN
ecj-12463	27	3	is	be	AUX
ecj-12463	27	4	licensed	license	VERB
ecj-12463	27	5	under	under	ADP
ecj-12463	27	6	a	a	DET
ecj-12463	27	7	creative	creative	ADJ
ecj-12463	27	8	commons	common	NOUN
ecj-12463	27	9	attribution	attribution	NOUN
ecj-12463	27	10	4.0	4.0	NUM
ecj-12463	27	11	license	license	NOUN
ecj-12463	27	12	(	(	PUNCT
ecj-12463	27	13	by	by	ADP
ecj-12463	27	14	-	-	PUNCT
ecj-12463	27	15	nc	nc	PROPN
ecj-12463	27	16	4.0	4.0	NUM
ecj-12463	27	17	)	)	PUNCT
ecj-12463	27	18	.	.	PUNCT
ecj-12463	28	1	©	©	PROPN
ecj-12463	28	2	copyright	copyright	NOUN
ecj-12463	28	3	:	:	PUNCT
ecj-12463	28	4	the	the	DET
ecj-12463	28	5	author(s	author(s	PROPN
ecj-12463	28	6	)	)	PUNCT
ecj-12463	28	7	,	,	PUNCT
ecj-12463	28	8	2024	2024	NUM
ecj-12463	28	9	licensee	licensee	NOUN
ecj-12463	28	10	pagepress	pagepress	NOUN
ecj-12463	28	11	,	,	PUNCT
ecj-12463	28	12	italy	italy	PROPN
ecj-12463	28	13	emergency	emergency	PROPN
ecj-12463	28	14	care	care	PROPN
ecj-12463	28	15	journal	journal	PROPN
ecj-12463	28	16	2024	2024	NUM
ecj-12463	28	17	;	;	PUNCT
ecj-12463	28	18	20:12463	20:12463	NUM
ecj-12463	28	19	doi:10.4081	doi:10.4081	NOUN
ecj-12463	28	20	/	/	SYM
ecj-12463	28	21	ecj.2024.12463	ecj.2024.12463	ADJ
ecj-12463	28	22	publisher	publisher	NOUN
ecj-12463	28	23	's	's	PART
ecj-12463	28	24	note	note	NOUN
ecj-12463	28	25	:	:	PUNCT
ecj-12463	28	26	all	all	DET
ecj-12463	28	27	claims	claim	NOUN
ecj-12463	28	28	expressed	express	VERB
ecj-12463	28	29	in	in	ADP
ecj-12463	28	30	this	this	DET
ecj-12463	28	31	article	article	NOUN
ecj-12463	28	32	are	be	AUX
ecj-12463	28	33	solely	solely	ADV
ecj-12463	28	34	those	those	PRON
ecj-12463	28	35	of	of	ADP
ecj-12463	28	36	the	the	DET
ecj-12463	28	37	authors	author	NOUN
ecj-12463	28	38	and	and	CCONJ
ecj-12463	28	39	do	do	AUX
ecj-12463	28	40	not	not	PART
ecj-12463	28	41	necessarily	necessarily	ADV
ecj-12463	28	42	represent	represent	VERB
ecj-12463	28	43	those	those	PRON
ecj-12463	28	44	of	of	ADP
ecj-12463	28	45	their	their	PRON
ecj-12463	28	46	affiliated	affiliated	ADJ
ecj-12463	28	47	organizations	organization	NOUN
ecj-12463	28	48	,	,	PUNCT
ecj-12463	28	49	or	or	CCONJ
ecj-12463	28	50	those	those	PRON
ecj-12463	28	51	of	of	ADP
ecj-12463	28	52	the	the	DET
ecj-12463	28	53	publisher	publisher	NOUN
ecj-12463	28	54	,	,	PUNCT
ecj-12463	28	55	the	the	DET
ecj-12463	28	56	editors	editor	NOUN
ecj-12463	28	57	and	and	CCONJ
ecj-12463	28	58	the	the	DET
ecj-12463	28	59	reviewers	reviewer	NOUN
ecj-12463	28	60	.	.	PUNCT
ecj-12463	29	1	any	any	DET
ecj-12463	29	2	product	product	NOUN
ecj-12463	29	3	that	that	PRON
ecj-12463	29	4	may	may	AUX
ecj-12463	29	5	be	be	AUX
ecj-12463	29	6	evaluated	evaluate	VERB
ecj-12463	29	7	in	in	ADP
ecj-12463	29	8	this	this	DET
ecj-12463	29	9	article	article	NOUN
ecj-12463	29	10	or	or	CCONJ
ecj-12463	29	11	claim	claim	NOUN
ecj-12463	29	12	that	that	PRON
ecj-12463	29	13	may	may	AUX
ecj-12463	29	14	be	be	AUX
ecj-12463	29	15	made	make	VERB
ecj-12463	29	16	by	by	ADP
ecj-12463	29	17	its	its	PRON
ecj-12463	29	18	manufacturer	manufacturer	NOUN
ecj-12463	29	19	is	be	AUX
ecj-12463	29	20	not	not	PART
ecj-12463	29	21	guaranteed	guarantee	VERB
ecj-12463	29	22	or	or	CCONJ
ecj-12463	29	23	endorsed	endorse	VERB
ecj-12463	29	24	by	by	ADP
ecj-12463	29	25	the	the	DET
ecj-12463	29	26	publisher	publisher	NOUN
ecj-12463	29	27	.	.	PUNCT
ecj-12463	30	1	multimarkers	multimarker	NOUN
ecj-12463	30	2	approach	approach	VERB
ecj-12463	30	3	in	in	ADP
ecj-12463	30	4	chest	chest	NOUN
ecj-12463	30	5	pain	pain	NOUN
ecj-12463	30	6	management	management	NOUN
ecj-12463	30	7	in	in	ADP
ecj-12463	30	8	emergency	emergency	NOUN
ecj-12463	30	9	department	department	NOUN
ecj-12463	30	10	:	:	PUNCT
ecj-12463	30	11	a	a	DET
ecj-12463	30	12	focus	focus	NOUN
ecj-12463	30	13	on	on	ADP
ecj-12463	30	14	the	the	DET
ecj-12463	30	15	prognostic	prognostic	ADJ
ecj-12463	30	16	role	role	NOUN
ecj-12463	30	17	of	of	ADP
ecj-12463	30	18	sst2	sst2	NOUN
ecj-12463	30	19	and	and	CCONJ
ecj-12463	30	20	supar	supar	PROPN
ecj-12463	30	21	andrea	andrea	PROPN
ecj-12463	30	22	piccioni,1	piccioni,1	VERB
ecj-12463	30	23	silvia	silvia	PROPN
ecj-12463	30	24	baroni,2	baroni,2	PROPN
ecj-12463	30	25	licia	licia	PROPN
ecj-12463	30	26	antonella	antonella	PROPN
ecj-12463	30	27	scatà,1	scatà,1	PROPN
ecj-12463	30	28	marta	marta	PROPN
ecj-12463	30	29	scaccia,1	scaccia,1	PROPN
ecj-12463	30	30	martina	martina	PROPN
ecj-12463	30	31	candela,1	candela,1	PROPN
ecj-12463	30	32	alessandra	alessandra	PROPN
ecj-12463	30	33	bronzino,1	bronzino,1	PROPN
ecj-12463	30	34	francesca	francesca	PROPN
ecj-12463	30	35	sarlo,2	sarlo,2	NOUN
ecj-12463	30	36	gabriele	gabriele	PROPN
ecj-12463	30	37	savioli,3	savioli,3	VERB
ecj-12463	30	38	marcello	marcello	PROPN
ecj-12463	30	39	candelli,1	candelli,1	PROPN
ecj-12463	30	40	marcello	marcello	PROPN
ecj-12463	30	41	covino,1	covino,1	PROPN
ecj-12463	30	42	antonio	antonio	PROPN
ecj-12463	30	43	gasbarrini,4	gasbarrini,4	NOUN
ecj-12463	30	44	francesco	francesco	PROPN
ecj-12463	30	45	franceschi1	franceschi1	VERB
ecj-12463	30	46	1department	1department	NUM
ecj-12463	30	47	of	of	ADP
ecj-12463	30	48	emergency	emergency	NOUN
ecj-12463	30	49	medicine	medicine	NOUN
ecj-12463	30	50	,	,	PUNCT
ecj-12463	30	51	fondazione	fondazione	PROPN
ecj-12463	30	52	policlinico	policlinico	PROPN
ecj-12463	30	53	universitario	universitario	PROPN
ecj-12463	30	54	a.	a.	PROPN
ecj-12463	30	55	gemelli	gemelli	PROPN
ecj-12463	30	56	-	-	PUNCT
ecj-12463	30	57	irccs	irccs	PROPN
ecj-12463	30	58	,	,	PUNCT
ecj-12463	30	59	università	università	PROPN
ecj-12463	30	60	cattolica	cattolica	PROPN
ecj-12463	30	61	del	del	PROPN
ecj-12463	30	62	sacro	sacro	PROPN
ecj-12463	30	63	cuore	cuore	PROPN
ecj-12463	30	64	,	,	PUNCT
ecj-12463	30	65	rome	rome	PROPN
ecj-12463	30	66	;	;	PUNCT
ecj-12463	30	67	2department	2department	NUM
ecj-12463	30	68	of	of	ADP
ecj-12463	30	69	laboratory	laboratory	NOUN
ecj-12463	30	70	and	and	CCONJ
ecj-12463	30	71	infectious	infectious	ADJ
ecj-12463	30	72	sciences	science	NOUN
ecj-12463	30	73	,	,	PUNCT
ecj-12463	30	74	fondazione	fondazione	PROPN
ecj-12463	30	75	policlinico	policlinico	PROPN
ecj-12463	30	76	universitario	universitario	PROPN
ecj-12463	30	77	a.	a.	PROPN
ecj-12463	30	78	gemelli	gemelli	PROPN
ecj-12463	30	79	-	-	PUNCT
ecj-12463	30	80	irccs	irccs	PROPN
ecj-12463	30	81	,	,	PUNCT
ecj-12463	30	82	università	università	PROPN
ecj-12463	30	83	cattolica	cattolica	PROPN
ecj-12463	30	84	del	del	PROPN
ecj-12463	30	85	sacro	sacro	PROPN
ecj-12463	30	86	cuore	cuore	PROPN
ecj-12463	30	87	,	,	PUNCT
ecj-12463	30	88	roma	roma	PROPN
ecj-12463	30	89	;	;	PUNCT
ecj-12463	30	90	3departement	3departement	NUM
ecj-12463	30	91	of	of	ADP
ecj-12463	30	92	emergency	emergency	NOUN
ecj-12463	30	93	,	,	PUNCT
ecj-12463	30	94	irccs	ircc	VERB
ecj-12463	30	95	fondazione	fondazione	NOUN
ecj-12463	30	96	policlinico	policlinico	PROPN
ecj-12463	30	97	san	san	PROPN
ecj-12463	30	98	matteo	matteo	PROPN
ecj-12463	30	99	,	,	PUNCT
ecj-12463	30	100	pavia	pavia	NOUN
ecj-12463	30	101	;	;	PUNCT
ecj-12463	30	102	4medical	4medical	NUM
ecj-12463	30	103	and	and	CCONJ
ecj-12463	30	104	surgical	surgical	ADJ
ecj-12463	30	105	science	science	NOUN
ecj-12463	30	106	department	department	NOUN
ecj-12463	30	107	,	,	PUNCT
ecj-12463	30	108	fondazione	fondazione	PROPN
ecj-12463	30	109	policlinico	policlinico	PROPN
ecj-12463	30	110	universitario	universitario	PROPN
ecj-12463	30	111	a.	a.	PROPN
ecj-12463	30	112	gemelli	gemelli	PROPN
ecj-12463	30	113	-	-	PUNCT
ecj-12463	30	114	irccs	irccs	PROPN
ecj-12463	30	115	,	,	PUNCT
ecj-12463	30	116	università	università	PROPN
ecj-12463	30	117	cattolica	cattolica	PROPN
ecj-12463	30	118	del	del	PROPN
ecj-12463	30	119	sacro	sacro	PROPN
ecj-12463	30	120	cuore	cuore	PROPN
ecj-12463	30	121	,	,	PUNCT
ecj-12463	30	122	roma	roma	PROPN
ecj-12463	30	123	,	,	PUNCT
ecj-12463	30	124	italy	italy	PROPN
ecj-12463	30	125	non	non	PROPN
ecj-12463	31	1	-co	-co	PROPN
ecj-12463	31	2	mmerc	mmerc	PROPN
ecj-12463	31	3	ial	ial	PROPN
ecj-12463	31	4	us	us	PROPN
ecj-12463	31	5	e	e	NOUN
ecj-12463	31	6	o	o	PUNCT
ecj-12463	31	7	nly	nly	ADV
ecj-12463	31	8	ing	e	VERB
ecj-12463	31	9	these	these	DET
ecj-12463	31	10	molecules	molecule	NOUN
ecj-12463	31	11	frequently	frequently	ADV
ecj-12463	31	12	results	result	VERB
ecj-12463	31	13	in	in	ADP
ecj-12463	31	14	false	false	ADJ
ecj-12463	31	15	positive	positive	ADJ
ecj-12463	31	16	results	result	NOUN
ecj-12463	31	17	.	.	PUNCT
ecj-12463	32	1	furthermore	furthermore	ADV
ecj-12463	32	2	,	,	PUNCT
ecj-12463	32	3	cardiac	cardiac	ADJ
ecj-12463	32	4	troponin	troponin	ADJ
ecj-12463	32	5	levels	level	NOUN
ecj-12463	32	6	in	in	ADP
ecj-12463	32	7	the	the	DET
ecj-12463	32	8	peripheral	peripheral	ADJ
ecj-12463	32	9	blood	blood	NOUN
ecj-12463	32	10	can	can	AUX
ecj-12463	32	11	be	be	AUX
ecj-12463	32	12	detected	detect	VERB
ecj-12463	32	13	for	for	ADP
ecj-12463	32	14	days	day	NOUN
ecj-12463	32	15	following	follow	VERB
ecj-12463	32	16	myocardial	myocardial	ADJ
ecj-12463	32	17	cell	cell	NOUN
ecj-12463	32	18	death	death	NOUN
ecj-12463	32	19	,	,	PUNCT
ecj-12463	32	20	which	which	PRON
ecj-12463	32	21	typically	typically	ADV
ecj-12463	32	22	occurs	occur	VERB
ecj-12463	32	23	2	2	NUM
ecj-12463	32	24	-	-	SYM
ecj-12463	32	25	4	4	NUM
ecj-12463	32	26	hours	hour	NOUN
ecj-12463	32	27	after	after	ADP
ecj-12463	32	28	the	the	DET
ecj-12463	32	29	ischemia	ischemia	NOUN
ecj-12463	32	30	event.2	event.2	VERB
ecj-12463	32	31	however	however	ADV
ecj-12463	32	32	,	,	PUNCT
ecj-12463	32	33	the	the	DET
ecj-12463	32	34	limitations	limitation	NOUN
ecj-12463	32	35	of	of	ADP
ecj-12463	32	36	troponin	troponin	ADJ
ecj-12463	32	37	entail	entail	NOUN
ecj-12463	32	38	the	the	DET
ecj-12463	32	39	search	search	NOUN
ecj-12463	32	40	for	for	ADP
ecj-12463	32	41	novel	novel	ADJ
ecj-12463	32	42	diagnostic	diagnostic	ADJ
ecj-12463	32	43	biomarkers	biomarker	NOUN
ecj-12463	32	44	of	of	ADP
ecj-12463	32	45	acs	acs	PROPN
ecj-12463	32	46	that	that	PRON
ecj-12463	32	47	could	could	AUX
ecj-12463	32	48	complement	complement	VERB
ecj-12463	32	49	troponin	troponin	ADJ
ecj-12463	32	50	.	.	PUNCT
ecj-12463	33	1	therefore	therefore	ADV
ecj-12463	33	2	,	,	PUNCT
ecj-12463	33	3	in	in	ADP
ecj-12463	33	4	recent	recent	ADJ
ecj-12463	33	5	years	year	NOUN
ecj-12463	33	6	,	,	PUNCT
ecj-12463	33	7	a	a	DET
ecj-12463	33	8	number	number	NOUN
ecj-12463	33	9	of	of	ADP
ecj-12463	33	10	emerging	emerge	VERB
ecj-12463	33	11	biomarkers	biomarker	NOUN
ecj-12463	33	12	have	have	AUX
ecj-12463	33	13	been	be	AUX
ecj-12463	33	14	proposed	propose	VERB
ecj-12463	33	15	to	to	PART
ecj-12463	33	16	facilitate	facilitate	VERB
ecj-12463	33	17	the	the	DET
ecj-12463	33	18	risk	risk	NOUN
ecj-12463	33	19	stratification	stratification	NOUN
ecj-12463	33	20	of	of	ADP
ecj-12463	33	21	patients	patient	NOUN
ecj-12463	33	22	with	with	ADP
ecj-12463	33	23	cvd	cvd	PROPN
ecj-12463	33	24	.	.	PUNCT
ecj-12463	34	1	these	these	PRON
ecj-12463	34	2	include	include	VERB
ecj-12463	34	3	sst2	sst2	PROPN
ecj-12463	34	4	,	,	PUNCT
ecj-12463	34	5	supar	supar	NOUN
ecj-12463	34	6	,	,	PUNCT
ecj-12463	34	7	mirna	mirna	PROPN
ecj-12463	34	8	,	,	PUNCT
ecj-12463	34	9	galectin-3	galectin-3	PROPN
ecj-12463	34	10	,	,	PUNCT
ecj-12463	34	11	gdf-15	gdf-15	NOUN
ecj-12463	34	12	and	and	CCONJ
ecj-12463	34	13	others	other	NOUN
ecj-12463	34	14	.	.	PUNCT
ecj-12463	35	1	for	for	ADP
ecj-12463	35	2	this	this	DET
ecj-12463	35	3	reason	reason	NOUN
ecj-12463	35	4	,	,	PUNCT
ecj-12463	35	5	the	the	DET
ecj-12463	35	6	aim	aim	NOUN
ecj-12463	35	7	of	of	ADP
ecj-12463	35	8	this	this	DET
ecj-12463	35	9	review	review	NOUN
ecj-12463	35	10	is	be	AUX
ecj-12463	35	11	to	to	PART
ecj-12463	35	12	evaluate	evaluate	VERB
ecj-12463	35	13	,	,	PUNCT
ecj-12463	35	14	on	on	ADP
ecj-12463	35	15	the	the	DET
ecj-12463	35	16	basis	basis	NOUN
ecj-12463	35	17	of	of	ADP
ecj-12463	35	18	the	the	DET
ecj-12463	35	19	most	most	ADV
ecj-12463	35	20	recent	recent	ADJ
ecj-12463	35	21	literature	literature	NOUN
ecj-12463	35	22	,	,	PUNCT
ecj-12463	35	23	which	which	PRON
ecj-12463	35	24	biomarkers	biomarker	NOUN
ecj-12463	35	25	are	be	AUX
ecj-12463	35	26	currently	currently	ADV
ecj-12463	35	27	most	most	ADV
ecj-12463	35	28	helpful	helpful	ADJ
ecj-12463	35	29	in	in	ADP
ecj-12463	35	30	the	the	DET
ecj-12463	35	31	diagnosis	diagnosis	NOUN
ecj-12463	35	32	of	of	ADP
ecj-12463	35	33	patients	patient	NOUN
ecj-12463	35	34	with	with	ADP
ecj-12463	35	35	chest	chest	NOUN
ecj-12463	35	36	pain	pain	NOUN
ecj-12463	35	37	and	and	CCONJ
ecj-12463	35	38	to	to	PART
ecj-12463	35	39	predict	predict	VERB
ecj-12463	35	40	cardiovascular	cardiovascular	ADJ
ecj-12463	35	41	risk	risk	NOUN
ecj-12463	35	42	,	,	PUNCT
ecj-12463	35	43	with	with	ADP
ecj-12463	35	44	a	a	DET
ecj-12463	35	45	special	special	ADJ
ecj-12463	35	46	focus	focus	NOUN
ecj-12463	35	47	on	on	ADP
ecj-12463	35	48	sst2	sst2	NOUN
ecj-12463	35	49	and	and	CCONJ
ecj-12463	35	50	supar	supar	NOUN
ecj-12463	35	51	,	,	PUNCT
ecj-12463	35	52	beyond	beyond	ADP
ecj-12463	35	53	the	the	DET
ecj-12463	35	54	widely	widely	ADV
ecj-12463	35	55	used	use	VERB
ecj-12463	35	56	troponin	troponin	NOUN
ecj-12463	35	57	,	,	PUNCT
ecj-12463	35	58	with	with	ADP
ecj-12463	35	59	the	the	DET
ecj-12463	35	60	further	further	ADJ
ecj-12463	35	61	aim	aim	NOUN
ecj-12463	35	62	of	of	ADP
ecj-12463	35	63	improving	improve	VERB
ecj-12463	35	64	patient	patient	ADJ
ecj-12463	35	65	management	management	NOUN
ecj-12463	35	66	within	within	ADP
ecj-12463	35	67	the	the	DET
ecj-12463	35	68	ed	ed	NOUN
ecj-12463	35	69	.	.	PUNCT
ecj-12463	36	1	indeed	indeed	ADV
ecj-12463	36	2	,	,	PUNCT
ecj-12463	36	3	emergency	emergency	NOUN
ecj-12463	36	4	department	department	NOUN
ecj-12463	36	5	overcrowding	overcrowding	NOUN
ecj-12463	36	6	is	be	AUX
ecj-12463	36	7	a	a	DET
ecj-12463	36	8	huge	huge	ADJ
ecj-12463	36	9	problem	problem	NOUN
ecj-12463	36	10	which	which	PRON
ecj-12463	36	11	entails	entail	VERB
ecj-12463	36	12	increased	increase	VERB
ecj-12463	36	13	mortality	mortality	NOUN
ecj-12463	36	14	rates	rate	NOUN
ecj-12463	36	15	,	,	PUNCT
ecj-12463	36	16	costs	cost	NOUN
ecj-12463	36	17	and	and	CCONJ
ecj-12463	36	18	prolonged	prolong	VERB
ecj-12463	36	19	length	length	NOUN
ecj-12463	36	20	of	of	ADP
ecj-12463	36	21	stays	stay	NOUN
ecj-12463	36	22	,	,	PUNCT
ecj-12463	36	23	decreased	decrease	VERB
ecj-12463	36	24	treatment	treatment	NOUN
ecj-12463	36	25	quality	quality	NOUN
ecj-12463	36	26	and	and	CCONJ
ecj-12463	36	27	decreased	decrease	VERB
ecj-12463	36	28	safety	safety	NOUN
ecj-12463	36	29	of	of	ADP
ecj-12463	36	30	acute	acute	ADJ
ecj-12463	36	31	care	care	NOUN
ecj-12463	36	32	.	.	PUNCT
ecj-12463	37	1	the	the	DET
ecj-12463	37	2	ability	ability	NOUN
ecj-12463	37	3	to	to	PART
ecj-12463	37	4	reliably	reliably	ADV
ecj-12463	37	5	predict	predict	VERB
ecj-12463	37	6	future	future	ADJ
ecj-12463	37	7	cardiac	cardiac	ADJ
ecj-12463	37	8	event	event	NOUN
ecj-12463	37	9	incidence	incidence	NOUN
ecj-12463	37	10	in	in	ADP
ecj-12463	37	11	patients	patient	NOUN
ecj-12463	37	12	is	be	AUX
ecj-12463	37	13	essential	essential	ADJ
ecj-12463	37	14	for	for	ADP
ecj-12463	37	15	their	their	PRON
ecj-12463	37	16	effective	effective	ADJ
ecj-12463	37	17	care	care	NOUN
ecj-12463	37	18	and	and	CCONJ
ecj-12463	37	19	for	for	ADP
ecj-12463	37	20	the	the	DET
ecj-12463	37	21	more	more	ADV
ecj-12463	37	22	appropriate	appropriate	ADJ
ecj-12463	37	23	allocation	allocation	NOUN
ecj-12463	37	24	of	of	ADP
ecj-12463	37	25	limited	limited	ADJ
ecj-12463	37	26	healthcare	healthcare	NOUN
ecj-12463	37	27	resources.4	resources.4	PROPN
ecj-12463	37	28	by	by	ADP
ecj-12463	37	29	allowing	allow	VERB
ecj-12463	37	30	more	more	ADV
ecj-12463	37	31	safe	safe	ADJ
ecj-12463	37	32	discharges	discharge	NOUN
ecj-12463	37	33	in	in	ADP
ecj-12463	37	34	a	a	DET
ecj-12463	37	35	short	short	ADJ
ecj-12463	37	36	time	time	NOUN
ecj-12463	37	37	,	,	PUNCT
ecj-12463	37	38	the	the	DET
ecj-12463	37	39	patient	patient	ADJ
ecj-12463	37	40	flow	flow	NOUN
ecj-12463	37	41	could	could	AUX
ecj-12463	37	42	be	be	AUX
ecj-12463	37	43	improved	improve	VERB
ecj-12463	37	44	and	and	CCONJ
ecj-12463	37	45	overcrowding	overcrowding	NOUN
ecj-12463	37	46	avoided	avoid	VERB
ecj-12463	37	47	.	.	PUNCT
ecj-12463	38	1	in	in	ADP
ecj-12463	38	2	a	a	DET
ecj-12463	38	3	clinical	clinical	ADJ
ecj-12463	38	4	setting	setting	NOUN
ecj-12463	38	5	where	where	SCONJ
ecj-12463	38	6	diagnostic	diagnostic	ADJ
ecj-12463	38	7	accuracy	accuracy	NOUN
ecj-12463	38	8	is	be	AUX
ecj-12463	38	9	crucial	crucial	ADJ
ecj-12463	38	10	,	,	PUNCT
ecj-12463	38	11	the	the	DET
ecj-12463	38	12	search	search	NOUN
ecj-12463	38	13	for	for	ADP
ecj-12463	38	14	additional	additional	ADJ
ecj-12463	38	15	and	and	CCONJ
ecj-12463	38	16	complementary	complementary	ADJ
ecj-12463	38	17	biomarkers	biomarker	NOUN
ecj-12463	38	18	to	to	ADP
ecj-12463	38	19	troponin	troponin	PROPN
ecj-12463	38	20	reflects	reflect	VERB
ecj-12463	38	21	the	the	DET
ecj-12463	38	22	growing	grow	VERB
ecj-12463	38	23	need	need	NOUN
ecj-12463	38	24	to	to	PART
ecj-12463	38	25	improve	improve	VERB
ecj-12463	38	26	the	the	DET
ecj-12463	38	27	sensitivity	sensitivity	NOUN
ecj-12463	38	28	and	and	CCONJ
ecj-12463	38	29	specificity	specificity	NOUN
ecj-12463	38	30	of	of	ADP
ecj-12463	38	31	diagnoses.5,6	diagnoses.5,6	PROPN
ecj-12463	38	32	ctn	ctn	NOUN
ecj-12463	38	33	cardiac	cardiac	ADJ
ecj-12463	38	34	troponin	troponin	ADJ
ecj-12463	38	35	is	be	AUX
ecj-12463	38	36	one	one	NUM
ecj-12463	38	37	of	of	ADP
ecj-12463	38	38	the	the	DET
ecj-12463	38	39	main	main	ADJ
ecj-12463	38	40	biomarkers	biomarker	NOUN
ecj-12463	38	41	used	use	VERB
ecj-12463	38	42	in	in	ADP
ecj-12463	38	43	the	the	DET
ecj-12463	38	44	assessment	assessment	NOUN
ecj-12463	38	45	of	of	ADP
ecj-12463	38	46	cardiac	cardiac	ADJ
ecj-12463	38	47	damage	damage	NOUN
ecj-12463	38	48	.	.	PUNCT
ecj-12463	39	1	its	its	PRON
ecj-12463	39	2	complex	complex	ADJ
ecj-12463	39	3	consists	consist	VERB
ecj-12463	39	4	of	of	ADP
ecj-12463	39	5	the	the	DET
ecj-12463	39	6	subunits	subunit	NOUN
ecj-12463	39	7	troponin	troponin	PROPN
ecj-12463	40	1	i	i	PROPN
ecj-12463	40	2	(	(	PUNCT
ecj-12463	40	3	tni	tni	NOUN
ecj-12463	40	4	)	)	PUNCT
ecj-12463	40	5	,	,	PUNCT
ecj-12463	40	6	troponin	troponin	PROPN
ecj-12463	40	7	t	t	PROPN
ecj-12463	40	8	(	(	PUNCT
ecj-12463	40	9	tnt	tnt	PROPN
ecj-12463	40	10	)	)	PUNCT
ecj-12463	40	11	,	,	PUNCT
ecj-12463	40	12	and	and	CCONJ
ecj-12463	40	13	troponin	troponin	PROPN
ecj-12463	40	14	c	c	PROPN
ecj-12463	40	15	(	(	PUNCT
ecj-12463	40	16	tnc	tnc	PROPN
ecj-12463	40	17	)	)	PUNCT
ecj-12463	40	18	.	.	PUNCT
ecj-12463	41	1	during	during	ADP
ecj-12463	41	2	the	the	DET
ecj-12463	41	3	cardiac	cardiac	ADJ
ecj-12463	41	4	cycle	cycle	NOUN
ecj-12463	41	5	,	,	PUNCT
ecj-12463	41	6	this	this	DET
ecj-12463	41	7	protein	protein	NOUN
ecj-12463	41	8	complex	complex	NOUN
ecj-12463	41	9	plays	play	VERB
ecj-12463	41	10	the	the	DET
ecj-12463	41	11	main	main	ADJ
ecj-12463	41	12	role	role	NOUN
ecj-12463	41	13	in	in	ADP
ecj-12463	41	14	regulating	regulate	VERB
ecj-12463	41	15	ca2	ca2	PROPN
ecj-12463	41	16	+	+	ADJ
ecj-12463	41	17	-dependent	-dependent	ADJ
ecj-12463	41	18	muscle	muscle	NOUN
ecj-12463	41	19	contraction	contraction	NOUN
ecj-12463	41	20	.	.	PUNCT
ecj-12463	42	1	these	these	DET
ecj-12463	42	2	three	three	NUM
ecj-12463	42	3	subunits	subunit	NOUN
ecj-12463	42	4	serve	serve	VERB
ecj-12463	42	5	different	different	ADJ
ecj-12463	42	6	functions	function	NOUN
ecj-12463	42	7	:	:	PUNCT
ecj-12463	42	8	tni	tni	NOUN
ecj-12463	42	9	regulates	regulate	VERB
ecj-12463	42	10	the	the	DET
ecj-12463	42	11	interaction	interaction	NOUN
ecj-12463	42	12	between	between	ADP
ecj-12463	42	13	actin	actin	NOUN
ecj-12463	42	14	and	and	CCONJ
ecj-12463	42	15	myosin	myosin	NOUN
ecj-12463	42	16	,	,	PUNCT
ecj-12463	42	17	thus	thus	ADV
ecj-12463	42	18	enabling	enable	VERB
ecj-12463	42	19	the	the	DET
ecj-12463	42	20	relaxation	relaxation	NOUN
ecj-12463	42	21	of	of	ADP
ecj-12463	42	22	the	the	DET
ecj-12463	42	23	heart	heart	NOUN
ecj-12463	42	24	.	.	PUNCT
ecj-12463	43	1	tnt	tnt	PROPN
ecj-12463	43	2	is	be	AUX
ecj-12463	43	3	involved	involve	VERB
ecj-12463	43	4	in	in	ADP
ecj-12463	43	5	tropomyosin	tropomyosin	NOUN
ecj-12463	43	6	binding	bind	VERB
ecj-12463	43	7	,	,	PUNCT
ecj-12463	43	8	promoting	promote	VERB
ecj-12463	43	9	a	a	DET
ecj-12463	43	10	controlled	control	VERB
ecj-12463	43	11	interaction	interaction	NOUN
ecj-12463	43	12	between	between	ADP
ecj-12463	43	13	actin	actin	NOUN
ecj-12463	43	14	and	and	CCONJ
ecj-12463	43	15	myosin	myosin	PROPN
ecj-12463	43	16	.	.	PUNCT
ecj-12463	44	1	tnc	tnc	PROPN
ecj-12463	44	2	,	,	PUNCT
ecj-12463	44	3	the	the	DET
ecj-12463	44	4	calcium	calcium	NOUN
ecj-12463	44	5	-	-	PUNCT
ecj-12463	44	6	sensitive	sensitive	ADJ
ecj-12463	44	7	subunit	subunit	NOUN
ecj-12463	44	8	,	,	PUNCT
ecj-12463	44	9	initiates	initiate	VERB
ecj-12463	44	10	muscle	muscle	NOUN
ecj-12463	44	11	contraction	contraction	NOUN
ecj-12463	44	12	,	,	PUNCT
ecj-12463	44	13	activating	activate	VERB
ecj-12463	44	14	the	the	DET
ecj-12463	44	15	complex.7	complex.7	NOUN
ecj-12463	44	16	-	-	PUNCT
ecj-12463	44	17	9	9	NUM
ecj-12463	44	18	this	this	DET
ecj-12463	44	19	complex	complex	NOUN
ecj-12463	44	20	meticulously	meticulously	ADV
ecj-12463	44	21	controls	control	VERB
ecj-12463	44	22	the	the	DET
ecj-12463	44	23	heart	heart	NOUN
ecj-12463	44	24	muscle	muscle	NOUN
ecj-12463	44	25	’s	’s	PART
ecj-12463	44	26	cycles	cycle	NOUN
ecj-12463	44	27	of	of	ADP
ecj-12463	44	28	contraction	contraction	NOUN
ecj-12463	44	29	and	and	CCONJ
ecj-12463	44	30	relaxation	relaxation	NOUN
ecj-12463	44	31	under	under	ADP
ecj-12463	44	32	normal	normal	ADJ
ecj-12463	44	33	circumstances	circumstance	NOUN
ecj-12463	44	34	.	.	PUNCT
ecj-12463	45	1	troponin	troponin	ADJ
ecj-12463	45	2	is	be	AUX
ecj-12463	45	3	typically	typically	ADV
ecj-12463	45	4	found	find	VERB
ecj-12463	45	5	in	in	ADP
ecj-12463	45	6	extremely	extremely	ADV
ecj-12463	45	7	low	low	ADJ
ecj-12463	45	8	amounts	amount	NOUN
ecj-12463	45	9	;	;	PUNCT
ecj-12463	45	10	it	it	PRON
ecj-12463	45	11	is	be	AUX
ecj-12463	45	12	released	release	VERB
ecj-12463	45	13	into	into	ADP
ecj-12463	45	14	the	the	DET
ecj-12463	45	15	bloodstream	bloodstream	NOUN
ecj-12463	45	16	when	when	SCONJ
ecj-12463	45	17	cardiac	cardiac	ADJ
ecj-12463	45	18	muscle	muscle	NOUN
ecj-12463	45	19	cells	cell	NOUN
ecj-12463	45	20	experience	experience	VERB
ecj-12463	45	21	injury	injury	NOUN
ecj-12463	45	22	and	and	CCONJ
ecj-12463	45	23	its	its	PRON
ecj-12463	45	24	concentration	concentration	NOUN
ecj-12463	45	25	in	in	ADP
ecj-12463	45	26	the	the	DET
ecj-12463	45	27	blood	blood	NOUN
ecj-12463	45	28	rises	rise	VERB
ecj-12463	45	29	with	with	ADP
ecj-12463	45	30	increasing	increase	VERB
ecj-12463	45	31	injury	injury	NOUN
ecj-12463	45	32	.	.	PUNCT
ecj-12463	46	1	since	since	SCONJ
ecj-12463	46	2	tnt	tnt	PROPN
ecj-12463	46	3	and	and	CCONJ
ecj-12463	46	4	tni	tni	NOUN
ecj-12463	46	5	subunit	subunit	NOUN
ecj-12463	46	6	assays	assay	NOUN
ecj-12463	46	7	are	be	AUX
ecj-12463	46	8	the	the	DET
ecj-12463	46	9	most	most	ADV
ecj-12463	46	10	cardiac	cardiac	ADJ
ecj-12463	46	11	-	-	PUNCT
ecj-12463	46	12	specific	specific	ADJ
ecj-12463	46	13	and	and	CCONJ
ecj-12463	46	14	offer	offer	VERB
ecj-12463	46	15	equivalent	equivalent	ADJ
ecj-12463	46	16	diagnostic	diagnostic	ADJ
ecj-12463	46	17	accuracy	accuracy	NOUN
ecj-12463	46	18	,	,	PUNCT
ecj-12463	46	19	they	they	PRON
ecj-12463	46	20	are	be	AUX
ecj-12463	46	21	frequently	frequently	ADV
ecj-12463	46	22	tested	test	VERB
ecj-12463	46	23	in	in	ADP
ecj-12463	46	24	the	the	DET
ecj-12463	46	25	context	context	NOUN
ecj-12463	46	26	of	of	ADP
ecj-12463	46	27	myocardial	myocardial	ADJ
ecj-12463	46	28	damage.10	damage.10	NOUN
ecj-12463	46	29	because	because	SCONJ
ecj-12463	46	30	of	of	ADP
ecj-12463	46	31	their	their	PRON
ecj-12463	46	32	increased	increase	VERB
ecj-12463	46	33	analytical	analytical	ADJ
ecj-12463	46	34	precision	precision	NOUN
ecj-12463	46	35	,	,	PUNCT
ecj-12463	46	36	high	high	ADJ
ecj-12463	46	37	-	-	PUNCT
ecj-12463	46	38	sensitivity	sensitivity	NOUN
ecj-12463	46	39	troponin	troponin	ADJ
ecj-12463	46	40	(	(	PUNCT
ecj-12463	46	41	hs	hs	NOUN
ecj-12463	46	42	-	-	PUNCT
ecj-12463	46	43	ctn	ctn	NOUN
ecj-12463	46	44	)	)	PUNCT
ecj-12463	46	45	tests	test	NOUN
ecj-12463	46	46	have	have	AUX
ecj-12463	46	47	made	make	VERB
ecj-12463	46	48	it	it	PRON
ecj-12463	46	49	possible	possible	ADJ
ecj-12463	46	50	to	to	PART
ecj-12463	46	51	develop	develop	VERB
ecj-12463	46	52	decision	decision	NOUN
ecj-12463	46	53	-	-	PUNCT
ecj-12463	46	54	making	make	VERB
ecj-12463	46	55	algorithms	algorithm	NOUN
ecj-12463	46	56	that	that	PRON
ecj-12463	46	57	are	be	AUX
ecj-12463	46	58	more	more	ADV
ecj-12463	46	59	accurate	accurate	ADJ
ecj-12463	46	60	.	.	PUNCT
ecj-12463	47	1	the	the	DET
ecj-12463	47	2	recent	recent	ADJ
ecj-12463	47	3	guideline	guideline	NOUN
ecj-12463	47	4	issued	issue	VERB
ecj-12463	47	5	by	by	ADP
ecj-12463	47	6	the	the	DET
ecj-12463	47	7	european	european	PROPN
ecj-12463	47	8	society	society	PROPN
ecj-12463	47	9	of	of	ADP
ecj-12463	47	10	cardiology	cardiology	NOUN
ecj-12463	47	11	reiterates	reiterate	VERB
ecj-12463	47	12	the	the	DET
ecj-12463	47	13	preeminent	preeminent	ADJ
ecj-12463	47	14	role	role	NOUN
ecj-12463	47	15	of	of	ADP
ecj-12463	47	16	cardiac	cardiac	ADJ
ecj-12463	47	17	troponins	troponin	NOUN
ecj-12463	47	18	.	.	PUNCT
ecj-12463	48	1	the	the	DET
ecj-12463	48	2	fourth	fourth	ADJ
ecj-12463	48	3	universal	universal	ADJ
ecj-12463	48	4	definition	definition	NOUN
ecj-12463	48	5	of	of	ADP
ecj-12463	48	6	mi	mi	PROPN
ecj-12463	48	7	in	in	ADP
ecj-12463	48	8	fact	fact	NOUN
ecj-12463	48	9	provided	provide	VERB
ecj-12463	48	10	that	that	SCONJ
ecj-12463	48	11	a	a	DET
ecj-12463	48	12	rise	rise	NOUN
ecj-12463	48	13	or	or	CCONJ
ecj-12463	48	14	fall	fall	NOUN
ecj-12463	48	15	of	of	ADP
ecj-12463	48	16	troponin	troponin	ADJ
ecj-12463	48	17	i	i	PROPN
ecj-12463	48	18	or	or	CCONJ
ecj-12463	48	19	t	t	PROPN
ecj-12463	48	20	,	,	PUNCT
ecj-12463	48	21	when	when	SCONJ
ecj-12463	48	22	at	at	ADV
ecj-12463	48	23	least	least	ADV
ecj-12463	48	24	one	one	NUM
ecj-12463	48	25	hs	hs	ADJ
ecj-12463	48	26	-	-	PUNCT
ecj-12463	48	27	ctn	ctn	NOUN
ecj-12463	48	28	value	value	NOUN
ecj-12463	48	29	is	be	AUX
ecj-12463	48	30	above	above	ADP
ecj-12463	48	31	the	the	DET
ecj-12463	48	32	99th	99th	ADJ
ecj-12463	48	33	percentile	percentile	NOUN
ecj-12463	48	34	of	of	ADP
ecj-12463	48	35	a	a	DET
ecj-12463	48	36	normal	normal	ADJ
ecj-12463	48	37	population	population	NOUN
ecj-12463	48	38	establishes	establish	VERB
ecj-12463	48	39	the	the	DET
ecj-12463	48	40	diagnosis	diagnosis	NOUN
ecj-12463	48	41	of	of	ADP
ecj-12463	48	42	acute	acute	ADJ
ecj-12463	48	43	myocardial	myocardial	PROPN
ecj-12463	48	44	infarction.11,12	infarction.11,12	ADV
ecj-12463	48	45	this	this	DET
ecj-12463	48	46	statement	statement	NOUN
ecj-12463	48	47	has	have	AUX
ecj-12463	48	48	been	be	AUX
ecj-12463	48	49	emphasized	emphasize	VERB
ecj-12463	48	50	by	by	ADP
ecj-12463	48	51	recommendations	recommendation	NOUN
ecj-12463	48	52	issued	issue	VERB
ecj-12463	48	53	by	by	ADP
ecj-12463	48	54	numerous	numerous	ADJ
ecj-12463	48	55	scientific	scientific	ADJ
ecj-12463	48	56	societies	society	NOUN
ecj-12463	48	57	and	and	CCONJ
ecj-12463	48	58	several	several	ADJ
ecj-12463	48	59	published	publish	VERB
ecj-12463	48	60	articles.13	articles.13	NOUN
ecj-12463	48	61	because	because	SCONJ
ecj-12463	48	62	of	of	ADP
ecj-12463	48	63	troponins	troponin	NOUN
ecj-12463	48	64	’	'	PUNCT
ecj-12463	48	65	excellent	excellent	ADJ
ecj-12463	48	66	diagnostic	diagnostic	ADJ
ecj-12463	48	67	accuracy	accuracy	NOUN
ecj-12463	48	68	,	,	PUNCT
ecj-12463	48	69	individuals	individual	NOUN
ecj-12463	48	70	with	with	ADP
ecj-12463	48	71	chest	chest	NOUN
ecj-12463	48	72	pain	pain	NOUN
ecj-12463	48	73	can	can	AUX
ecj-12463	48	74	be	be	AUX
ecj-12463	48	75	quickly	quickly	ADV
ecj-12463	48	76	diagnosed	diagnose	VERB
ecj-12463	48	77	with	with	ADP
ecj-12463	48	78	acute	acute	ADJ
ecj-12463	48	79	cardiac	cardiac	ADJ
ecj-12463	48	80	injury	injury	NOUN
ecj-12463	48	81	,	,	PUNCT
ecj-12463	48	82	facilitating	facilitate	VERB
ecj-12463	48	83	safer	safe	ADJ
ecj-12463	48	84	and	and	CCONJ
ecj-12463	48	85	quicker	quick	ADJ
ecj-12463	48	86	“	"	PUNCT
ecj-12463	48	87	rule	rule	NOUN
ecj-12463	48	88	-	-	PUNCT
ecj-12463	48	89	in	in	ADP
ecj-12463	48	90	”	"	PUNCT
ecj-12463	48	91	and	and	CCONJ
ecj-12463	48	92	“	"	PUNCT
ecj-12463	48	93	rule	rule	VERB
ecj-12463	48	94	-	-	PUNCT
ecj-12463	48	95	out	out	ADP
ecj-12463	48	96	”	"	PUNCT
ecj-12463	48	97	procedures	procedure	NOUN
ecj-12463	48	98	.	.	PUNCT
ecj-12463	49	1	however	however	ADV
ecj-12463	49	2	,	,	PUNCT
ecj-12463	49	3	despite	despite	SCONJ
ecj-12463	49	4	the	the	DET
ecj-12463	49	5	broad	broad	ADJ
ecj-12463	49	6	support	support	NOUN
ecj-12463	49	7	and	and	CCONJ
ecj-12463	49	8	evidence	evidence	NOUN
ecj-12463	49	9	in	in	ADP
ecj-12463	49	10	favor	favor	NOUN
ecj-12463	49	11	of	of	ADP
ecj-12463	49	12	cardiac	cardiac	ADJ
ecj-12463	49	13	troponins	troponin	NOUN
ecj-12463	49	14	,	,	PUNCT
ecj-12463	49	15	several	several	ADJ
ecj-12463	49	16	studies	study	NOUN
ecj-12463	49	17	highlight	highlight	VERB
ecj-12463	49	18	a	a	DET
ecj-12463	49	19	persistent	persistent	ADJ
ecj-12463	49	20	lack	lack	NOUN
ecj-12463	49	21	of	of	ADP
ecj-12463	49	22	confidence	confidence	NOUN
ecj-12463	49	23	on	on	ADP
ecj-12463	49	24	the	the	DET
ecj-12463	49	25	part	part	NOUN
ecj-12463	49	26	of	of	ADP
ecj-12463	49	27	some	some	DET
ecj-12463	49	28	physicians	physician	NOUN
ecj-12463	49	29	,	,	PUNCT
ecj-12463	49	30	who	who	PRON
ecj-12463	49	31	continue	continue	VERB
ecj-12463	49	32	to	to	PART
ecj-12463	49	33	use	use	VERB
ecj-12463	49	34	a	a	DET
ecj-12463	49	35	combination	combination	NOUN
ecj-12463	49	36	of	of	ADP
ecj-12463	49	37	sometimes	sometimes	ADV
ecj-12463	49	38	obsolete	obsolete	ADJ
ecj-12463	49	39	biomarkers	biomarker	NOUN
ecj-12463	49	40	.	.	PUNCT
ecj-12463	50	1	this	this	DET
ecj-12463	50	2	discrepancy	discrepancy	NOUN
ecj-12463	50	3	underscores	underscore	VERB
ecj-12463	50	4	the	the	DET
ecj-12463	50	5	importance	importance	NOUN
ecj-12463	50	6	of	of	ADP
ecj-12463	50	7	carefully	carefully	ADV
ecj-12463	50	8	considering	consider	VERB
ecj-12463	50	9	the	the	DET
ecj-12463	50	10	clinical	clinical	ADJ
ecj-12463	50	11	context	context	NOUN
ecj-12463	50	12	and	and	CCONJ
ecj-12463	50	13	the	the	DET
ecj-12463	50	14	different	different	ADJ
ecj-12463	50	15	subcategories	subcategorie	NOUN
ecj-12463	50	16	of	of	ADP
ecj-12463	50	17	cardiac	cardiac	ADJ
ecj-12463	50	18	injury	injury	NOUN
ecj-12463	50	19	when	when	SCONJ
ecj-12463	50	20	adopting	adopt	VERB
ecj-12463	50	21	valid	valid	ADJ
ecj-12463	50	22	multi	multi	ADJ
ecj-12463	50	23	-	-	NOUN
ecj-12463	50	24	marker	marker	NOUN
ecj-12463	50	25	approaches	approach	NOUN
ecj-12463	50	26	for	for	ADP
ecj-12463	50	27	the	the	DET
ecj-12463	50	28	diagnosis	diagnosis	NOUN
ecj-12463	50	29	,	,	PUNCT
ecj-12463	50	30	prognosis	prognosis	NOUN
ecj-12463	50	31	and	and	CCONJ
ecj-12463	50	32	management	management	NOUN
ecj-12463	50	33	of	of	ADP
ecj-12463	50	34	cardiac	cardiac	ADJ
ecj-12463	50	35	conditions	condition	NOUN
ecj-12463	50	36	.	.	PUNCT
ecj-12463	51	1	four	four	NUM
ecj-12463	51	2	clinical	clinical	ADJ
ecj-12463	51	3	factors	factor	NOUN
ecj-12463	51	4	,	,	PUNCT
ecj-12463	51	5	in	in	ADP
ecj-12463	51	6	addition	addition	NOUN
ecj-12463	51	7	to	to	ADP
ecj-12463	51	8	the	the	DET
ecj-12463	51	9	presence	presence	NOUN
ecj-12463	51	10	or	or	CCONJ
ecj-12463	51	11	absence	absence	NOUN
ecj-12463	51	12	of	of	ADP
ecj-12463	51	13	mi	mi	PROPN
ecj-12463	51	14	,	,	PUNCT
ecj-12463	51	15	can	can	AUX
ecj-12463	51	16	influence	influence	VERB
ecj-12463	51	17	hs	hs	PROPN
ecj-12463	51	18	-	-	PUNCT
ecj-12463	51	19	ctn	ctn	NOUN
ecj-12463	51	20	values	value	NOUN
ecj-12463	51	21	in	in	ADP
ecj-12463	51	22	a	a	DET
ecj-12463	51	23	patient	patient	NOUN
ecj-12463	51	24	presenting	presenting	NOUN
ecj-12463	51	25	with	with	ADP
ecj-12463	51	26	a	a	DET
ecj-12463	51	27	suspected	suspect	VERB
ecj-12463	51	28	acs	ac	NOUN
ecj-12463	51	29	,	,	PUNCT
ecj-12463	51	30	according	accord	VERB
ecj-12463	51	31	to	to	ADP
ecj-12463	51	32	the	the	DET
ecj-12463	51	33	2023	2023	NUM
ecj-12463	51	34	esc	esc	NOUN
ecj-12463	51	35	guidelines	guideline	NOUN
ecj-12463	51	36	for	for	ADP
ecj-12463	51	37	the	the	DET
ecj-12463	51	38	management	management	NOUN
ecj-12463	51	39	of	of	ADP
ecj-12463	51	40	acute	acute	ADJ
ecj-12463	51	41	coronary	coronary	ADJ
ecj-12463	51	42	syndromes	syndrome	NOUN
ecj-12463	51	43	.	.	PUNCT
ecj-12463	52	1	these	these	DET
ecj-12463	52	2	variables	variable	NOUN
ecj-12463	52	3	are	be	AUX
ecj-12463	52	4	:	:	PUNCT
ecj-12463	52	5	age	age	NOUN
ecj-12463	52	6	,	,	PUNCT
ecj-12463	52	7	renal	renal	ADJ
ecj-12463	52	8	dysfunction	dysfunction	NOUN
ecj-12463	52	9	,	,	PUNCT
ecj-12463	52	10	time	time	NOUN
ecj-12463	52	11	from	from	ADP
ecj-12463	52	12	chest	chest	NOUN
ecj-12463	52	13	pain	pain	NOUN
ecj-12463	52	14	onset	onset	NOUN
ecj-12463	52	15	and	and	CCONJ
ecj-12463	52	16	sex.14	sex.14	PRON
ecj-12463	52	17	it	it	PRON
ecj-12463	52	18	is	be	AUX
ecj-12463	52	19	important	important	ADJ
ecj-12463	52	20	to	to	PART
ecj-12463	52	21	note	note	VERB
ecj-12463	52	22	that	that	SCONJ
ecj-12463	52	23	,	,	PUNCT
ecj-12463	52	24	despite	despite	SCONJ
ecj-12463	52	25	the	the	DET
ecj-12463	52	26	significant	significant	ADJ
ecj-12463	52	27	innovation	innovation	NOUN
ecj-12463	52	28	represented	represent	VERB
ecj-12463	52	29	,	,	PUNCT
ecj-12463	52	30	high	high	ADJ
ecj-12463	52	31	-	-	PUNCT
ecj-12463	52	32	sensitivity	sensitivity	NOUN
ecj-12463	52	33	troponin	troponin	ADJ
ecj-12463	52	34	presents	present	NOUN
ecj-12463	52	35	some	some	DET
ecj-12463	52	36	limitations	limitation	NOUN
ecj-12463	52	37	in	in	ADP
ecj-12463	52	38	the	the	DET
ecj-12463	52	39	evaluation	evaluation	NOUN
ecj-12463	52	40	of	of	ADP
ecj-12463	52	41	suspected	suspect	VERB
ecj-12463	52	42	acs	ac	NOUN
ecj-12463	52	43	.	.	PUNCT
ecj-12463	53	1	as	as	SCONJ
ecj-12463	53	2	non	non	ADJ
ecj-12463	53	3	-	-	ADJ
ecj-12463	53	4	cardiac	cardiac	ADJ
ecj-12463	53	5	disease	disease	NOUN
ecj-12463	53	6	can	can	AUX
ecj-12463	53	7	cause	cause	VERB
ecj-12463	53	8	increased	increase	VERB
ecj-12463	53	9	troponin	troponin	ADJ
ecj-12463	53	10	levels	level	NOUN
ecj-12463	53	11	,	,	PUNCT
ecj-12463	53	12	troponin	troponin	ADJ
ecj-12463	53	13	results	result	NOUN
ecj-12463	53	14	need	need	VERB
ecj-12463	53	15	to	to	PART
ecj-12463	53	16	be	be	AUX
ecj-12463	53	17	interpreted	interpret	VERB
ecj-12463	53	18	within	within	ADP
ecj-12463	53	19	a	a	DET
ecj-12463	53	20	clinical	clinical	ADJ
ecj-12463	53	21	decision	decision	NOUN
ecj-12463	53	22	protocol.8	protocol.8	PROPN
ecj-12463	53	23	in	in	ADP
ecj-12463	53	24	some	some	DET
ecj-12463	53	25	cases	case	NOUN
ecj-12463	53	26	,	,	PUNCT
ecj-12463	53	27	troponin	troponin	ADJ
ecj-12463	53	28	baseline	baseline	NOUN
ecj-12463	53	29	value	value	NOUN
ecj-12463	53	30	is	be	AUX
ecj-12463	53	31	chronically	chronically	ADV
ecj-12463	53	32	elevated	elevated	ADJ
ecj-12463	53	33	and	and	CCONJ
ecj-12463	53	34	remains	remain	VERB
ecj-12463	53	35	stable	stable	ADJ
ecj-12463	53	36	over	over	ADP
ecj-12463	53	37	time	time	NOUN
ecj-12463	53	38	,	,	PUNCT
ecj-12463	53	39	as	as	ADP
ecj-12463	53	40	in	in	ADP
ecj-12463	53	41	heart	heart	NOUN
ecj-12463	53	42	failure	failure	NOUN
ecj-12463	53	43	(	(	PUNCT
ecj-12463	53	44	hf	hf	NOUN
ecj-12463	53	45	)	)	PUNCT
ecj-12463	53	46	,	,	PUNCT
ecj-12463	53	47	a	a	DET
ecj-12463	53	48	condition	condition	NOUN
ecj-12463	53	49	in	in	ADP
ecj-12463	53	50	which	which	PRON
ecj-12463	53	51	troponin	troponin	NOUN
ecj-12463	53	52	has	have	AUX
ecj-12463	53	53	been	be	AUX
ecj-12463	53	54	shown	show	VERB
ecj-12463	53	55	to	to	PART
ecj-12463	53	56	be	be	AUX
ecj-12463	53	57	an	an	DET
ecj-12463	53	58	important	important	ADJ
ecj-12463	53	59	prognostic	prognostic	ADJ
ecj-12463	53	60	factor	factor	NOUN
ecj-12463	53	61	.	.	PUNCT
ecj-12463	54	1	elevated	elevate	VERB
ecj-12463	54	2	cardiac	cardiac	ADJ
ecj-12463	54	3	troponins	troponin	NOUN
ecj-12463	54	4	(	(	PUNCT
ecj-12463	54	5	tnt	tnt	NOUN
ecj-12463	54	6	and	and	CCONJ
ecj-12463	54	7	tni	tni	NOUN
ecj-12463	54	8	)	)	PUNCT
ecj-12463	54	9	mainly	mainly	ADV
ecj-12463	54	10	reflect	reflect	VERB
ecj-12463	54	11	the	the	DET
ecj-12463	54	12	progressive	progressive	ADJ
ecj-12463	54	13	death	death	NOUN
ecj-12463	54	14	of	of	ADP
ecj-12463	54	15	cardiomyocytes	cardiomyocyte	NOUN
ecj-12463	54	16	and	and	CCONJ
ecj-12463	54	17	the	the	DET
ecj-12463	54	18	exosomal	exosomal	ADJ
ecj-12463	54	19	release	release	NOUN
ecj-12463	54	20	of	of	ADP
ecj-12463	54	21	cytosolic	cytosolic	ADJ
ecj-12463	54	22	troponin	troponin	NOUN
ecj-12463	54	23	and	and	CCONJ
ecj-12463	54	24	are	be	AUX
ecj-12463	54	25	associated	associate	VERB
ecj-12463	54	26	with	with	ADP
ecj-12463	54	27	an	an	DET
ecj-12463	54	28	increased	increase	VERB
ecj-12463	54	29	rate	rate	NOUN
ecj-12463	54	30	of	of	ADP
ecj-12463	54	31	hospitalization	hospitalization	NOUN
ecj-12463	54	32	and	and	CCONJ
ecj-12463	54	33	death.11	death.11	ADJ
ecj-12463	54	34	in	in	ADP
ecj-12463	54	35	contrast	contrast	NOUN
ecj-12463	54	36	,	,	PUNCT
ecj-12463	54	37	a	a	DET
ecj-12463	54	38	rising	rise	VERB
ecj-12463	54	39	or	or	CCONJ
ecj-12463	54	40	falling	fall	VERB
ecj-12463	54	41	troponin	troponin	ADJ
ecj-12463	54	42	pattern	pattern	NOUN
ecj-12463	54	43	can	can	AUX
ecj-12463	54	44	be	be	AUX
ecj-12463	54	45	attributable	attributable	ADJ
ecj-12463	54	46	to	to	ADP
ecj-12463	54	47	a	a	DET
ecj-12463	54	48	variety	variety	NOUN
ecj-12463	54	49	of	of	ADP
ecj-12463	54	50	underlying	underlie	VERB
ecj-12463	54	51	conditions	condition	NOUN
ecj-12463	54	52	other	other	ADJ
ecj-12463	54	53	than	than	ADP
ecj-12463	54	54	acs	acs	PROPN
ecj-12463	54	55	(	(	PUNCT
ecj-12463	54	56	e.g.	e.g.	ADV
ecj-12463	54	57	,	,	PUNCT
ecj-12463	54	58	valvular	valvular	ADJ
ecj-12463	54	59	heart	heart	NOUN
ecj-12463	54	60	diseases	disease	NOUN
ecj-12463	54	61	,	,	PUNCT
ecj-12463	54	62	pulmonary	pulmonary	ADJ
ecj-12463	54	63	embolism	embolism	NOUN
ecj-12463	54	64	,	,	PUNCT
ecj-12463	54	65	sepsis	sepsis	NOUN
ecj-12463	54	66	,	,	PUNCT
ecj-12463	54	67	atrial	atrial	ADJ
ecj-12463	54	68	fibrillation).8,10,12	fibrillation).8,10,12	PROPN
ecj-12463	54	69	furthermore	furthermore	ADV
ecj-12463	54	70	,	,	PUNCT
ecj-12463	54	71	due	due	ADP
ecj-12463	54	72	to	to	ADP
ecj-12463	54	73	a	a	DET
ecj-12463	54	74	decreased	decrease	VERB
ecj-12463	54	75	renal	renal	ADJ
ecj-12463	54	76	clearance	clearance	NOUN
ecj-12463	54	77	of	of	ADP
ecj-12463	54	78	troponin	troponin	PROPN
ecj-12463	54	79	and	and	CCONJ
ecj-12463	54	80	a	a	DET
ecj-12463	54	81	myocardial	myocardial	ADJ
ecj-12463	54	82	damage	damage	NOUN
ecj-12463	54	83	associated	associate	VERB
ecj-12463	54	84	with	with	ADP
ecj-12463	54	85	ckd	ckd	PROPN
ecj-12463	54	86	,	,	PUNCT
ecj-12463	54	87	increased	increase	VERB
ecj-12463	54	88	hstn	hstn	NOUN
ecj-12463	54	89	concentrations	concentration	NOUN
ecj-12463	54	90	may	may	AUX
ecj-12463	54	91	be	be	AUX
ecj-12463	54	92	found	find	VERB
ecj-12463	54	93	in	in	ADP
ecj-12463	54	94	individuals	individual	NOUN
ecj-12463	54	95	with	with	ADP
ecj-12463	54	96	severe	severe	ADJ
ecj-12463	54	97	chronic	chronic	ADJ
ecj-12463	54	98	kidney	kidney	NOUN
ecj-12463	54	99	disease	disease	NOUN
ecj-12463	54	100	,	,	PUNCT
ecj-12463	54	101	even	even	ADV
ecj-12463	54	102	in	in	ADP
ecj-12463	54	103	the	the	DET
ecj-12463	54	104	absence	absence	NOUN
ecj-12463	54	105	of	of	ADP
ecj-12463	54	106	acs.15	acs.15	PROPN
ecj-12463	54	107	more	more	ADV
ecj-12463	54	108	crucial	crucial	ADJ
ecj-12463	54	109	to	to	ADP
ecj-12463	54	110	proving	prove	VERB
ecj-12463	54	111	the	the	DET
ecj-12463	54	112	acs	acs	PROPN
ecj-12463	54	113	hypothesis	hypothesis	NOUN
ecj-12463	54	114	is	be	AUX
ecj-12463	54	115	the	the	DET
ecj-12463	54	116	different	different	ADJ
ecj-12463	54	117	increase	increase	NOUN
ecj-12463	54	118	and	and	CCONJ
ecj-12463	54	119	fall	fall	NOUN
ecj-12463	54	120	of	of	ADP
ecj-12463	54	121	hstn	hstn	NOUN
ecj-12463	54	122	.	.	PUNCT
ecj-12463	55	1	regarding	regard	VERB
ecj-12463	55	2	sex	sex	NOUN
ecj-12463	55	3	,	,	PUNCT
ecj-12463	55	4	significant	significant	ADJ
ecj-12463	55	5	variations	variation	NOUN
ecj-12463	55	6	in	in	ADP
ecj-12463	55	7	baseline	baseline	ADJ
ecj-12463	55	8	results	result	NOUN
ecj-12463	55	9	of	of	ADP
ecj-12463	55	10	extremely	extremely	ADV
ecj-12463	55	11	sensitive	sensitive	ADJ
ecj-12463	55	12	cardiac	cardiac	ADJ
ecj-12463	55	13	troponin	troponin	NOUN
ecj-12463	55	14	may	may	AUX
ecj-12463	55	15	be	be	AUX
ecj-12463	55	16	explained	explain	VERB
ecj-12463	55	17	by	by	ADP
ecj-12463	55	18	anatomical	anatomical	ADJ
ecj-12463	55	19	differences	difference	NOUN
ecj-12463	55	20	in	in	ADP
ecj-12463	55	21	the	the	DET
ecj-12463	55	22	heart	heart	NOUN
ecj-12463	55	23	between	between	ADP
ecj-12463	55	24	men	man	NOUN
ecj-12463	55	25	and	and	CCONJ
ecj-12463	55	26	women	woman	NOUN
ecj-12463	55	27	;	;	PUNCT
ecj-12463	55	28	nevertheless	nevertheless	ADV
ecj-12463	55	29	,	,	PUNCT
ecj-12463	55	30	sex	sex	NOUN
ecj-12463	55	31	-	-	PUNCT
ecj-12463	55	32	specific	specific	ADJ
ecj-12463	55	33	thresholds	threshold	NOUN
ecj-12463	55	34	for	for	ADP
ecj-12463	55	35	acs	acs	NOUN
ecj-12463	55	36	diagnosis	diagnosis	NOUN
ecj-12463	55	37	are	be	AUX
ecj-12463	55	38	debatable.16,17	debatable.16,17	ADJ
ecj-12463	55	39	therefore	therefore	ADV
ecj-12463	55	40	,	,	PUNCT
ecj-12463	55	41	biotin	biotin	NOUN
ecj-12463	55	42	,	,	PUNCT
ecj-12463	55	43	a	a	DET
ecj-12463	55	44	water	water	NOUN
ecj-12463	55	45	-	-	PUNCT
ecj-12463	55	46	soluble	soluble	ADJ
ecj-12463	55	47	vitamin	vitamin	NOUN
ecj-12463	55	48	,	,	PUNCT
ecj-12463	55	49	could	could	AUX
ecj-12463	55	50	interfere	interfere	VERB
ecj-12463	55	51	with	with	ADP
ecj-12463	55	52	cardiac	cardiac	ADJ
ecj-12463	55	53	troponin	troponin	ADJ
ecj-12463	55	54	assays	assay	NOUN
ecj-12463	55	55	.	.	PUNCT
ecj-12463	56	1	an	an	DET
ecj-12463	56	2	elevated	elevated	ADJ
ecj-12463	56	3	biotin	biotin	NOUN
ecj-12463	56	4	concentration	concentration	NOUN
ecj-12463	56	5	would	would	AUX
ecj-12463	56	6	in	in	ADP
ecj-12463	56	7	fact	fact	NOUN
ecj-12463	56	8	be	be	AUX
ecj-12463	56	9	responsible	responsible	ADJ
ecj-12463	56	10	for	for	ADP
ecj-12463	56	11	falsely	falsely	ADV
ecj-12463	56	12	low	low	ADJ
ecj-12463	56	13	hstn	hstn	NOUN
ecj-12463	56	14	results	result	NOUN
ecj-12463	56	15	.	.	PUNCT
ecj-12463	57	1	for	for	ADP
ecj-12463	57	2	that	that	DET
ecj-12463	57	3	reason	reason	NOUN
ecj-12463	57	4	,	,	PUNCT
ecj-12463	57	5	a	a	DET
ecj-12463	57	6	safety	safety	NOUN
ecj-12463	57	7	communication	communication	NOUN
ecj-12463	57	8	to	to	PART
ecj-12463	57	9	ward	ward	VERB
ecj-12463	57	10	against	against	ADP
ecj-12463	57	11	this	this	DET
ecj-12463	57	12	possible	possible	ADJ
ecj-12463	57	13	interference	interference	NOUN
ecj-12463	57	14	has	have	AUX
ecj-12463	57	15	recently	recently	ADV
ecj-12463	57	16	been	be	AUX
ecj-12463	57	17	released	release	VERB
ecj-12463	57	18	by	by	ADP
ecj-12463	57	19	the	the	DET
ecj-12463	57	20	food	food	NOUN
ecj-12463	57	21	and	and	CCONJ
ecj-12463	57	22	drug	drug	PROPN
ecj-12463	57	23	administration	administration	NOUN
ecj-12463	57	24	(	(	PUNCT
ecj-12463	57	25	fda).18	fda).18	NOUN
ecj-12463	57	26	this	this	DET
ecj-12463	57	27	potential	potential	ADJ
ecj-12463	57	28	phenomenon	phenomenon	NOUN
ecj-12463	57	29	is	be	AUX
ecj-12463	57	30	of	of	ADP
ecj-12463	57	31	increasing	increase	VERB
ecj-12463	57	32	interest	interest	NOUN
ecj-12463	57	33	due	due	ADP
ecj-12463	57	34	to	to	ADP
ecj-12463	57	35	high	high	ADJ
ecj-12463	57	36	-	-	PUNCT
ecj-12463	57	37	dose	dose	NOUN
ecj-12463	57	38	biotin	biotin	NOUN
ecj-12463	57	39	supplements	supplement	NOUN
ecj-12463	57	40	taken	take	VERB
ecj-12463	57	41	for	for	ADP
ecj-12463	57	42	multiple	multiple	ADJ
ecj-12463	57	43	sclerosis	sclerosis	NOUN
ecj-12463	57	44	,	,	PUNCT
ecj-12463	57	45	dietary	dietary	ADJ
ecj-12463	57	46	multivitamin	multivitamin	NOUN
ecj-12463	57	47	preparations	preparation	NOUN
ecj-12463	57	48	,	,	PUNCT
ecj-12463	57	49	and	and	CCONJ
ecj-12463	57	50	cosmetics	cosmetic	NOUN
ecj-12463	57	51	.	.	PUNCT
ecj-12463	58	1	high	high	ADJ
ecj-12463	58	2	-	-	PUNCT
ecj-12463	58	3	dose	dose	NOUN
ecj-12463	58	4	biotin	biotin	NOUN
ecj-12463	58	5	could	could	AUX
ecj-12463	58	6	also	also	ADV
ecj-12463	58	7	be	be	AUX
ecj-12463	58	8	used	use	VERB
ecj-12463	58	9	by	by	ADP
ecj-12463	58	10	patients	patient	NOUN
ecj-12463	58	11	with	with	ADP
ecj-12463	58	12	metabolic	metabolic	NOUN
ecj-12463	58	13	disorders.12,19,20	disorders.12,19,20	PROPN
ecj-12463	58	14	hs	hs	PROPN
ecj-12463	58	15	-	-	NOUN
ecj-12463	58	16	ctn	ctn	NOUN
ecj-12463	58	17	may	may	AUX
ecj-12463	58	18	be	be	AUX
ecj-12463	58	19	susceptible	susceptible	ADJ
ecj-12463	58	20	to	to	PART
ecj-12463	58	21	interfere	interfere	VERB
ecj-12463	58	22	from	from	ADP
ecj-12463	58	23	heterophile	heterophile	ADJ
ecj-12463	58	24	antibodies,8	antibodies,8	ADV
ecj-12463	58	25	-	-	PUNCT
ecj-12463	58	26	20	20	NUM
ecj-12463	58	27	hemolysis	hemolysis	NOUN
ecj-12463	58	28	,	,	PUNCT
ecj-12463	58	29	biological	biological	ADJ
ecj-12463	58	30	variation	variation	NOUN
ecj-12463	58	31	of	of	ADP
ecj-12463	58	32	cardiac	cardiac	ADJ
ecj-12463	58	33	troponin	troponin	PROPN
ecj-12463	58	34	t	t	PROPN
ecj-12463	58	35	,	,	PUNCT
ecj-12463	58	36	cardiac	cardiac	ADJ
ecj-12463	58	37	troponin	troponin	ADJ
ecj-12463	58	38	autoantibodies	autoantibody	NOUN
ecj-12463	58	39	,	,	PUNCT
ecj-12463	58	40	rheumatoid	rheumatoid	NOUN
ecj-12463	58	41	factor	factor	NOUN
ecj-12463	58	42	,	,	PUNCT
ecj-12463	58	43	lipemia	lipemia	NOUN
ecj-12463	58	44	,	,	PUNCT
ecj-12463	58	45	and	and	CCONJ
ecj-12463	58	46	hyperbilirubinemia.12	hyperbilirubinemia.12	NOUN
ecj-12463	58	47	lastly	lastly	ADV
ecj-12463	58	48	,	,	PUNCT
ecj-12463	58	49	elevated	elevated	ADJ
ecj-12463	58	50	values	value	NOUN
ecj-12463	58	51	could	could	AUX
ecj-12463	58	52	be	be	AUX
ecj-12463	58	53	found	find	VERB
ecj-12463	58	54	in	in	ADP
ecj-12463	58	55	some	some	DET
ecj-12463	58	56	patients	patient	NOUN
ecj-12463	58	57	with	with	ADP
ecj-12463	58	58	skeletal	skeletal	ADJ
ecj-12463	58	59	muscle	muscle	NOUN
ecj-12463	58	60	disease.8	disease.8	VERB
ecj-12463	58	61	in	in	ADP
ecj-12463	58	62	conclusion	conclusion	NOUN
ecj-12463	58	63	,	,	PUNCT
ecj-12463	58	64	multiple	multiple	ADJ
ecj-12463	58	65	biomarkers	biomarker	NOUN
ecj-12463	58	66	in	in	ADP
ecj-12463	58	67	addition	addition	NOUN
ecj-12463	58	68	to	to	ADP
ecj-12463	58	69	cardiac	cardiac	ADJ
ecj-12463	58	70	troponin	troponin	NOUN
ecj-12463	58	71	should	should	AUX
ecj-12463	58	72	be	be	AUX
ecj-12463	58	73	used	use	VERB
ecj-12463	58	74	to	to	PART
ecj-12463	58	75	gain	gain	VERB
ecj-12463	58	76	a	a	DET
ecj-12463	58	77	more	more	ADV
ecj-12463	58	78	comprehensive	comprehensive	ADJ
ecj-12463	58	79	and	and	CCONJ
ecj-12463	58	80	differentiated	differentiated	ADJ
ecj-12463	58	81	perspective	perspective	NOUN
ecj-12463	58	82	of	of	ADP
ecj-12463	58	83	cardiac	cardiac	ADJ
ecj-12463	58	84	conditions	condition	NOUN
ecj-12463	58	85	due	due	ADP
ecj-12463	58	86	to	to	ADP
ecj-12463	58	87	the	the	DET
ecj-12463	58	88	aforementioned	aforementioned	ADJ
ecj-12463	58	89	restrictions	restriction	NOUN
ecj-12463	58	90	.	.	PUNCT
ecj-12463	59	1	this	this	DET
ecj-12463	59	2	method	method	NOUN
ecj-12463	59	3	enables	enable	VERB
ecj-12463	59	4	the	the	DET
ecj-12463	59	5	evaluation	evaluation	NOUN
ecj-12463	59	6	of	of	ADP
ecj-12463	59	7	specific	specific	ADJ
ecj-12463	59	8	aspects	aspect	NOUN
ecj-12463	59	9	of	of	ADP
ecj-12463	59	10	cardiac	cardiac	ADJ
ecj-12463	59	11	function	function	NOUN
ecj-12463	59	12	,	,	PUNCT
ecj-12463	59	13	inflammatory	inflammatory	ADJ
ecj-12463	59	14	responses	response	NOUN
ecj-12463	59	15	and	and	CCONJ
ecj-12463	59	16	other	other	ADJ
ecj-12463	59	17	factors	factor	NOUN
ecj-12463	59	18	that	that	PRON
ecj-12463	59	19	may	may	AUX
ecj-12463	59	20	contribute	contribute	VERB
ecj-12463	59	21	to	to	ADP
ecj-12463	59	22	diagnosis	diagnosis	NOUN
ecj-12463	59	23	and	and	CCONJ
ecj-12463	59	24	prognosis	prognosis	NOUN
ecj-12463	59	25	.	.	PUNCT
ecj-12463	60	1	the	the	DET
ecj-12463	60	2	combination	combination	NOUN
ecj-12463	60	3	of	of	ADP
ecj-12463	60	4	biomarkers	biomarker	NOUN
ecj-12463	60	5	improves	improve	VERB
ecj-12463	60	6	the	the	DET
ecj-12463	60	7	sensitivity	sensitivity	NOUN
ecj-12463	60	8	and	and	CCONJ
ecj-12463	60	9	specificity	specificity	NOUN
ecj-12463	60	10	of	of	ADP
ecj-12463	60	11	assessment	assessment	NOUN
ecj-12463	60	12	,	,	PUNCT
ecj-12463	60	13	especially	especially	ADV
ecj-12463	60	14	in	in	ADP
ecj-12463	60	15	complex	complex	ADJ
ecj-12463	60	16	situations	situation	NOUN
ecj-12463	60	17	,	,	PUNCT
ecj-12463	60	18	allowing	allow	VERB
ecj-12463	60	19	for	for	ADP
ecj-12463	60	20	more	more	ADV
ecj-12463	60	21	precise	precise	ADJ
ecj-12463	60	22	and	and	CCONJ
ecj-12463	60	23	individualized	individualized	ADJ
ecj-12463	60	24	management	management	NOUN
ecj-12463	60	25	of	of	ADP
ecj-12463	60	26	cardiac	cardiac	ADJ
ecj-12463	60	27	conditions	condition	NOUN
ecj-12463	60	28	.	.	PUNCT
ecj-12463	61	1	sst2	sst2	NOUN
ecj-12463	61	2	suppression	suppression	NOUN
ecj-12463	61	3	of	of	ADP
ecj-12463	61	4	tumorigenesis-2	tumorigenesis-2	NUM
ecj-12463	61	5	(	(	PUNCT
ecj-12463	61	6	st2	st2	NOUN
ecj-12463	61	7	)	)	PUNCT
ecj-12463	61	8	,	,	PUNCT
ecj-12463	61	9	originally	originally	ADV
ecj-12463	61	10	described	describe	VERB
ecj-12463	61	11	in	in	ADP
ecj-12463	61	12	1989,21	1989,21	PROPN
ecj-12463	61	13	is	be	AUX
ecj-12463	61	14	a	a	DET
ecj-12463	61	15	member	member	NOUN
ecj-12463	61	16	of	of	ADP
ecj-12463	61	17	interleukin	interleukin	NOUN
ecj-12463	61	18	(	(	PUNCT
ecj-12463	61	19	il)-1	il)-1	ADP
ecj-12463	61	20	family	family	NOUN
ecj-12463	61	21	receptors	receptor	NOUN
ecj-12463	61	22	that	that	PRON
ecj-12463	61	23	review	review	VERB
ecj-12463	61	24	[	[	PUNCT
ecj-12463	61	25	emergency	emergency	NOUN
ecj-12463	61	26	care	care	NOUN
ecj-12463	61	27	journal	journal	PROPN
ecj-12463	61	28	2024	2024	NUM
ecj-12463	61	29	;	;	PUNCT
ecj-12463	61	30	20:12463	20:12463	NUM
ecj-12463	61	31	]	]	X
ecj-12463	62	1	[	[	X
ecj-12463	62	2	page	page	NOUN
ecj-12463	62	3	50	50	NUM
ecj-12463	62	4	]	]	PUNCT
ecj-12463	62	5	non	non	ADJ
ecj-12463	62	6	-co	-co	PROPN
ecj-12463	62	7	mmerc	mmerc	PROPN
ecj-12463	62	8	ial	ial	PROPN
ecj-12463	62	9	us	us	PROPN
ecj-12463	62	10	e	e	NOUN
ecj-12463	62	11	o	o	NOUN
ecj-12463	62	12	nly	nly	ADV
ecj-12463	62	13	exists	exist	VERB
ecj-12463	62	14	in	in	ADP
ecj-12463	62	15	two	two	NUM
ecj-12463	62	16	forms	form	NOUN
ecj-12463	62	17	:	:	PUNCT
ecj-12463	62	18	a	a	DET
ecj-12463	62	19	membrane	membrane	NOUN
ecj-12463	62	20	-	-	PUNCT
ecj-12463	62	21	bound	bind	VERB
ecj-12463	62	22	receptor	receptor	NOUN
ecj-12463	62	23	(	(	PUNCT
ecj-12463	62	24	st2l	st2l	PROPN
ecj-12463	62	25	)	)	PUNCT
ecj-12463	62	26	and	and	CCONJ
ecj-12463	62	27	a	a	DET
ecj-12463	62	28	soluble	soluble	ADJ
ecj-12463	62	29	one	one	NOUN
ecj-12463	62	30	(	(	PUNCT
ecj-12463	62	31	sst2	sst2	NOUN
ecj-12463	62	32	)	)	PUNCT
ecj-12463	62	33	.	.	PUNCT
ecj-12463	63	1	the	the	DET
ecj-12463	63	2	natural	natural	ADJ
ecj-12463	63	3	ligand	ligand	NOUN
ecj-12463	63	4	of	of	ADP
ecj-12463	63	5	st2	st2	NOUN
ecj-12463	63	6	is	be	AUX
ecj-12463	63	7	il-33	il-33	ADJ
ecj-12463	63	8	,	,	PUNCT
ecj-12463	63	9	a	a	DET
ecj-12463	63	10	member	member	NOUN
ecj-12463	63	11	of	of	ADP
ecj-12463	63	12	the	the	DET
ecj-12463	63	13	il-1	il-1	X
ecj-12463	63	14	family	family	NOUN
ecj-12463	63	15	,	,	PUNCT
ecj-12463	63	16	that	that	PRON
ecj-12463	63	17	has	have	AUX
ecj-12463	63	18	been	be	AUX
ecj-12463	63	19	involved	involve	VERB
ecj-12463	63	20	in	in	ADP
ecj-12463	63	21	the	the	DET
ecj-12463	63	22	pathogenesis	pathogenesis	NOUN
ecj-12463	63	23	of	of	ADP
ecj-12463	63	24	several	several	ADJ
ecj-12463	63	25	diseases.22	diseases.22	NOUN
ecj-12463	63	26	the	the	DET
ecj-12463	63	27	il-33	il-33	ADJ
ecj-12463	63	28	/	/	SYM
ecj-12463	63	29	st2l	st2l	PROPN
ecj-12463	63	30	signaling	signal	VERB
ecj-12463	63	31	inhibits	inhibit	VERB
ecj-12463	63	32	th1	th1	NOUN
ecj-12463	63	33	cytokine	cytokine	NOUN
ecj-12463	63	34	production	production	NOUN
ecj-12463	63	35	and	and	CCONJ
ecj-12463	63	36	leads	lead	VERB
ecj-12463	63	37	to	to	ADP
ecj-12463	63	38	transcriptional	transcriptional	ADJ
ecj-12463	63	39	activation	activation	NOUN
ecj-12463	63	40	of	of	ADP
ecj-12463	63	41	inflammatory	inflammatory	ADJ
ecj-12463	63	42	genes	gene	NOUN
ecj-12463	63	43	,	,	PUNCT
ecj-12463	63	44	thereby	thereby	ADV
ecj-12463	63	45	increasing	increase	VERB
ecj-12463	63	46	th2	th2	PROPN
ecj-12463	63	47	cytokine	cytokine	ADJ
ecj-12463	63	48	production	production	NOUN
ecj-12463	63	49	that	that	PRON
ecj-12463	63	50	inhibits	inhibit	VERB
ecj-12463	63	51	adverse	adverse	ADJ
ecj-12463	63	52	cardiac	cardiac	ADJ
ecj-12463	63	53	remodeling	remodeling	NOUN
ecj-12463	63	54	and	and	CCONJ
ecj-12463	63	55	fibrosis	fibrosis	NOUN
ecj-12463	63	56	,	,	PUNCT
ecj-12463	63	57	significantly	significantly	ADV
ecj-12463	63	58	reducing	reduce	VERB
ecj-12463	63	59	atherosclerosis	atherosclerosis	NOUN
ecj-12463	63	60	progression.23,24	progression.23,24	NOUN
ecj-12463	63	61	therefore	therefore	ADV
ecj-12463	63	62	,	,	PUNCT
ecj-12463	63	63	the	the	DET
ecj-12463	63	64	interaction	interaction	NOUN
ecj-12463	63	65	of	of	ADP
ecj-12463	63	66	il-33	il-33	VERB
ecj-12463	63	67	and	and	CCONJ
ecj-12463	63	68	st2l	st2l	PROPN
ecj-12463	63	69	may	may	AUX
ecj-12463	63	70	represent	represent	VERB
ecj-12463	63	71	a	a	DET
ecj-12463	63	72	cardioprotective	cardioprotective	ADJ
ecj-12463	63	73	factor	factor	NOUN
ecj-12463	63	74	.	.	PUNCT
ecj-12463	64	1	conversely	conversely	ADV
ecj-12463	64	2	,	,	PUNCT
ecj-12463	64	3	sst2	sst2	PROPN
ecj-12463	64	4	is	be	AUX
ecj-12463	64	5	known	know	VERB
ecj-12463	64	6	to	to	PART
ecj-12463	64	7	bind	bind	VERB
ecj-12463	64	8	il-33	il-33	NOUN
ecj-12463	64	9	thus	thus	ADV
ecj-12463	64	10	playing	play	VERB
ecj-12463	64	11	a	a	DET
ecj-12463	64	12	role	role	NOUN
ecj-12463	64	13	of	of	ADP
ecj-12463	64	14	a	a	DET
ecj-12463	64	15	decoy	decoy	NOUN
ecj-12463	64	16	receptor	receptor	NOUN
ecj-12463	64	17	and	and	CCONJ
ecj-12463	64	18	attenuates	attenuate	VERB
ecj-12463	64	19	positive	positive	ADJ
ecj-12463	64	20	cardiac	cardiac	ADJ
ecj-12463	64	21	effects	effect	NOUN
ecj-12463	64	22	of	of	ADP
ecj-12463	64	23	il-33	il-33	PRON
ecj-12463	64	24	/	/	SYM
ecj-12463	64	25	st2l	st2l	PROPN
ecj-12463	64	26	pathway.22	pathway.22	NOUN
ecj-12463	64	27	-	-	PUNCT
ecj-12463	64	28	28	28	NUM
ecj-12463	64	29	st2l	st2l	PROPN
ecj-12463	64	30	and	and	CCONJ
ecj-12463	64	31	sst2	sst2	NOUN
ecj-12463	64	32	in	in	ADP
ecj-12463	64	33	the	the	DET
ecj-12463	64	34	circulatory	circulatory	ADJ
ecj-12463	64	35	system	system	NOUN
ecj-12463	64	36	are	be	AUX
ecj-12463	64	37	mainly	mainly	ADV
ecj-12463	64	38	found	find	VERB
ecj-12463	64	39	in	in	ADP
ecj-12463	64	40	the	the	DET
ecj-12463	64	41	endothelial	endothelial	ADJ
ecj-12463	64	42	cells	cell	NOUN
ecj-12463	64	43	and	and	CCONJ
ecj-12463	64	44	secreted	secrete	VERB
ecj-12463	64	45	by	by	ADP
ecj-12463	64	46	fibroblasts	fibroblast	NOUN
ecj-12463	64	47	and	and	CCONJ
ecj-12463	64	48	cardiomyocytes	cardiomyocyte	NOUN
ecj-12463	64	49	in	in	ADP
ecj-12463	64	50	response	response	NOUN
ecj-12463	64	51	to	to	ADP
ecj-12463	64	52	mechanical	mechanical	ADJ
ecj-12463	64	53	stretching.22	stretching.22	NOUN
ecj-12463	64	54	cytokines	cytokine	NOUN
ecj-12463	64	55	from	from	ADP
ecj-12463	64	56	damaged	damaged	ADJ
ecj-12463	64	57	tissues	tissue	NOUN
ecj-12463	64	58	seem	seem	VERB
ecj-12463	64	59	to	to	PART
ecj-12463	64	60	induce	induce	VERB
ecj-12463	64	61	the	the	DET
ecj-12463	64	62	production	production	NOUN
ecj-12463	64	63	of	of	ADP
ecj-12463	64	64	sst2	sst2	NOUN
ecj-12463	64	65	by	by	ADP
ecj-12463	64	66	the	the	DET
ecj-12463	64	67	neighboring	neighboring	NOUN
ecj-12463	64	68	cells.29	cells.29	NOUN
ecj-12463	64	69	st2	st2	PROPN
ecj-12463	64	70	has	have	AUX
ecj-12463	64	71	gained	gain	VERB
ecj-12463	64	72	interest	interest	NOUN
ecj-12463	64	73	as	as	ADP
ecj-12463	64	74	a	a	DET
ecj-12463	64	75	relevant	relevant	ADJ
ecj-12463	64	76	tool	tool	NOUN
ecj-12463	64	77	in	in	ADP
ecj-12463	64	78	many	many	ADJ
ecj-12463	64	79	fields	field	NOUN
ecj-12463	64	80	.	.	PUNCT
ecj-12463	65	1	it	it	PRON
ecj-12463	65	2	was	be	AUX
ecj-12463	65	3	originally	originally	ADV
ecj-12463	65	4	thought	think	VERB
ecj-12463	65	5	to	to	PART
ecj-12463	65	6	be	be	AUX
ecj-12463	65	7	primarily	primarily	ADV
ecj-12463	65	8	involved	involve	VERB
ecj-12463	65	9	in	in	ADP
ecj-12463	65	10	inflammatory	inflammatory	ADJ
ecj-12463	65	11	diseases	disease	NOUN
ecj-12463	65	12	and	and	CCONJ
ecj-12463	65	13	allergies	allergy	NOUN
ecj-12463	65	14	,	,	PUNCT
ecj-12463	65	15	including	include	VERB
ecj-12463	65	16	asthma	asthma	NOUN
ecj-12463	65	17	,	,	PUNCT
ecj-12463	65	18	rheumatoid	rheumatoid	VERB
ecj-12463	65	19	arthritis	arthritis	NOUN
ecj-12463	65	20	and	and	CCONJ
ecj-12463	65	21	inflammatory	inflammatory	ADJ
ecj-12463	65	22	bowel	bowel	NOUN
ecj-12463	65	23	disease.21	disease.21	NOUN
ecj-12463	65	24	currently	currently	ADV
ecj-12463	65	25	its	its	PRON
ecj-12463	65	26	role	role	NOUN
ecj-12463	65	27	as	as	ADP
ecj-12463	65	28	a	a	DET
ecj-12463	65	29	relevant	relevant	ADJ
ecj-12463	65	30	biomarker	biomarker	NOUN
ecj-12463	65	31	for	for	ADP
ecj-12463	65	32	patients	patient	NOUN
ecj-12463	65	33	with	with	ADP
ecj-12463	65	34	various	various	ADJ
ecj-12463	65	35	cardiovascular	cardiovascular	ADJ
ecj-12463	65	36	diseases	disease	NOUN
ecj-12463	65	37	is	be	AUX
ecj-12463	65	38	recognized	recognize	VERB
ecj-12463	65	39	.	.	PUNCT
ecj-12463	66	1	an	an	DET
ecj-12463	66	2	increasing	increase	VERB
ecj-12463	66	3	number	number	NOUN
ecj-12463	66	4	of	of	ADP
ecj-12463	66	5	recent	recent	ADJ
ecj-12463	66	6	studies	study	NOUN
ecj-12463	66	7	have	have	AUX
ecj-12463	66	8	advocated	advocate	VERB
ecj-12463	66	9	an	an	DET
ecj-12463	66	10	important	important	ADJ
ecj-12463	66	11	prognostic	prognostic	ADJ
ecj-12463	66	12	value	value	NOUN
ecj-12463	66	13	of	of	ADP
ecj-12463	66	14	sst2	sst2	NOUN
ecj-12463	66	15	,	,	PUNCT
ecj-12463	66	16	in	in	ADP
ecj-12463	66	17	both	both	CCONJ
ecj-12463	66	18	chronic	chronic	ADJ
ecj-12463	66	19	and	and	CCONJ
ecj-12463	66	20	acute	acute	ADJ
ecj-12463	66	21	heart	heart	NOUN
ecj-12463	66	22	failure	failure	NOUN
ecj-12463	66	23	since	since	SCONJ
ecj-12463	66	24	it	it	PRON
ecj-12463	66	25	is	be	AUX
ecj-12463	66	26	less	less	ADV
ecj-12463	66	27	influenced	influence	VERB
ecj-12463	66	28	by	by	ADP
ecj-12463	66	29	age	age	NOUN
ecj-12463	66	30	,	,	PUNCT
ecj-12463	66	31	renal	renal	ADJ
ecj-12463	66	32	function	function	NOUN
ecj-12463	66	33	than	than	ADP
ecj-12463	66	34	traditional	traditional	ADJ
ecj-12463	66	35	biomarkers	biomarker	NOUN
ecj-12463	66	36	(	(	PUNCT
ecj-12463	66	37	nt	nt	NOUN
ecj-12463	66	38	-	-	PUNCT
ecj-12463	66	39	probnp	probnp	NOUN
ecj-12463	66	40	and	and	CCONJ
ecj-12463	66	41	hs	h	NOUN
ecj-12463	66	42	-	-	PUNCT
ecj-12463	66	43	tnt).30	tnt).30	PROPN
ecj-12463	66	44	sst2	sst2	NOUN
ecj-12463	66	45	in	in	ADP
ecj-12463	66	46	fact	fact	NOUN
ecj-12463	66	47	meets	meet	VERB
ecj-12463	66	48	some	some	DET
ecj-12463	66	49	interesting	interesting	ADJ
ecj-12463	66	50	criteria	criterion	NOUN
ecj-12463	66	51	of	of	ADP
ecj-12463	66	52	clinically	clinically	ADV
ecj-12463	66	53	useful	useful	ADJ
ecj-12463	66	54	biomarkers	biomarker	NOUN
ecj-12463	66	55	.	.	PUNCT
ecj-12463	67	1	first	first	ADV
ecj-12463	67	2	of	of	ADP
ecj-12463	67	3	all	all	PRON
ecj-12463	67	4	,	,	PUNCT
ecj-12463	67	5	it	it	PRON
ecj-12463	67	6	’s	’	VERB
ecj-12463	67	7	accurate	accurate	ADJ
ecj-12463	67	8	and	and	CCONJ
ecj-12463	67	9	provides	provide	VERB
ecj-12463	67	10	information	information	NOUN
ecj-12463	67	11	to	to	PART
ecj-12463	67	12	guide	guide	VERB
ecj-12463	67	13	risk	risk	NOUN
ecj-12463	67	14	stratification	stratification	NOUN
ecj-12463	67	15	;	;	PUNCT
ecj-12463	67	16	secondly	secondly	ADV
ecj-12463	67	17	it	it	PRON
ecj-12463	67	18	has	have	VERB
ecj-12463	67	19	a	a	DET
ecj-12463	67	20	reasonable	reasonable	ADJ
ecj-12463	67	21	cost.28	cost.28	NOUN
ecj-12463	67	22	a	a	DET
ecj-12463	67	23	prospective	prospective	ADJ
ecj-12463	67	24	cohort	cohort	NOUN
ecj-12463	67	25	study	study	NOUN
ecj-12463	67	26	by	by	ADP
ecj-12463	67	27	wang	wang	PROPN
ecj-12463	67	28	et	et	PROPN
ecj-12463	67	29	al	al	PROPN
ecj-12463	67	30	.	.	PROPN
ecj-12463	67	31	enrolled	enrol	VERB
ecj-12463	67	32	331	331	NUM
ecj-12463	67	33	patients	patient	NOUN
ecj-12463	67	34	with	with	ADP
ecj-12463	67	35	acute	acute	PROPN
ecj-12463	67	36	hf	hf	NOUN
ecj-12463	67	37	stratifying	stratify	VERB
ecj-12463	67	38	them	they	PRON
ecj-12463	67	39	according	accord	VERB
ecj-12463	67	40	to	to	ADP
ecj-12463	67	41	sst2	sst2	NOUN
ecj-12463	67	42	levels	level	NOUN
ecj-12463	67	43	.	.	PUNCT
ecj-12463	68	1	the	the	DET
ecj-12463	68	2	study	study	NOUN
ecj-12463	68	3	revealed	reveal	VERB
ecj-12463	68	4	that	that	SCONJ
ecj-12463	68	5	higher	high	ADJ
ecj-12463	68	6	sst2	sst2	NOUN
ecj-12463	68	7	concentrations	concentration	NOUN
ecj-12463	68	8	are	be	AUX
ecj-12463	68	9	strongly	strongly	ADV
ecj-12463	68	10	correlated	correlate	VERB
ecj-12463	68	11	with	with	ADP
ecj-12463	68	12	adverse	adverse	ADJ
ecj-12463	68	13	outcomes.31,32	outcomes.31,32	NOUN
ecj-12463	68	14	a	a	DET
ecj-12463	68	15	systematic	systematic	ADJ
ecj-12463	68	16	review	review	NOUN
ecj-12463	68	17	and	and	CCONJ
ecj-12463	68	18	meta	meta	NOUN
ecj-12463	68	19	-	-	PUNCT
ecj-12463	68	20	analysis	analysis	NOUN
ecj-12463	68	21	by	by	ADP
ecj-12463	68	22	ip	ip	NUM
ecj-12463	68	23	et	et	PROPN
ecj-12463	68	24	al	al	PROPN
ecj-12463	68	25	.	.	PROPN
ecj-12463	68	26	demonstrated	demonstrate	VERB
ecj-12463	68	27	that	that	SCONJ
ecj-12463	68	28	elevated	elevated	ADJ
ecj-12463	68	29	levels	level	NOUN
ecj-12463	68	30	of	of	ADP
ecj-12463	68	31	sst2	sst2	NOUN
ecj-12463	68	32	are	be	AUX
ecj-12463	68	33	a	a	DET
ecj-12463	68	34	predictor	predictor	NOUN
ecj-12463	68	35	of	of	ADP
ecj-12463	68	36	severe	severe	ADJ
ecj-12463	68	37	chronic	chronic	ADJ
ecj-12463	68	38	hf	hf	NOUN
ecj-12463	68	39	and	and	CCONJ
ecj-12463	68	40	tend	tend	VERB
ecj-12463	68	41	to	to	PART
ecj-12463	68	42	be	be	AUX
ecj-12463	68	43	associated	associate	VERB
ecj-12463	68	44	with	with	ADP
ecj-12463	68	45	a	a	DET
ecj-12463	68	46	higher	high	ADJ
ecj-12463	68	47	risk	risk	NOUN
ecj-12463	68	48	of	of	ADP
ecj-12463	68	49	mortality	mortality	NOUN
ecj-12463	68	50	in	in	ADP
ecj-12463	68	51	chronic	chronic	ADJ
ecj-12463	68	52	hf	hf	NOUN
ecj-12463	68	53	and	and	CCONJ
ecj-12463	68	54	stable	stable	ADJ
ecj-12463	68	55	cad.29	cad.29	VERB
ecj-12463	68	56	a	a	DET
ecj-12463	68	57	prospective	prospective	ADJ
ecj-12463	68	58	study	study	NOUN
ecj-12463	68	59	by	by	ADP
ecj-12463	68	60	rezar	rezar	PROPN
ecj-12463	68	61	et	et	PROPN
ecj-12463	68	62	al	al	PROPN
ecj-12463	68	63	.	.	PROPN
ecj-12463	69	1	also	also	ADV
ecj-12463	69	2	suggests	suggest	VERB
ecj-12463	69	3	measuring	measure	VERB
ecj-12463	69	4	serum	serum	NOUN
ecj-12463	69	5	sst2	sst2	NOUN
ecj-12463	69	6	levels	level	NOUN
ecj-12463	69	7	24	24	NUM
ecj-12463	69	8	h	h	NOUN
ecj-12463	69	9	after	after	ADP
ecj-12463	69	10	admission	admission	NOUN
ecj-12463	69	11	for	for	ADP
ecj-12463	69	12	prognostication	prognostication	NOUN
ecj-12463	69	13	after	after	ADP
ecj-12463	69	14	cardiopulmonary	cardiopulmonary	ADJ
ecj-12463	69	15	resuscitation.33	resuscitation.33	NOUN
ecj-12463	69	16	furthermore	furthermore	ADV
ecj-12463	69	17	,	,	PUNCT
ecj-12463	69	18	in	in	ADP
ecj-12463	69	19	the	the	DET
ecj-12463	69	20	stade	stade	NOUN
ecj-12463	69	21	-	-	PUNCT
ecj-12463	69	22	hf	hf	PROPN
ecj-12463	69	23	study	study	NOUN
ecj-12463	69	24	,	,	PUNCT
ecj-12463	69	25	an	an	DET
ecj-12463	69	26	ancillary	ancillary	ADJ
ecj-12463	69	27	study	study	NOUN
ecj-12463	69	28	of	of	ADP
ecj-12463	69	29	a	a	DET
ecj-12463	69	30	randomized	randomized	ADJ
ecj-12463	69	31	trial	trial	NOUN
ecj-12463	69	32	:	:	PUNCT
ecj-12463	69	33	nct02963272	nct02963272	NOUN
ecj-12463	69	34	,	,	PUNCT
ecj-12463	69	35	sst2	sst2	PROPN
ecj-12463	69	36	showed	show	VERB
ecj-12463	69	37	to	to	PART
ecj-12463	69	38	be	be	AUX
ecj-12463	69	39	better	well	ADV
ecj-12463	69	40	associated	associate	VERB
ecj-12463	69	41	with	with	ADP
ecj-12463	69	42	the	the	DET
ecj-12463	69	43	risk	risk	NOUN
ecj-12463	69	44	of	of	ADP
ecj-12463	69	45	hospitalization	hospitalization	NOUN
ecj-12463	69	46	when	when	SCONJ
ecj-12463	69	47	compared	compare	VERB
ecj-12463	69	48	to	to	ADP
ecj-12463	69	49	supar	supar	NOUN
ecj-12463	69	50	,	,	PUNCT
ecj-12463	69	51	which	which	PRON
ecj-12463	69	52	,	,	PUNCT
ecj-12463	69	53	in	in	ADP
ecj-12463	69	54	contrast	contrast	NOUN
ecj-12463	69	55	,	,	PUNCT
ecj-12463	69	56	resulted	result	VERB
ecj-12463	69	57	associated	associate	VERB
ecj-12463	69	58	with	with	ADP
ecj-12463	69	59	long	long	ADJ
ecj-12463	69	60	term	term	NOUN
ecj-12463	69	61	mortality.34	mortality.34	NOUN
ecj-12463	69	62	it	it	PRON
ecj-12463	69	63	was	be	AUX
ecj-12463	69	64	also	also	ADV
ecj-12463	69	65	revealed	reveal	VERB
ecj-12463	69	66	that	that	SCONJ
ecj-12463	69	67	sst2	sst2	NOUN
ecj-12463	69	68	-	-	PUNCT
ecj-12463	69	69	guided	guide	VERB
ecj-12463	69	70	therapy	therapy	NOUN
ecj-12463	69	71	does	do	AUX
ecj-12463	69	72	not	not	PART
ecj-12463	69	73	decrease	decrease	VERB
ecj-12463	69	74	readmissions	readmission	NOUN
ecj-12463	69	75	.	.	PUNCT
ecj-12463	70	1	this	this	DET
ecj-12463	70	2	study	study	NOUN
ecj-12463	70	3	was	be	AUX
ecj-12463	70	4	aimed	aim	VERB
ecj-12463	70	5	to	to	PART
ecj-12463	70	6	evaluate	evaluate	VERB
ecj-12463	70	7	a	a	DET
ecj-12463	70	8	sst2	sst2	NOUN
ecj-12463	70	9	-	-	PUNCT
ecj-12463	70	10	guided	guide	VERB
ecj-12463	70	11	treatment	treatment	NOUN
ecj-12463	70	12	in	in	ADP
ecj-12463	70	13	patients	patient	NOUN
ecj-12463	70	14	hospitalized	hospitalize	VERB
ecj-12463	70	15	for	for	ADP
ecj-12463	70	16	acute	acute	ADJ
ecj-12463	70	17	hf	hf	PROPN
ecj-12463	70	18	.	.	PUNCT
ecj-12463	71	1	unlikely	unlikely	ADJ
ecj-12463	71	2	,	,	PUNCT
ecj-12463	71	3	the	the	DET
ecj-12463	71	4	approach	approach	NOUN
ecj-12463	71	5	proposed	propose	VERB
ecj-12463	71	6	failed.35	failed.35	NOUN
ecj-12463	71	7	the	the	DET
ecj-12463	71	8	american	american	ADJ
ecj-12463	71	9	heart	heart	PROPN
ecj-12463	71	10	association	association	PROPN
ecj-12463	71	11	/	/	SYM
ecj-12463	71	12	american	american	PROPN
ecj-12463	71	13	college	college	PROPN
ecj-12463	71	14	of	of	ADP
ecj-12463	71	15	cardiology	cardiology	NOUN
ecj-12463	71	16	(	(	PUNCT
ecj-12463	71	17	aha	aha	INTJ
ecj-12463	71	18	/	/	SYM
ecj-12463	71	19	acc	acc	PROPN
ecj-12463	71	20	)	)	PUNCT
ecj-12463	71	21	guidelines	guideline	NOUN
ecj-12463	71	22	for	for	ADP
ecj-12463	71	23	hf	hf	PROPN
ecj-12463	71	24	management	management	NOUN
ecj-12463	71	25	included	include	VERB
ecj-12463	71	26	as	as	ADP
ecj-12463	71	27	a	a	DET
ecj-12463	71	28	risk	risk	NOUN
ecj-12463	71	29	stratification	stratification	NOUN
ecj-12463	71	30	marker	marker	NOUN
ecj-12463	71	31	(	(	PUNCT
ecj-12463	71	32	class	class	NOUN
ecj-12463	71	33	ii	ii	NOUN
ecj-12463	71	34	level	level	NOUN
ecj-12463	71	35	of	of	ADP
ecj-12463	71	36	evidence	evidence	NOUN
ecj-12463	71	37	b	b	X
ecj-12463	71	38	)	)	PUNCT
ecj-12463	71	39	the	the	DET
ecj-12463	71	40	measurement	measurement	NOUN
ecj-12463	71	41	of	of	ADP
ecj-12463	71	42	sst2	sst2	NOUN
ecj-12463	71	43	levels	level	NOUN
ecj-12463	71	44	in	in	ADP
ecj-12463	71	45	patients	patient	NOUN
ecj-12463	71	46	with	with	ADP
ecj-12463	71	47	adhf	adhf	NOUN
ecj-12463	71	48	.	.	PUNCT
ecj-12463	72	1	a	a	DET
ecj-12463	72	2	cut	cut	VERB
ecj-12463	72	3	-	-	PUNCT
ecj-12463	72	4	off	off	ADP
ecj-12463	72	5	value	value	NOUN
ecj-12463	72	6	of	of	ADP
ecj-12463	72	7	sst2	sst2	PROPN
ecj-12463	72	8	≥	≥	PROPN
ecj-12463	72	9	35	35	NUM
ecj-12463	72	10	ng	ng	NOUN
ecj-12463	72	11	/	/	SYM
ecj-12463	72	12	ml	ml	PROPN
ecj-12463	72	13	is	be	AUX
ecj-12463	72	14	proposed	propose	VERB
ecj-12463	72	15	as	as	ADP
ecj-12463	72	16	a	a	DET
ecj-12463	72	17	predictor	predictor	NOUN
ecj-12463	72	18	for	for	ADP
ecj-12463	72	19	worse	bad	ADJ
ecj-12463	72	20	prognosis	prognosis	NOUN
ecj-12463	72	21	in	in	ADP
ecj-12463	72	22	patients	patient	NOUN
ecj-12463	72	23	with	with	ADP
ecj-12463	72	24	hf.36	hf.36	NOUN
ecj-12463	72	25	in	in	ADP
ecj-12463	72	26	the	the	DET
ecj-12463	72	27	latest	late	ADJ
ecj-12463	72	28	edition	edition	NOUN
ecj-12463	72	29	of	of	ADP
ecj-12463	72	30	the	the	DET
ecj-12463	72	31	same	same	ADJ
ecj-12463	72	32	guidelines	guideline	NOUN
ecj-12463	72	33	,	,	PUNCT
ecj-12463	72	34	dated	date	VERB
ecj-12463	72	35	2022	2022	NUM
ecj-12463	72	36	,	,	PUNCT
ecj-12463	72	37	however	however	ADV
ecj-12463	72	38	,	,	PUNCT
ecj-12463	72	39	this	this	DET
ecj-12463	72	40	recommendation	recommendation	NOUN
ecj-12463	72	41	is	be	AUX
ecj-12463	72	42	not	not	PART
ecj-12463	72	43	reported.28	reported.28	NOUN
ecj-12463	72	44	concerning	concern	VERB
ecj-12463	72	45	acs	acs	PROPN
ecj-12463	72	46	,	,	PUNCT
ecj-12463	72	47	the	the	DET
ecj-12463	72	48	role	role	NOUN
ecj-12463	72	49	of	of	ADP
ecj-12463	72	50	sst2	sst2	NOUN
ecj-12463	72	51	in	in	ADP
ecj-12463	72	52	less	less	ADV
ecj-12463	72	53	clear	clear	ADJ
ecj-12463	72	54	.	.	PUNCT
ecj-12463	73	1	it	it	PRON
ecj-12463	73	2	seems	seem	VERB
ecj-12463	73	3	to	to	PART
ecj-12463	73	4	be	be	AUX
ecj-12463	73	5	involved	involve	VERB
ecj-12463	73	6	in	in	ADP
ecj-12463	73	7	the	the	DET
ecj-12463	73	8	progression	progression	NOUN
ecj-12463	73	9	of	of	ADP
ecj-12463	73	10	atherosclerosis	atherosclerosis	NOUN
ecj-12463	73	11	.	.	PUNCT
ecj-12463	74	1	several	several	ADJ
ecj-12463	74	2	studies	study	NOUN
ecj-12463	74	3	have	have	AUX
ecj-12463	74	4	proposed	propose	VERB
ecj-12463	74	5	that	that	SCONJ
ecj-12463	74	6	the	the	DET
ecj-12463	74	7	il-33	il-33	PRON
ecj-12463	74	8	/	/	SYM
ecj-12463	74	9	st2l	st2l	PROPN
ecj-12463	74	10	interaction	interaction	NOUN
ecj-12463	74	11	in	in	ADP
ecj-12463	74	12	the	the	DET
ecj-12463	74	13	coronary	coronary	ADJ
ecj-12463	74	14	arterial	arterial	NOUN
ecj-12463	74	15	wall	wall	NOUN
ecj-12463	74	16	may	may	AUX
ecj-12463	74	17	prevent	prevent	VERB
ecj-12463	74	18	cardiomyocyte	cardiomyocyte	NOUN
ecj-12463	74	19	apoptosis	apoptosis	NOUN
ecj-12463	74	20	,	,	PUNCT
ecj-12463	74	21	reduce	reduce	VERB
ecj-12463	74	22	myocardial	myocardial	ADJ
ecj-12463	74	23	fibrosis	fibrosis	NOUN
ecj-12463	74	24	and	and	CCONJ
ecj-12463	74	25	myocardial	myocardial	ADJ
ecj-12463	74	26	maladaptive	maladaptive	ADJ
ecj-12463	74	27	hypertrophy	hypertrophy	NOUN
ecj-12463	74	28	thus	thus	ADV
ecj-12463	74	29	limiting	limit	VERB
ecj-12463	74	30	plaque	plaque	ADJ
ecj-12463	74	31	inflammation	inflammation	NOUN
ecj-12463	74	32	and	and	CCONJ
ecj-12463	74	33	evolution.21,26,29	evolution.21,26,29	SYM
ecj-12463	74	34	therefore	therefore	ADV
ecj-12463	74	35	,	,	PUNCT
ecj-12463	74	36	elevated	elevated	ADJ
ecj-12463	74	37	sst2	sst2	NOUN
ecj-12463	74	38	levels	level	NOUN
ecj-12463	74	39	would	would	AUX
ecj-12463	74	40	promote	promote	VERB
ecj-12463	74	41	inflammation	inflammation	NOUN
ecj-12463	74	42	and	and	CCONJ
ecj-12463	74	43	result	result	VERB
ecj-12463	74	44	in	in	ADP
ecj-12463	74	45	plaque	plaque	NOUN
ecj-12463	74	46	progression	progression	NOUN
ecj-12463	74	47	preventing	prevent	VERB
ecj-12463	74	48	the	the	DET
ecj-12463	74	49	circulating	circulating	NOUN
ecj-12463	74	50	il-33	il-33	ADJ
ecj-12463	74	51	from	from	ADP
ecj-12463	74	52	binding	bind	VERB
ecj-12463	74	53	to	to	ADP
ecj-12463	74	54	st2l	st2l	PROPN
ecj-12463	74	55	.	.	PUNCT
ecj-12463	75	1	a	a	DET
ecj-12463	75	2	recent	recent	ADJ
ecj-12463	75	3	review	review	NOUN
ecj-12463	75	4	proposes	propose	VERB
ecj-12463	75	5	sst2	sst2	NOUN
ecj-12463	75	6	assisted	assist	VERB
ecj-12463	75	7	flowcharts	flowchart	NOUN
ecj-12463	75	8	as	as	ADP
ecj-12463	75	9	an	an	DET
ecj-12463	75	10	innovative	innovative	ADJ
ecj-12463	75	11	useful	useful	ADJ
ecj-12463	75	12	tool	tool	NOUN
ecj-12463	75	13	to	to	PART
ecj-12463	75	14	manage	manage	VERB
ecj-12463	75	15	very	very	ADV
ecj-12463	75	16	common	common	ADJ
ecj-12463	75	17	clinical	clinical	ADJ
ecj-12463	75	18	scenarios	scenario	NOUN
ecj-12463	75	19	of	of	ADP
ecj-12463	75	20	the	the	DET
ecj-12463	75	21	ed	ed	NOUN
ecj-12463	75	22	:	:	PUNCT
ecj-12463	75	23	acute	acute	ADJ
ecj-12463	75	24	hf	hf	NOUN
ecj-12463	75	25	,	,	PUNCT
ecj-12463	75	26	type	type	NOUN
ecj-12463	75	27	1	1	NUM
ecj-12463	75	28	,	,	PUNCT
ecj-12463	75	29	and	and	CCONJ
ecj-12463	75	30	type	type	NOUN
ecj-12463	75	31	2	2	NUM
ecj-12463	75	32	ami.22	ami.22	NOUN
ecj-12463	75	33	the	the	DET
ecj-12463	75	34	predictive	predictive	ADJ
ecj-12463	75	35	value	value	NOUN
ecj-12463	75	36	of	of	ADP
ecj-12463	75	37	sst2	sst2	NOUN
ecj-12463	75	38	and	and	CCONJ
ecj-12463	75	39	il-33	il-33	ADJ
ecj-12463	75	40	in	in	ADP
ecj-12463	75	41	patients	patient	NOUN
ecj-12463	75	42	with	with	ADP
ecj-12463	75	43	acs	acs	PROPN
ecj-12463	75	44	has	have	AUX
ecj-12463	75	45	been	be	AUX
ecj-12463	75	46	investigated	investigate	VERB
ecj-12463	75	47	recently	recently	ADV
ecj-12463	75	48	.	.	PUNCT
ecj-12463	76	1	a	a	DET
ecj-12463	76	2	significant	significant	ADJ
ecj-12463	76	3	increase	increase	NOUN
ecj-12463	76	4	in	in	ADP
ecj-12463	76	5	sst2	sst2	NOUN
ecj-12463	76	6	and	and	CCONJ
ecj-12463	76	7	il-33	il-33	ADJ
ecj-12463	76	8	was	be	AUX
ecj-12463	76	9	found	find	VERB
ecj-12463	76	10	in	in	ADP
ecj-12463	76	11	patients	patient	NOUN
ecj-12463	76	12	with	with	ADP
ecj-12463	76	13	ami	ami	NOUN
ecj-12463	76	14	compared	compare	VERB
ecj-12463	76	15	with	with	ADP
ecj-12463	76	16	healthy	healthy	ADJ
ecj-12463	76	17	controls.25	controls.25	NOUN
ecj-12463	76	18	a	a	DET
ecj-12463	76	19	recent	recent	ADJ
ecj-12463	76	20	cross	cross	ADJ
ecj-12463	76	21	-	-	ADJ
ecj-12463	76	22	sectional	sectional	ADJ
ecj-12463	76	23	study	study	NOUN
ecj-12463	76	24	found	find	VERB
ecj-12463	76	25	that	that	SCONJ
ecj-12463	76	26	sst2	sst2	NOUN
ecj-12463	76	27	levels	level	NOUN
ecj-12463	76	28	did	do	AUX
ecj-12463	76	29	not	not	PART
ecj-12463	76	30	correlate	correlate	VERB
ecj-12463	76	31	with	with	ADP
ecj-12463	76	32	infarct	infarct	ADJ
ecj-12463	76	33	location	location	NOUN
ecj-12463	76	34	in	in	ADP
ecj-12463	76	35	a	a	DET
ecj-12463	76	36	statistically	statistically	ADV
ecj-12463	76	37	significant	significant	ADJ
ecj-12463	76	38	way	way	NOUN
ecj-12463	76	39	.	.	PUNCT
ecj-12463	77	1	on	on	ADP
ecj-12463	77	2	the	the	DET
ecj-12463	77	3	contrary	contrary	NOUN
ecj-12463	77	4	,	,	PUNCT
ecj-12463	77	5	it	it	PRON
ecj-12463	77	6	was	be	AUX
ecj-12463	77	7	advocated	advocate	VERB
ecj-12463	77	8	that	that	SCONJ
ecj-12463	77	9	serum	serum	PROPN
ecj-12463	77	10	sst2	sst2	NOUN
ecj-12463	77	11	levels	level	NOUN
ecj-12463	77	12	correlated	correlate	VERB
ecj-12463	77	13	with	with	ADP
ecj-12463	77	14	baseline	baseline	NOUN
ecj-12463	77	15	infarct	infarct	ADJ
ecj-12463	77	16	volume	volume	NOUN
ecj-12463	77	17	and	and	CCONJ
ecj-12463	77	18	endocardial	endocardial	ADJ
ecj-12463	77	19	extent	extent	NOUN
ecj-12463	77	20	of	of	ADP
ecj-12463	77	21	infarction.37	infarction.37	PROPN
ecj-12463	77	22	a	a	DET
ecj-12463	77	23	recent	recent	ADJ
ecj-12463	77	24	study	study	NOUN
ecj-12463	77	25	by	by	ADP
ecj-12463	77	26	zhang	zhang	PROPN
ecj-12463	77	27	et	et	PROPN
ecj-12463	77	28	al	al	PROPN
ecj-12463	77	29	.	.	PROPN
ecj-12463	77	30	also	also	ADV
ecj-12463	77	31	proposed	propose	VERB
ecj-12463	77	32	that	that	SCONJ
ecj-12463	77	33	sst2	sst2	NOUN
ecj-12463	77	34	could	could	AUX
ecj-12463	77	35	be	be	AUX
ecj-12463	77	36	a	a	DET
ecj-12463	77	37	useful	useful	ADJ
ecj-12463	77	38	tool	tool	NOUN
ecj-12463	77	39	in	in	ADP
ecj-12463	77	40	the	the	DET
ecj-12463	77	41	detection	detection	NOUN
ecj-12463	77	42	of	of	ADP
ecj-12463	77	43	atherosclerotic	atherosclerotic	ADJ
ecj-12463	77	44	plaques	plaque	NOUN
ecj-12463	77	45	vulnerability38	vulnerability38	VERB
ecj-12463	77	46	and	and	CCONJ
ecj-12463	77	47	this	this	DET
ecj-12463	77	48	correlation	correlation	NOUN
ecj-12463	77	49	was	be	AUX
ecj-12463	77	50	further	far	ADV
ecj-12463	77	51	investigated	investigate	VERB
ecj-12463	77	52	by	by	ADP
ecj-12463	77	53	luo	luo	PROPN
ecj-12463	77	54	et	et	PROPN
ecj-12463	77	55	al	al	PROPN
ecj-12463	77	56	.	.	PROPN
ecj-12463	77	57	who	who	PRON
ecj-12463	77	58	proposed	propose	VERB
ecj-12463	77	59	a	a	DET
ecj-12463	77	60	correlation	correlation	NOUN
ecj-12463	77	61	between	between	ADP
ecj-12463	77	62	serum	serum	NOUN
ecj-12463	77	63	sst2	sst2	NOUN
ecj-12463	77	64	levels	level	NOUN
ecj-12463	77	65	and	and	CCONJ
ecj-12463	77	66	the	the	DET
ecj-12463	77	67	necrotic	necrotic	ADJ
ecj-12463	77	68	core	core	NOUN
ecj-12463	77	69	in	in	ADP
ecj-12463	77	70	coronary	coronary	ADJ
ecj-12463	77	71	lesions.39	lesions.39	NOUN
ecj-12463	77	72	furthermore	furthermore	ADV
ecj-12463	77	73	,	,	PUNCT
ecj-12463	77	74	van	van	PROPN
ecj-12463	77	75	den	den	PROPN
ecj-12463	77	76	berg	berg	PROPN
ecj-12463	77	77	et	et	PROPN
ecj-12463	77	78	al	al	PROPN
ecj-12463	77	79	.	.	PROPN
ecj-12463	77	80	showed	show	VERB
ecj-12463	77	81	that	that	SCONJ
ecj-12463	77	82	post	post	ADJ
ecj-12463	77	83	-	-	ADJ
ecj-12463	77	84	acs	acs	ADJ
ecj-12463	77	85	patients	patient	NOUN
ecj-12463	77	86	with	with	ADP
ecj-12463	77	87	persistently	persistently	ADV
ecj-12463	77	88	elevated	elevated	ADJ
ecj-12463	77	89	sst2	sst2	NOUN
ecj-12463	77	90	concentrations	concentration	NOUN
ecj-12463	77	91	are	be	AUX
ecj-12463	77	92	at	at	ADP
ecj-12463	77	93	higher	high	ADJ
ecj-12463	77	94	risk	risk	NOUN
ecj-12463	77	95	of	of	ADP
ecj-12463	77	96	recurrent	recurrent	ADJ
ecj-12463	77	97	acs	acs	NOUN
ecj-12463	77	98	or	or	CCONJ
ecj-12463	77	99	cardiac	cardiac	ADJ
ecj-12463	77	100	death	death	NOUN
ecj-12463	77	101	during	during	ADP
ecj-12463	77	102	one	one	NUM
ecj-12463	77	103	year	year	NOUN
ecj-12463	77	104	of	of	ADP
ecj-12463	77	105	follow	follow	NOUN
ecj-12463	77	106	-	-	PUNCT
ecj-12463	77	107	up.40	up.40	NOUN
ecj-12463	77	108	in	in	ADP
ecj-12463	77	109	agreement	agreement	NOUN
ecj-12463	77	110	with	with	ADP
ecj-12463	77	111	these	these	DET
ecj-12463	77	112	findings	finding	NOUN
ecj-12463	77	113	,	,	PUNCT
ecj-12463	77	114	a	a	DET
ecj-12463	77	115	recent	recent	ADJ
ecj-12463	77	116	meta	meta	ADJ
ecj-12463	77	117	-	-	PUNCT
ecj-12463	77	118	analysis	analysis	NOUN
ecj-12463	77	119	and	and	CCONJ
ecj-12463	77	120	a	a	DET
ecj-12463	77	121	prospective	prospective	ADJ
ecj-12463	77	122	observational	observational	ADJ
ecj-12463	77	123	study	study	NOUN
ecj-12463	77	124	investigated	investigate	VERB
ecj-12463	77	125	the	the	DET
ecj-12463	77	126	association	association	NOUN
ecj-12463	77	127	between	between	ADP
ecj-12463	77	128	sst2	sst2	PROPN
ecj-12463	77	129	and	and	CCONJ
ecj-12463	77	130	long	long	ADJ
ecj-12463	77	131	-	-	PUNCT
ecj-12463	77	132	term	term	NOUN
ecj-12463	77	133	prognosis	prognosis	NOUN
ecj-12463	77	134	of	of	ADP
ecj-12463	77	135	patients	patient	NOUN
ecj-12463	77	136	with	with	ADP
ecj-12463	77	137	cvd	cvd	PROPN
ecj-12463	77	138	showing	show	VERB
ecj-12463	77	139	that	that	SCONJ
ecj-12463	77	140	elevated	elevated	ADJ
ecj-12463	77	141	baseline	baseline	NOUN
ecj-12463	77	142	sst2	sst2	NOUN
ecj-12463	77	143	concentrations	concentration	NOUN
ecj-12463	77	144	were	be	AUX
ecj-12463	77	145	associated	associate	VERB
ecj-12463	77	146	with	with	ADP
ecj-12463	77	147	higher	high	ADJ
ecj-12463	77	148	risk	risk	NOUN
ecj-12463	77	149	of	of	ADP
ecj-12463	77	150	major	major	ADJ
ecj-12463	77	151	adverse	adverse	ADJ
ecj-12463	77	152	cardiovascular	cardiovascular	ADJ
ecj-12463	77	153	events	event	NOUN
ecj-12463	77	154	(	(	PUNCT
ecj-12463	77	155	mace).41,42	mace).41,42	PROPN
ecj-12463	77	156	chen	chen	PROPN
ecj-12463	77	157	et	et	PROPN
ecj-12463	77	158	al	al	PROPN
ecj-12463	77	159	.	.	PROPN
ecj-12463	77	160	hypothesized	hypothesize	VERB
ecj-12463	77	161	that	that	SCONJ
ecj-12463	77	162	in	in	ADP
ecj-12463	77	163	a	a	DET
ecj-12463	77	164	cohort	cohort	NOUN
ecj-12463	77	165	of	of	ADP
ecj-12463	77	166	patients	patient	NOUN
ecj-12463	77	167	admitted	admit	VERB
ecj-12463	77	168	to	to	ADP
ecj-12463	77	169	hospital	hospital	NOUN
ecj-12463	77	170	with	with	ADP
ecj-12463	77	171	various	various	ADJ
ecj-12463	77	172	forms	form	NOUN
ecj-12463	77	173	of	of	ADP
ecj-12463	77	174	cvd	cvd	PROPN
ecj-12463	77	175	higher	high	ADJ
ecj-12463	77	176	sst2	sst2	PROPN
ecj-12463	77	177	level	level	NOUN
ecj-12463	77	178	correlated	correlate	VERB
ecj-12463	77	179	with	with	ADP
ecj-12463	77	180	the	the	DET
ecj-12463	77	181	risk	risk	NOUN
ecj-12463	77	182	of	of	ADP
ecj-12463	77	183	future	future	ADJ
ecj-12463	77	184	hospital	hospital	NOUN
ecj-12463	77	185	admission	admission	NOUN
ecj-12463	77	186	due	due	ADP
ecj-12463	77	187	to	to	ADP
ecj-12463	77	188	mace	mace	VERB
ecj-12463	77	189	within	within	ADP
ecj-12463	77	190	1	1	NUM
ecj-12463	77	191	year.43	year.43	NOUN
ecj-12463	77	192	supar	supar	NOUN
ecj-12463	77	193	the	the	DET
ecj-12463	77	194	soluble	soluble	ADJ
ecj-12463	77	195	urokinase	urokinase	NOUN
ecj-12463	77	196	plasminogen	plasminogen	NOUN
ecj-12463	77	197	activator	activator	NOUN
ecj-12463	77	198	receptor	receptor	NOUN
ecj-12463	77	199	(	(	PUNCT
ecj-12463	77	200	supar	supar	NOUN
ecj-12463	77	201	)	)	PUNCT
ecj-12463	77	202	is	be	AUX
ecj-12463	77	203	a	a	DET
ecj-12463	77	204	soluble	soluble	ADJ
ecj-12463	77	205	form	form	NOUN
ecj-12463	77	206	of	of	ADP
ecj-12463	77	207	the	the	DET
ecj-12463	77	208	urokinase	urokinase	NOUN
ecj-12463	77	209	plasminogen	plasminogen	NOUN
ecj-12463	77	210	activator	activator	NOUN
ecj-12463	77	211	receptor	receptor	NOUN
ecj-12463	77	212	(	(	PUNCT
ecj-12463	77	213	upar	upar	NOUN
ecj-12463	77	214	)	)	PUNCT
ecj-12463	77	215	,	,	PUNCT
ecj-12463	77	216	bound	bind	VERB
ecj-12463	77	217	to	to	ADP
ecj-12463	77	218	the	the	DET
ecj-12463	77	219	cell	cell	NOUN
ecj-12463	77	220	membrane	membrane	NOUN
ecj-12463	77	221	across	across	ADP
ecj-12463	77	222	a	a	DET
ecj-12463	77	223	glycosylphosphatidylinositol	glycosylphosphatidylinositol	ADJ
ecj-12463	77	224	anchor	anchor	NOUN
ecj-12463	77	225	,	,	PUNCT
ecj-12463	77	226	and	and	CCONJ
ecj-12463	77	227	released	release	VERB
ecj-12463	77	228	from	from	ADP
ecj-12463	77	229	the	the	DET
ecj-12463	77	230	proteolytic	proteolytic	ADJ
ecj-12463	77	231	cleavage	cleavage	NOUN
ecj-12463	77	232	of	of	ADP
ecj-12463	77	233	upar.44	upar.44	NOUN
ecj-12463	77	234	this	this	DET
ecj-12463	77	235	protein	protein	NOUN
ecj-12463	77	236	is	be	AUX
ecj-12463	77	237	anchored	anchor	VERB
ecj-12463	77	238	to	to	ADP
ecj-12463	77	239	the	the	DET
ecj-12463	77	240	membranes	membrane	NOUN
ecj-12463	77	241	of	of	ADP
ecj-12463	77	242	different	different	ADJ
ecj-12463	77	243	types	type	NOUN
ecj-12463	77	244	of	of	ADP
ecj-12463	77	245	cells	cell	NOUN
ecj-12463	77	246	,	,	PUNCT
ecj-12463	77	247	like	like	ADP
ecj-12463	77	248	endothelial	endothelial	NOUN
ecj-12463	77	249	and	and	CCONJ
ecj-12463	77	250	smooth	smooth	ADJ
ecj-12463	77	251	cells	cell	NOUN
ecj-12463	77	252	,	,	PUNCT
ecj-12463	77	253	and	and	CCONJ
ecj-12463	77	254	it	it	PRON
ecj-12463	77	255	is	be	AUX
ecj-12463	77	256	involved	involve	VERB
ecj-12463	77	257	in	in	ADP
ecj-12463	77	258	different	different	ADJ
ecj-12463	77	259	pathophysiological	pathophysiological	ADJ
ecj-12463	77	260	pathways	pathway	NOUN
ecj-12463	77	261	,	,	PUNCT
ecj-12463	77	262	like	like	ADP
ecj-12463	77	263	plasminogen	plasminogen	NOUN
ecj-12463	77	264	activation	activation	NOUN
ecj-12463	77	265	,	,	PUNCT
ecj-12463	77	266	fibrinolysis	fibrinolysis	NOUN
ecj-12463	77	267	,	,	PUNCT
ecj-12463	77	268	angiogenesis	angiogenesis	NOUN
ecj-12463	77	269	,	,	PUNCT
ecj-12463	77	270	and	and	CCONJ
ecj-12463	77	271	inflammatory	inflammatory	ADJ
ecj-12463	77	272	response	response	NOUN
ecj-12463	77	273	,	,	PUNCT
ecj-12463	77	274	contributing	contribute	VERB
ecj-12463	77	275	to	to	ADP
ecj-12463	77	276	leukocyte	leukocyte	NOUN
ecj-12463	77	277	migration.45,46	migration.45,46	NOUN
ecj-12463	77	278	supar	supar	NOUN
ecj-12463	77	279	is	be	AUX
ecj-12463	77	280	mainly	mainly	ADV
ecj-12463	77	281	localized	localize	VERB
ecj-12463	77	282	in	in	ADP
ecj-12463	77	283	immunity	immunity	NOUN
ecj-12463	77	284	cells	cell	NOUN
ecj-12463	77	285	;	;	PUNCT
ecj-12463	77	286	therefore	therefore	ADV
ecj-12463	77	287	,	,	PUNCT
ecj-12463	77	288	plasma	plasma	NOUN
ecj-12463	77	289	levels	level	NOUN
ecj-12463	77	290	of	of	ADP
ecj-12463	77	291	this	this	DET
ecj-12463	77	292	protein	protein	NOUN
ecj-12463	77	293	correlate	correlate	VERB
ecj-12463	77	294	to	to	ADP
ecj-12463	77	295	immunological	immunological	ADJ
ecj-12463	77	296	activation.3	activation.3	NOUN
ecj-12463	77	297	a	a	DET
ecj-12463	77	298	correlation	correlation	NOUN
ecj-12463	77	299	between	between	ADP
ecj-12463	77	300	increased	increase	VERB
ecj-12463	77	301	supar	supar	NOUN
ecj-12463	77	302	values	value	NOUN
ecj-12463	77	303	and	and	CCONJ
ecj-12463	77	304	molecules	molecule	NOUN
ecj-12463	77	305	involved	involve	VERB
ecj-12463	77	306	in	in	ADP
ecj-12463	77	307	the	the	DET
ecj-12463	77	308	inflammatory	inflammatory	ADJ
ecj-12463	77	309	response	response	NOUN
ecj-12463	77	310	like	like	ADP
ecj-12463	77	311	tnfα	tnfα	NOUN
ecj-12463	77	312	,	,	PUNCT
ecj-12463	77	313	il-6	il-6	NOUN
ecj-12463	77	314	,	,	PUNCT
ecj-12463	77	315	and	and	CCONJ
ecj-12463	77	316	crp	crp	PROPN
ecj-12463	77	317	is	be	AUX
ecj-12463	77	318	known.45	known.45	PROPN
ecj-12463	77	319	supar	supar	NOUN
ecj-12463	77	320	can	can	AUX
ecj-12463	77	321	be	be	AUX
ecj-12463	77	322	measured	measure	VERB
ecj-12463	77	323	in	in	ADP
ecj-12463	77	324	different	different	ADJ
ecj-12463	77	325	biological	biological	ADJ
ecj-12463	77	326	fluids	fluid	NOUN
ecj-12463	77	327	,	,	PUNCT
ecj-12463	77	328	like	like	ADP
ecj-12463	77	329	plasma	plasma	NOUN
ecj-12463	77	330	,	,	PUNCT
ecj-12463	77	331	urine	urine	NOUN
ecj-12463	77	332	,	,	PUNCT
ecj-12463	77	333	and	and	CCONJ
ecj-12463	77	334	cerebrospinal	cerebrospinal	ADJ
ecj-12463	77	335	fluid;47	fluid;47	NOUN
ecj-12463	77	336	generally	generally	ADV
ecj-12463	77	337	,	,	PUNCT
ecj-12463	77	338	it	it	PRON
ecj-12463	77	339	is	be	AUX
ecj-12463	77	340	assessed	assess	VERB
ecj-12463	77	341	in	in	ADP
ecj-12463	77	342	plasma	plasma	NOUN
ecj-12463	77	343	using	use	VERB
ecj-12463	77	344	the	the	DET
ecj-12463	77	345	enzyme	enzyme	NOUN
ecj-12463	77	346	-	-	PUNCT
ecj-12463	77	347	linked	link	VERB
ecj-12463	77	348	immunosorbent	immunosorbent	NOUN
ecj-12463	77	349	test	test	NOUN
ecj-12463	77	350	(	(	PUNCT
ecj-12463	77	351	elisa).44	elisa).44	X
ecj-12463	77	352	commonly	commonly	ADV
ecj-12463	77	353	,	,	PUNCT
ecj-12463	77	354	values	value	NOUN
ecj-12463	77	355	<3	<3	X
ecj-12463	77	356	ng	ng	PROPN
ecj-12463	77	357	/	/	SYM
ecj-12463	77	358	ml	ml	NOUN
ecj-12463	77	359	are	be	AUX
ecj-12463	77	360	considered	consider	VERB
ecj-12463	77	361	normal	normal	ADJ
ecj-12463	77	362	,	,	PUNCT
ecj-12463	77	363	values	value	NOUN
ecj-12463	77	364	>	>	X
ecj-12463	77	365	6	6	NUM
ecj-12463	77	366	ng	ng	NOUN
ecj-12463	77	367	/	/	SYM
ecj-12463	77	368	ml	ml	X
ecj-12463	77	369	are	be	AUX
ecj-12463	77	370	indicative	indicative	ADJ
ecj-12463	77	371	of	of	ADP
ecj-12463	77	372	abnormalities	abnormality	NOUN
ecj-12463	77	373	,	,	PUNCT
ecj-12463	77	374	and	and	CCONJ
ecj-12463	77	375	intermediate	intermediate	ADJ
ecj-12463	77	376	values	value	NOUN
ecj-12463	77	377	(	(	PUNCT
ecj-12463	77	378	3	3	NUM
ecj-12463	77	379	-	-	SYM
ecj-12463	77	380	6	6	NUM
ecj-12463	77	381	ng	ng	PROPN
ecj-12463	77	382	/	/	SYM
ecj-12463	77	383	ml	ml	NOUN
ecj-12463	77	384	)	)	PUNCT
ecj-12463	77	385	need	need	VERB
ecj-12463	77	386	to	to	PART
ecj-12463	77	387	be	be	AUX
ecj-12463	77	388	contextualized.45	contextualized.45	NOUN
ecj-12463	77	389	literature	literature	NOUN
ecj-12463	77	390	reports	report	VERB
ecj-12463	77	391	variations	variation	NOUN
ecj-12463	77	392	in	in	ADP
ecj-12463	77	393	supar	supar	NOUN
ecj-12463	77	394	values	value	NOUN
ecj-12463	77	395	in	in	ADP
ecj-12463	77	396	relation	relation	NOUN
ecj-12463	77	397	to	to	PART
ecj-12463	77	398	socio	socio	VERB
ecj-12463	77	399	-	-	PUNCT
ecj-12463	77	400	biological	biological	ADJ
ecj-12463	77	401	factors	factor	NOUN
ecj-12463	77	402	.	.	PUNCT
ecj-12463	78	1	for	for	ADP
ecj-12463	78	2	example	example	NOUN
ecj-12463	78	3	,	,	PUNCT
ecj-12463	78	4	differences	difference	NOUN
ecj-12463	78	5	based	base	VERB
ecj-12463	78	6	on	on	ADP
ecj-12463	78	7	sex	sex	NOUN
ecj-12463	78	8	and	and	CCONJ
ecj-12463	78	9	age	age	NOUN
ecj-12463	78	10	are	be	AUX
ecj-12463	78	11	known	know	VERB
ecj-12463	78	12	;	;	PUNCT
ecj-12463	78	13	in	in	ADP
ecj-12463	78	14	their	their	PRON
ecj-12463	78	15	study	study	NOUN
ecj-12463	78	16	,	,	PUNCT
ecj-12463	78	17	rasmussen	rasmussen	PROPN
ecj-12463	78	18	et	et	PROPN
ecj-12463	78	19	al	al	PROPN
ecj-12463	78	20	.	.	PROPN
ecj-12463	78	21	showed	show	VERB
ecj-12463	78	22	that	that	SCONJ
ecj-12463	78	23	men	man	NOUN
ecj-12463	78	24	and	and	CCONJ
ecj-12463	78	25	women	woman	NOUN
ecj-12463	78	26	≥74	≥74	NOUN
ecj-12463	78	27	years	year	NOUN
ecj-12463	78	28	present	present	ADJ
ecj-12463	78	29	approximately	approximately	ADV
ecj-12463	78	30	the	the	DET
ecj-12463	78	31	same	same	ADJ
ecj-12463	78	32	supar	supar	NOUN
ecj-12463	78	33	levels	level	NOUN
ecj-12463	78	34	,	,	PUNCT
ecj-12463	78	35	while	while	SCONJ
ecj-12463	78	36	in	in	ADP
ecj-12463	78	37	younger	young	ADJ
ecj-12463	78	38	women	woman	NOUN
ecj-12463	78	39	supar	supar	PROPN
ecj-12463	78	40	levels	level	NOUN
ecj-12463	78	41	are	be	AUX
ecj-12463	78	42	higher	high	ADJ
ecj-12463	78	43	;	;	PUNCT
ecj-12463	78	44	however	however	ADV
ecj-12463	78	45	,	,	PUNCT
ecj-12463	78	46	in	in	ADP
ecj-12463	78	47	males	male	NOUN
ecj-12463	78	48	supar	supar	PROPN
ecj-12463	78	49	appears	appear	VERB
ecj-12463	78	50	to	to	PART
ecj-12463	78	51	rise	rise	VERB
ecj-12463	78	52	more	more	ADV
ecj-12463	78	53	with	with	ADP
ecj-12463	78	54	increasing	increase	VERB
ecj-12463	78	55	age	age	NOUN
ecj-12463	78	56	than	than	ADP
ecj-12463	78	57	in	in	ADP
ecj-12463	78	58	women.45	women.45	NOUN
ecj-12463	78	59	furthermore	furthermore	ADV
ecj-12463	78	60	,	,	PUNCT
ecj-12463	78	61	habits	habit	NOUN
ecj-12463	78	62	like	like	ADP
ecj-12463	78	63	drinking	drink	VERB
ecj-12463	78	64	or	or	CCONJ
ecj-12463	78	65	smoking	smoking	NOUN
ecj-12463	78	66	appear	appear	VERB
ecj-12463	78	67	to	to	PART
ecj-12463	78	68	be	be	AUX
ecj-12463	78	69	related	relate	VERB
ecj-12463	78	70	to	to	ADP
ecj-12463	78	71	increased	increase	VERB
ecj-12463	78	72	supar	supar	NOUN
ecj-12463	78	73	values.48	values.48	ADJ
ecj-12463	78	74	about	about	ADP
ecj-12463	78	75	that	that	PRON
ecj-12463	78	76	,	,	PUNCT
ecj-12463	78	77	wohlwend	wohlwend	VERB
ecj-12463	78	78	et	et	PROPN
ecj-12463	78	79	al	al	PROPN
ecj-12463	78	80	.	.	PROPN
ecj-12463	78	81	demonstrated	demonstrate	VERB
ecj-12463	78	82	higher	high	ADJ
ecj-12463	78	83	supar	supar	NOUN
ecj-12463	78	84	plasma	plasma	NOUN
ecj-12463	78	85	levels	level	NOUN
ecj-12463	78	86	in	in	ADP
ecj-12463	78	87	smokers	smoker	NOUN
ecj-12463	78	88	,	,	PUNCT
ecj-12463	78	89	an	an	DET
ecj-12463	78	90	inverse	inverse	NOUN
ecj-12463	78	91	proportionality	proportionality	NOUN
ecj-12463	78	92	between	between	ADP
ecj-12463	78	93	supar	supar	PROPN
ecj-12463	78	94	and	and	CCONJ
ecj-12463	78	95	hdl	hdl	PROPN
ecj-12463	78	96	serum	serum	PROPN
ecj-12463	78	97	values	value	NOUN
ecj-12463	78	98	,	,	PUNCT
ecj-12463	78	99	and	and	CCONJ
ecj-12463	78	100	the	the	DET
ecj-12463	78	101	relationship	relationship	NOUN
ecj-12463	78	102	between	between	ADP
ecj-12463	78	103	supar	supar	NOUN
ecj-12463	78	104	and	and	CCONJ
ecj-12463	78	105	endothelial	endothelial	PROPN
ecj-12463	78	106	dysfunction.49	dysfunction.49	PROPN
ecj-12463	78	107	due	due	ADP
ecj-12463	78	108	to	to	ADP
ecj-12463	78	109	its	its	PRON
ecj-12463	78	110	involvement	involvement	NOUN
ecj-12463	78	111	in	in	ADP
ecj-12463	78	112	various	various	ADJ
ecj-12463	78	113	pathophysiological	pathophysiological	ADJ
ecj-12463	78	114	pathways	pathway	NOUN
ecj-12463	78	115	and	and	CCONJ
ecj-12463	78	116	its	its	PRON
ecj-12463	78	117	examination	examination	NOUN
ecj-12463	78	118	review	review	NOUN
ecj-12463	79	1	[	[	X
ecj-12463	79	2	page	page	NOUN
ecj-12463	79	3	51	51	NUM
ecj-12463	79	4	]	]	PUNCT
ecj-12463	80	1	[	[	X
ecj-12463	80	2	emergency	emergency	NOUN
ecj-12463	80	3	care	care	NOUN
ecj-12463	80	4	journal	journal	PROPN
ecj-12463	80	5	2024	2024	NUM
ecj-12463	80	6	;	;	PUNCT
ecj-12463	80	7	20:12463	20:12463	NUM
ecj-12463	80	8	]	]	X
ecj-12463	80	9	non	non	ADJ
ecj-12463	80	10	-co	-co	PROPN
ecj-12463	80	11	mmerc	mmerc	PROPN
ecj-12463	80	12	ial	ial	PROPN
ecj-12463	80	13	us	us	PROPN
ecj-12463	80	14	e	e	NOUN
ecj-12463	80	15	o	o	X
ecj-12463	80	16	nly	nly	ADV
ecj-12463	80	17	in	in	ADP
ecj-12463	80	18	various	various	ADJ
ecj-12463	80	19	situations	situation	NOUN
ecj-12463	80	20	for	for	ADP
ecj-12463	80	21	its	its	PRON
ecj-12463	80	22	diagnostic	diagnostic	ADJ
ecj-12463	80	23	and	and	CCONJ
ecj-12463	80	24	prognostic	prognostic	ADJ
ecj-12463	80	25	role	role	NOUN
ecj-12463	80	26	,	,	PUNCT
ecj-12463	80	27	supar	supar	NOUN
ecj-12463	80	28	has	have	AUX
ecj-12463	80	29	generated	generate	VERB
ecj-12463	80	30	a	a	DET
ecj-12463	80	31	great	great	ADJ
ecj-12463	80	32	deal	deal	NOUN
ecj-12463	80	33	of	of	ADP
ecj-12463	80	34	fascination	fascination	NOUN
ecj-12463	80	35	in	in	ADP
ecj-12463	80	36	recent	recent	ADJ
ecj-12463	80	37	years	year	NOUN
ecj-12463	80	38	.	.	PUNCT
ecj-12463	81	1	it	it	PRON
ecj-12463	81	2	has	have	AUX
ecj-12463	81	3	been	be	AUX
ecj-12463	81	4	studied	study	VERB
ecj-12463	81	5	,	,	PUNCT
ecj-12463	81	6	for	for	ADP
ecj-12463	81	7	instance	instance	NOUN
ecj-12463	81	8	,	,	PUNCT
ecj-12463	81	9	in	in	ADP
ecj-12463	81	10	cases	case	NOUN
ecj-12463	81	11	of	of	ADP
ecj-12463	81	12	septic	septic	ADJ
ecj-12463	81	13	shock	shock	NOUN
ecj-12463	81	14	,	,	PUNCT
ecj-12463	81	15	acute	acute	NOUN
ecj-12463	81	16	pancreatitis	pancreatitis	NOUN
ecj-12463	81	17	,	,	PUNCT
ecj-12463	81	18	cardiovascular	cardiovascular	ADJ
ecj-12463	81	19	and	and	CCONJ
ecj-12463	81	20	pulmonary	pulmonary	ADJ
ecj-12463	81	21	disease	disease	NOUN
ecj-12463	81	22	,	,	PUNCT
ecj-12463	81	23	and	and	CCONJ
ecj-12463	81	24	sars	sar	NOUN
ecj-12463	81	25	-	-	PUNCT
ecj-12463	81	26	cov-2	cov-2	NOUN
ecj-12463	81	27	infection.47	infection.47	NOUN
ecj-12463	81	28	a	a	DET
ecj-12463	81	29	few	few	ADJ
ecj-12463	81	30	numbers	number	NOUN
ecj-12463	81	31	of	of	ADP
ecj-12463	81	32	studies	study	NOUN
ecj-12463	81	33	show	show	VERB
ecj-12463	81	34	a	a	DET
ecj-12463	81	35	relationship	relationship	NOUN
ecj-12463	81	36	between	between	ADP
ecj-12463	81	37	supar	supar	NOUN
ecj-12463	81	38	and	and	CCONJ
ecj-12463	81	39	proinflammatory	proinflammatory	ADJ
ecj-12463	81	40	cytokines	cytokine	NOUN
ecj-12463	81	41	,	,	PUNCT
ecj-12463	81	42	including	include	VERB
ecj-12463	81	43	tnf	tnf	PROPN
ecj-12463	81	44	-	-	PUNCT
ecj-12463	81	45	α	α	PROPN
ecj-12463	81	46	,	,	PUNCT
ecj-12463	81	47	il-1β	il-1β	PROPN
ecj-12463	81	48	,	,	PUNCT
ecj-12463	81	49	and	and	CCONJ
ecj-12463	81	50	il-66,50	il-66,50	NUM
ecj-12463	81	51	which	which	PRON
ecj-12463	81	52	may	may	AUX
ecj-12463	81	53	be	be	AUX
ecj-12463	81	54	connected	connect	VERB
ecj-12463	81	55	to	to	ADP
ecj-12463	81	56	the	the	DET
ecj-12463	81	57	susceptibility	susceptibility	NOUN
ecj-12463	81	58	of	of	ADP
ecj-12463	81	59	the	the	DET
ecj-12463	81	60	atherosclerotic	atherosclerotic	ADJ
ecj-12463	81	61	plaque	plaque	NOUN
ecj-12463	81	62	to	to	ADP
ecj-12463	81	63	rupture.47	rupture.47	NOUN
ecj-12463	81	64	indeed	indeed	ADV
ecj-12463	81	65	,	,	PUNCT
ecj-12463	81	66	various	various	ADJ
ecj-12463	81	67	cell	cell	NOUN
ecj-12463	81	68	types	type	NOUN
ecj-12463	81	69	that	that	PRON
ecj-12463	81	70	express	express	VERB
ecj-12463	81	71	upar	upar	NOUN
ecj-12463	81	72	on	on	ADP
ecj-12463	81	73	their	their	PRON
ecj-12463	81	74	cell	cell	NOUN
ecj-12463	81	75	membranes	membrane	NOUN
ecj-12463	81	76	have	have	AUX
ecj-12463	81	77	been	be	AUX
ecj-12463	81	78	discovered	discover	VERB
ecj-12463	81	79	in	in	ADP
ecj-12463	81	80	the	the	DET
ecj-12463	81	81	atherosclerotic	atherosclerotic	ADJ
ecj-12463	81	82	arteries	artery	NOUN
ecj-12463	81	83	,	,	PUNCT
ecj-12463	81	84	including	include	VERB
ecj-12463	81	85	macrophages	macrophage	NOUN
ecj-12463	81	86	and	and	CCONJ
ecj-12463	81	87	endothelial	endothelial	ADJ
ecj-12463	81	88	cells	cell	NOUN
ecj-12463	81	89	.	.	PUNCT
ecj-12463	82	1	proinflammatory	proinflammatory	ADJ
ecj-12463	82	2	cytokines	cytokine	NOUN
ecj-12463	82	3	and	and	CCONJ
ecj-12463	82	4	proteolytic	proteolytic	ADJ
ecj-12463	82	5	enzymes	enzyme	NOUN
ecj-12463	82	6	are	be	AUX
ecj-12463	82	7	generated	generate	VERB
ecj-12463	82	8	throughout	throughout	ADP
ecj-12463	82	9	time	time	NOUN
ecj-12463	82	10	,	,	PUNCT
ecj-12463	82	11	increasing	increase	VERB
ecj-12463	82	12	the	the	DET
ecj-12463	82	13	quantity	quantity	NOUN
ecj-12463	82	14	of	of	ADP
ecj-12463	82	15	supar	supar	NOUN
ecj-12463	82	16	and	and	CCONJ
ecj-12463	82	17	encouraging	encourage	VERB
ecj-12463	82	18	upar	upar	NOUN
ecj-12463	82	19	cleavage.4	cleavage.4	PROPN
ecj-12463	82	20	hindi	hindi	PROPN
ecj-12463	82	21	et	et	PROPN
ecj-12463	82	22	al	al	PROPN
ecj-12463	82	23	.	.	PROPN
ecj-12463	82	24	showed	show	VERB
ecj-12463	82	25	increased	increase	VERB
ecj-12463	82	26	circulation	circulation	NOUN
ecj-12463	82	27	levels	level	NOUN
ecj-12463	82	28	of	of	ADP
ecj-12463	82	29	supar	supar	NOUN
ecj-12463	82	30	in	in	ADP
ecj-12463	82	31	supartg	supartg	ADJ
ecj-12463	82	32	animals	animal	NOUN
ecj-12463	82	33	with	with	ADP
ecj-12463	82	34	larger	large	ADJ
ecj-12463	82	35	atherosclerotic	atherosclerotic	ADJ
ecj-12463	82	36	plaques	plaque	NOUN
ecj-12463	82	37	in	in	ADP
ecj-12463	82	38	a	a	DET
ecj-12463	82	39	study	study	NOUN
ecj-12463	82	40	based	base	VERB
ecj-12463	82	41	on	on	ADP
ecj-12463	82	42	transgenic	transgenic	NOUN
ecj-12463	82	43	mice	mouse	NOUN
ecj-12463	82	44	(	(	PUNCT
ecj-12463	82	45	supartg	supartg	NOUN
ecj-12463	82	46	)	)	PUNCT
ecj-12463	82	47	.	.	PUNCT
ecj-12463	83	1	several	several	ADJ
ecj-12463	83	2	studies	study	NOUN
ecj-12463	83	3	have	have	AUX
ecj-12463	83	4	examined	examine	VERB
ecj-12463	83	5	the	the	DET
ecj-12463	83	6	connection	connection	NOUN
ecj-12463	83	7	between	between	ADP
ecj-12463	83	8	cardiovascular	cardiovascular	ADJ
ecj-12463	83	9	disease	disease	NOUN
ecj-12463	83	10	and	and	CCONJ
ecj-12463	83	11	supar	supar	NOUN
ecj-12463	83	12	levels	level	NOUN
ecj-12463	83	13	in	in	ADP
ecj-12463	83	14	recent	recent	ADJ
ecj-12463	83	15	years	year	NOUN
ecj-12463	83	16	,	,	PUNCT
ecj-12463	83	17	considering	consider	VERB
ecj-12463	83	18	the	the	DET
ecj-12463	83	19	protein	protein	NOUN
ecj-12463	83	20	’s	’s	PART
ecj-12463	83	21	function	function	NOUN
ecj-12463	83	22	in	in	ADP
ecj-12463	83	23	endothelial	endothelial	ADJ
ecj-12463	83	24	damage	damage	NOUN
ecj-12463	83	25	and	and	CCONJ
ecj-12463	83	26	inflammatory	inflammatory	ADJ
ecj-12463	83	27	response.50	response.50	NOUN
ecj-12463	83	28	in	in	ADP
ecj-12463	83	29	one	one	NUM
ecj-12463	83	30	of	of	ADP
ecj-12463	83	31	their	their	PRON
ecj-12463	83	32	meta	meta	ADJ
ecj-12463	83	33	-	-	PUNCT
ecj-12463	83	34	analyses	analysis	NOUN
ecj-12463	83	35	,	,	PUNCT
ecj-12463	83	36	pruc	pruc	PROPN
ecj-12463	83	37	et	et	PROPN
ecj-12463	83	38	al	al	PROPN
ecj-12463	83	39	.	.	PROPN
ecj-12463	83	40	underline	underline	VERB
ecj-12463	83	41	how	how	SCONJ
ecj-12463	83	42	supar	supar	NOUN
ecj-12463	83	43	seems	seem	VERB
ecj-12463	83	44	to	to	PART
ecj-12463	83	45	be	be	AUX
ecj-12463	83	46	involved	involve	VERB
ecj-12463	83	47	in	in	ADP
ecj-12463	83	48	the	the	DET
ecj-12463	83	49	pathogenesis	pathogenesis	NOUN
ecj-12463	83	50	of	of	ADP
ecj-12463	83	51	acs	acs	PROPN
ecj-12463	83	52	.	.	PUNCT
ecj-12463	84	1	indeed	indeed	ADV
ecj-12463	84	2	,	,	PUNCT
ecj-12463	84	3	in	in	ADP
ecj-12463	84	4	the	the	DET
ecj-12463	84	5	5	5	NUM
ecj-12463	84	6	studies	study	NOUN
ecj-12463	84	7	that	that	PRON
ecj-12463	84	8	they	they	PRON
ecj-12463	84	9	have	have	AUX
ecj-12463	84	10	examined	examine	VERB
ecj-12463	84	11	,	,	PUNCT
ecj-12463	84	12	including	include	VERB
ecj-12463	84	13	3417	3417	NUM
ecj-12463	84	14	patients	patient	NOUN
ecj-12463	84	15	(	(	PUNCT
ecj-12463	84	16	1148	1148	NUM
ecj-12463	84	17	with	with	ADP
ecj-12463	84	18	acs	acs	PROPN
ecj-12463	84	19	and	and	CCONJ
ecj-12463	84	20	2269	2269	NUM
ecj-12463	84	21	in	in	ADP
ecj-12463	84	22	the	the	DET
ecj-12463	84	23	control	control	NOUN
ecj-12463	84	24	group	group	NOUN
ecj-12463	84	25	)	)	PUNCT
ecj-12463	84	26	,	,	PUNCT
ecj-12463	84	27	they	they	PRON
ecj-12463	84	28	demonstrated	demonstrate	VERB
ecj-12463	84	29	a	a	DET
ecj-12463	84	30	statistically	statistically	ADV
ecj-12463	84	31	significant	significant	ADJ
ecj-12463	84	32	relationship	relationship	NOUN
ecj-12463	84	33	between	between	ADP
ecj-12463	84	34	acs	acs	PROPN
ecj-12463	84	35	and	and	CCONJ
ecj-12463	84	36	supar	supar	PROPN
ecj-12463	84	37	levels.47	levels.47	PROPN
ecj-12463	84	38	literature	literature	PROPN
ecj-12463	84	39	shows	show	VERB
ecj-12463	84	40	many	many	ADJ
ecj-12463	84	41	studies	study	NOUN
ecj-12463	84	42	which	which	PRON
ecj-12463	84	43	suggest	suggest	VERB
ecj-12463	84	44	that	that	SCONJ
ecj-12463	84	45	prognostic	prognostic	ADJ
ecj-12463	84	46	data	datum	NOUN
ecj-12463	84	47	may	may	AUX
ecj-12463	84	48	be	be	AUX
ecj-12463	84	49	obtained	obtain	VERB
ecj-12463	84	50	from	from	ADP
ecj-12463	84	51	supar	supar	NOUN
ecj-12463	84	52	for	for	ADP
ecj-12463	84	53	patients	patient	NOUN
ecj-12463	84	54	with	with	ADP
ecj-12463	84	55	suspected	suspect	VERB
ecj-12463	84	56	ami	ami	NOUN
ecj-12463	84	57	,	,	PUNCT
ecj-12463	84	58	considering	consider	VERB
ecj-12463	84	59	the	the	DET
ecj-12463	84	60	prognostic	prognostic	ADJ
ecj-12463	84	61	value	value	NOUN
ecj-12463	84	62	in	in	ADP
ecj-12463	84	63	the	the	DET
ecj-12463	84	64	short	short	ADJ
ecj-12463	84	65	and	and	CCONJ
ecj-12463	84	66	long	long	ADJ
ecj-12463	84	67	term	term	NOUN
ecj-12463	84	68	.	.	PUNCT
ecj-12463	85	1	in	in	ADP
ecj-12463	85	2	their	their	PRON
ecj-12463	85	3	study	study	NOUN
ecj-12463	85	4	,	,	PUNCT
ecj-12463	85	5	sörensen	sörensen	VERB
ecj-12463	85	6	et	et	PROPN
ecj-12463	85	7	al	al	PROPN
ecj-12463	85	8	.	.	PROPN
ecj-12463	86	1	evaluated	evaluate	VERB
ecj-12463	86	2	supar	supar	NOUN
ecj-12463	86	3	in	in	ADP
ecj-12463	86	4	a	a	DET
ecj-12463	86	5	population	population	NOUN
ecj-12463	86	6	of	of	ADP
ecj-12463	86	7	1314	1314	NUM
ecj-12463	86	8	patients	patient	NOUN
ecj-12463	86	9	presenting	present	VERB
ecj-12463	86	10	to	to	ADP
ecj-12463	86	11	the	the	DET
ecj-12463	86	12	emergency	emergency	NOUN
ecj-12463	86	13	department	department	NOUN
ecj-12463	86	14	for	for	ADP
ecj-12463	86	15	chest	chest	NOUN
ecj-12463	86	16	pain	pain	NOUN
ecj-12463	86	17	and	and	CCONJ
ecj-12463	86	18	suspected	suspect	VERB
ecj-12463	86	19	ami	ami	NOUN
ecj-12463	86	20	.	.	PUNCT
ecj-12463	87	1	to	to	PART
ecj-12463	87	2	evaluate	evaluate	VERB
ecj-12463	87	3	the	the	DET
ecj-12463	87	4	one	one	NUM
ecj-12463	87	5	-	-	PUNCT
ecj-12463	87	6	year	year	NOUN
ecj-12463	87	7	mortality	mortality	NOUN
ecj-12463	87	8	,	,	PUNCT
ecj-12463	87	9	these	these	DET
ecj-12463	87	10	patients	patient	NOUN
ecj-12463	87	11	have	have	AUX
ecj-12463	87	12	been	be	AUX
ecj-12463	87	13	followed	follow	VERB
ecj-12463	87	14	for	for	ADP
ecj-12463	87	15	12	12	NUM
ecj-12463	87	16	months	month	NOUN
ecj-12463	87	17	.	.	PUNCT
ecj-12463	88	1	supar	supar	PROPN
ecj-12463	88	2	levels	level	NOUN
ecj-12463	88	3	were	be	AUX
ecj-12463	88	4	slightly	slightly	ADV
ecj-12463	88	5	higher	high	ADJ
ecj-12463	88	6	in	in	ADP
ecj-12463	88	7	the	the	DET
ecj-12463	88	8	patients	patient	NOUN
ecj-12463	88	9	who	who	PRON
ecj-12463	88	10	were	be	AUX
ecj-12463	88	11	diagnosed	diagnose	VERB
ecj-12463	88	12	with	with	ADP
ecj-12463	88	13	ami	ami	NOUN
ecj-12463	88	14	than	than	ADP
ecj-12463	88	15	in	in	ADP
ecj-12463	88	16	the	the	DET
ecj-12463	88	17	non	non	ADJ
ecj-12463	88	18	-	-	ADJ
ecj-12463	88	19	ami	ami	ADJ
ecj-12463	88	20	patients	patient	NOUN
ecj-12463	88	21	;	;	PUNCT
ecj-12463	88	22	however	however	ADV
ecj-12463	88	23	,	,	PUNCT
ecj-12463	88	24	in	in	ADP
ecj-12463	88	25	this	this	DET
ecj-12463	88	26	study	study	NOUN
ecj-12463	88	27	,	,	PUNCT
ecj-12463	88	28	the	the	DET
ecj-12463	88	29	difference	difference	NOUN
ecj-12463	88	30	did	do	AUX
ecj-12463	88	31	not	not	PART
ecj-12463	88	32	reach	reach	VERB
ecj-12463	88	33	statistical	statistical	ADJ
ecj-12463	88	34	significance	significance	NOUN
ecj-12463	88	35	.	.	PUNCT
ecj-12463	89	1	follow	follow	VERB
ecj-12463	89	2	-	-	PUNCT
ecj-12463	89	3	up	up	NOUN
ecj-12463	89	4	of	of	ADP
ecj-12463	89	5	1	1	NUM
ecj-12463	89	6	year	year	NOUN
ecj-12463	89	7	documented	document	VERB
ecj-12463	89	8	39	39	NUM
ecj-12463	89	9	deaths	death	NOUN
ecj-12463	89	10	among	among	ADP
ecj-12463	89	11	non	non	ADJ
ecj-12463	89	12	-	-	ADJ
ecj-12463	89	13	ami	ami	ADJ
ecj-12463	89	14	patients	patient	NOUN
ecj-12463	89	15	and	and	CCONJ
ecj-12463	89	16	29	29	NUM
ecj-12463	89	17	among	among	ADP
ecj-12463	89	18	ami	ami	NOUN
ecj-12463	89	19	patients	patient	NOUN
ecj-12463	89	20	;	;	PUNCT
ecj-12463	89	21	in	in	ADP
ecj-12463	89	22	this	this	DET
ecj-12463	89	23	case	case	NOUN
ecj-12463	89	24	,	,	PUNCT
ecj-12463	89	25	supar	supar	NOUN
ecj-12463	89	26	was	be	AUX
ecj-12463	89	27	revealed	reveal	VERB
ecj-12463	89	28	to	to	PART
ecj-12463	89	29	be	be	AUX
ecj-12463	89	30	an	an	DET
ecj-12463	89	31	independent	independent	ADJ
ecj-12463	89	32	risk	risk	NOUN
ecj-12463	89	33	factor	factor	NOUN
ecj-12463	89	34	for	for	ADP
ecj-12463	89	35	all	all	DET
ecj-12463	89	36	-	-	PUNCT
ecj-12463	89	37	cause	cause	VERB
ecj-12463	89	38	mortality.51	mortality.51	PROPN
ecj-12463	89	39	a	a	DET
ecj-12463	89	40	recently	recently	ADV
ecj-12463	89	41	published	publish	VERB
ecj-12463	89	42	meta	meta	ADJ
ecj-12463	89	43	-	-	PUNCT
ecj-12463	89	44	analysis	analysis	NOUN
ecj-12463	89	45	by	by	ADP
ecj-12463	89	46	rehan	rehan	PROPN
ecj-12463	89	47	et	et	PROPN
ecj-12463	89	48	al	al	PROPN
ecj-12463	89	49	.	.	PROPN
ecj-12463	89	50	investigated	investigate	VERB
ecj-12463	89	51	the	the	DET
ecj-12463	89	52	impact	impact	NOUN
ecj-12463	89	53	of	of	ADP
ecj-12463	89	54	supar	supar	NOUN
ecj-12463	89	55	in	in	ADP
ecj-12463	89	56	the	the	DET
ecj-12463	89	57	setting	setting	NOUN
ecj-12463	89	58	of	of	ADP
ecj-12463	89	59	the	the	DET
ecj-12463	89	60	emergency	emergency	NOUN
ecj-12463	89	61	department	department	NOUN
ecj-12463	89	62	,	,	PUNCT
ecj-12463	89	63	valuing	value	VERB
ecj-12463	89	64	different	different	ADJ
ecj-12463	89	65	outcomes	outcome	NOUN
ecj-12463	89	66	such	such	ADJ
ecj-12463	89	67	as	as	ADP
ecj-12463	89	68	30	30	NUM
ecj-12463	89	69	-	-	PUNCT
ecj-12463	89	70	day	day	NOUN
ecj-12463	89	71	mortality	mortality	NOUN
ecj-12463	89	72	,	,	PUNCT
ecj-12463	89	73	90	90	NUM
ecj-12463	89	74	-	-	PUNCT
ecj-12463	89	75	day	day	NOUN
ecj-12463	89	76	mortality	mortality	NOUN
ecj-12463	89	77	,	,	PUNCT
ecj-12463	89	78	30	30	NUM
ecj-12463	89	79	-	-	PUNCT
ecj-12463	89	80	day	day	NOUN
ecj-12463	89	81	readmission	readmission	NOUN
ecj-12463	89	82	,	,	PUNCT
ecj-12463	89	83	discharge	discharge	VERB
ecj-12463	89	84	within	within	ADP
ecj-12463	89	85	24	24	NUM
ecj-12463	89	86	hours	hour	NOUN
ecj-12463	89	87	and	and	CCONJ
ecj-12463	89	88	length	length	NOUN
ecj-12463	89	89	of	of	ADP
ecj-12463	89	90	hospital	hospital	NOUN
ecj-12463	89	91	stay	stay	NOUN
ecj-12463	89	92	.	.	PUNCT
ecj-12463	90	1	in	in	ADP
ecj-12463	90	2	particular	particular	ADJ
ecj-12463	90	3	,	,	PUNCT
ecj-12463	90	4	they	they	PRON
ecj-12463	90	5	showed	show	VERB
ecj-12463	90	6	that	that	SCONJ
ecj-12463	90	7	there	there	PRON
ecj-12463	90	8	is	be	VERB
ecj-12463	90	9	a	a	DET
ecj-12463	90	10	higher	high	ADJ
ecj-12463	90	11	risk	risk	NOUN
ecj-12463	90	12	of	of	ADP
ecj-12463	90	13	death	death	NOUN
ecj-12463	90	14	within	within	ADP
ecj-12463	90	15	30	30	NUM
ecj-12463	90	16	and	and	CCONJ
ecj-12463	90	17	90	90	NUM
ecj-12463	90	18	days	day	NOUN
ecj-12463	90	19	when	when	SCONJ
ecj-12463	90	20	supar	supar	NOUN
ecj-12463	90	21	concentrations	concentration	NOUN
ecj-12463	90	22	are	be	AUX
ecj-12463	90	23	elevated	elevate	VERB
ecj-12463	90	24	.	.	PUNCT
ecj-12463	91	1	indeed	indeed	ADV
ecj-12463	91	2	,	,	PUNCT
ecj-12463	91	3	they	they	PRON
ecj-12463	91	4	observed	observe	VERB
ecj-12463	91	5	a	a	DET
ecj-12463	91	6	significant	significant	ADJ
ecj-12463	91	7	association	association	NOUN
ecj-12463	91	8	with	with	ADP
ecj-12463	91	9	30	30	NUM
ecj-12463	91	10	-	-	PUNCT
ecj-12463	91	11	day	day	NOUN
ecj-12463	91	12	readmissions	readmission	NOUN
ecj-12463	91	13	and	and	CCONJ
ecj-12463	91	14	a	a	DET
ecj-12463	91	15	lengthening	lengthen	VERB
ecj-12463	91	16	hospital	hospital	NOUN
ecj-12463	91	17	stay.3	stay.3	PROPN
ecj-12463	91	18	several	several	ADJ
ecj-12463	91	19	studies	study	NOUN
ecj-12463	91	20	demonstrated	demonstrate	VERB
ecj-12463	91	21	that	that	SCONJ
ecj-12463	91	22	supar	supar	NOUN
ecj-12463	91	23	is	be	AUX
ecj-12463	91	24	elevated	elevate	VERB
ecj-12463	91	25	in	in	ADP
ecj-12463	91	26	patients	patient	NOUN
ecj-12463	91	27	with	with	ADP
ecj-12463	91	28	cardiovascular	cardiovascular	ADJ
ecj-12463	91	29	disease	disease	NOUN
ecj-12463	91	30	and	and	CCONJ
ecj-12463	91	31	acute	acute	ADJ
ecj-12463	91	32	myocardial	myocardial	ADJ
ecj-12463	91	33	infarction	infarction	NOUN
ecj-12463	91	34	.	.	PUNCT
ecj-12463	92	1	in	in	ADP
ecj-12463	92	2	one	one	NUM
ecj-12463	92	3	of	of	ADP
ecj-12463	92	4	their	their	PRON
ecj-12463	92	5	studies	study	NOUN
ecj-12463	92	6	,	,	PUNCT
ecj-12463	92	7	chenevier	chenevier	NOUN
ecj-12463	92	8	-	-	PUNCT
ecj-12463	92	9	gobeaux	gobeaux	NOUN
ecj-12463	92	10	et	et	PROPN
ecj-12463	92	11	al	al	PROPN
ecj-12463	92	12	.	.	PROPN
ecj-12463	92	13	considered	consider	VERB
ecj-12463	92	14	the	the	DET
ecj-12463	92	15	early	early	ADJ
ecj-12463	92	16	prognostic	prognostic	ADJ
ecj-12463	92	17	value	value	NOUN
ecj-12463	92	18	of	of	ADP
ecj-12463	92	19	supar	supar	NOUN
ecj-12463	92	20	in	in	ADP
ecj-12463	92	21	patients	patient	NOUN
ecj-12463	92	22	presenting	present	VERB
ecj-12463	92	23	to	to	ADP
ecj-12463	92	24	the	the	DET
ecj-12463	92	25	ed	ed	NOUN
ecj-12463	92	26	with	with	ADP
ecj-12463	92	27	chest	chest	NOUN
ecj-12463	92	28	pain	pain	NOUN
ecj-12463	92	29	suggestive	suggestive	ADJ
ecj-12463	92	30	of	of	ADP
ecj-12463	92	31	acs	acs	PROPN
ecj-12463	92	32	,	,	PUNCT
ecj-12463	92	33	compared	compare	VERB
ecj-12463	92	34	to	to	ADP
ecj-12463	92	35	that	that	PRON
ecj-12463	92	36	of	of	ADP
ecj-12463	92	37	usual	usual	ADJ
ecj-12463	92	38	cardiac	cardiac	ADJ
ecj-12463	92	39	biomarkers	biomarker	NOUN
ecj-12463	92	40	.	.	PUNCT
ecj-12463	93	1	their	their	PRON
ecj-12463	93	2	results	result	NOUN
ecj-12463	93	3	showed	show	VERB
ecj-12463	93	4	that	that	SCONJ
ecj-12463	93	5	supar	supar	NOUN
ecj-12463	93	6	concentrations	concentration	NOUN
ecj-12463	93	7	at	at	ADP
ecj-12463	93	8	the	the	DET
ecj-12463	93	9	admission	admission	NOUN
ecj-12463	93	10	were	be	AUX
ecj-12463	93	11	higher	high	ADJ
ecj-12463	93	12	in	in	ADP
ecj-12463	93	13	chest	chest	NOUN
ecj-12463	93	14	pain	pain	NOUN
ecj-12463	93	15	patients	patient	NOUN
ecj-12463	93	16	with	with	ADP
ecj-12463	93	17	a	a	DET
ecj-12463	93	18	30day	30day	NOUN
ecj-12463	93	19	event	event	NOUN
ecj-12463	93	20	in	in	ADP
ecj-12463	93	21	comparison	comparison	NOUN
ecj-12463	93	22	to	to	ADP
ecj-12463	93	23	patients	patient	NOUN
ecj-12463	93	24	without	without	ADP
ecj-12463	93	25	,	,	PUNCT
ecj-12463	93	26	and	and	CCONJ
ecj-12463	93	27	a	a	DET
ecj-12463	93	28	supar	supar	NOUN
ecj-12463	93	29	value	value	NOUN
ecj-12463	93	30	at	at	ADP
ecj-12463	93	31	admission	admission	NOUN
ecj-12463	93	32	above	above	ADP
ecj-12463	93	33	3.3	3.3	NUM
ecj-12463	93	34	ng	ng	NOUN
ecj-12463	93	35	/	/	SYM
ecj-12463	93	36	ml	ml	PROPN
ecj-12463	93	37	was	be	AUX
ecj-12463	93	38	independently	independently	ADV
ecj-12463	93	39	associated	associate	VERB
ecj-12463	93	40	with	with	ADP
ecj-12463	93	41	a	a	DET
ecj-12463	93	42	30	30	NUM
ecj-12463	93	43	-	-	PUNCT
ecj-12463	93	44	day	day	NOUN
ecj-12463	93	45	event	event	NOUN
ecj-12463	93	46	.	.	PUNCT
ecj-12463	94	1	therefore	therefore	ADV
ecj-12463	94	2	,	,	PUNCT
ecj-12463	94	3	supar	supar	PROPN
ecj-12463	94	4	demonstrated	demonstrate	VERB
ecj-12463	94	5	to	to	PART
ecj-12463	94	6	be	be	AUX
ecj-12463	94	7	a	a	DET
ecj-12463	94	8	strong	strong	ADJ
ecj-12463	94	9	predictor	predictor	NOUN
ecj-12463	94	10	of	of	ADP
ecj-12463	94	11	mortality	mortality	NOUN
ecj-12463	94	12	and	and	CCONJ
ecj-12463	94	13	of	of	ADP
ecj-12463	94	14	readmission	readmission	NOUN
ecj-12463	94	15	.	.	PUNCT
ecj-12463	95	1	they	they	PRON
ecj-12463	95	2	also	also	ADV
ecj-12463	95	3	showed	show	VERB
ecj-12463	95	4	an	an	DET
ecj-12463	95	5	association	association	NOUN
ecj-12463	95	6	of	of	ADP
ecj-12463	95	7	heart	heart	NOUN
ecj-12463	95	8	score	score	NOUN
ecj-12463	95	9	(	(	PUNCT
ecj-12463	95	10	a	a	DET
ecj-12463	95	11	esc	esc	NOUN
ecj-12463	95	12	tool	tool	NOUN
ecj-12463	95	13	wich	wich	PRON
ecj-12463	95	14	calculate	calculate	VERB
ecj-12463	95	15	the	the	DET
ecj-12463	95	16	10	10	NUM
ecj-12463	95	17	-	-	PUNCT
ecj-12463	95	18	year	year	NOUN
ecj-12463	95	19	risk	risk	NOUN
ecj-12463	95	20	of	of	ADP
ecj-12463	95	21	fatal	fatal	ADJ
ecj-12463	95	22	and	and	CCONJ
ecj-12463	95	23	non	non	ADJ
ecj-12463	95	24	-	-	ADJ
ecj-12463	95	25	fatal	fatal	ADJ
ecj-12463	95	26	cardiovascular	cardiovascular	ADJ
ecj-12463	95	27	disease	disease	NOUN
ecj-12463	95	28	events	event	NOUN
ecj-12463	95	29	,	,	PUNCT
ecj-12463	95	30	based	base	VERB
ecj-12463	95	31	on	on	ADP
ecj-12463	95	32	5	5	NUM
ecj-12463	95	33	points	point	NOUN
ecj-12463	95	34	:	:	PUNCT
ecj-12463	95	35	history	history	NOUN
ecj-12463	95	36	,	,	PUNCT
ecj-12463	95	37	ecg	ecg	PROPN
ecj-12463	95	38	,	,	PUNCT
ecj-12463	95	39	age	age	NOUN
ecj-12463	95	40	,	,	PUNCT
ecj-12463	95	41	risk	risk	NOUN
ecj-12463	95	42	factors	factor	NOUN
ecj-12463	95	43	,	,	PUNCT
ecj-12463	95	44	troponin	troponin	ADJ
ecj-12463	95	45	)	)	PUNCT
ecj-12463	95	46	and	and	CCONJ
ecj-12463	95	47	biomarkers	biomarker	NOUN
ecj-12463	95	48	at	at	ADP
ecj-12463	95	49	admission	admission	NOUN
ecj-12463	95	50	;	;	PUNCT
ecj-12463	95	51	particularly	particularly	ADV
ecj-12463	95	52	,	,	PUNCT
ecj-12463	95	53	low	low	ADJ
ecj-12463	95	54	supar	supar	NOUN
ecj-12463	95	55	,	,	PUNCT
ecj-12463	95	56	low	low	ADJ
ecj-12463	95	57	nt	nt	NOUN
ecj-12463	95	58	-	-	PUNCT
ecj-12463	95	59	probnp	probnp	NOUN
ecj-12463	95	60	and	and	CCONJ
ecj-12463	95	61	a	a	DET
ecj-12463	95	62	low	low	ADJ
ecj-12463	95	63	heart	heart	NOUN
ecj-12463	95	64	score	score	NOUN
ecj-12463	95	65	had	have	VERB
ecj-12463	95	66	a	a	DET
ecj-12463	95	67	high	high	ADJ
ecj-12463	95	68	negative	negative	ADJ
ecj-12463	95	69	predictive	predictive	ADJ
ecj-12463	95	70	value	value	NOUN
ecj-12463	95	71	to	to	PART
ecj-12463	95	72	exclude	exclude	VERB
ecj-12463	95	73	a	a	DET
ecj-12463	95	74	30day	30day	NOUN
ecj-12463	95	75	event.52	event.52	NOUN
ecj-12463	95	76	in	in	ADP
ecj-12463	95	77	their	their	PRON
ecj-12463	95	78	study	study	NOUN
ecj-12463	95	79	based	base	VERB
ecj-12463	95	80	on	on	ADP
ecj-12463	95	81	1747	1747	NUM
ecj-12463	95	82	acute	acute	ADJ
ecj-12463	95	83	medical	medical	ADJ
ecj-12463	95	84	patients	patient	NOUN
ecj-12463	95	85	,	,	PUNCT
ecj-12463	95	86	santeri	santeri	PROPN
ecj-12463	95	87	et	et	PROPN
ecj-12463	95	88	al	al	PROPN
ecj-12463	95	89	.	.	PROPN
ecj-12463	95	90	proposed	propose	VERB
ecj-12463	95	91	possible	possible	ADJ
ecj-12463	95	92	cutoffs	cutoff	NOUN
ecj-12463	95	93	of	of	ADP
ecj-12463	95	94	supar	supar	NOUN
ecj-12463	95	95	to	to	PART
ecj-12463	95	96	predict	predict	VERB
ecj-12463	95	97	low	low	ADJ
ecj-12463	95	98	,	,	PUNCT
ecj-12463	95	99	medium	medium	ADJ
ecj-12463	95	100	and	and	CCONJ
ecj-12463	95	101	high	high	ADJ
ecj-12463	95	102	risk	risk	NOUN
ecj-12463	95	103	of	of	ADP
ecj-12463	95	104	30and	30and	NOUN
ecj-12463	95	105	90	90	NUM
ecj-12463	95	106	-	-	PUNCT
ecj-12463	95	107	day	day	NOUN
ecj-12463	95	108	follow	follow	NOUN
ecj-12463	95	109	-	-	PUNCT
ecj-12463	95	110	up	up	NOUN
ecj-12463	95	111	.	.	PUNCT
ecj-12463	96	1	of	of	ADP
ecj-12463	96	2	these	these	DET
ecj-12463	96	3	patients	patient	NOUN
ecj-12463	96	4	,	,	PUNCT
ecj-12463	96	5	almost	almost	ADV
ecj-12463	96	6	half	half	ADV
ecj-12463	96	7	had	have	VERB
ecj-12463	96	8	a	a	DET
ecj-12463	96	9	supar	supar	NOUN
ecj-12463	96	10	level	level	NOUN
ecj-12463	96	11	below	below	ADP
ecj-12463	96	12	4	4	NUM
ecj-12463	96	13	ng	ng	NOUN
ecj-12463	96	14	/	/	SYM
ecj-12463	96	15	ml	ml	PROPN
ecj-12463	96	16	,	,	PUNCT
ecj-12463	96	17	and	and	CCONJ
ecj-12463	96	18	the	the	DET
ecj-12463	96	19	30and	30and	NOUN
ecj-12463	96	20	90	90	NUM
ecj-12463	96	21	-	-	PUNCT
ecj-12463	96	22	day	day	NOUN
ecj-12463	96	23	risk	risk	NOUN
ecj-12463	96	24	of	of	ADP
ecj-12463	96	25	mortality	mortality	NOUN
ecj-12463	96	26	were	be	AUX
ecj-12463	96	27	below	below	ADP
ecj-12463	96	28	1	1	NUM
ecj-12463	96	29	%	%	NOUN
ecj-12463	96	30	,	,	PUNCT
ecj-12463	96	31	while	while	SCONJ
ecj-12463	96	32	patients	patient	NOUN
ecj-12463	96	33	with	with	ADP
ecj-12463	96	34	supar	supar	NOUN
ecj-12463	96	35	above	above	ADP
ecj-12463	96	36	6	6	NUM
ecj-12463	96	37	ng	ng	NOUN
ecj-12463	96	38	/	/	SYM
ecj-12463	96	39	ml	ml	PROPN
ecj-12463	96	40	had	have	VERB
ecj-12463	96	41	a	a	DET
ecj-12463	96	42	high	high	ADJ
ecj-12463	96	43	90	90	NUM
ecj-12463	96	44	-	-	PUNCT
ecj-12463	96	45	day	day	NOUN
ecj-12463	96	46	mortality	mortality	NOUN
ecj-12463	96	47	of	of	ADP
ecj-12463	96	48	20	20	NUM
ecj-12463	96	49	%	%	NOUN
ecj-12463	96	50	.	.	PUNCT
ecj-12463	97	1	in	in	ADP
ecj-12463	97	2	consideration	consideration	NOUN
ecj-12463	97	3	of	of	ADP
ecj-12463	97	4	these	these	DET
ecj-12463	97	5	data	datum	NOUN
ecj-12463	97	6	,	,	PUNCT
ecj-12463	97	7	they	they	PRON
ecj-12463	97	8	suggest	suggest	VERB
ecj-12463	97	9	that	that	SCONJ
ecj-12463	97	10	a	a	DET
ecj-12463	97	11	cut	cut	NOUN
ecj-12463	97	12	-	-	PUNCT
ecj-12463	97	13	off	off	NOUN
ecj-12463	97	14	below	below	ADP
ecj-12463	97	15	4	4	NUM
ecj-12463	97	16	ng	ng	NOUN
ecj-12463	97	17	/	/	SYM
ecj-12463	97	18	ml	ml	NOUN
ecj-12463	97	19	seems	seem	VERB
ecj-12463	97	20	useful	useful	ADJ
ecj-12463	97	21	as	as	ADP
ecj-12463	97	22	a	a	DET
ecj-12463	97	23	potential	potential	ADJ
ecj-12463	97	24	discharge	discharge	NOUN
ecj-12463	97	25	biomarker	biomarker	NOUN
ecj-12463	97	26	,	,	PUNCT
ecj-12463	97	27	and	and	CCONJ
ecj-12463	97	28	may	may	AUX
ecj-12463	97	29	be	be	AUX
ecj-12463	97	30	part	part	NOUN
ecj-12463	97	31	of	of	ADP
ecj-12463	97	32	a	a	DET
ecj-12463	97	33	decision	decision	NOUN
ecj-12463	97	34	to	to	PART
ecj-12463	97	35	discharge	discharge	VERB
ecj-12463	97	36	the	the	DET
ecj-12463	97	37	patient.53	patient.53	NOUN
ecj-12463	97	38	in	in	ADP
ecj-12463	97	39	their	their	PRON
ecj-12463	97	40	review	review	NOUN
ecj-12463	97	41	of	of	ADP
ecj-12463	97	42	39	39	NUM
ecj-12463	97	43	studies	study	NOUN
ecj-12463	97	44	,	,	PUNCT
ecj-12463	97	45	vellisaris	vellisaris	PROPN
ecj-12463	97	46	et	et	PROPN
ecj-12463	97	47	al	al	PROPN
ecj-12463	97	48	.	.	PROPN
ecj-12463	98	1	summarizes	summarize	VERB
ecj-12463	98	2	the	the	DET
ecj-12463	98	3	published	publish	VERB
ecj-12463	98	4	literature	literature	NOUN
ecj-12463	98	5	about	about	ADP
ecj-12463	98	6	supar	supar	NOUN
ecj-12463	98	7	values	value	NOUN
ecj-12463	98	8	in	in	ADP
ecj-12463	98	9	patients	patient	NOUN
ecj-12463	98	10	with	with	ADP
ecj-12463	98	11	cardiac	cardiac	ADJ
ecj-12463	98	12	diseases	disease	NOUN
ecj-12463	98	13	.	.	PUNCT
ecj-12463	99	1	they	they	PRON
ecj-12463	99	2	considered	consider	VERB
ecj-12463	99	3	patients	patient	NOUN
ecj-12463	99	4	with	with	ADP
ecj-12463	99	5	acute	acute	ADJ
ecj-12463	99	6	coronary	coronary	ADJ
ecj-12463	99	7	syndromes	syndrome	NOUN
ecj-12463	99	8	and	and	CCONJ
ecj-12463	99	9	congestive	congestive	ADJ
ecj-12463	99	10	heart	heart	NOUN
ecj-12463	99	11	failure	failure	NOUN
ecj-12463	99	12	,	,	PUNCT
ecj-12463	99	13	and	and	CCONJ
ecj-12463	99	14	demonstrated	demonstrate	VERB
ecj-12463	99	15	that	that	SCONJ
ecj-12463	99	16	supar	supar	NOUN
ecj-12463	99	17	elevation	elevation	NOUN
ecj-12463	99	18	may	may	AUX
ecj-12463	99	19	be	be	AUX
ecj-12463	99	20	an	an	DET
ecj-12463	99	21	independent	independent	ADJ
ecj-12463	99	22	predictor	predictor	NOUN
ecj-12463	99	23	of	of	ADP
ecj-12463	99	24	mortality	mortality	NOUN
ecj-12463	99	25	in	in	ADP
ecj-12463	99	26	these	these	DET
ecj-12463	99	27	conditions	condition	NOUN
ecj-12463	99	28	,	,	PUNCT
ecj-12463	99	29	representing	represent	VERB
ecj-12463	99	30	a	a	DET
ecj-12463	99	31	promising	promising	ADJ
ecj-12463	99	32	prognostic	prognostic	ADJ
ecj-12463	99	33	and	and	CCONJ
ecj-12463	99	34	diagnostic	diagnostic	ADJ
ecj-12463	99	35	indicator	indicator	NOUN
ecj-12463	99	36	for	for	ADP
ecj-12463	99	37	improved	improved	ADJ
ecj-12463	99	38	accuracy	accuracy	NOUN
ecj-12463	99	39	in	in	ADP
ecj-12463	99	40	patient	patient	ADJ
ecj-12463	99	41	risk	risk	NOUN
ecj-12463	99	42	stratification.54	stratification.54	ADV
ecj-12463	99	43	in	in	ADP
ecj-12463	99	44	their	their	PRON
ecj-12463	99	45	study	study	NOUN
ecj-12463	99	46	(	(	PUNCT
ecj-12463	99	47	stade	stade	NOUN
ecj-12463	99	48	-	-	PUNCT
ecj-12463	99	49	hf	hf	PROPN
ecj-12463	99	50	study	study	NOUN
ecj-12463	99	51	)	)	PUNCT
ecj-12463	99	52	,	,	PUNCT
ecj-12463	99	53	huet	huet	PROPN
ecj-12463	99	54	et	et	PROPN
ecj-12463	99	55	al	al	PROPN
ecj-12463	99	56	.	.	PROPN
ecj-12463	99	57	showed	show	VERB
ecj-12463	99	58	high	high	ADJ
ecj-12463	99	59	supar	supar	NOUN
ecj-12463	99	60	serum	serum	NOUN
ecj-12463	99	61	levels	level	NOUN
ecj-12463	99	62	in	in	ADP
ecj-12463	99	63	case	case	NOUN
ecj-12463	99	64	of	of	ADP
ecj-12463	99	65	hf	hf	NOUN
ecj-12463	99	66	,	,	PUNCT
ecj-12463	99	67	evaluating	evaluate	VERB
ecj-12463	99	68	its	its	PRON
ecj-12463	99	69	use	use	NOUN
ecj-12463	99	70	as	as	ADP
ecj-12463	99	71	a	a	DET
ecj-12463	99	72	prognosis	prognosis	NOUN
ecj-12463	99	73	biomarker	biomarker	NOUN
ecj-12463	99	74	in	in	ADP
ecj-12463	99	75	global	global	ADJ
ecj-12463	99	76	mortality	mortality	NOUN
ecj-12463	99	77	and	and	CCONJ
ecj-12463	99	78	risk	risk	NOUN
ecj-12463	99	79	of	of	ADP
ecj-12463	99	80	readmission	readmission	NOUN
ecj-12463	99	81	after	after	ADP
ecj-12463	99	82	acute	acute	ADJ
ecj-12463	99	83	hf	hf	NOUN
ecj-12463	99	84	.	.	PUNCT
ecj-12463	100	1	they	they	PRON
ecj-12463	100	2	measured	measure	VERB
ecj-12463	100	3	supar	supar	NOUN
ecj-12463	100	4	level	level	NOUN
ecj-12463	100	5	at	at	ADP
ecj-12463	100	6	patient	patient	ADJ
ecj-12463	100	7	admission	admission	NOUN
ecj-12463	100	8	in	in	ADP
ecj-12463	100	9	47	47	NUM
ecj-12463	100	10	patients	patient	NOUN
ecj-12463	100	11	from	from	ADP
ecj-12463	100	12	the	the	DET
ecj-12463	100	13	control	control	NOUN
ecj-12463	100	14	group	group	NOUN
ecj-12463	100	15	;	;	PUNCT
ecj-12463	100	16	moreover	moreover	ADV
ecj-12463	100	17	,	,	PUNCT
ecj-12463	100	18	they	they	PRON
ecj-12463	100	19	measured	measure	VERB
ecj-12463	100	20	sst2	sst2	NOUN
ecj-12463	100	21	in	in	ADP
ecj-12463	100	22	50	50	NUM
ecj-12463	100	23	patients	patient	NOUN
ecj-12463	100	24	belonging	belong	VERB
ecj-12463	100	25	to	to	ADP
ecj-12463	100	26	the	the	DET
ecj-12463	100	27	sst2	sst2	NOUN
ecj-12463	100	28	group	group	NOUN
ecj-12463	100	29	.	.	PUNCT
ecj-12463	101	1	they	they	PRON
ecj-12463	101	2	proved	prove	VERB
ecj-12463	101	3	that	that	SCONJ
ecj-12463	101	4	supar	supar	NOUN
ecj-12463	101	5	levels	level	NOUN
ecj-12463	101	6	were	be	AUX
ecj-12463	101	7	independently	independently	ADV
ecj-12463	101	8	associated	associate	VERB
ecj-12463	101	9	with	with	ADP
ecj-12463	101	10	mortality	mortality	NOUN
ecj-12463	101	11	at	at	ADP
ecj-12463	101	12	1	1	NUM
ecj-12463	101	13	month	month	NOUN
ecj-12463	101	14	and	and	CCONJ
ecj-12463	101	15	1	1	NUM
ecj-12463	101	16	year	year	NOUN
ecj-12463	101	17	for	for	ADP
ecj-12463	101	18	patients	patient	NOUN
ecj-12463	101	19	with	with	ADP
ecj-12463	101	20	acute	acute	ADJ
ecj-12463	101	21	hf	hf	NOUN
ecj-12463	101	22	,	,	PUNCT
ecj-12463	101	23	but	but	CCONJ
ecj-12463	101	24	without	without	ADP
ecj-12463	101	25	significant	significant	ADJ
ecj-12463	101	26	prediction	prediction	NOUN
ecj-12463	101	27	of	of	ADP
ecj-12463	101	28	the	the	DET
ecj-12463	101	29	hospitalization	hospitalization	NOUN
ecj-12463	101	30	risk	risk	NOUN
ecj-12463	101	31	and	and	CCONJ
ecj-12463	101	32	it	it	PRON
ecj-12463	101	33	was	be	AUX
ecj-12463	101	34	a	a	DET
ecj-12463	101	35	stronger	strong	ADJ
ecj-12463	101	36	predictor	predictor	NOUN
ecj-12463	101	37	for	for	ADP
ecj-12463	101	38	mortality	mortality	NOUN
ecj-12463	101	39	than	than	ADP
ecj-12463	101	40	other	other	ADJ
ecj-12463	101	41	biomarkers	biomarker	NOUN
ecj-12463	101	42	(	(	PUNCT
ecj-12463	101	43	sst2	sst2	NOUN
ecj-12463	101	44	,	,	PUNCT
ecj-12463	101	45	ntprobnp	ntprobnp	NOUN
ecj-12463	101	46	or	or	CCONJ
ecj-12463	101	47	crp).34	crp).34	NOUN
ecj-12463	101	48	bengaard	bengaard	NOUN
ecj-12463	101	49	et	et	PROPN
ecj-12463	101	50	al	al	PROPN
ecj-12463	101	51	.	.	PROPN
ecj-12463	101	52	described	describe	VERB
ecj-12463	101	53	an	an	DET
ecj-12463	101	54	overall	overall	ADJ
ecj-12463	101	55	risk	risk	NOUN
ecj-12463	101	56	of	of	ADP
ecj-12463	101	57	readmission	readmission	NOUN
ecj-12463	101	58	and	and	CCONJ
ecj-12463	101	59	mortality	mortality	NOUN
ecj-12463	101	60	significantly	significantly	ADV
ecj-12463	101	61	increased	increase	VERB
ecj-12463	101	62	for	for	ADP
ecj-12463	101	63	patients	patient	NOUN
ecj-12463	101	64	with	with	ADP
ecj-12463	101	65	higher	high	ADJ
ecj-12463	101	66	supar,55	supar,55	NOUN
ecj-12463	101	67	while	while	SCONJ
ecj-12463	101	68	al	al	PROPN
ecj-12463	101	69	-	-	PUNCT
ecj-12463	101	70	badri	badri	PROPN
ecj-12463	101	71	et	et	PROPN
ecj-12463	101	72	al	al	PROPN
ecj-12463	101	73	.	.	PROPN
ecj-12463	101	74	showed	show	VERB
ecj-12463	101	75	that	that	SCONJ
ecj-12463	101	76	high	high	ADJ
ecj-12463	101	77	supar	supar	NOUN
ecj-12463	101	78	and	and	CCONJ
ecj-12463	101	79	hstni	hstni	PROPN
ecj-12463	101	80	levels	level	NOUN
ecj-12463	101	81	were	be	AUX
ecj-12463	101	82	independently	independently	ADV
ecj-12463	101	83	associated	associate	VERB
ecj-12463	101	84	with	with	ADP
ecj-12463	101	85	a	a	DET
ecj-12463	101	86	higher	high	ADJ
ecj-12463	101	87	risk	risk	NOUN
ecj-12463	101	88	of	of	ADP
ecj-12463	101	89	all	all	DET
ecj-12463	101	90	�	�	NOUN
ecj-12463	101	91	cause	cause	VERB
ecj-12463	101	92	death	death	NOUN
ecj-12463	101	93	and	and	CCONJ
ecj-12463	101	94	mace.56	mace.56	NOUN
ecj-12463	101	95	moreover	moreover	ADV
ecj-12463	101	96	,	,	PUNCT
ecj-12463	101	97	hs	hs	PROPN
ecj-12463	101	98	-	-	PROPN
ecj-12463	101	99	crp	crp	NOUN
ecj-12463	101	100	,	,	PUNCT
ecj-12463	101	101	nt	nt	NOUN
ecj-12463	101	102	-	-	PUNCT
ecj-12463	101	103	probnp	probnp	NOUN
ecj-12463	101	104	,	,	PUNCT
ecj-12463	101	105	and	and	CCONJ
ecj-12463	101	106	supar	supar	NOUN
ecj-12463	101	107	showed	show	VERB
ecj-12463	101	108	different	different	ADJ
ecj-12463	101	109	associations	association	NOUN
ecj-12463	101	110	with	with	ADP
ecj-12463	101	111	cardiovascular	cardiovascular	ADJ
ecj-12463	101	112	death	death	NOUN
ecj-12463	101	113	among	among	ADP
ecj-12463	101	114	apparently	apparently	ADV
ecj-12463	101	115	healthy	healthy	ADJ
ecj-12463	101	116	younger	young	ADJ
ecj-12463	101	117	and	and	CCONJ
ecj-12463	101	118	older	old	ADJ
ecj-12463	101	119	men	man	NOUN
ecj-12463	101	120	and	and	CCONJ
ecj-12463	101	121	women.57	women.57	PROPN
ecj-12463	101	122	hodges	hodges	PROPN
ecj-12463	101	123	et	et	PROPN
ecj-12463	101	124	al	al	PROPN
ecj-12463	101	125	.	.	PROPN
ecj-12463	101	126	also	also	ADV
ecj-12463	101	127	demonstrated	demonstrate	VERB
ecj-12463	101	128	that	that	SCONJ
ecj-12463	101	129	supar	supar	NOUN
ecj-12463	101	130	is	be	AUX
ecj-12463	101	131	an	an	DET
ecj-12463	101	132	independent	independent	ADJ
ecj-12463	101	133	predictor	predictor	NOUN
ecj-12463	101	134	of	of	ADP
ecj-12463	101	135	death	death	NOUN
ecj-12463	101	136	/	/	SYM
ecj-12463	101	137	myocardial	myocardial	ADJ
ecj-12463	101	138	infarction	infarction	NOUN
ecj-12463	101	139	in	in	ADP
ecj-12463	101	140	patients	patient	NOUN
ecj-12463	101	141	with	with	ADP
ecj-12463	101	142	suspected	suspect	VERB
ecj-12463	101	143	or	or	CCONJ
ecj-12463	101	144	known	know	VERB
ecj-12463	101	145	coronary	coronary	ADJ
ecj-12463	101	146	artery	artery	NOUN
ecj-12463	101	147	disease	disease	NOUN
ecj-12463	101	148	,	,	PUNCT
ecj-12463	101	149	but	but	CCONJ
ecj-12463	101	150	they	they	PRON
ecj-12463	101	151	showed	show	VERB
ecj-12463	101	152	that	that	SCONJ
ecj-12463	101	153	it	it	PRON
ecj-12463	101	154	is	be	AUX
ecj-12463	101	155	not	not	PART
ecj-12463	101	156	associated	associate	VERB
ecj-12463	101	157	with	with	ADP
ecj-12463	101	158	the	the	DET
ecj-12463	101	159	presence	presence	NOUN
ecj-12463	101	160	or	or	CCONJ
ecj-12463	101	161	severity	severity	NOUN
ecj-12463	101	162	of	of	ADP
ecj-12463	101	163	coronary	coronary	ADJ
ecj-12463	101	164	artery	artery	NOUN
ecj-12463	101	165	disease	disease	NOUN
ecj-12463	101	166	,	,	PUNCT
ecj-12463	101	167	probably	probably	ADV
ecj-12463	101	168	because	because	SCONJ
ecj-12463	101	169	a	a	DET
ecj-12463	101	170	high	high	ADJ
ecj-12463	101	171	supar	supar	NOUN
ecj-12463	101	172	is	be	AUX
ecj-12463	101	173	reflecting	reflect	VERB
ecj-12463	101	174	end	end	NOUN
ecj-12463	101	175	organ	organ	NOUN
ecj-12463	101	176	damage	damage	NOUN
ecj-12463	101	177	regardless	regardless	ADV
ecj-12463	101	178	the	the	DET
ecj-12463	101	179	degree	degree	NOUN
ecj-12463	101	180	of	of	ADP
ecj-12463	101	181	atherosclerosis.58	atherosclerosis.58	NOUN
ecj-12463	101	182	in	in	ADP
ecj-12463	101	183	a	a	DET
ecj-12463	101	184	their	their	PRON
ecj-12463	101	185	interesting	interesting	ADJ
ecj-12463	101	186	study	study	NOUN
ecj-12463	101	187	,	,	PUNCT
ecj-12463	101	188	vellisaris	vellisaris	PROPN
ecj-12463	101	189	et	et	PROPN
ecj-12463	101	190	al	al	PROPN
ecj-12463	101	191	.	.	PROPN
ecj-12463	102	1	are	be	AUX
ecj-12463	102	2	agree	agree	VERB
ecj-12463	102	3	that	that	SCONJ
ecj-12463	102	4	supar	supar	NOUN
ecj-12463	102	5	may	may	AUX
ecj-12463	102	6	be	be	AUX
ecj-12463	102	7	a	a	DET
ecj-12463	102	8	promising	promising	ADJ
ecj-12463	102	9	addition	addition	NOUN
ecj-12463	102	10	to	to	ADP
ecj-12463	102	11	the	the	DET
ecj-12463	102	12	established	establish	VERB
ecj-12463	102	13	biomarkers	biomarker	NOUN
ecj-12463	102	14	for	for	ADP
ecj-12463	102	15	the	the	DET
ecj-12463	102	16	initial	initial	ADJ
ecj-12463	102	17	assessment	assessment	NOUN
ecj-12463	102	18	of	of	ADP
ecj-12463	102	19	patients	patient	NOUN
ecj-12463	102	20	in	in	ADP
ecj-12463	102	21	the	the	DET
ecj-12463	102	22	ed	ed	NOUN
ecj-12463	102	23	,	,	PUNCT
ecj-12463	102	24	management	management	NOUN
ecj-12463	102	25	and	and	CCONJ
ecj-12463	102	26	risk	risk	NOUN
ecj-12463	102	27	stratification	stratification	NOUN
ecj-12463	102	28	,	,	PUNCT
ecj-12463	102	29	but	but	CCONJ
ecj-12463	102	30	additional	additional	ADJ
ecj-12463	102	31	studies	study	NOUN
ecj-12463	102	32	are	be	AUX
ecj-12463	102	33	necessary	necessary	ADJ
ecj-12463	102	34	to	to	PART
ecj-12463	102	35	evaluate	evaluate	VERB
ecj-12463	102	36	the	the	DET
ecj-12463	102	37	usefulness	usefulness	NOUN
ecj-12463	102	38	of	of	ADP
ecj-12463	102	39	supar	supar	NOUN
ecj-12463	102	40	guided	guide	VERB
ecj-12463	102	41	management	management	NOUN
ecj-12463	102	42	algorithms.48	algorithms.48	ADP
ecj-12463	102	43	these	these	DET
ecj-12463	102	44	results	result	NOUN
ecj-12463	102	45	are	be	AUX
ecj-12463	102	46	in	in	ADP
ecj-12463	102	47	line	line	NOUN
ecj-12463	102	48	with	with	ADP
ecj-12463	102	49	the	the	DET
ecj-12463	102	50	recent	recent	ADJ
ecj-12463	102	51	literature	literature	NOUN
ecj-12463	102	52	and	and	CCONJ
ecj-12463	102	53	suggest	suggest	VERB
ecj-12463	102	54	that	that	SCONJ
ecj-12463	102	55	supar	supar	PROPN
ecj-12463	102	56	appears	appear	VERB
ecj-12463	102	57	to	to	PART
ecj-12463	102	58	be	be	AUX
ecj-12463	102	59	more	more	ADV
ecj-12463	102	60	effective	effective	ADJ
ecj-12463	102	61	than	than	ADP
ecj-12463	102	62	diagnostic	diagnostic	ADJ
ecj-12463	102	63	biomarkers	biomarker	NOUN
ecj-12463	102	64	,	,	PUNCT
ecj-12463	102	65	and	and	CCONJ
ecj-12463	102	66	it	it	PRON
ecj-12463	102	67	can	can	AUX
ecj-12463	102	68	predict	predict	VERB
ecj-12463	102	69	the	the	DET
ecj-12463	102	70	occurrence	occurrence	NOUN
ecj-12463	102	71	of	of	ADP
ecj-12463	102	72	cardiovascular	cardiovascular	ADJ
ecj-12463	102	73	disease	disease	NOUN
ecj-12463	102	74	and	and	CCONJ
ecj-12463	102	75	tends	tend	VERB
ecj-12463	102	76	to	to	PART
ecj-12463	102	77	positively	positively	ADV
ecj-12463	102	78	correlate	correlate	VERB
ecj-12463	102	79	with	with	ADP
ecj-12463	102	80	its	its	PRON
ecj-12463	102	81	severity.47	severity.47	NOUN
ecj-12463	102	82	for	for	ADP
ecj-12463	102	83	this	this	DET
ecj-12463	102	84	reason	reason	NOUN
ecj-12463	102	85	,	,	PUNCT
ecj-12463	102	86	supar	supar	PROPN
ecj-12463	102	87	may	may	AUX
ecj-12463	102	88	be	be	AUX
ecj-12463	102	89	useful	useful	ADJ
ecj-12463	102	90	in	in	ADP
ecj-12463	102	91	the	the	DET
ecj-12463	102	92	assessment	assessment	NOUN
ecj-12463	102	93	of	of	ADP
ecj-12463	102	94	the	the	DET
ecj-12463	102	95	emergency	emergency	NOUN
ecj-12463	102	96	department	department	NOUN
ecj-12463	102	97	’s	’s	PART
ecj-12463	102	98	risk	risk	NOUN
ecj-12463	102	99	stratification	stratification	NOUN
ecj-12463	102	100	and	and	CCONJ
ecj-12463	102	101	in	in	ADP
ecj-12463	102	102	improving	improve	VERB
ecj-12463	102	103	its	its	PRON
ecj-12463	102	104	management.59	management.59	NOUN
ecj-12463	102	105	however	however	ADV
ecj-12463	102	106	,	,	PUNCT
ecj-12463	102	107	further	further	ADJ
ecj-12463	102	108	evidence	evidence	NOUN
ecj-12463	102	109	is	be	AUX
ecj-12463	102	110	needed	need	VERB
ecj-12463	102	111	.	.	PUNCT
ecj-12463	103	1	other	other	ADJ
ecj-12463	103	2	biomarkers	biomarker	NOUN
ecj-12463	103	3	in	in	ADP
ecj-12463	103	4	the	the	DET
ecj-12463	103	5	past	past	ADJ
ecj-12463	103	6	few	few	ADJ
ecj-12463	103	7	years	year	NOUN
ecj-12463	103	8	,	,	PUNCT
ecj-12463	103	9	numerous	numerous	ADJ
ecj-12463	103	10	inflammatory	inflammatory	ADJ
ecj-12463	103	11	mediators	mediator	NOUN
ecj-12463	103	12	have	have	AUX
ecj-12463	103	13	been	be	AUX
ecj-12463	103	14	studied	study	VERB
ecj-12463	103	15	as	as	ADP
ecj-12463	103	16	potential	potential	ADJ
ecj-12463	103	17	biomarkers	biomarker	NOUN
ecj-12463	103	18	of	of	ADP
ecj-12463	103	19	cardiovascular	cardiovascular	ADJ
ecj-12463	103	20	and	and	CCONJ
ecj-12463	103	21	ischemic	ischemic	ADJ
ecj-12463	103	22	heart	heart	NOUN
ecj-12463	103	23	disorders	disorder	NOUN
ecj-12463	103	24	in	in	ADP
ecj-12463	103	25	addition	addition	NOUN
ecj-12463	103	26	to	to	ADP
ecj-12463	103	27	the	the	DET
ecj-12463	103	28	molecules	molecule	NOUN
ecj-12463	103	29	previously	previously	ADV
ecj-12463	103	30	described	describe	VERB
ecj-12463	103	31	.	.	PUNCT
ecj-12463	104	1	in	in	ADP
ecj-12463	104	2	particular	particular	ADJ
ecj-12463	104	3	,	,	PUNCT
ecj-12463	104	4	these	these	PRON
ecj-12463	104	5	are	be	AUX
ecj-12463	104	6	mediators	mediator	NOUN
ecj-12463	104	7	implicated	implicate	VERB
ecj-12463	104	8	in	in	ADP
ecj-12463	104	9	the	the	DET
ecj-12463	104	10	inflammatory	inflammatory	ADJ
ecj-12463	104	11	response	response	NOUN
ecj-12463	104	12	and	and	CCONJ
ecj-12463	104	13	in	in	ADP
ecj-12463	104	14	the	the	DET
ecj-12463	104	15	process	process	NOUN
ecj-12463	104	16	of	of	ADP
ecj-12463	104	17	formation	formation	NOUN
ecj-12463	104	18	and	and	CCONJ
ecj-12463	104	19	complication	complication	NOUN
ecj-12463	104	20	of	of	ADP
ecj-12463	104	21	atherosclerotic	atherosclerotic	ADJ
ecj-12463	104	22	plaques	plaque	NOUN
ecj-12463	104	23	which	which	PRON
ecj-12463	104	24	,	,	PUNCT
ecj-12463	104	25	as	as	SCONJ
ecj-12463	104	26	is	be	AUX
ecj-12463	104	27	known	know	VERB
ecj-12463	104	28	,	,	PUNCT
ecj-12463	104	29	are	be	AUX
ecj-12463	104	30	often	often	ADV
ecj-12463	104	31	implicated	implicate	VERB
ecj-12463	104	32	in	in	ADP
ecj-12463	104	33	cardiovascular	cardiovascular	ADJ
ecj-12463	104	34	disease	disease	NOUN
ecj-12463	104	35	.	.	PUNCT
ecj-12463	105	1	indeed	indeed	ADV
ecj-12463	105	2	,	,	PUNCT
ecj-12463	105	3	a	a	DET
ecj-12463	105	4	plaque	plaque	NOUN
ecj-12463	105	5	complication	complication	NOUN
ecj-12463	105	6	is	be	AUX
ecj-12463	105	7	actually	actually	ADV
ecj-12463	105	8	the	the	DET
ecj-12463	105	9	primary	primary	ADJ
ecj-12463	105	10	cause	cause	NOUN
ecj-12463	105	11	of	of	ADP
ecj-12463	105	12	ami	ami	NOUN
ecj-12463	105	13	in	in	ADP
ecj-12463	105	14	most	most	ADJ
ecj-12463	105	15	patients	patient	NOUN
ecj-12463	105	16	.	.	PUNCT
ecj-12463	106	1	likewise	likewise	ADV
ecj-12463	106	2	,	,	PUNCT
ecj-12463	106	3	inflammatory	inflammatory	ADJ
ecj-12463	106	4	processes	process	NOUN
ecj-12463	106	5	in	in	ADP
ecj-12463	106	6	the	the	DET
ecj-12463	106	7	core	core	NOUN
ecj-12463	106	8	of	of	ADP
ecj-12463	106	9	a	a	DET
ecj-12463	106	10	complex	complex	ADJ
ecj-12463	106	11	atheromatous	atheromatous	ADJ
ecj-12463	106	12	plaque	plaque	NOUN
ecj-12463	106	13	dictate	dictate	VERB
ecj-12463	106	14	its	its	PRON
ecj-12463	106	15	rupture	rupture	NOUN
ecj-12463	106	16	and	and	CCONJ
ecj-12463	106	17	consequent	consequent	ADJ
ecj-12463	106	18	acs	ac	NOUN
ecj-12463	106	19	.	.	PUNCT
ecj-12463	107	1	while	while	SCONJ
ecj-12463	107	2	sst2	sst2	NOUN
ecj-12463	107	3	and	and	CCONJ
ecj-12463	107	4	supar	supar	NOUN
ecj-12463	107	5	,	,	PUNCT
ecj-12463	107	6	beyond	beyond	ADP
ecj-12463	107	7	troponin	troponin	NOUN
ecj-12463	107	8	,	,	PUNCT
ecj-12463	107	9	seem	seem	VERB
ecj-12463	107	10	to	to	PART
ecj-12463	107	11	be	be	AUX
ecj-12463	107	12	the	the	DET
ecj-12463	107	13	emerging	emerge	VERB
ecj-12463	107	14	biomarkers	biomarker	NOUN
ecj-12463	107	15	for	for	ADP
ecj-12463	107	16	acs	acs	PROPN
ecj-12463	107	17	risk	risk	NOUN
ecj-12463	107	18	,	,	PUNCT
ecj-12463	107	19	involved	involve	VERB
ecj-12463	107	20	in	in	ADP
ecj-12463	107	21	patient	patient	ADJ
ecj-12463	107	22	outcome	outcome	NOUN
ecj-12463	107	23	prediction	prediction	NOUN
ecj-12463	107	24	too	too	ADV
ecj-12463	107	25	,	,	PUNCT
ecj-12463	107	26	other	other	ADJ
ecj-12463	107	27	biomarkers	biomarker	NOUN
ecj-12463	107	28	that	that	PRON
ecj-12463	107	29	are	be	AUX
ecj-12463	107	30	still	still	ADV
ecj-12463	107	31	under	under	ADP
ecj-12463	107	32	investigation	investigation	NOUN
ecj-12463	107	33	appear	appear	VERB
ecj-12463	107	34	to	to	PART
ecj-12463	107	35	be	be	AUX
ecj-12463	107	36	signifi	signifi	NOUN
ecj-12463	107	37	review	review	NOUN
ecj-12463	107	38	[	[	X
ecj-12463	107	39	emergency	emergency	NOUN
ecj-12463	107	40	care	care	NOUN
ecj-12463	107	41	journal	journal	PROPN
ecj-12463	107	42	2024	2024	NUM
ecj-12463	107	43	;	;	PUNCT
ecj-12463	108	1	20:12463	20:12463	NUM
ecj-12463	108	2	]	]	X
ecj-12463	109	1	[	[	X
ecj-12463	109	2	page	page	NOUN
ecj-12463	109	3	52	52	NUM
ecj-12463	109	4	]	]	PUNCT
ecj-12463	109	5	non	non	ADJ
ecj-12463	109	6	-co	-co	PROPN
ecj-12463	109	7	mmerc	mmerc	PROPN
ecj-12463	109	8	ial	ial	PROPN
ecj-12463	109	9	us	us	PROPN
ecj-12463	109	10	e	e	NOUN
ecj-12463	109	11	o	o	PROPN
ecj-12463	109	12	nly	nly	ADV
ecj-12463	109	13	ca	can	AUX
ecj-12463	109	14	nt	not	PART
ecj-12463	109	15	in	in	ADP
ecj-12463	109	16	the	the	DET
ecj-12463	109	17	prediction	prediction	NOUN
ecj-12463	109	18	of	of	ADP
ecj-12463	109	19	cardiovascular	cardiovascular	ADJ
ecj-12463	109	20	events	event	NOUN
ecj-12463	109	21	such	such	ADJ
ecj-12463	109	22	as	as	ADP
ecj-12463	109	23	interleukin	interleukin	NOUN
ecj-12463	109	24	,	,	PUNCT
ecj-12463	109	25	mirs	mir	NOUN
ecj-12463	109	26	and	and	CCONJ
ecj-12463	109	27	gdf-15	gdf-15	NOUN
ecj-12463	109	28	.	.	PUNCT
ecj-12463	110	1	some	some	DET
ecj-12463	110	2	examples	example	NOUN
ecj-12463	110	3	are	be	AUX
ecj-12463	110	4	briefly	briefly	ADV
ecj-12463	110	5	shown	show	VERB
ecj-12463	110	6	below	below	ADP
ecj-12463	110	7	.	.	PUNCT
ecj-12463	111	1	copeptin	copeptin	PROPN
ecj-12463	111	2	copeptin	copeptin	PROPN
ecj-12463	111	3	,	,	PUNCT
ecj-12463	111	4	first	first	ADV
ecj-12463	111	5	described	describe	VERB
ecj-12463	111	6	in	in	ADP
ecj-12463	111	7	1972	1972	NUM
ecj-12463	111	8	by	by	ADP
ecj-12463	111	9	holwerda	holwerda	PROPN
ecj-12463	111	10	,	,	PUNCT
ecj-12463	111	11	is	be	AUX
ecj-12463	111	12	a	a	DET
ecj-12463	111	13	39aminoacid	39aminoacid	NUM
ecj-12463	111	14	glycopeptide	glycopeptide	NOUN
ecj-12463	111	15	derived	derive	VERB
ecj-12463	111	16	from	from	ADP
ecj-12463	111	17	the	the	DET
ecj-12463	111	18	c	c	NOUN
ecj-12463	111	19	-	-	PUNCT
ecj-12463	111	20	terminal	terminal	ADJ
ecj-12463	111	21	segment	segment	NOUN
ecj-12463	111	22	of	of	ADP
ecj-12463	111	23	arginine	arginine	NOUN
ecj-12463	111	24	vasopressin	vasopressin	NOUN
ecj-12463	111	25	(	(	PUNCT
ecj-12463	111	26	avp	avp	ADJ
ecj-12463	111	27	)	)	PUNCT
ecj-12463	111	28	precursor	precursor	NOUN
ecj-12463	111	29	.	.	PUNCT
ecj-12463	112	1	avp	avp	PROPN
ecj-12463	112	2	has	have	VERB
ecj-12463	112	3	a	a	DET
ecj-12463	112	4	role	role	NOUN
ecj-12463	112	5	in	in	ADP
ecj-12463	112	6	fluid	fluid	ADJ
ecj-12463	112	7	imbalance	imbalance	NOUN
ecj-12463	112	8	and	and	CCONJ
ecj-12463	112	9	in	in	ADP
ecj-12463	112	10	vascular	vascular	ADJ
ecj-12463	112	11	tone	tone	NOUN
ecj-12463	112	12	regulation	regulation	NOUN
ecj-12463	112	13	,	,	PUNCT
ecj-12463	112	14	thus	thus	ADV
ecj-12463	112	15	contributing	contribute	VERB
ecj-12463	112	16	to	to	ADP
ecj-12463	112	17	cardiovascular	cardiovascular	ADJ
ecj-12463	112	18	system	system	NOUN
ecj-12463	112	19	homeostasis	homeostasis	NOUN
ecj-12463	112	20	.	.	PUNCT
ecj-12463	113	1	copeptin	copeptin	NOUN
ecj-12463	113	2	is	be	AUX
ecj-12463	113	3	released	release	VERB
ecj-12463	113	4	into	into	ADP
ecj-12463	113	5	the	the	DET
ecj-12463	113	6	bloodstream	bloodstream	NOUN
ecj-12463	113	7	,	,	PUNCT
ecj-12463	113	8	in	in	ADP
ecj-12463	113	9	equivalent	equivalent	ADJ
ecj-12463	113	10	amounts	amount	NOUN
ecj-12463	113	11	to	to	ADP
ecj-12463	113	12	avp	avp	PROPN
ecj-12463	113	13	,	,	PUNCT
ecj-12463	113	14	so	so	ADV
ecj-12463	113	15	measuring	measure	VERB
ecj-12463	113	16	copeptin	copeptin	NOUN
ecj-12463	113	17	appears	appear	VERB
ecj-12463	113	18	to	to	PART
ecj-12463	113	19	be	be	AUX
ecj-12463	113	20	a	a	DET
ecj-12463	113	21	clinically	clinically	ADV
ecj-12463	113	22	valuable	valuable	ADJ
ecj-12463	113	23	approach	approach	NOUN
ecj-12463	113	24	for	for	ADP
ecj-12463	113	25	assessing	assess	VERB
ecj-12463	113	26	plasma	plasma	NOUN
ecj-12463	113	27	amount	amount	NOUN
ecj-12463	113	28	of	of	ADP
ecj-12463	113	29	vasopressin	vasopressin	NOUN
ecj-12463	113	30	.	.	PUNCT
ecj-12463	114	1	unlike	unlike	ADP
ecj-12463	114	2	avp	avp	PROPN
ecj-12463	114	3	,	,	PUNCT
ecj-12463	114	4	copeptin	copeptin	PROPN
ecj-12463	114	5	’s	’s	PART
ecj-12463	114	6	physiologic	physiologic	ADJ
ecj-12463	114	7	role	role	NOUN
ecj-12463	114	8	is	be	AUX
ecj-12463	114	9	not	not	PART
ecj-12463	114	10	yet	yet	ADV
ecj-12463	114	11	clear	clear	ADJ
ecj-12463	114	12	.	.	PUNCT
ecj-12463	115	1	at	at	ADP
ecj-12463	115	2	present	present	ADJ
ecj-12463	115	3	,	,	PUNCT
ecj-12463	115	4	copeptin	copeptin	NOUN
ecj-12463	115	5	was	be	AUX
ecj-12463	115	6	proven	prove	VERB
ecj-12463	115	7	to	to	PART
ecj-12463	115	8	show	show	VERB
ecj-12463	115	9	the	the	DET
ecj-12463	115	10	same	same	ADJ
ecj-12463	115	11	response	response	NOUN
ecj-12463	115	12	as	as	ADP
ecj-12463	115	13	avp	avp	VERB
ecj-12463	115	14	to	to	ADP
ecj-12463	115	15	hypotension	hypotension	NOUN
ecj-12463	115	16	or	or	CCONJ
ecj-12463	115	17	hemodynamic	hemodynamic	ADJ
ecj-12463	115	18	stress.60	stress.60	NOUN
ecj-12463	115	19	-	-	PUNCT
ecj-12463	115	20	64	64	NUM
ecj-12463	115	21	in	in	ADP
ecj-12463	115	22	recent	recent	ADJ
ecj-12463	115	23	years	year	NOUN
ecj-12463	115	24	,	,	PUNCT
ecj-12463	115	25	copeptin	copeptin	NOUN
ecj-12463	115	26	has	have	AUX
ecj-12463	115	27	gained	gain	VERB
ecj-12463	115	28	growing	grow	VERB
ecj-12463	115	29	interest	interest	NOUN
ecj-12463	115	30	as	as	ADP
ecj-12463	115	31	part	part	NOUN
ecj-12463	115	32	of	of	ADP
ecj-12463	115	33	a	a	DET
ecj-12463	115	34	dual	dual	ADJ
ecj-12463	115	35	marker	marker	NOUN
ecj-12463	115	36	strategy	strategy	NOUN
ecj-12463	115	37	(	(	PUNCT
ecj-12463	115	38	dms	dms	NOUN
ecj-12463	115	39	)	)	PUNCT
ecj-12463	115	40	in	in	ADP
ecj-12463	115	41	combination	combination	NOUN
ecj-12463	115	42	with	with	ADP
ecj-12463	115	43	cardiac	cardiac	ADJ
ecj-12463	115	44	troponin	troponin	ADJ
ecj-12463	115	45	(	(	PUNCT
ecj-12463	115	46	ctn	ctn	NOUN
ecj-12463	115	47	)	)	PUNCT
ecj-12463	115	48	in	in	ADP
ecj-12463	115	49	promptly	promptly	ADV
ecj-12463	115	50	ruling	rule	VERB
ecj-12463	115	51	out	out	ADP
ecj-12463	115	52	acute	acute	ADJ
ecj-12463	115	53	myocardial	myocardial	ADJ
ecj-12463	115	54	infarction	infarction	NOUN
ecj-12463	115	55	(	(	PUNCT
ecj-12463	115	56	ami	ami	NOUN
ecj-12463	115	57	)	)	PUNCT
ecj-12463	115	58	in	in	ADP
ecj-12463	115	59	patients	patient	NOUN
ecj-12463	115	60	presenting	present	VERB
ecj-12463	115	61	with	with	ADP
ecj-12463	115	62	symptoms	symptom	NOUN
ecj-12463	115	63	suggestive	suggestive	ADJ
ecj-12463	115	64	of	of	ADP
ecj-12463	115	65	acs.63	acs.63	DET
ecj-12463	115	66	several	several	ADJ
ecj-12463	115	67	studies	study	NOUN
ecj-12463	115	68	,	,	PUNCT
ecj-12463	115	69	among	among	ADP
ecj-12463	115	70	which	which	PRON
ecj-12463	115	71	the	the	DET
ecj-12463	115	72	most	most	ADV
ecj-12463	115	73	important	important	ADJ
ecj-12463	115	74	is	be	AUX
ecj-12463	115	75	the	the	DET
ecj-12463	115	76	copeptin	copeptin	NOUN
ecj-12463	115	77	helps	help	VERB
ecj-12463	115	78	in	in	ADP
ecj-12463	115	79	the	the	DET
ecj-12463	115	80	early	early	ADJ
ecj-12463	115	81	detection	detection	NOUN
ecj-12463	115	82	of	of	ADP
ecj-12463	115	83	patients	patient	NOUN
ecj-12463	115	84	with	with	ADP
ecj-12463	115	85	acute	acute	ADJ
ecj-12463	115	86	myocardial	myocardial	ADJ
ecj-12463	115	87	infarction	infarction	NOUN
ecj-12463	115	88	(	(	PUNCT
ecj-12463	115	89	chopin	chopin	NOUN
ecj-12463	115	90	)	)	PUNCT
ecj-12463	115	91	trial	trial	NOUN
ecj-12463	115	92	,	,	PUNCT
ecj-12463	115	93	a	a	DET
ecj-12463	115	94	multicenter	multicenter	ADJ
ecj-12463	115	95	international	international	ADJ
ecj-12463	115	96	cohort	cohort	NOUN
ecj-12463	115	97	study	study	NOUN
ecj-12463	115	98	,	,	PUNCT
ecj-12463	115	99	support	support	VERB
ecj-12463	115	100	that	that	PRON
ecj-12463	115	101	copeptin	copeptin	NOUN
ecj-12463	115	102	and	and	CCONJ
ecj-12463	115	103	hs	hs	NOUN
ecj-12463	115	104	-	-	NOUN
ecj-12463	115	105	ctnt	ctnt	NOUN
ecj-12463	115	106	in	in	ADP
ecj-12463	115	107	combination	combination	NOUN
ecj-12463	115	108	has	have	VERB
ecj-12463	115	109	the	the	DET
ecj-12463	115	110	potential	potential	NOUN
ecj-12463	115	111	to	to	PART
ecj-12463	115	112	allow	allow	VERB
ecj-12463	115	113	a	a	DET
ecj-12463	115	114	faster	fast	ADJ
ecj-12463	115	115	ruling	ruling	NOUN
ecj-12463	115	116	of	of	ADP
ecj-12463	115	117	ami	ami	NOUN
ecj-12463	115	118	when	when	SCONJ
ecj-12463	115	119	compared	compare	VERB
ecj-12463	115	120	to	to	ADP
ecj-12463	115	121	the	the	DET
ecj-12463	115	122	hsctnt	hsctnt	NOUN
ecj-12463	115	123	-	-	PUNCT
ecj-12463	115	124	only	only	ADV
ecj-12463	115	125	-	-	PUNCT
ecj-12463	115	126	based	base	VERB
ecj-12463	115	127	algorithms	algorithm	NOUN
ecj-12463	115	128	and	and	CCONJ
ecj-12463	115	129	enables	enable	VERB
ecj-12463	115	130	a	a	DET
ecj-12463	115	131	useful	useful	ADJ
ecj-12463	115	132	reclassification	reclassification	NOUN
ecj-12463	115	133	of	of	ADP
ecj-12463	115	134	profile	profile	ADJ
ecj-12463	115	135	risk	risk	NOUN
ecj-12463	115	136	of	of	ADP
ecj-12463	115	137	patients.65	patients.65	PROPN
ecj-12463	115	138	-	-	PUNCT
ecj-12463	115	139	68	68	NUM
ecj-12463	115	140	in	in	ADP
ecj-12463	115	141	fact	fact	NOUN
ecj-12463	115	142	,	,	PUNCT
ecj-12463	115	143	it	it	PRON
ecj-12463	115	144	has	have	AUX
ecj-12463	115	145	been	be	AUX
ecj-12463	115	146	shown	show	VERB
ecj-12463	115	147	that	that	SCONJ
ecj-12463	115	148	copeptin	copeptin	NOUN
ecj-12463	115	149	rises	rise	VERB
ecj-12463	115	150	to	to	ADP
ecj-12463	115	151	peak	peak	VERB
ecj-12463	115	152	values	value	NOUN
ecj-12463	115	153	within	within	ADP
ecj-12463	115	154	30	30	NUM
ecj-12463	115	155	min	min	NOUN
ecj-12463	115	156	after	after	ADP
ecj-12463	115	157	the	the	DET
ecj-12463	115	158	onset	onset	NOUN
ecj-12463	115	159	of	of	ADP
ecj-12463	115	160	chest	chest	NOUN
ecj-12463	115	161	pain	pain	NOUN
ecj-12463	115	162	in	in	ADP
ecj-12463	115	163	patients	patient	NOUN
ecj-12463	115	164	with	with	ADP
ecj-12463	115	165	acute	acute	PROPN
ecj-12463	115	166	mi	mi	PROPN
ecj-12463	115	167	,	,	PUNCT
ecj-12463	115	168	thus	thus	ADV
ecj-12463	115	169	covering	cover	VERB
ecj-12463	115	170	the	the	DET
ecj-12463	115	171	period	period	NOUN
ecj-12463	115	172	where	where	SCONJ
ecj-12463	115	173	hstn	hstn	ADJ
ecj-12463	115	174	levels	level	NOUN
ecj-12463	115	175	are	be	AUX
ecj-12463	115	176	still	still	ADV
ecj-12463	115	177	undetectable	undetectable	ADJ
ecj-12463	115	178	and	and	CCONJ
ecj-12463	115	179	gradually	gradually	ADV
ecj-12463	115	180	decreases	decrease	VERB
ecj-12463	115	181	within	within	ADP
ecj-12463	115	182	12–36	12–36	NUM
ecj-12463	115	183	hours	hour	NOUN
ecj-12463	115	184	in	in	ADP
ecj-12463	115	185	early	early	ADJ
ecj-12463	115	186	presenters.66,69	presenters.66,69	NOUN
ecj-12463	115	187	-	-	SYM
ecj-12463	115	188	72	72	NUM
ecj-12463	115	189	therefore	therefore	ADV
ecj-12463	115	190	,	,	PUNCT
ecj-12463	115	191	the	the	DET
ecj-12463	115	192	dms	dms	NOUN
ecj-12463	115	193	has	have	AUX
ecj-12463	115	194	been	be	AUX
ecj-12463	115	195	seen	see	VERB
ecj-12463	115	196	to	to	PART
ecj-12463	115	197	early	early	ADV
ecj-12463	115	198	detect	detect	VERB
ecj-12463	115	199	acute	acute	ADJ
ecj-12463	115	200	myocardial	myocardial	ADJ
ecj-12463	115	201	injury	injury	NOUN
ecj-12463	115	202	and	and	CCONJ
ecj-12463	115	203	also	also	ADV
ecj-12463	115	204	obviates	obviate	VERB
ecj-12463	115	205	the	the	DET
ecj-12463	115	206	need	need	NOUN
ecj-12463	115	207	for	for	ADP
ecj-12463	115	208	serial	serial	ADJ
ecj-12463	115	209	sampling	sampling	NOUN
ecj-12463	115	210	.	.	PUNCT
ecj-12463	116	1	in	in	ADP
ecj-12463	116	2	contrast	contrast	NOUN
ecj-12463	116	3	,	,	PUNCT
ecj-12463	116	4	it	it	PRON
ecj-12463	116	5	provides	provide	VERB
ecj-12463	116	6	no	no	DET
ecj-12463	116	7	further	further	ADJ
ecj-12463	116	8	information	information	NOUN
ecj-12463	116	9	that	that	SCONJ
ecj-12463	116	10	standard	standard	ADJ
ecj-12463	116	11	troponin	troponin	NOUN
ecj-12463	116	12	in	in	ADP
ecj-12463	116	13	late	late	ADJ
ecj-12463	116	14	presenters.68,69	presenters.68,69	NOUN
ecj-12463	116	15	-	-	PUNCT
ecj-12463	116	16	71	71	NUM
ecj-12463	116	17	furthermore	furthermore	ADV
ecj-12463	116	18	,	,	PUNCT
ecj-12463	116	19	in	in	ADP
ecj-12463	116	20	the	the	DET
ecj-12463	116	21	accelerated	accelerated	ADJ
ecj-12463	116	22	rule	rule	NOUN
ecj-12463	116	23	-	-	PUNCT
ecj-12463	116	24	out	out	NOUN
ecj-12463	116	25	of	of	ADP
ecj-12463	116	26	ami	ami	NOUN
ecj-12463	116	27	using	use	VERB
ecj-12463	116	28	copeptin	copeptin	NOUN
ecj-12463	116	29	and	and	CCONJ
ecj-12463	116	30	high	high	ADJ
ecj-12463	116	31	sensitivity	sensitivity	NOUN
ecj-12463	116	32	troponin	troponin	ADJ
ecj-12463	116	33	(	(	PUNCT
ecj-12463	116	34	aromi	aromi	ADJ
ecj-12463	116	35	)	)	PUNCT
ecj-12463	116	36	trial	trial	NOUN
ecj-12463	116	37	,	,	PUNCT
ecj-12463	116	38	that	that	PRON
ecj-12463	116	39	enrolled	enrol	VERB
ecj-12463	116	40	4351	4351	NUM
ecj-12463	116	41	patients	patient	NOUN
ecj-12463	116	42	with	with	ADP
ecj-12463	116	43	chest	chest	NOUN
ecj-12463	116	44	pain	pain	NOUN
ecj-12463	116	45	,	,	PUNCT
ecj-12463	116	46	it	it	PRON
ecj-12463	116	47	was	be	AUX
ecj-12463	116	48	found	find	VERB
ecj-12463	116	49	that	that	SCONJ
ecj-12463	116	50	an	an	DET
ecj-12463	116	51	accelerated	accelerated	ADJ
ecj-12463	116	52	dms	dms	NOUN
ecj-12463	116	53	that	that	PRON
ecj-12463	116	54	integrates	integrate	VERB
ecj-12463	116	55	prehospital	prehospital	ADJ
ecj-12463	116	56	copeptin	copeptin	NOUN
ecj-12463	116	57	and	and	CCONJ
ecj-12463	116	58	first	first	ADJ
ecj-12463	116	59	in	in	ADP
ecj-12463	116	60	-	-	PUNCT
ecj-12463	116	61	hospital	hospital	NOUN
ecj-12463	116	62	hs	hs	NOUN
ecj-12463	116	63	-	-	NOUN
ecj-12463	116	64	ctnt	ctnt	ADJ
ecj-12463	116	65	can	can	AUX
ecj-12463	116	66	safely	safely	ADV
ecj-12463	116	67	reduce	reduce	VERB
ecj-12463	116	68	patients	patient	NOUN
ecj-12463	116	69	’	'	PUNCT
ecj-12463	116	70	length	length	NOUN
ecj-12463	116	71	of	of	ADP
ecj-12463	116	72	stay	stay	NOUN
ecj-12463	116	73	in	in	ADP
ecj-12463	116	74	ed.73	ed.73	NOUN
ecj-12463	116	75	in	in	ADP
ecj-12463	116	76	addition	addition	NOUN
ecj-12463	116	77	,	,	PUNCT
ecj-12463	116	78	the	the	DET
ecj-12463	116	79	2023	2023	NUM
ecj-12463	116	80	esc	esc	NOUN
ecj-12463	116	81	guidelines	guideline	NOUN
ecj-12463	116	82	on	on	ADP
ecj-12463	116	83	patients	patient	NOUN
ecj-12463	116	84	without	without	ADP
ecj-12463	116	85	persistent	persistent	ADJ
ecj-12463	116	86	st	st	PROPN
ecj-12463	116	87	-	-	PUNCT
ecj-12463	116	88	segment	segment	NOUN
ecj-12463	116	89	elevation	elevation	NOUN
ecj-12463	116	90	states	state	VERB
ecj-12463	116	91	a	a	DET
ecj-12463	116	92	possible	possible	ADJ
ecj-12463	116	93	value	value	NOUN
ecj-12463	116	94	of	of	ADP
ecj-12463	116	95	copeptin	copeptin	NOUN
ecj-12463	116	96	as	as	ADP
ecj-12463	116	97	additional	additional	ADJ
ecj-12463	116	98	biomarker	biomarker	NOUN
ecj-12463	116	99	to	to	ADP
ecj-12463	116	100	high	high	ADJ
ecj-12463	116	101	-	-	PUNCT
ecj-12463	116	102	sensitivity	sensitivity	NOUN
ecj-12463	116	103	ctn	ctn	NOUN
ecj-12463	116	104	,	,	PUNCT
ecj-12463	116	105	since	since	SCONJ
ecj-12463	116	106	copeptin	copeptin	NOUN
ecj-12463	116	107	may	may	AUX
ecj-12463	116	108	quantify	quantify	VERB
ecj-12463	116	109	the	the	DET
ecj-12463	116	110	endogenous	endogenous	ADJ
ecj-12463	116	111	stress	stress	NOUN
ecj-12463	116	112	level	level	NOUN
ecj-12463	116	113	that	that	PRON
ecj-12463	116	114	characterize	characterize	VERB
ecj-12463	116	115	mi	mi	NOUN
ecj-12463	116	116	even	even	ADV
ecj-12463	116	117	if	if	SCONJ
ecj-12463	116	118	its	its	PRON
ecj-12463	116	119	incremental	incremental	ADJ
ecj-12463	116	120	value	value	NOUN
ecj-12463	116	121	beyond	beyond	ADP
ecj-12463	116	122	ctn	ctn	NOUN
ecj-12463	116	123	is	be	AUX
ecj-12463	116	124	referred	refer	VERB
ecj-12463	116	125	as	as	ADP
ecj-12463	116	126	limited.14	limited.14	PROPN
ecj-12463	116	127	moreover	moreover	ADV
ecj-12463	116	128	,	,	PUNCT
ecj-12463	116	129	copeptin	copeptin	NOUN
ecj-12463	116	130	plays	play	VERB
ecj-12463	116	131	a	a	DET
ecj-12463	116	132	role	role	NOUN
ecj-12463	116	133	as	as	ADP
ecj-12463	116	134	a	a	DET
ecj-12463	116	135	prognostic	prognostic	ADJ
ecj-12463	116	136	biomarker	biomarker	NOUN
ecj-12463	116	137	,	,	PUNCT
ecj-12463	116	138	being	be	AUX
ecj-12463	116	139	associated	associate	VERB
ecj-12463	116	140	with	with	ADP
ecj-12463	116	141	the	the	DET
ecj-12463	116	142	1	1	NUM
ecj-12463	116	143	-	-	PUNCT
ecj-12463	116	144	year	year	NOUN
ecj-12463	116	145	mortality	mortality	NOUN
ecj-12463	116	146	and	and	CCONJ
ecj-12463	116	147	adverse	adverse	ADJ
ecj-12463	116	148	outcomes	outcome	NOUN
ecj-12463	116	149	not	not	PART
ecj-12463	116	150	only	only	ADV
ecj-12463	116	151	in	in	ADP
ecj-12463	116	152	acs	acs	PROPN
ecj-12463	116	153	but	but	CCONJ
ecj-12463	116	154	also	also	ADV
ecj-12463	116	155	in	in	ADP
ecj-12463	116	156	non	non	ADJ
ecj-12463	116	157	-	-	ADJ
ecj-12463	116	158	acs	acs	ADJ
ecj-12463	116	159	conditions	condition	NOUN
ecj-12463	116	160	.	.	PUNCT
ecj-12463	117	1	64	64	NUM
ecj-12463	117	2	-	-	SYM
ecj-12463	117	3	67	67	NUM
ecj-12463	117	4	however	however	ADV
ecj-12463	117	5	,	,	PUNCT
ecj-12463	117	6	recent	recent	ADJ
ecj-12463	117	7	studies	study	NOUN
ecj-12463	117	8	,	,	PUNCT
ecj-12463	117	9	suggest	suggest	VERB
ecj-12463	117	10	that	that	SCONJ
ecj-12463	117	11	serum	serum	NOUN
ecj-12463	117	12	levels	level	NOUN
ecj-12463	117	13	of	of	ADP
ecj-12463	117	14	copeptin	copeptin	NOUN
ecj-12463	117	15	are	be	AUX
ecj-12463	117	16	upregulated	upregulate	VERB
ecj-12463	117	17	under	under	ADP
ecj-12463	117	18	various	various	ADJ
ecj-12463	117	19	conditions	condition	NOUN
ecj-12463	117	20	(	(	PUNCT
ecj-12463	117	21	e.g.	e.g.	ADV
ecj-12463	117	22	heart	heart	NOUN
ecj-12463	117	23	failure	failure	NOUN
ecj-12463	117	24	,	,	PUNCT
ecj-12463	117	25	metabolic	metabolic	NOUN
ecj-12463	117	26	syndrome	syndrome	NOUN
ecj-12463	117	27	,	,	PUNCT
ecj-12463	117	28	hypertension	hypertension	NOUN
ecj-12463	117	29	,	,	PUNCT
ecj-12463	117	30	acute	acute	ADJ
ecj-12463	117	31	kidney	kidney	NOUN
ecj-12463	117	32	injury	injury	NOUN
ecj-12463	117	33	,	,	PUNCT
ecj-12463	117	34	pulmonary	pulmonary	ADJ
ecj-12463	117	35	embolism	embolism	NOUN
ecj-12463	117	36	,	,	PUNCT
ecj-12463	117	37	sepsis	sepsis	NOUN
ecj-12463	117	38	,	,	PUNCT
ecj-12463	117	39	acute	acute	PROPN
ecj-12463	117	40	pancreatitis	pancreatitis	PROPN
ecj-12463	117	41	,	,	PUNCT
ecj-12463	117	42	ischemic	ischemic	ADJ
ecj-12463	117	43	stroke	stroke	NOUN
ecj-12463	117	44	)	)	PUNCT
ecj-12463	117	45	and	and	CCONJ
ecj-12463	117	46	that	that	SCONJ
ecj-12463	117	47	they	they	PRON
ecj-12463	117	48	are	be	AUX
ecj-12463	117	49	linked	link	VERB
ecj-12463	117	50	to	to	ADP
ecj-12463	117	51	the	the	DET
ecj-12463	117	52	severity	severity	NOUN
ecj-12463	117	53	of	of	ADP
ecj-12463	117	54	these	these	DET
ecj-12463	117	55	clinical	clinical	ADJ
ecj-12463	117	56	situation.62	situation.62	NOUN
ecj-12463	117	57	-	-	PUNCT
ecj-12463	117	58	64,66,67	64,66,67	NUM
ecj-12463	117	59	-	-	SYM
ecj-12463	117	60	70	70	NUM
ecj-12463	117	61	interleukins	interleukin	VERB
ecj-12463	117	62	the	the	DET
ecj-12463	117	63	interleukin	interleukin	NOUN
ecj-12463	117	64	(	(	PUNCT
ecj-12463	117	65	il	il	PROPN
ecj-12463	117	66	)	)	PUNCT
ecj-12463	117	67	family	family	NOUN
ecj-12463	117	68	includes	include	VERB
ecj-12463	117	69	numerous	numerous	ADJ
ecj-12463	117	70	molecules	molecule	NOUN
ecj-12463	117	71	implicated	implicate	VERB
ecj-12463	117	72	in	in	ADP
ecj-12463	117	73	various	various	ADJ
ecj-12463	117	74	biochemical	biochemical	ADJ
ecj-12463	117	75	pathways	pathway	NOUN
ecj-12463	117	76	and	and	CCONJ
ecj-12463	117	77	in	in	ADP
ecj-12463	117	78	the	the	DET
ecj-12463	117	79	majority	majority	NOUN
ecj-12463	117	80	of	of	ADP
ecj-12463	117	81	inflammatory	inflammatory	ADJ
ecj-12463	117	82	processes	process	NOUN
ecj-12463	117	83	.	.	PUNCT
ecj-12463	118	1	in	in	ADP
ecj-12463	118	2	recent	recent	ADJ
ecj-12463	118	3	years	year	NOUN
ecj-12463	118	4	,	,	PUNCT
ecj-12463	118	5	many	many	ADJ
ecj-12463	118	6	of	of	ADP
ecj-12463	118	7	these	these	PRON
ecj-12463	118	8	have	have	AUX
ecj-12463	118	9	been	be	AUX
ecj-12463	118	10	studied	study	VERB
ecj-12463	118	11	for	for	ADP
ecj-12463	118	12	their	their	PRON
ecj-12463	118	13	role	role	NOUN
ecj-12463	118	14	in	in	ADP
ecj-12463	118	15	cvd	cvd	PROPN
ecj-12463	118	16	.	.	PUNCT
ecj-12463	119	1	of	of	ADP
ecj-12463	119	2	these	these	PRON
ecj-12463	119	3	,	,	PUNCT
ecj-12463	119	4	the	the	DET
ecj-12463	119	5	il-17	il-17	NUM
ecj-12463	119	6	family	family	NOUN
ecj-12463	119	7	better	well	ADV
ecj-12463	119	8	correlates	correlate	VERB
ecj-12463	119	9	with	with	ADP
ecj-12463	119	10	the	the	DET
ecj-12463	119	11	development	development	NOUN
ecj-12463	119	12	of	of	ADP
ecj-12463	119	13	acs	acs	PROPN
ecj-12463	119	14	;	;	PUNCT
ecj-12463	119	15	it	it	PRON
ecj-12463	119	16	has	have	AUX
ecj-12463	119	17	been	be	AUX
ecj-12463	119	18	demonstrated	demonstrate	VERB
ecj-12463	119	19	that	that	SCONJ
ecj-12463	119	20	both	both	CCONJ
ecj-12463	119	21	il-17a	il-17a	PROPN
ecj-12463	119	22	and	and	CCONJ
ecj-12463	119	23	il-17e	il-17e	NOUN
ecj-12463	119	24	plasma	plasma	NOUN
ecj-12463	119	25	levels	level	NOUN
ecj-12463	119	26	are	be	AUX
ecj-12463	119	27	increased	increase	VERB
ecj-12463	119	28	in	in	ADP
ecj-12463	119	29	such	such	ADJ
ecj-12463	119	30	patients	patient	NOUN
ecj-12463	119	31	.	.	PUNCT
ecj-12463	120	1	furthermore	furthermore	ADV
ecj-12463	120	2	,	,	PUNCT
ecj-12463	120	3	their	their	PRON
ecj-12463	120	4	increase	increase	NOUN
ecj-12463	120	5	correlates	correlate	VERB
ecj-12463	120	6	with	with	ADP
ecj-12463	120	7	the	the	DET
ecj-12463	120	8	severity	severity	NOUN
ecj-12463	120	9	of	of	ADP
ecj-12463	120	10	the	the	DET
ecj-12463	120	11	condition	condition	NOUN
ecj-12463	120	12	.	.	PUNCT
ecj-12463	121	1	moreover	moreover	ADV
ecj-12463	121	2	,	,	PUNCT
ecj-12463	121	3	inflammatory	inflammatory	ADJ
ecj-12463	121	4	cytokines	cytokine	NOUN
ecj-12463	121	5	such	such	ADJ
ecj-12463	121	6	as	as	ADP
ecj-12463	121	7	il-1β	il-1β	PROPN
ecj-12463	121	8	and	and	CCONJ
ecj-12463	121	9	il-6	il-6	NOUN
ecj-12463	121	10	have	have	VERB
ecj-12463	121	11	adverse	adverse	ADJ
ecj-12463	121	12	impacts	impact	NOUN
ecj-12463	121	13	on	on	ADP
ecj-12463	121	14	the	the	DET
ecj-12463	121	15	structure	structure	NOUN
ecj-12463	121	16	and	and	CCONJ
ecj-12463	121	17	function	function	NOUN
ecj-12463	121	18	of	of	ADP
ecj-12463	121	19	the	the	DET
ecj-12463	121	20	heart	heart	NOUN
ecj-12463	121	21	.	.	PUNCT
ecj-12463	122	1	according	accord	VERB
ecj-12463	122	2	to	to	ADP
ecj-12463	122	3	some	some	DET
ecj-12463	122	4	studies	study	NOUN
ecj-12463	122	5	,	,	PUNCT
ecj-12463	122	6	a	a	DET
ecj-12463	122	7	correlation	correlation	NOUN
ecj-12463	122	8	between	between	ADP
ecj-12463	122	9	sst2	sst2	PROPN
ecj-12463	122	10	and	and	CCONJ
ecj-12463	122	11	il-1β	il-1β	PROPN
ecj-12463	122	12	has	have	AUX
ecj-12463	122	13	been	be	AUX
ecj-12463	122	14	identified	identify	VERB
ecj-12463	122	15	in	in	ADP
ecj-12463	122	16	patients	patient	NOUN
ecj-12463	122	17	with	with	ADP
ecj-12463	122	18	hf	hf	NOUN
ecj-12463	122	19	:	:	PUNCT
ecj-12463	122	20	patients	patient	NOUN
ecj-12463	122	21	with	with	ADP
ecj-12463	122	22	heart	heart	NOUN
ecj-12463	122	23	failure	failure	NOUN
ecj-12463	122	24	who	who	PRON
ecj-12463	122	25	had	have	VERB
ecj-12463	122	26	low	low	ADJ
ecj-12463	122	27	sst2	sst2	NOUN
ecj-12463	122	28	and	and	CCONJ
ecj-12463	122	29	low	low	ADJ
ecj-12463	122	30	il-1β	il-1β	PROPN
ecj-12463	122	31	,	,	PUNCT
ecj-12463	122	32	in	in	ADP
ecj-12463	122	33	particular	particular	ADJ
ecj-12463	122	34	,	,	PUNCT
ecj-12463	122	35	had	have	VERB
ecj-12463	122	36	a	a	DET
ecj-12463	122	37	much	much	ADJ
ecj-12463	122	38	decreased	decrease	VERB
ecj-12463	122	39	risk	risk	NOUN
ecj-12463	122	40	of	of	ADP
ecj-12463	122	41	dying	die	VERB
ecj-12463	122	42	from	from	ADP
ecj-12463	122	43	cardiovascular	cardiovascular	ADJ
ecj-12463	122	44	disease	disease	NOUN
ecj-12463	122	45	as	as	ADP
ecj-12463	122	46	compared	compare	VERB
ecj-12463	122	47	to	to	ADP
ecj-12463	122	48	patients	patient	NOUN
ecj-12463	122	49	with	with	ADP
ecj-12463	122	50	high	high	ADJ
ecj-12463	122	51	sst2	sst2	NOUN
ecj-12463	122	52	and	and	CCONJ
ecj-12463	122	53	high	high	ADJ
ecj-12463	122	54	il-1β.2,62	il-1β.2,62	ADJ
ecj-12463	122	55	adhesion	adhesion	NOUN
ecj-12463	122	56	molecules	molecule	NOUN
ecj-12463	122	57	(	(	PUNCT
ecj-12463	122	58	icam-1	icam-1	NUM
ecj-12463	122	59	and	and	CCONJ
ecj-12463	122	60	vcam-1	vcam-1	NOUN
ecj-12463	122	61	)	)	PUNCT
ecj-12463	122	62	adhesion	adhesion	NOUN
ecj-12463	122	63	molecules	molecule	NOUN
ecj-12463	122	64	called	call	VERB
ecj-12463	122	65	vcam-1	vcam-1	NOUN
ecj-12463	122	66	and	and	CCONJ
ecj-12463	122	67	icam-1	icam-1	PRON
ecj-12463	122	68	also	also	ADV
ecj-12463	122	69	appear	appear	VERB
ecj-12463	122	70	to	to	PART
ecj-12463	122	71	participate	participate	VERB
ecj-12463	122	72	in	in	ADP
ecj-12463	122	73	the	the	DET
ecj-12463	122	74	inflammatory	inflammatory	ADJ
ecj-12463	122	75	process	process	NOUN
ecj-12463	122	76	and	and	CCONJ
ecj-12463	122	77	,	,	PUNCT
ecj-12463	122	78	in	in	ADP
ecj-12463	122	79	particular	particular	ADJ
ecj-12463	122	80	,	,	PUNCT
ecj-12463	122	81	shown	show	VERB
ecj-12463	122	82	a	a	DET
ecj-12463	122	83	role	role	NOUN
ecj-12463	122	84	in	in	ADP
ecj-12463	122	85	drawing	draw	VERB
ecj-12463	122	86	leukocytes	leukocyte	NOUN
ecj-12463	122	87	to	to	ADP
ecj-12463	122	88	the	the	DET
ecj-12463	122	89	endothelium	endothelium	NOUN
ecj-12463	122	90	during	during	ADP
ecj-12463	122	91	inflammation	inflammation	NOUN
ecj-12463	122	92	and	and	CCONJ
ecj-12463	122	93	sustaining	sustain	VERB
ecj-12463	122	94	the	the	DET
ecj-12463	122	95	inflammatory	inflammatory	ADJ
ecj-12463	122	96	response	response	NOUN
ecj-12463	122	97	.	.	PUNCT
ecj-12463	123	1	these	these	PRON
ecj-12463	123	2	leads	lead	VERB
ecj-12463	123	3	to	to	ADP
ecj-12463	123	4	the	the	DET
ecj-12463	123	5	creation	creation	NOUN
ecj-12463	123	6	of	of	ADP
ecj-12463	123	7	atheromatous	atheromatous	ADJ
ecj-12463	123	8	plaques	plaque	NOUN
ecj-12463	123	9	,	,	PUNCT
ecj-12463	123	10	which	which	PRON
ecj-12463	123	11	raises	raise	VERB
ecj-12463	123	12	the	the	DET
ecj-12463	123	13	risk	risk	NOUN
ecj-12463	123	14	of	of	ADP
ecj-12463	123	15	cvd	cvd	PROPN
ecj-12463	123	16	and	and	CCONJ
ecj-12463	123	17	acs.2	acs.2	PROPN
ecj-12463	123	18	mirs	mir	NOUN
ecj-12463	123	19	mirs	mir	NOUN
ecj-12463	123	20	are	be	AUX
ecj-12463	123	21	small	small	ADJ
ecj-12463	123	22	,	,	PUNCT
ecj-12463	123	23	non	non	ADJ
ecj-12463	123	24	-	-	ADJ
ecj-12463	123	25	coding	coding	ADJ
ecj-12463	123	26	rnas	rna	NOUN
ecj-12463	123	27	,	,	PUNCT
ecj-12463	123	28	which	which	PRON
ecj-12463	123	29	are	be	AUX
ecj-12463	123	30	involved	involve	VERB
ecj-12463	123	31	in	in	ADP
ecj-12463	123	32	the	the	DET
ecj-12463	123	33	regulation	regulation	NOUN
ecj-12463	123	34	of	of	ADP
ecj-12463	123	35	gene	gene	NOUN
ecj-12463	123	36	expression	expression	NOUN
ecj-12463	123	37	,	,	PUNCT
ecj-12463	123	38	modulating	modulate	VERB
ecj-12463	123	39	protein	protein	NOUN
ecj-12463	123	40	synthesis	synthesis	NOUN
ecj-12463	123	41	.	.	PUNCT
ecj-12463	124	1	different	different	ADJ
ecj-12463	124	2	mirs	mir	NOUN
ecj-12463	124	3	could	could	AUX
ecj-12463	124	4	be	be	AUX
ecj-12463	124	5	involved	involve	VERB
ecj-12463	124	6	in	in	ADP
ecj-12463	124	7	atherosclerosis	atherosclerosis	NOUN
ecj-12463	124	8	and	and	CCONJ
ecj-12463	124	9	cvd	cvd	PROPN
ecj-12463	124	10	,	,	PUNCT
ecj-12463	124	11	such	such	ADJ
ecj-12463	124	12	as	as	ADP
ecj-12463	124	13	mir-146a	mir-146a	ADJ
ecj-12463	124	14	,	,	PUNCT
ecj-12463	124	15	mir-26a	mir-26a	NOUN
ecj-12463	124	16	,	,	PUNCT
ecj-12463	124	17	mir-499	mir-499	NOUN
ecj-12463	124	18	,	,	PUNCT
ecj-12463	124	19	mir-133b	mir-133b	PROPN
ecj-12463	124	20	and	and	CCONJ
ecj-12463	124	21	mir-21	mir-21	PROPN
ecj-12463	124	22	.	.	PROPN
ecj-12463	124	23	of	of	ADP
ecj-12463	124	24	these	these	PRON
ecj-12463	124	25	,	,	PUNCT
ecj-12463	124	26	mir-146a	mir-146a	PROPN
ecj-12463	124	27	seems	seem	VERB
ecj-12463	124	28	to	to	PART
ecj-12463	124	29	be	be	AUX
ecj-12463	124	30	more	more	ADV
ecj-12463	124	31	involved	involved	ADJ
ecj-12463	124	32	in	in	ADP
ecj-12463	124	33	development	development	NOUN
ecj-12463	124	34	of	of	ADP
ecj-12463	124	35	coronary	coronary	ADJ
ecj-12463	124	36	heart	heart	NOUN
ecj-12463	124	37	disease	disease	NOUN
ecj-12463	124	38	.	.	PUNCT
ecj-12463	125	1	xue	xue	PROPN
ecj-12463	125	2	et	et	PROPN
ecj-12463	125	3	al	al	PROPN
ecj-12463	125	4	.	.	PROPN
ecj-12463	125	5	studied	study	VERB
ecj-12463	125	6	patients	patient	NOUN
ecj-12463	125	7	with	with	ADP
ecj-12463	125	8	acute	acute	ADJ
ecj-12463	125	9	myocardial	myocardial	ADJ
ecj-12463	125	10	infarction	infarction	NOUN
ecj-12463	125	11	observing	observe	VERB
ecj-12463	125	12	how	how	SCONJ
ecj-12463	125	13	mir-146a	mir-146a	ADJ
ecj-12463	125	14	represents	represent	VERB
ecj-12463	125	15	an	an	DET
ecj-12463	125	16	optimal	optimal	ADJ
ecj-12463	125	17	diagnostic	diagnostic	ADJ
ecj-12463	125	18	biomarker	biomarker	NOUN
ecj-12463	125	19	of	of	ADP
ecj-12463	125	20	cardiovascular	cardiovascular	ADJ
ecj-12463	125	21	disease.74	disease.74	VERB
ecj-12463	125	22	however	however	ADV
ecj-12463	125	23	,	,	PUNCT
ecj-12463	125	24	while	while	SCONJ
ecj-12463	125	25	some	some	DET
ecj-12463	125	26	mirs	mir	NOUN
ecj-12463	125	27	correlate	correlate	VERB
ecj-12463	125	28	positively	positively	ADV
ecj-12463	125	29	with	with	ADP
ecj-12463	125	30	cardiovascular	cardiovascular	ADJ
ecj-12463	125	31	risk	risk	NOUN
ecj-12463	125	32	,	,	PUNCT
ecj-12463	125	33	others	other	NOUN
ecj-12463	125	34	correlate	correlate	VERB
ecj-12463	125	35	negatively	negatively	ADV
ecj-12463	125	36	,	,	PUNCT
ecj-12463	125	37	being	be	AUX
ecj-12463	125	38	downregulated	downregulate	VERB
ecj-12463	125	39	in	in	ADP
ecj-12463	125	40	presence	presence	NOUN
ecj-12463	125	41	of	of	ADP
ecj-12463	125	42	myocardial	myocardial	ADJ
ecj-12463	125	43	damage.2	damage.2	PROPN
ecj-12463	125	44	in	in	ADP
ecj-12463	125	45	recent	recent	ADJ
ecj-12463	125	46	years	year	NOUN
ecj-12463	125	47	,	,	PUNCT
ecj-12463	125	48	several	several	ADJ
ecj-12463	125	49	studies	study	NOUN
ecj-12463	125	50	have	have	AUX
ecj-12463	125	51	addressed	address	VERB
ecj-12463	125	52	these	these	DET
ecj-12463	125	53	molecules	molecule	NOUN
ecj-12463	125	54	as	as	ADP
ecj-12463	125	55	possible	possible	ADJ
ecj-12463	125	56	biomarkers	biomarker	NOUN
ecj-12463	125	57	of	of	ADP
ecj-12463	125	58	cardiac	cardiac	ADJ
ecj-12463	125	59	damage	damage	NOUN
ecj-12463	125	60	and	and	CCONJ
ecj-12463	125	61	prediction	prediction	NOUN
ecj-12463	125	62	of	of	ADP
ecj-12463	125	63	cardiovascular	cardiovascular	ADJ
ecj-12463	125	64	risk	risk	NOUN
ecj-12463	125	65	;	;	PUNCT
ecj-12463	125	66	however	however	ADV
ecj-12463	125	67	,	,	PUNCT
ecj-12463	125	68	further	further	ADJ
ecj-12463	125	69	evidence	evidence	NOUN
ecj-12463	125	70	is	be	AUX
ecj-12463	125	71	needed	need	VERB
ecj-12463	125	72	.	.	PUNCT
ecj-12463	126	1	gdf-15	gdf-15	NOUN
ecj-12463	126	2	growth	growth	NOUN
ecj-12463	126	3	differentiation	differentiation	NOUN
ecj-12463	126	4	factor	factor	NOUN
ecj-12463	126	5	15	15	NUM
ecj-12463	126	6	(	(	PUNCT
ecj-12463	126	7	gdf-15	gdf-15	NOUN
ecj-12463	126	8	)	)	PUNCT
ecj-12463	126	9	is	be	AUX
ecj-12463	126	10	a	a	DET
ecj-12463	126	11	biomarker	biomarker	NOUN
ecj-12463	126	12	belonging	belong	VERB
ecj-12463	126	13	to	to	ADP
ecj-12463	126	14	the	the	DET
ecj-12463	126	15	tgf	tgf	PROPN
ecj-12463	126	16	-	-	PUNCT
ecj-12463	126	17	β	β	X
ecj-12463	126	18	cytokine	cytokine	NOUN
ecj-12463	126	19	,	,	PUNCT
ecj-12463	126	20	especially	especially	ADV
ecj-12463	126	21	expressed	express	VERB
ecj-12463	126	22	in	in	ADP
ecj-12463	126	23	myocardium	myocardium	ADJ
ecj-12463	126	24	and	and	CCONJ
ecj-12463	126	25	endothelial	endothelial	ADJ
ecj-12463	126	26	cells	cell	NOUN
ecj-12463	126	27	,	,	PUNCT
ecj-12463	126	28	implicated	implicate	VERB
ecj-12463	126	29	in	in	ADP
ecj-12463	126	30	the	the	DET
ecj-12463	126	31	inflammatory	inflammatory	ADJ
ecj-12463	126	32	response	response	NOUN
ecj-12463	126	33	and	and	CCONJ
ecj-12463	126	34	oxidative	oxidative	ADJ
ecj-12463	126	35	damage	damage	NOUN
ecj-12463	126	36	,	,	PUNCT
ecj-12463	126	37	considered	consider	VERB
ecj-12463	126	38	as	as	ADP
ecj-12463	126	39	the	the	DET
ecj-12463	126	40	triggers	trigger	NOUN
ecj-12463	126	41	that	that	PRON
ecj-12463	126	42	can	can	AUX
ecj-12463	126	43	up	up	ADP
ecj-12463	126	44	regulate	regulate	VERB
ecj-12463	126	45	its	its	PRON
ecj-12463	126	46	expression.75	expression.75	NOUN
ecj-12463	126	47	it	it	PRON
ecj-12463	126	48	has	have	AUX
ecj-12463	126	49	been	be	AUX
ecj-12463	126	50	mainly	mainly	ADV
ecj-12463	126	51	studied	study	VERB
ecj-12463	126	52	in	in	ADP
ecj-12463	126	53	the	the	DET
ecj-12463	126	54	context	context	NOUN
ecj-12463	126	55	of	of	ADP
ecj-12463	126	56	acute	acute	ADJ
ecj-12463	126	57	and	and	CCONJ
ecj-12463	126	58	chronic	chronic	ADJ
ecj-12463	126	59	heart	heart	NOUN
ecj-12463	126	60	failure	failure	NOUN
ecj-12463	126	61	.	.	PUNCT
ecj-12463	127	1	however	however	ADV
ecj-12463	127	2	,	,	PUNCT
ecj-12463	127	3	it	it	PRON
ecj-12463	127	4	is	be	AUX
ecj-12463	127	5	currently	currently	ADV
ecj-12463	127	6	being	be	AUX
ecj-12463	127	7	studied	study	VERB
ecj-12463	127	8	primarily	primarily	ADV
ecj-12463	127	9	for	for	ADP
ecj-12463	127	10	its	its	PRON
ecj-12463	127	11	role	role	NOUN
ecj-12463	127	12	in	in	ADP
ecj-12463	127	13	chronic	chronic	ADJ
ecj-12463	127	14	heart	heart	NOUN
ecj-12463	127	15	failure	failure	NOUN
ecj-12463	127	16	.	.	PUNCT
ecj-12463	128	1	based	base	VERB
ecj-12463	128	2	on	on	ADP
ecj-12463	128	3	current	current	ADJ
ecj-12463	128	4	evidence	evidence	NOUN
ecj-12463	128	5	,	,	PUNCT
ecj-12463	128	6	high	high	ADJ
ecj-12463	128	7	levels	level	NOUN
ecj-12463	128	8	of	of	ADP
ecj-12463	128	9	gdf-15	gdf-15	X
ecj-12463	128	10	are	be	AUX
ecj-12463	128	11	associated	associate	VERB
ecj-12463	128	12	with	with	ADP
ecj-12463	128	13	a	a	DET
ecj-12463	128	14	poor	poor	ADJ
ecj-12463	128	15	prognosis	prognosis	NOUN
ecj-12463	128	16	for	for	ADP
ecj-12463	128	17	patients	patient	NOUN
ecj-12463	128	18	with	with	ADP
ecj-12463	128	19	acute	acute	ADJ
ecj-12463	128	20	heart	heart	NOUN
ecj-12463	128	21	failure	failure	NOUN
ecj-12463	128	22	.	.	PUNCT
ecj-12463	129	1	the	the	DET
ecj-12463	129	2	elevated	elevated	ADJ
ecj-12463	129	3	serum	serum	NOUN
ecj-12463	129	4	level	level	NOUN
ecj-12463	129	5	of	of	ADP
ecj-12463	129	6	gdf-15	gdf-15	CCONJ
ecj-12463	129	7	was	be	AUX
ecj-12463	129	8	the	the	DET
ecj-12463	129	9	most	most	ADV
ecj-12463	129	10	prognostic	prognostic	ADJ
ecj-12463	129	11	biomarker	biomarker	NOUN
ecj-12463	129	12	in	in	ADP
ecj-12463	129	13	comparison	comparison	NOUN
ecj-12463	129	14	to	to	ADP
ecj-12463	129	15	nt	nt	NOUN
ecj-12463	129	16	-	-	PUNCT
ecj-12463	129	17	probnp	probnp	NOUN
ecj-12463	129	18	,	,	PUNCT
ecj-12463	129	19	hs	hs	PROPN
ecj-12463	129	20	-	-	PROPN
ecj-12463	129	21	crp	crp	NOUN
ecj-12463	129	22	,	,	PUNCT
ecj-12463	129	23	and	and	CCONJ
ecj-12463	129	24	hs	hs	PROPN
ecj-12463	129	25	-	-	PROPN
ecj-12463	129	26	tnt	tnt	PROPN
ecj-12463	129	27	and	and	CCONJ
ecj-12463	129	28	an	an	DET
ecj-12463	129	29	independent	independent	ADJ
ecj-12463	129	30	predictor	predictor	NOUN
ecj-12463	129	31	of	of	ADP
ecj-12463	129	32	long	long	ADJ
ecj-12463	129	33	-	-	PUNCT
ecj-12463	129	34	term	term	NOUN
ecj-12463	129	35	mortality	mortality	NOUN
ecj-12463	129	36	in	in	ADP
ecj-12463	129	37	advanced	advanced	ADJ
ecj-12463	129	38	hf.62,76	hf.62,76	ADJ
ecj-12463	129	39	recent	recent	ADJ
ecj-12463	129	40	studies	study	NOUN
ecj-12463	129	41	propose	propose	VERB
ecj-12463	129	42	an	an	DET
ecj-12463	129	43	association	association	NOUN
ecj-12463	129	44	between	between	ADP
ecj-12463	129	45	elevated	elevate	VERB
ecj-12463	129	46	gdf-15	gdf-15	NOUN
ecj-12463	129	47	levels	level	NOUN
ecj-12463	129	48	and	and	CCONJ
ecj-12463	129	49	different	different	ADJ
ecj-12463	129	50	clinical	clinical	ADJ
ecj-12463	129	51	conditions	condition	NOUN
ecj-12463	129	52	(	(	PUNCT
ecj-12463	129	53	e.g.	e.g.	ADV
ecj-12463	129	54	,	,	PUNCT
ecj-12463	129	55	ineffective	ineffective	ADJ
ecj-12463	129	56	erythropoiesis	erythropoiesis	NOUN
ecj-12463	129	57	inflammation	inflammation	NOUN
ecj-12463	129	58	,	,	PUNCT
ecj-12463	129	59	acute	acute	ADJ
ecj-12463	129	60	injury	injury	NOUN
ecj-12463	129	61	,	,	PUNCT
ecj-12463	129	62	cancer	cancer	NOUN
ecj-12463	129	63	,	,	PUNCT
ecj-12463	129	64	and	and	CCONJ
ecj-12463	129	65	chronic	chronic	ADJ
ecj-12463	129	66	kidney	kidney	NOUN
ecj-12463	129	67	disease	disease	NOUN
ecj-12463	129	68	,	,	PUNCT
ecj-12463	129	69	ischemic	ischemic	ADJ
ecj-12463	129	70	stroke	stroke	NOUN
ecj-12463	129	71	)	)	PUNCT
ecj-12463	129	72	.	.	PUNCT
ecj-12463	130	1	concerning	concern	VERB
ecj-12463	130	2	acs	acs	PROPN
ecj-12463	130	3	,	,	PUNCT
ecj-12463	130	4	it	it	PRON
ecj-12463	130	5	has	have	AUX
ecj-12463	130	6	been	be	AUX
ecj-12463	130	7	established	establish	VERB
ecj-12463	130	8	that	that	SCONJ
ecj-12463	130	9	gdf-15	gdf-15	NOUN
ecj-12463	130	10	levels	level	NOUN
ecj-12463	130	11	rise	rise	VERB
ecj-12463	130	12	in	in	ADP
ecj-12463	130	13	just	just	ADV
ecj-12463	130	14	a	a	DET
ecj-12463	130	15	few	few	ADJ
ecj-12463	130	16	hours	hour	NOUN
ecj-12463	130	17	after	after	ADP
ecj-12463	130	18	mi.64	mi.64	NOUN
ecj-12463	130	19	however	however	ADV
ecj-12463	130	20	,	,	PUNCT
ecj-12463	130	21	in	in	ADP
ecj-12463	130	22	consideration	consideration	NOUN
ecj-12463	130	23	of	of	ADP
ecj-12463	130	24	its	its	PRON
ecj-12463	130	25	important	important	ADJ
ecj-12463	130	26	functions	function	NOUN
ecj-12463	130	27	,	,	PUNCT
ecj-12463	130	28	a	a	DET
ecj-12463	130	29	role	role	NOUN
ecj-12463	130	30	in	in	ADP
ecj-12463	130	31	acute	acute	ADJ
ecj-12463	130	32	care	care	NOUN
ecj-12463	130	33	must	must	AUX
ecj-12463	130	34	be	be	AUX
ecj-12463	130	35	further	far	ADV
ecj-12463	130	36	evaluated	evaluate	VERB
ecj-12463	130	37	;	;	PUNCT
ecj-12463	130	38	for	for	ADP
ecj-12463	130	39	these	these	DET
ecj-12463	130	40	reasons	reason	NOUN
ecj-12463	130	41	focused	focus	VERB
ecj-12463	130	42	studies	study	NOUN
ecj-12463	130	43	are	be	AUX
ecj-12463	130	44	necessary	necessary	ADJ
ecj-12463	130	45	.	.	PUNCT
ecj-12463	131	1	mr	mr	PROPN
ecj-12463	131	2	-	-	PUNCT
ecj-12463	131	3	proadm	proadm	PROPN
ecj-12463	131	4	mid	mid	ADJ
ecj-12463	131	5	regional	regional	ADJ
ecj-12463	131	6	pro	pro	ADJ
ecj-12463	131	7	adrenomedullin	adrenomedullin	NOUN
ecj-12463	131	8	(	(	PUNCT
ecj-12463	131	9	mr	mr	PROPN
ecj-12463	131	10	-	-	PUNCT
ecj-12463	131	11	proadm	proadm	NOUN
ecj-12463	131	12	)	)	PUNCT
ecj-12463	131	13	is	be	AUX
ecj-12463	131	14	the	the	DET
ecj-12463	131	15	precursor	precursor	NOUN
ecj-12463	131	16	of	of	ADP
ecj-12463	131	17	adrenomedullin	adrenomedullin	NOUN
ecj-12463	131	18	,	,	PUNCT
ecj-12463	131	19	a	a	DET
ecj-12463	131	20	protein	protein	NOUN
ecj-12463	131	21	expressed	express	VERB
ecj-12463	131	22	in	in	ADP
ecj-12463	131	23	different	different	ADJ
ecj-12463	131	24	tissues	tissue	NOUN
ecj-12463	131	25	and	and	CCONJ
ecj-12463	131	26	cells	cell	NOUN
ecj-12463	131	27	and	and	CCONJ
ecj-12463	131	28	involved	involve	VERB
ecj-12463	131	29	in	in	ADP
ecj-12463	131	30	several	several	ADJ
ecj-12463	131	31	pathways	pathway	NOUN
ecj-12463	131	32	and	and	CCONJ
ecj-12463	131	33	biological	biological	ADJ
ecj-12463	131	34	mechanisms	mechanism	NOUN
ecj-12463	131	35	,	,	PUNCT
ecj-12463	131	36	such	such	ADJ
ecj-12463	131	37	as	as	ADP
ecj-12463	131	38	natriuresis	natriuresis	NOUN
ecj-12463	131	39	or	or	CCONJ
ecj-12463	131	40	vasodilatation	vasodilatation	NOUN
ecj-12463	131	41	.	.	PUNCT
ecj-12463	132	1	in	in	ADP
ecj-12463	132	2	recent	recent	ADJ
ecj-12463	132	3	years	year	NOUN
ecj-12463	132	4	,	,	PUNCT
ecj-12463	132	5	it	it	PRON
ecj-12463	132	6	has	have	AUX
ecj-12463	132	7	been	be	AUX
ecj-12463	132	8	demonstrated	demonstrate	VERB
ecj-12463	132	9	that	that	SCONJ
ecj-12463	132	10	mr	mr	PROPN
ecj-12463	132	11	-	-	PUNCT
ecj-12463	132	12	proadm	proadm	PROPN
ecj-12463	132	13	plays	play	VERB
ecj-12463	132	14	an	an	DET
ecj-12463	132	15	important	important	ADJ
ecj-12463	132	16	role	role	NOUN
ecj-12463	132	17	in	in	ADP
ecj-12463	132	18	the	the	DET
ecj-12463	132	19	course	course	NOUN
ecj-12463	132	20	of	of	ADP
ecj-12463	132	21	cardiovascular	cardiovascular	ADJ
ecj-12463	132	22	disease	disease	NOUN
ecj-12463	132	23	,	,	PUNCT
ecj-12463	132	24	in	in	ADP
ecj-12463	132	25	relation	relation	NOUN
ecj-12463	132	26	to	to	ADP
ecj-12463	132	27	its	its	PRON
ecj-12463	132	28	multiple	multiple	ADJ
ecj-12463	132	29	functions	function	NOUN
ecj-12463	132	30	.	.	PUNCT
ecj-12463	133	1	a	a	DET
ecj-12463	133	2	significant	significant	ADJ
ecj-12463	133	3	review	review	NOUN
ecj-12463	133	4	by	by	ADP
ecj-12463	133	5	berezin	berezin	PROPN
ecj-12463	133	6	ae	ae	PROPN
ecj-12463	133	7	and	and	CCONJ
ecj-12463	133	8	berezin	berezin	PROPN
ecj-12463	133	9	aa	aa	PROPN
ecj-12463	133	10	,	,	PUNCT
ecj-12463	133	11	showed	show	VERB
ecj-12463	133	12	that	that	SCONJ
ecj-12463	133	13	circulating	circulate	VERB
ecj-12463	133	14	levels	level	NOUN
ecj-12463	133	15	of	of	ADP
ecj-12463	133	16	mr	mr	PROPN
ecj-12463	133	17	-	-	PUNCT
ecj-12463	133	18	proadm	proadm	PROPN
ecj-12463	133	19	were	be	AUX
ecj-12463	133	20	increased	increase	VERB
ecj-12463	133	21	in	in	ADP
ecj-12463	133	22	patients	patient	NOUN
ecj-12463	133	23	with	with	ADP
ecj-12463	133	24	acute	acute	ADJ
ecj-12463	133	25	hf	hf	NOUN
ecj-12463	133	26	and	and	CCONJ
ecj-12463	133	27	stemi	stemi	NOUN
ecj-12463	133	28	,	,	PUNCT
ecj-12463	133	29	and	and	CCONJ
ecj-12463	133	30	also	also	ADV
ecj-12463	133	31	allowed	allow	VERB
ecj-12463	133	32	to	to	PART
ecj-12463	133	33	estimate	estimate	VERB
ecj-12463	133	34	adverse	adverse	ADJ
ecj-12463	133	35	outcomes	outcome	NOUN
ecj-12463	133	36	,	,	PUNCT
ecj-12463	133	37	including	include	VERB
ecj-12463	133	38	death	death	NOUN
ecj-12463	133	39	.	.	PUNCT
ecj-12463	134	1	additionally	additionally	ADV
ecj-12463	134	2	,	,	PUNCT
ecj-12463	134	3	serum	serum	NOUN
ecj-12463	134	4	levels	level	NOUN
ecj-12463	134	5	of	of	ADP
ecj-12463	134	6	mr	mr	PROPN
ecj-12463	134	7	review	review	PROPN
ecj-12463	134	8	[	[	X
ecj-12463	134	9	page	page	NOUN
ecj-12463	134	10	53	53	NUM
ecj-12463	134	11	]	]	PUNCT
ecj-12463	135	1	[	[	X
ecj-12463	135	2	emergency	emergency	NOUN
ecj-12463	135	3	care	care	NOUN
ecj-12463	135	4	journal	journal	PROPN
ecj-12463	135	5	2024	2024	NUM
ecj-12463	135	6	;	;	PUNCT
ecj-12463	135	7	20:12463	20:12463	NUM
ecj-12463	135	8	]	]	X
ecj-12463	135	9	non	non	ADJ
ecj-12463	135	10	-co	-co	PROPN
ecj-12463	135	11	mmerc	mmerc	PROPN
ecj-12463	135	12	ial	ial	PROPN
ecj-12463	135	13	us	us	PROPN
ecj-12463	135	14	e	e	NOUN
ecj-12463	135	15	o	o	NOUN
ecj-12463	135	16	nly	nly	ADV
ecj-12463	135	17	proadm	proadm	ADJ
ecj-12463	135	18	>	>	PUNCT
ecj-12463	135	19	0.70	0.70	NUM
ecj-12463	135	20	nmol	nmol	NOUN
ecj-12463	135	21	/	/	SYM
ecj-12463	135	22	l	l	NOUN
ecj-12463	135	23	were	be	AUX
ecj-12463	135	24	proposed	propose	VERB
ecj-12463	135	25	to	to	PART
ecj-12463	135	26	be	be	AUX
ecj-12463	135	27	the	the	DET
ecj-12463	135	28	rule	rule	NOUN
ecj-12463	135	29	-	-	PUNCT
ecj-12463	135	30	in	in	ADP
ecj-12463	135	31	criteria	criterion	NOUN
ecj-12463	135	32	of	of	ADP
ecj-12463	135	33	ami	ami	NOUN
ecj-12463	135	34	.	.	PUNCT
ecj-12463	136	1	in	in	ADP
ecj-12463	136	2	the	the	DET
ecj-12463	136	3	same	same	ADJ
ecj-12463	136	4	review	review	NOUN
ecj-12463	136	5	,	,	PUNCT
ecj-12463	136	6	the	the	DET
ecj-12463	136	7	results	result	NOUN
ecj-12463	136	8	of	of	ADP
ecj-12463	136	9	the	the	DET
ecj-12463	136	10	danami-3	danami-3	PROPN
ecj-12463	136	11	(	(	PUNCT
ecj-12463	136	12	the	the	DET
ecj-12463	136	13	danish	danish	ADJ
ecj-12463	136	14	study	study	NOUN
ecj-12463	136	15	of	of	ADP
ecj-12463	136	16	optimal	optimal	ADJ
ecj-12463	136	17	acute	acute	ADJ
ecj-12463	136	18	treatment	treatment	NOUN
ecj-12463	136	19	of	of	ADP
ecj-12463	136	20	patients	patient	NOUN
ecj-12463	136	21	with	with	ADP
ecj-12463	136	22	st	st	PROPN
ecj-12463	136	23	-	-	PUNCT
ecj-12463	136	24	segment	segment	NOUN
ecj-12463	136	25	-	-	PUNCT
ecj-12463	136	26	elevation	elevation	NOUN
ecj-12463	136	27	myocardial	myocardial	ADJ
ecj-12463	136	28	infarction	infarction	NOUN
ecj-12463	136	29	)	)	PUNCT
ecj-12463	136	30	study	study	NOUN
ecj-12463	136	31	have	have	AUX
ecj-12463	136	32	shown	show	VERB
ecj-12463	136	33	that	that	SCONJ
ecj-12463	136	34	elevated	elevated	ADJ
ecj-12463	136	35	levels	level	NOUN
ecj-12463	136	36	of	of	ADP
ecj-12463	136	37	mr	mr	PROPN
ecj-12463	136	38	-	-	PUNCT
ecj-12463	136	39	proadm	proadm	PROPN
ecj-12463	136	40	were	be	AUX
ecj-12463	136	41	strong	strong	ADJ
ecj-12463	136	42	predictor	predictor	NOUN
ecj-12463	136	43	of	of	ADP
ecj-12463	136	44	shortand	shortand	NOUN
ecj-12463	136	45	long	long	ADJ
ecj-12463	136	46	-	-	PUNCT
ecj-12463	136	47	term	term	NOUN
ecj-12463	136	48	mortality	mortality	NOUN
ecj-12463	136	49	and	and	CCONJ
ecj-12463	136	50	hospital	hospital	NOUN
ecj-12463	136	51	admission	admission	NOUN
ecj-12463	136	52	for	for	ADP
ecj-12463	136	53	hf	hf	NOUN
ecj-12463	136	54	after	after	ADP
ecj-12463	136	55	ami	ami	NOUN
ecj-12463	136	56	.	.	PUNCT
ecj-12463	137	1	mostly	mostly	ADV
ecj-12463	137	2	,	,	PUNCT
ecj-12463	137	3	mr	mr	PROPN
ecj-12463	137	4	-	-	PUNCT
ecj-12463	137	5	proadm	proadm	PROPN
ecj-12463	137	6	was	be	AUX
ecj-12463	137	7	able	able	ADJ
ecj-12463	137	8	to	to	PART
ecj-12463	137	9	predict	predict	VERB
ecj-12463	137	10	major	major	ADJ
ecj-12463	137	11	adverse	adverse	ADJ
ecj-12463	137	12	cardiac	cardiac	ADJ
ecj-12463	137	13	events	event	NOUN
ecj-12463	137	14	in	in	ADP
ecj-12463	137	15	patients	patient	NOUN
ecj-12463	137	16	suspecting	suspect	VERB
ecj-12463	137	17	ami	ami	NOUN
ecj-12463	137	18	regardless	regardless	ADV
ecj-12463	137	19	of	of	ADP
ecj-12463	137	20	hf.62	hf.62	NOUN
ecj-12463	137	21	mrproadm	mrproadm	PRON
ecj-12463	137	22	also	also	ADV
ecj-12463	137	23	emerged	emerge	VERB
ecj-12463	137	24	as	as	ADP
ecj-12463	137	25	the	the	DET
ecj-12463	137	26	best	good	ADJ
ecj-12463	137	27	predictor	predictor	NOUN
ecj-12463	137	28	of	of	ADP
ecj-12463	137	29	1	1	NUM
ecj-12463	137	30	-	-	PUNCT
ecj-12463	137	31	year	year	NOUN
ecj-12463	137	32	death	death	NOUN
ecj-12463	137	33	after	after	ADP
ecj-12463	137	34	the	the	DET
ecj-12463	137	35	diagnosis	diagnosis	NOUN
ecj-12463	137	36	of	of	ADP
ecj-12463	137	37	acute	acute	ADJ
ecj-12463	137	38	hf	hf	NOUN
ecj-12463	137	39	in	in	ADP
ecj-12463	137	40	some	some	DET
ecj-12463	137	41	recent	recent	ADJ
ecj-12463	137	42	studies.76	studies.76	NOUN
ecj-12463	137	43	galectin-3	galectin-3	PROPN
ecj-12463	137	44	galectin-3	galectin-3	PROPN
ecj-12463	137	45	is	be	AUX
ecj-12463	137	46	a	a	DET
ecj-12463	137	47	β	β	NOUN
ecj-12463	137	48	-	-	ADJ
ecj-12463	137	49	galactoside	galactoside	NOUN
ecj-12463	137	50	-	-	PUNCT
ecj-12463	137	51	binding	bind	VERB
ecj-12463	137	52	protein	protein	NOUN
ecj-12463	137	53	expressed	express	VERB
ecj-12463	137	54	in	in	ADP
ecj-12463	137	55	myocardial	myocardial	ADJ
ecj-12463	137	56	cells	cell	NOUN
ecj-12463	137	57	and	and	CCONJ
ecj-12463	137	58	released	release	VERB
ecj-12463	137	59	from	from	ADP
ecj-12463	137	60	activated	activate	VERB
ecj-12463	137	61	macrophages	macrophage	NOUN
ecj-12463	137	62	,	,	PUNCT
ecj-12463	137	63	and	and	CCONJ
ecj-12463	137	64	it	it	PRON
ecj-12463	137	65	is	be	AUX
ecj-12463	137	66	implicated	implicate	VERB
ecj-12463	137	67	in	in	ADP
ecj-12463	137	68	myocardial	myocardial	ADJ
ecj-12463	137	69	remodeling.63	remodeling.63	NOUN
ecj-12463	137	70	it	it	PRON
ecj-12463	137	71	had	have	AUX
ecj-12463	137	72	been	be	AUX
ecj-12463	137	73	investigated	investigate	VERB
ecj-12463	137	74	as	as	ADP
ecj-12463	137	75	a	a	DET
ecj-12463	137	76	biomarker	biomarker	NOUN
ecj-12463	137	77	of	of	ADP
ecj-12463	137	78	inflammation	inflammation	NOUN
ecj-12463	137	79	with	with	ADP
ecj-12463	137	80	a	a	DET
ecj-12463	137	81	promising	promising	ADJ
ecj-12463	137	82	predictive	predictive	ADJ
ecj-12463	137	83	value	value	NOUN
ecj-12463	137	84	for	for	ADP
ecj-12463	137	85	heart	heart	NOUN
ecj-12463	137	86	failure	failure	NOUN
ecj-12463	137	87	and	and	CCONJ
ecj-12463	137	88	cardiovascular	cardiovascular	ADJ
ecj-12463	137	89	events	event	NOUN
ecj-12463	137	90	.	.	PUNCT
ecj-12463	138	1	galectin-3	galectin-3	NOUN
ecj-12463	138	2	,	,	PUNCT
ecj-12463	138	3	like	like	ADP
ecj-12463	138	4	gdf15	gdf15	NOUN
ecj-12463	138	5	,	,	PUNCT
ecj-12463	138	6	has	have	AUX
ecj-12463	138	7	also	also	ADV
ecj-12463	138	8	been	be	AUX
ecj-12463	138	9	more	more	ADV
ecj-12463	138	10	investigated	investigate	VERB
ecj-12463	138	11	in	in	ADP
ecj-12463	138	12	heart	heart	NOUN
ecj-12463	138	13	failure	failure	NOUN
ecj-12463	138	14	.	.	PUNCT
ecj-12463	139	1	different	different	ADJ
ecj-12463	139	2	studies	study	NOUN
ecj-12463	139	3	showed	show	VERB
ecj-12463	139	4	that	that	SCONJ
ecj-12463	139	5	serum	serum	NOUN
ecj-12463	139	6	galectin-3	galectin-3	PROPN
ecj-12463	139	7	values	value	NOUN
ecj-12463	139	8	were	be	AUX
ecj-12463	139	9	significantly	significantly	ADV
ecj-12463	139	10	higher	high	ADJ
ecj-12463	139	11	in	in	ADP
ecj-12463	139	12	patients	patient	NOUN
ecj-12463	139	13	with	with	ADP
ecj-12463	139	14	acute	acute	PROPN
ecj-12463	139	15	hf	hf	NOUN
ecj-12463	139	16	.	.	PUNCT
ecj-12463	140	1	in	in	ADP
ecj-12463	140	2	a	a	DET
ecj-12463	140	3	prospective	prospective	ADJ
ecj-12463	140	4	study	study	NOUN
ecj-12463	140	5	on	on	ADP
ecj-12463	140	6	chronic	chronic	ADJ
ecj-12463	140	7	hf	hf	NOUN
ecj-12463	140	8	and	and	CCONJ
ecj-12463	140	9	coronary	coronary	ADJ
ecj-12463	140	10	heart	heart	NOUN
ecj-12463	140	11	disease	disease	NOUN
ecj-12463	140	12	,	,	PUNCT
ecj-12463	140	13	increased	increase	VERB
ecj-12463	140	14	galectin-3	galectin-3	PROPN
ecj-12463	140	15	levels	level	NOUN
ecj-12463	140	16	in	in	ADP
ecj-12463	140	17	patients	patient	NOUN
ecj-12463	140	18	with	with	ADP
ecj-12463	140	19	hf	hf	PROPN
ecj-12463	140	20	were	be	AUX
ecj-12463	140	21	an	an	DET
ecj-12463	140	22	independent	independent	ADJ
ecj-12463	140	23	predictor	predictor	NOUN
ecj-12463	140	24	of	of	ADP
ecj-12463	140	25	all	all	DET
ecj-12463	140	26	-	-	PUNCT
ecj-12463	140	27	cause	cause	NOUN
ecj-12463	140	28	mortality	mortality	NOUN
ecj-12463	140	29	and	and	CCONJ
ecj-12463	140	30	rehospitalization	rehospitalization	NOUN
ecj-12463	140	31	within	within	ADP
ecj-12463	140	32	a	a	DET
ecj-12463	140	33	12	12	NUM
ecj-12463	140	34	-	-	PUNCT
ecj-12463	140	35	month	month	NOUN
ecj-12463	140	36	follow	follow	NOUN
ecj-12463	140	37	-	-	PUNCT
ecj-12463	140	38	up	up	ADP
ecj-12463	140	39	period.77	period.77	NOUN
ecj-12463	140	40	elevated	elevate	VERB
ecj-12463	140	41	levels	level	NOUN
ecj-12463	140	42	of	of	ADP
ecj-12463	140	43	galectin-3	galectin-3	PROPN
ecj-12463	140	44	were	be	AUX
ecj-12463	140	45	also	also	ADV
ecj-12463	140	46	found	find	VERB
ecj-12463	140	47	in	in	ADP
ecj-12463	140	48	patients	patient	NOUN
ecj-12463	140	49	with	with	ADP
ecj-12463	140	50	adverse	adverse	ADJ
ecj-12463	140	51	cardiac	cardiac	ADJ
ecj-12463	140	52	remodeling	remodeling	NOUN
ecj-12463	140	53	,	,	PUNCT
ecj-12463	140	54	but	but	CCONJ
ecj-12463	140	55	comparison	comparison	NOUN
ecj-12463	140	56	of	of	ADP
ecj-12463	140	57	sst2	sst2	PROPN
ecj-12463	140	58	and	and	CCONJ
ecj-12463	140	59	galectin-3	galectin-3	PROPN
ecj-12463	140	60	has	have	AUX
ecj-12463	140	61	revealed	reveal	VERB
ecj-12463	140	62	the	the	DET
ecj-12463	140	63	superiority	superiority	NOUN
ecj-12463	140	64	of	of	ADP
ecj-12463	140	65	sst2	sst2	NOUN
ecj-12463	140	66	in	in	ADP
ecj-12463	140	67	long	long	ADJ
ecj-12463	140	68	-	-	PUNCT
ecj-12463	140	69	term	term	NOUN
ecj-12463	140	70	risk	risk	NOUN
ecj-12463	140	71	stratification.62,76	stratification.62,76	NOUN
ecj-12463	140	72	patients	patient	NOUN
ecj-12463	140	73	who	who	PRON
ecj-12463	140	74	experienced	experience	VERB
ecj-12463	140	75	early	early	ADJ
ecj-12463	140	76	mace	mace	NOUN
ecj-12463	140	77	had	have	VERB
ecj-12463	140	78	significantly	significantly	ADV
ecj-12463	140	79	higher	high	ADJ
ecj-12463	140	80	galectin-3	galectin-3	PROPN
ecj-12463	140	81	and	and	CCONJ
ecj-12463	140	82	mr	mr	PROPN
ecj-12463	140	83	-	-	PUNCT
ecj-12463	140	84	proanp	proanp	PROPN
ecj-12463	140	85	levels	level	NOUN
ecj-12463	140	86	assessed	assess	VERB
ecj-12463	140	87	on	on	ADP
ecj-12463	140	88	admission	admission	NOUN
ecj-12463	140	89	;	;	PUNCT
ecj-12463	140	90	however	however	ADV
ecj-12463	140	91	,	,	PUNCT
ecj-12463	140	92	a	a	DET
ecj-12463	140	93	high	high	ADJ
ecj-12463	140	94	concentration	concentration	NOUN
ecj-12463	140	95	of	of	ADP
ecj-12463	140	96	galectin-3	galectin-3	PROPN
ecj-12463	140	97	observed	observe	VERB
ecj-12463	140	98	on	on	ADP
ecj-12463	140	99	admission	admission	NOUN
ecj-12463	140	100	may	may	AUX
ecj-12463	140	101	also	also	ADV
ecj-12463	140	102	identify	identify	VERB
ecj-12463	140	103	patients	patient	NOUN
ecj-12463	140	104	at	at	ADP
ecj-12463	140	105	high	high	ADJ
ecj-12463	140	106	risk	risk	NOUN
ecj-12463	140	107	of	of	ADP
ecj-12463	140	108	late	late	ADJ
ecj-12463	140	109	mace.78	mace.78	NOUN
ecj-12463	140	110	h	h	NOUN
ecj-12463	140	111	-	-	PUNCT
ecj-12463	140	112	fabp	fabp	VERB
ecj-12463	140	113	heart	heart	NOUN
ecj-12463	140	114	-	-	PUNCT
ecj-12463	140	115	type	type	NOUN
ecj-12463	140	116	fatty	fatty	NOUN
ecj-12463	140	117	acid	acid	NOUN
ecj-12463	140	118	binding	bind	VERB
ecj-12463	140	119	protein	protein	NOUN
ecj-12463	140	120	(	(	PUNCT
ecj-12463	140	121	h	h	NOUN
ecj-12463	140	122	-	-	PUNCT
ecj-12463	140	123	fabp	fabp	NOUN
ecj-12463	140	124	)	)	PUNCT
ecj-12463	140	125	is	be	AUX
ecj-12463	140	126	a	a	DET
ecj-12463	140	127	low	low	ADJ
ecj-12463	140	128	molecular	molecular	ADJ
ecj-12463	140	129	weight	weight	NOUN
ecj-12463	140	130	protein	protein	NOUN
ecj-12463	140	131	that	that	PRON
ecj-12463	140	132	is	be	AUX
ecj-12463	140	133	expressed	express	VERB
ecj-12463	140	134	in	in	ADP
ecj-12463	140	135	cardiomyocytes	cardiomyocyte	NOUN
ecj-12463	140	136	and	and	CCONJ
ecj-12463	140	137	released	release	VERB
ecj-12463	140	138	when	when	SCONJ
ecj-12463	140	139	myocardial	myocardial	ADJ
ecj-12463	140	140	damage	damage	NOUN
ecj-12463	140	141	has	have	AUX
ecj-12463	140	142	occurred	occur	VERB
ecj-12463	140	143	.	.	PUNCT
ecj-12463	141	1	this	this	PRON
ecj-12463	141	2	is	be	AUX
ecj-12463	141	3	the	the	DET
ecj-12463	141	4	reason	reason	NOUN
ecj-12463	141	5	why	why	SCONJ
ecj-12463	141	6	it	it	PRON
ecj-12463	141	7	could	could	AUX
ecj-12463	141	8	be	be	AUX
ecj-12463	141	9	considered	consider	VERB
ecj-12463	141	10	as	as	ADP
ecj-12463	141	11	an	an	DET
ecj-12463	141	12	early	early	ADJ
ecj-12463	141	13	predictor	predictor	NOUN
ecj-12463	141	14	of	of	ADP
ecj-12463	141	15	ischemic	ischemic	ADJ
ecj-12463	141	16	heart	heart	NOUN
ecj-12463	141	17	damage	damage	NOUN
ecj-12463	141	18	.	.	PUNCT
ecj-12463	142	1	its	its	PRON
ecj-12463	142	2	concentration	concentration	NOUN
ecj-12463	142	3	increases	increase	NOUN
ecj-12463	142	4	before	before	ADP
ecj-12463	142	5	that	that	PRON
ecj-12463	142	6	of	of	ADP
ecj-12463	142	7	troponin	troponin	NOUN
ecj-12463	142	8	in	in	ADP
ecj-12463	142	9	acs	acs	PROPN
ecj-12463	142	10	and	and	CCONJ
ecj-12463	142	11	is	be	AUX
ecj-12463	142	12	not	not	PART
ecj-12463	142	13	affected	affect	VERB
ecj-12463	142	14	by	by	ADP
ecj-12463	142	15	renal	renal	ADJ
ecj-12463	142	16	function	function	NOUN
ecj-12463	142	17	.	.	PUNCT
ecj-12463	143	1	these	these	DET
ecj-12463	143	2	features	feature	NOUN
ecj-12463	143	3	suggest	suggest	VERB
ecj-12463	143	4	hfabp	hfabp	VERB
ecj-12463	143	5	could	could	AUX
ecj-12463	143	6	be	be	AUX
ecj-12463	143	7	a	a	DET
ecj-12463	143	8	useful	useful	ADJ
ecj-12463	143	9	tool	tool	NOUN
ecj-12463	143	10	in	in	ADP
ecj-12463	143	11	clinical	clinical	ADJ
ecj-12463	143	12	practice.75	practice.75	PROPN
ecj-12463	143	13	furthermore	furthermore	ADV
ecj-12463	143	14	,	,	PUNCT
ecj-12463	143	15	hfabp	hfabp	PROPN
ecj-12463	143	16	and	and	CCONJ
ecj-12463	143	17	sst-2	sst-2	X
ecj-12463	143	18	are	be	AUX
ecj-12463	143	19	the	the	DET
ecj-12463	143	20	most	most	ADV
ecj-12463	143	21	promising	promising	ADJ
ecj-12463	143	22	markers	marker	NOUN
ecj-12463	143	23	with	with	ADP
ecj-12463	143	24	better	well	ADJ
ecj-12463	143	25	accuracy	accuracy	NOUN
ecj-12463	143	26	in	in	ADP
ecj-12463	143	27	differential	differential	ADJ
ecj-12463	143	28	diagnosis	diagnosis	NOUN
ecj-12463	143	29	between	between	ADP
ecj-12463	143	30	takotsubo	takotsubo	NOUN
ecj-12463	143	31	syndrome	syndrome	PROPN
ecj-12463	143	32	and	and	CCONJ
ecj-12463	143	33	acute	acute	ADJ
ecj-12463	143	34	coronary	coronary	ADJ
ecj-12463	143	35	syndrome	syndrome	NOUN
ecj-12463	143	36	,	,	PUNCT
ecj-12463	143	37	which	which	PRON
ecj-12463	143	38	are	be	AUX
ecj-12463	143	39	clinically	clinically	ADV
ecj-12463	143	40	indistinguishable	indistinguishable	ADJ
ecj-12463	143	41	.	.	PUNCT
ecj-12463	144	1	in	in	ADP
ecj-12463	144	2	their	their	PRON
ecj-12463	144	3	study	study	NOUN
ecj-12463	144	4	,	,	PUNCT
ecj-12463	144	5	topf	topf	VERB
ecj-12463	144	6	et	et	PROPN
ecj-12463	144	7	al	al	PROPN
ecj-12463	144	8	.	.	PROPN
ecj-12463	144	9	show	show	VERB
ecj-12463	144	10	how	how	SCONJ
ecj-12463	144	11	h	h	NOUN
ecj-12463	144	12	-	-	PUNCT
ecj-12463	144	13	fabp	fabp	PROPN
ecj-12463	144	14	is	be	AUX
ecj-12463	144	15	significantly	significantly	ADV
ecj-12463	144	16	higher	high	ADJ
ecj-12463	144	17	in	in	ADP
ecj-12463	144	18	acs	acs	PROPN
ecj-12463	144	19	patients	patient	NOUN
ecj-12463	144	20	compared	compare	VERB
ecj-12463	144	21	to	to	ADP
ecj-12463	144	22	tts	tts	PROPN
ecj-12463	144	23	patients	patient	NOUN
ecj-12463	144	24	;	;	PUNCT
ecj-12463	144	25	whereas	whereas	SCONJ
ecj-12463	144	26	sst-2	sst-2	PUNCT
ecj-12463	144	27	was	be	AUX
ecj-12463	144	28	significantly	significantly	ADV
ecj-12463	144	29	elevated	elevate	VERB
ecj-12463	144	30	in	in	ADP
ecj-12463	144	31	tts	tts	PROPN
ecj-12463	144	32	patients.75,79	patients.75,79	PROPN
ecj-12463	144	33	renelase	renelase	NOUN
ecj-12463	144	34	renalase	renalase	NOUN
ecj-12463	144	35	is	be	AUX
ecj-12463	144	36	a	a	DET
ecj-12463	144	37	new	new	ADJ
ecj-12463	144	38	class	class	NOUN
ecj-12463	144	39	of	of	ADP
ecj-12463	144	40	flavin	flavin	NOUN
ecj-12463	144	41	adenine	adenine	ADJ
ecj-12463	144	42	dinucleotide	dinucleotide	NOUN
ecj-12463	144	43	-	-	PUNCT
ecj-12463	144	44	containing	contain	VERB
ecj-12463	144	45	monoamine	monoamine	NOUN
ecj-12463	144	46	oxidases	oxidase	NOUN
ecj-12463	144	47	(	(	PUNCT
ecj-12463	144	48	maos	maos	PROPN
ecj-12463	144	49	)	)	PUNCT
ecj-12463	144	50	.	.	PUNCT
ecj-12463	145	1	they	they	PRON
ecj-12463	145	2	are	be	AUX
ecj-12463	145	3	involved	involve	VERB
ecj-12463	145	4	in	in	ADP
ecj-12463	145	5	numerous	numerous	ADJ
ecj-12463	145	6	cardiovascular	cardiovascular	ADJ
ecj-12463	145	7	diseases	disease	NOUN
ecj-12463	145	8	,	,	PUNCT
ecj-12463	145	9	such	such	ADJ
ecj-12463	145	10	as	as	ADP
ecj-12463	145	11	hf	hf	PROPN
ecj-12463	145	12	,	,	PUNCT
ecj-12463	145	13	coronary	coronary	ADJ
ecj-12463	145	14	artery	artery	NOUN
ecj-12463	145	15	disease	disease	NOUN
ecj-12463	145	16	(	(	PUNCT
ecj-12463	145	17	cad	cad	NOUN
ecj-12463	145	18	)	)	PUNCT
ecj-12463	145	19	,	,	PUNCT
ecj-12463	145	20	hypertension	hypertension	NOUN
ecj-12463	145	21	,	,	PUNCT
ecj-12463	145	22	diabetes	diabetes	NOUN
ecj-12463	145	23	mellitus	mellitus	NOUN
ecj-12463	145	24	.	.	PUNCT
ecj-12463	146	1	stojanovic	stojanovic	PROPN
ecj-12463	146	2	et	et	PROPN
ecj-12463	146	3	al	al	PROPN
ecj-12463	146	4	.	.	PROPN
ecj-12463	146	5	confirmed	confirm	VERB
ecj-12463	146	6	that	that	SCONJ
ecj-12463	146	7	elevated	elevated	ADJ
ecj-12463	146	8	plasma	plasma	NOUN
ecj-12463	146	9	renalase	renalase	NOUN
ecj-12463	146	10	concentration	concentration	NOUN
ecj-12463	146	11	in	in	ADP
ecj-12463	146	12	chronic	chronic	ADJ
ecj-12463	146	13	hf	hf	NOUN
ecj-12463	146	14	patients.80	patients.80	PROPN
ecj-12463	146	15	renalase	renalase	NOUN
ecj-12463	146	16	may	may	AUX
ecj-12463	146	17	be	be	AUX
ecj-12463	146	18	a	a	DET
ecj-12463	146	19	valuable	valuable	ADJ
ecj-12463	146	20	prognostic	prognostic	ADJ
ecj-12463	146	21	factor	factor	NOUN
ecj-12463	146	22	for	for	ADP
ecj-12463	146	23	ischemia	ischemia	NOUN
ecj-12463	146	24	during	during	ADP
ecj-12463	146	25	exercise	exercise	NOUN
ecj-12463	146	26	stress	stress	NOUN
ecj-12463	146	27	tests	test	NOUN
ecj-12463	146	28	in	in	ADP
ecj-12463	146	29	chronic	chronic	ADJ
ecj-12463	146	30	hf	hf	PROPN
ecj-12463	146	31	patients	patient	NOUN
ecj-12463	146	32	.	.	PUNCT
ecj-12463	147	1	renalase	renalase	VERB
ecj-12463	147	2	,	,	PUNCT
ecj-12463	147	3	in	in	ADP
ecj-12463	147	4	line	line	NOUN
ecj-12463	147	5	with	with	ADP
ecj-12463	147	6	sst2	sst2	PROPN
ecj-12463	147	7	,	,	PUNCT
ecj-12463	147	8	galectin-3	galectin-3	PROPN
ecj-12463	147	9	,	,	PUNCT
ecj-12463	147	10	and	and	CCONJ
ecj-12463	147	11	gdf-15	gdf-15	NOUN
ecj-12463	147	12	,	,	PUNCT
ecj-12463	147	13	clearly	clearly	ADV
ecj-12463	147	14	demonstrated	demonstrate	VERB
ecj-12463	147	15	non	non	ADJ
ecj-12463	147	16	-	-	ADJ
ecj-12463	147	17	inferiority	inferiority	NOUN
ecj-12463	147	18	for	for	ADP
ecj-12463	147	19	ischemia	ischemia	NOUN
ecj-12463	147	20	prediction	prediction	NOUN
ecj-12463	147	21	compared	compare	VERB
ecj-12463	147	22	to	to	ADP
ecj-12463	147	23	bnp	bnp	PROPN
ecj-12463	147	24	.	.	PROPN
ecj-12463	148	1	in	in	ADP
ecj-12463	148	2	the	the	DET
ecj-12463	148	3	hf	hf	NOUN
ecj-12463	148	4	,	,	PUNCT
ecj-12463	148	5	renalase	renalase	VERB
ecj-12463	148	6	discriminatory	discriminatory	ADJ
ecj-12463	148	7	potential	potential	NOUN
ecj-12463	148	8	was	be	AUX
ecj-12463	148	9	similar	similar	ADJ
ecj-12463	148	10	to	to	ADP
ecj-12463	148	11	that	that	PRON
ecj-12463	148	12	of	of	ADP
ecj-12463	148	13	sst2	sst2	NOUN
ecj-12463	148	14	,	,	PUNCT
ecj-12463	148	15	but	but	CCONJ
ecj-12463	148	16	better	well	ADV
ecj-12463	148	17	compared	compare	VERB
ecj-12463	148	18	to	to	ADP
ecj-12463	148	19	those	those	PRON
ecj-12463	148	20	of	of	ADP
ecj-12463	148	21	galectin-3	galectin-3	PROPN
ecj-12463	148	22	and	and	CCONJ
ecj-12463	148	23	gdf15.80	gdf15.80	PROPN
ecj-12463	148	24	discussion	discussion	NOUN
ecj-12463	148	25	acs	acs	PROPN
ecj-12463	148	26	remains	remain	VERB
ecj-12463	148	27	the	the	DET
ecj-12463	148	28	leading	lead	VERB
ecj-12463	148	29	cause	cause	NOUN
ecj-12463	148	30	of	of	ADP
ecj-12463	148	31	death	death	NOUN
ecj-12463	148	32	in	in	ADP
ecj-12463	148	33	the	the	DET
ecj-12463	148	34	world	world	NOUN
ecj-12463	148	35	and	and	CCONJ
ecj-12463	148	36	carries	carry	VERB
ecj-12463	148	37	the	the	DET
ecj-12463	148	38	risk	risk	NOUN
ecj-12463	148	39	of	of	ADP
ecj-12463	148	40	the	the	DET
ecj-12463	148	41	development	development	NOUN
ecj-12463	148	42	of	of	ADP
ecj-12463	148	43	major	major	ADJ
ecj-12463	148	44	adverse	adverse	ADJ
ecj-12463	148	45	cardiovascular	cardiovascular	ADJ
ecj-12463	148	46	events	event	NOUN
ecj-12463	148	47	(	(	PUNCT
ecj-12463	148	48	mace	mace	NOUN
ecj-12463	148	49	)	)	PUNCT
ecj-12463	148	50	.	.	PUNCT
ecj-12463	149	1	according	accord	VERB
ecj-12463	149	2	to	to	ADP
ecj-12463	149	3	standard	standard	ADJ
ecj-12463	149	4	clinical	clinical	ADJ
ecj-12463	149	5	care	care	NOUN
ecj-12463	149	6	,	,	PUNCT
ecj-12463	149	7	sequential	sequential	ADJ
ecj-12463	149	8	troponin	troponin	ADJ
ecj-12463	149	9	measurement	measurement	NOUN
ecj-12463	149	10	(	(	PUNCT
ecj-12463	149	11	0	0	NUM
ecj-12463	149	12	-	-	SYM
ecj-12463	149	13	1h	1h	NUM
ecj-12463	149	14	)	)	PUNCT
ecj-12463	149	15	accompanied	accompany	VERB
ecj-12463	149	16	by	by	ADP
ecj-12463	149	17	ecg	ecg	PROPN
ecj-12463	149	18	tracing	tracing	NOUN
ecj-12463	149	19	represents	represent	VERB
ecj-12463	149	20	the	the	DET
ecj-12463	149	21	goal	goal	NOUN
ecj-12463	149	22	standard	standard	NOUN
ecj-12463	149	23	of	of	ADP
ecj-12463	149	24	diagnosis	diagnosis	NOUN
ecj-12463	149	25	.	.	PUNCT
ecj-12463	150	1	despite	despite	SCONJ
ecj-12463	150	2	several	several	ADJ
ecj-12463	150	3	attempts	attempt	NOUN
ecj-12463	150	4	to	to	PART
ecj-12463	150	5	build	build	VERB
ecj-12463	150	6	standardized	standardized	ADJ
ecj-12463	150	7	models	model	NOUN
ecj-12463	150	8	for	for	ADP
ecj-12463	150	9	the	the	DET
ecj-12463	150	10	correct	correct	ADJ
ecj-12463	150	11	management	management	NOUN
ecj-12463	150	12	of	of	ADP
ecj-12463	150	13	patients	patient	NOUN
ecj-12463	150	14	presenting	present	VERB
ecj-12463	150	15	with	with	ADP
ecj-12463	150	16	chest	chest	NOUN
ecj-12463	150	17	pain	pain	NOUN
ecj-12463	150	18	and	and	CCONJ
ecj-12463	150	19	no	no	DET
ecj-12463	150	20	diriment	diriment	NOUN
ecj-12463	150	21	ecg	ecg	PROPN
ecj-12463	150	22	findings	finding	NOUN
ecj-12463	150	23	and	and	CCONJ
ecj-12463	150	24	troponin	troponin	ADJ
ecj-12463	150	25	measurement	measurement	NOUN
ecj-12463	150	26	,	,	PUNCT
ecj-12463	150	27	there	there	PRON
ecj-12463	150	28	are	be	VERB
ecj-12463	150	29	no	no	DET
ecj-12463	150	30	ideal	ideal	ADJ
ecj-12463	150	31	criteria	criterion	NOUN
ecj-12463	150	32	for	for	ADP
ecj-12463	150	33	determining	determine	VERB
ecj-12463	150	34	the	the	DET
ecj-12463	150	35	likelihood	likelihood	NOUN
ecj-12463	150	36	of	of	ADP
ecj-12463	150	37	a	a	DET
ecj-12463	150	38	cardiovascular	cardiovascular	ADJ
ecj-12463	150	39	etiology	etiology	NOUN
ecj-12463	150	40	and	and	CCONJ
ecj-12463	150	41	the	the	DET
ecj-12463	150	42	diagnostic	diagnostic	ADJ
ecj-12463	150	43	pathway	pathway	NOUN
ecj-12463	150	44	.	.	PUNCT
ecj-12463	151	1	because	because	SCONJ
ecj-12463	151	2	of	of	ADP
ecj-12463	151	3	this	this	PRON
ecj-12463	151	4	,	,	PUNCT
ecj-12463	151	5	numerous	numerous	ADJ
ecj-12463	151	6	biomarkers	biomarker	NOUN
ecj-12463	151	7	have	have	AUX
ecj-12463	151	8	gained	gain	VERB
ecj-12463	151	9	growing	grow	VERB
ecj-12463	151	10	interest	interest	NOUN
ecj-12463	151	11	with	with	ADP
ecj-12463	151	12	the	the	DET
ecj-12463	151	13	purpose	purpose	NOUN
ecj-12463	151	14	of	of	ADP
ecj-12463	151	15	helping	help	VERB
ecj-12463	151	16	ed	ed	PROPN
ecj-12463	151	17	physicians	physician	NOUN
ecj-12463	151	18	to	to	PART
ecj-12463	151	19	diagnose	diagnose	VERB
ecj-12463	151	20	and	and	CCONJ
ecj-12463	151	21	treat	treat	VERB
ecj-12463	151	22	these	these	DET
ecj-12463	151	23	conditions	condition	NOUN
ecj-12463	151	24	in	in	ADP
ecj-12463	151	25	a	a	DET
ecj-12463	151	26	proper	proper	ADJ
ecj-12463	151	27	way	way	NOUN
ecj-12463	151	28	also	also	ADV
ecj-12463	151	29	allowing	allow	VERB
ecj-12463	151	30	faster	fast	ADJ
ecj-12463	151	31	discharge	discharge	NOUN
ecj-12463	151	32	.	.	PUNCT
ecj-12463	152	1	this	this	DET
ecj-12463	152	2	review	review	NOUN
ecj-12463	152	3	has	have	VERB
ecj-12463	152	4	the	the	DET
ecj-12463	152	5	aim	aim	NOUN
ecj-12463	152	6	to	to	PART
ecj-12463	152	7	summarize	summarize	VERB
ecj-12463	152	8	the	the	DET
ecj-12463	152	9	published	publish	VERB
ecj-12463	152	10	literature	literature	NOUN
ecj-12463	152	11	in	in	ADP
ecj-12463	152	12	the	the	DET
ecj-12463	152	13	last	last	ADJ
ecj-12463	152	14	five	five	NUM
ecj-12463	152	15	years	year	NOUN
ecj-12463	152	16	referring	refer	VERB
ecj-12463	152	17	to	to	ADP
ecj-12463	152	18	the	the	DET
ecj-12463	152	19	contemporary	contemporary	ADJ
ecj-12463	152	20	use	use	NOUN
ecj-12463	152	21	of	of	ADP
ecj-12463	152	22	some	some	DET
ecj-12463	152	23	promising	promising	ADJ
ecj-12463	152	24	biomarkers	biomarker	NOUN
ecj-12463	152	25	.	.	PUNCT
ecj-12463	153	1	the	the	DET
ecj-12463	153	2	strengths	strength	NOUN
ecj-12463	153	3	and	and	CCONJ
ecj-12463	153	4	limitations	limitation	NOUN
ecj-12463	153	5	of	of	ADP
ecj-12463	153	6	conventional	conventional	ADJ
ecj-12463	153	7	biomarkers	biomarker	NOUN
ecj-12463	153	8	as	as	ADP
ecj-12463	153	9	ctn	ctn	NOUN
ecj-12463	153	10	have	have	AUX
ecj-12463	153	11	also	also	ADV
ecj-12463	153	12	been	be	AUX
ecj-12463	153	13	evaluated	evaluate	VERB
ecj-12463	153	14	.	.	PUNCT
ecj-12463	154	1	a	a	DET
ecj-12463	154	2	pubmed	pubmed	NOUN
ecj-12463	154	3	and	and	CCONJ
ecj-12463	154	4	reviews	review	NOUN
ecj-12463	154	5	in	in	ADP
ecj-12463	154	6	cardiovascular	cardiovascular	ADJ
ecj-12463	154	7	medicine	medicine	NOUN
ecj-12463	154	8	search	search	NOUN
ecj-12463	154	9	was	be	AUX
ecj-12463	154	10	conducted	conduct	VERB
ecj-12463	154	11	from	from	ADP
ecj-12463	154	12	january	january	PROPN
ecj-12463	154	13	2019	2019	NUM
ecj-12463	154	14	to	to	ADP
ecj-12463	154	15	january	january	PROPN
ecj-12463	154	16	2024	2024	NUM
ecj-12463	154	17	aiming	aim	VERB
ecj-12463	154	18	to	to	PART
ecj-12463	154	19	identify	identify	VERB
ecj-12463	154	20	all	all	DET
ecj-12463	154	21	interesting	interesting	ADJ
ecj-12463	154	22	publications	publication	NOUN
ecj-12463	154	23	.	.	PUNCT
ecj-12463	155	1	the	the	DET
ecj-12463	155	2	search	search	NOUN
ecj-12463	155	3	terms	term	NOUN
ecj-12463	155	4	were	be	AUX
ecj-12463	155	5	:	:	PUNCT
ecj-12463	155	6	supar	supar	NOUN
ecj-12463	155	7	(	(	PUNCT
ecj-12463	155	8	or	or	CCONJ
ecj-12463	155	9	soluble	soluble	ADJ
ecj-12463	155	10	urokinase	urokinase	NOUN
ecj-12463	155	11	plasminogen	plasminogen	NOUN
ecj-12463	155	12	activator	activator	NOUN
ecj-12463	155	13	receptor	receptor	NOUN
ecj-12463	155	14	)	)	PUNCT
ecj-12463	155	15	,	,	PUNCT
ecj-12463	155	16	sst2	sst2	NOUN
ecj-12463	155	17	(	(	PUNCT
ecj-12463	155	18	or	or	CCONJ
ecj-12463	155	19	soluble	soluble	ADJ
ecj-12463	155	20	suppression	suppression	NOUN
ecj-12463	155	21	of	of	ADP
ecj-12463	155	22	tumorigenesis	tumorigenesis	NOUN
ecj-12463	155	23	)	)	PUNCT
ecj-12463	155	24	,	,	PUNCT
ecj-12463	155	25	acute	acute	ADJ
ecj-12463	155	26	coronary	coronary	ADJ
ecj-12463	155	27	syndrome	syndrome	NOUN
ecj-12463	155	28	,	,	PUNCT
ecj-12463	155	29	cardiac	cardiac	ADJ
ecj-12463	155	30	troponin	troponin	ADJ
ecj-12463	155	31	.	.	PUNCT
ecj-12463	156	1	a	a	DET
ecj-12463	156	2	total	total	NOUN
ecj-12463	156	3	of	of	ADP
ecj-12463	156	4	80	80	NUM
ecj-12463	156	5	articles	article	NOUN
ecj-12463	156	6	were	be	AUX
ecj-12463	156	7	included	include	VERB
ecj-12463	156	8	in	in	ADP
ecj-12463	156	9	the	the	DET
ecj-12463	156	10	final	final	ADJ
ecj-12463	156	11	review	review	NOUN
ecj-12463	156	12	.	.	PUNCT
ecj-12463	157	1	at	at	ADP
ecj-12463	157	2	first	first	ADV
ecj-12463	157	3	this	this	DET
ecj-12463	157	4	review	review	NOUN
ecj-12463	157	5	focuses	focus	VERB
ecj-12463	157	6	on	on	ADP
ecj-12463	157	7	cardiac	cardiac	ADJ
ecj-12463	157	8	troponin	troponin	ADJ
ecj-12463	157	9	(	(	PUNCT
ecj-12463	157	10	ctn	ctn	NOUN
ecj-12463	157	11	)	)	PUNCT
ecj-12463	157	12	that	that	SCONJ
ecj-12463	157	13	,	,	PUNCT
ecj-12463	157	14	to	to	ADP
ecj-12463	157	15	date	date	NOUN
ecj-12463	157	16	,	,	PUNCT
ecj-12463	157	17	is	be	AUX
ecj-12463	157	18	the	the	DET
ecj-12463	157	19	main	main	ADJ
ecj-12463	157	20	biomarker	biomarker	NOUN
ecj-12463	157	21	used	use	VERB
ecj-12463	157	22	in	in	ADP
ecj-12463	157	23	the	the	DET
ecj-12463	157	24	assessment	assessment	NOUN
ecj-12463	157	25	of	of	ADP
ecj-12463	157	26	cardiac	cardiac	ADJ
ecj-12463	157	27	damage	damage	NOUN
ecj-12463	157	28	,	,	PUNCT
ecj-12463	157	29	being	be	AUX
ecj-12463	157	30	released	release	VERB
ecj-12463	157	31	into	into	ADP
ecj-12463	157	32	the	the	DET
ecj-12463	157	33	bloodstream	bloodstream	NOUN
ecj-12463	157	34	when	when	SCONJ
ecj-12463	157	35	cardiac	cardiac	ADJ
ecj-12463	157	36	muscle	muscle	NOUN
ecj-12463	157	37	is	be	AUX
ecj-12463	157	38	injured	injure	VERB
ecj-12463	157	39	.	.	PUNCT
ecj-12463	158	1	for	for	ADP
ecj-12463	158	2	its	its	PRON
ecj-12463	158	3	elevated	elevated	ADJ
ecj-12463	158	4	accuracy	accuracy	NOUN
ecj-12463	158	5	,	,	PUNCT
ecj-12463	158	6	numerous	numerous	ADJ
ecj-12463	158	7	scientific	scientific	ADJ
ecj-12463	158	8	societies	society	NOUN
ecj-12463	158	9	indicate	indicate	VERB
ecj-12463	158	10	determination	determination	NOUN
ecj-12463	158	11	of	of	ADP
ecj-12463	158	12	serum	serum	NOUN
ecj-12463	158	13	ctn	ctn	NOUN
ecj-12463	158	14	as	as	SCONJ
ecj-12463	158	15	the	the	DET
ecj-12463	158	16	choice	choice	NOUN
ecj-12463	158	17	criteria	criterion	NOUN
ecj-12463	158	18	for	for	ADP
ecj-12463	158	19	the	the	DET
ecj-12463	158	20	diagnosis	diagnosis	NOUN
ecj-12463	158	21	of	of	ADP
ecj-12463	158	22	acute	acute	ADJ
ecj-12463	158	23	cardiac	cardiac	ADJ
ecj-12463	158	24	ischemia	ischemia	NOUN
ecj-12463	158	25	and	and	CCONJ
ecj-12463	158	26	to	to	PART
ecj-12463	158	27	facilitate	facilitate	VERB
ecj-12463	158	28	safer	safe	ADJ
ecj-12463	158	29	and	and	CCONJ
ecj-12463	158	30	quicker	quick	ADJ
ecj-12463	158	31	patients	patient	NOUN
ecj-12463	158	32	“	"	PUNCT
ecj-12463	158	33	rule	rule	NOUN
ecj-12463	158	34	-	-	PUNCT
ecj-12463	158	35	in	in	ADP
ecj-12463	158	36	”	"	PUNCT
ecj-12463	158	37	and	and	CCONJ
ecj-12463	158	38	“	"	PUNCT
ecj-12463	158	39	rule	rule	VERB
ecj-12463	158	40	-	-	PUNCT
ecj-12463	158	41	out	out	NOUN
ecj-12463	158	42	”	"	PUNCT
ecj-12463	158	43	.	.	PUNCT
ecj-12463	159	1	however	however	ADV
ecj-12463	159	2	,	,	PUNCT
ecj-12463	159	3	ctn	ctn	NOUN
ecj-12463	159	4	values	value	NOUN
ecj-12463	159	5	must	must	AUX
ecj-12463	159	6	be	be	AUX
ecj-12463	159	7	contextualized	contextualize	VERB
ecj-12463	159	8	with	with	ADP
ecj-12463	159	9	the	the	DET
ecj-12463	159	10	clinics	clinic	NOUN
ecj-12463	159	11	and	and	CCONJ
ecj-12463	159	12	electrocardiographic	electrocardiographic	ADJ
ecj-12463	159	13	findings	finding	NOUN
ecj-12463	159	14	.	.	PUNCT
ecj-12463	160	1	in	in	ADP
ecj-12463	160	2	fact	fact	NOUN
ecj-12463	160	3	,	,	PUNCT
ecj-12463	160	4	non	non	ADJ
ecj-12463	160	5	-	-	ADJ
ecj-12463	160	6	cardiac	cardiac	ADJ
ecj-12463	160	7	etiologies	etiology	NOUN
ecj-12463	160	8	of	of	ADP
ecj-12463	160	9	myocardial	myocardial	ADJ
ecj-12463	160	10	damage	damage	NOUN
ecj-12463	160	11	can	can	AUX
ecj-12463	160	12	cause	cause	VERB
ecj-12463	160	13	increased	increase	VERB
ecj-12463	160	14	troponin	troponin	ADJ
ecj-12463	160	15	levels.8,10,12,14	levels.8,10,12,14	ADJ
ecj-12463	160	16	sst2	sst2	NOUN
ecj-12463	160	17	and	and	CCONJ
ecj-12463	160	18	supar	supar	PROPN
ecj-12463	160	19	(	(	PUNCT
ecj-12463	160	20	the	the	DET
ecj-12463	160	21	two	two	NUM
ecj-12463	160	22	main	main	ADJ
ecj-12463	160	23	biomarkers	biomarker	NOUN
ecj-12463	160	24	on	on	ADP
ecj-12463	160	25	which	which	PRON
ecj-12463	160	26	we	we	PRON
ecj-12463	160	27	focused	focus	VERB
ecj-12463	160	28	)	)	PUNCT
ecj-12463	160	29	have	have	AUX
ecj-12463	160	30	been	be	AUX
ecj-12463	160	31	investigated	investigate	VERB
ecj-12463	160	32	for	for	ADP
ecj-12463	160	33	their	their	PRON
ecj-12463	160	34	diagnostic	diagnostic	ADJ
ecj-12463	160	35	role	role	NOUN
ecj-12463	160	36	and	and	CCONJ
ecj-12463	160	37	for	for	ADP
ecj-12463	160	38	their	their	PRON
ecj-12463	160	39	ability	ability	NOUN
ecj-12463	160	40	to	to	PART
ecj-12463	160	41	predict	predict	VERB
ecj-12463	160	42	short	short	ADJ
ecj-12463	160	43	and	and	CCONJ
ecj-12463	160	44	long	long	ADJ
ecj-12463	160	45	-	-	PUNCT
ecj-12463	160	46	term	term	NOUN
ecj-12463	160	47	mortality	mortality	NOUN
ecj-12463	160	48	.	.	PUNCT
ecj-12463	161	1	recently	recently	ADV
ecj-12463	161	2	,	,	PUNCT
ecj-12463	161	3	those	those	DET
ecj-12463	161	4	tools	tool	NOUN
ecj-12463	161	5	have	have	AUX
ecj-12463	161	6	also	also	ADV
ecj-12463	161	7	been	be	AUX
ecj-12463	161	8	considered	consider	VERB
ecj-12463	161	9	in	in	ADP
ecj-12463	161	10	the	the	DET
ecj-12463	161	11	context	context	NOUN
ecj-12463	161	12	of	of	ADP
ecj-12463	161	13	chronic	chronic	ADJ
ecj-12463	161	14	cardiovascular	cardiovascular	ADJ
ecj-12463	161	15	pathologies	pathology	NOUN
ecj-12463	161	16	.	.	PUNCT
ecj-12463	162	1	sst2	sst2	PROPN
ecj-12463	162	2	is	be	AUX
ecj-12463	162	3	the	the	DET
ecj-12463	162	4	soluble	soluble	ADJ
ecj-12463	162	5	form	form	NOUN
ecj-12463	162	6	of	of	ADP
ecj-12463	162	7	st2	st2	NOUN
ecj-12463	162	8	,	,	PUNCT
ecj-12463	162	9	a	a	DET
ecj-12463	162	10	member	member	NOUN
ecj-12463	162	11	of	of	ADP
ecj-12463	162	12	interleukin-1	interleukin-1	NOUN
ecj-12463	162	13	family	family	NOUN
ecj-12463	162	14	receptors	receptor	NOUN
ecj-12463	162	15	.	.	PUNCT
ecj-12463	163	1	cytokines	cytokine	NOUN
ecj-12463	163	2	from	from	ADP
ecj-12463	163	3	damaged	damage	VERB
ecj-12463	163	4	tissues	tissue	NOUN
ecj-12463	163	5	,	,	PUNCT
ecj-12463	163	6	such	such	ADJ
ecj-12463	163	7	as	as	ADP
ecj-12463	163	8	myocardium	myocardium	ADJ
ecj-12463	163	9	,	,	PUNCT
ecj-12463	163	10	seem	seem	VERB
ecj-12463	163	11	to	to	PART
ecj-12463	163	12	induce	induce	VERB
ecj-12463	163	13	the	the	DET
ecj-12463	163	14	production	production	NOUN
ecj-12463	163	15	of	of	ADP
ecj-12463	163	16	sst2	sst2	NOUN
ecj-12463	163	17	,	,	PUNCT
ecj-12463	163	18	contributing	contribute	VERB
ecj-12463	163	19	to	to	ADP
ecj-12463	163	20	the	the	DET
ecj-12463	163	21	persistence	persistence	NOUN
ecj-12463	163	22	of	of	ADP
ecj-12463	163	23	the	the	DET
ecj-12463	163	24	inflammatory	inflammatory	ADJ
ecj-12463	163	25	process	process	NOUN
ecj-12463	163	26	.	.	PUNCT
ecj-12463	164	1	21,22,25	21,22,25	NUM
ecj-12463	164	2	-	-	SYM
ecj-12463	164	3	28	28	NUM
ecj-12463	164	4	recently	recently	ADV
ecj-12463	164	5	,	,	PUNCT
ecj-12463	164	6	several	several	ADJ
ecj-12463	164	7	studies	study	NOUN
ecj-12463	164	8	have	have	AUX
ecj-12463	164	9	advocated	advocate	VERB
ecj-12463	164	10	an	an	DET
ecj-12463	164	11	important	important	ADJ
ecj-12463	164	12	prognostic	prognostic	ADJ
ecj-12463	164	13	value	value	NOUN
ecj-12463	164	14	of	of	ADP
ecj-12463	164	15	sst2	sst2	NOUN
ecj-12463	164	16	;	;	PUNCT
ecj-12463	164	17	indeed	indeed	ADV
ecj-12463	164	18	,	,	PUNCT
ecj-12463	164	19	its	its	PRON
ecj-12463	164	20	values	value	NOUN
ecj-12463	164	21	do	do	AUX
ecj-12463	164	22	not	not	PART
ecj-12463	164	23	depend	depend	VERB
ecj-12463	164	24	on	on	ADP
ecj-12463	164	25	factors	factor	NOUN
ecj-12463	164	26	such	such	ADJ
ecj-12463	164	27	as	as	ADP
ecj-12463	164	28	age	age	NOUN
ecj-12463	164	29	or	or	CCONJ
ecj-12463	164	30	renal	renal	ADJ
ecj-12463	164	31	function	function	NOUN
ecj-12463	164	32	than	than	ADP
ecj-12463	164	33	standard	standard	ADJ
ecj-12463	164	34	biomarkers.30	biomarkers.30	NOUN
ecj-12463	164	35	different	different	ADJ
ecj-12463	164	36	studies	study	NOUN
ecj-12463	164	37	showed	show	VERB
ecj-12463	164	38	a	a	DET
ecj-12463	164	39	correlation	correlation	NOUN
ecj-12463	164	40	between	between	ADP
ecj-12463	164	41	its	its	PRON
ecj-12463	164	42	levels	level	NOUN
ecj-12463	164	43	and	and	CCONJ
ecj-12463	164	44	chronic	chronic	ADJ
ecj-12463	164	45	cardiovascular	cardiovascular	ADJ
ecj-12463	164	46	diseases	disease	NOUN
ecj-12463	164	47	associated	associate	VERB
ecj-12463	164	48	with	with	ADP
ecj-12463	164	49	higher	high	ADJ
ecj-12463	164	50	risk	risk	NOUN
ecj-12463	164	51	of	of	ADP
ecj-12463	164	52	mace.29,41	mace.29,41	NOUN
ecj-12463	164	53	in	in	ADP
ecj-12463	164	54	the	the	DET
ecj-12463	164	55	ed	ed	NOUN
ecj-12463	164	56	setting	setting	NOUN
ecj-12463	164	57	,	,	PUNCT
ecj-12463	164	58	the	the	DET
ecj-12463	164	59	role	role	NOUN
ecj-12463	164	60	of	of	ADP
ecj-12463	164	61	sst2	sst2	NOUN
ecj-12463	164	62	in	in	ADP
ecj-12463	164	63	acs	acs	PROPN
ecj-12463	164	64	is	be	AUX
ecj-12463	164	65	still	still	ADV
ecj-12463	164	66	unclear	unclear	ADJ
ecj-12463	164	67	.	.	PUNCT
ecj-12463	165	1	certainly	certainly	ADV
ecj-12463	165	2	,	,	PUNCT
ecj-12463	165	3	it	it	PRON
ecj-12463	165	4	seems	seem	VERB
ecj-12463	165	5	to	to	PART
ecj-12463	165	6	be	be	AUX
ecj-12463	165	7	involved	involve	VERB
ecj-12463	165	8	in	in	ADP
ecj-12463	165	9	the	the	DET
ecj-12463	165	10	progression	progression	NOUN
ecj-12463	165	11	of	of	ADP
ecj-12463	165	12	atherosclerosis	atherosclerosis	NOUN
ecj-12463	165	13	and	and	CCONJ
ecj-12463	165	14	its	its	PRON
ecj-12463	165	15	complications	complication	NOUN
ecj-12463	165	16	,	,	PUNCT
ecj-12463	165	17	thus	thus	ADV
ecj-12463	165	18	often	often	ADV
ecj-12463	165	19	representing	represent	VERB
ecj-12463	165	20	the	the	DET
ecj-12463	165	21	acs	acs	NOUN
ecj-12463	165	22	trigger.20,25,28	trigger.20,25,28	PUNCT
ecj-12463	165	23	some	some	DET
ecj-12463	165	24	studies	study	NOUN
ecj-12463	165	25	showed	show	VERB
ecj-12463	165	26	a	a	DET
ecj-12463	165	27	significant	significant	ADJ
ecj-12463	165	28	increase	increase	NOUN
ecj-12463	165	29	of	of	ADP
ecj-12463	165	30	sst2	sst2	NOUN
ecj-12463	165	31	and	and	CCONJ
ecj-12463	165	32	il-33	il-33	ADJ
ecj-12463	165	33	in	in	ADP
ecj-12463	165	34	patients	patient	NOUN
ecj-12463	165	35	with	with	ADP
ecj-12463	165	36	ami	ami	NOUN
ecj-12463	165	37	when	when	SCONJ
ecj-12463	165	38	compared	compare	VERB
ecj-12463	165	39	to	to	ADP
ecj-12463	165	40	healthy	healthy	ADJ
ecj-12463	165	41	controls.22	controls.22	PROPN
ecj-12463	165	42	sst2	sst2	NOUN
ecj-12463	165	43	levels	level	NOUN
ecj-12463	165	44	were	be	AUX
ecj-12463	165	45	also	also	ADV
ecj-12463	165	46	evaluated	evaluate	VERB
ecj-12463	165	47	as	as	ADP
ecj-12463	165	48	a	a	DET
ecj-12463	165	49	prognostic	prognostic	ADJ
ecj-12463	165	50	factor	factor	NOUN
ecj-12463	165	51	after	after	ADP
ecj-12463	165	52	cardiopulmonary	cardiopulmonary	ADJ
ecj-12463	165	53	resuscitation.33	resuscitation.33	ADV
ecj-12463	165	54	in	in	ADP
ecj-12463	165	55	addition	addition	NOUN
ecj-12463	165	56	,	,	PUNCT
ecj-12463	165	57	other	other	ADJ
ecj-12463	165	58	studies	study	NOUN
ecj-12463	165	59	highlighted	highlight	VERB
ecj-12463	165	60	that	that	SCONJ
ecj-12463	165	61	patients	patient	NOUN
ecj-12463	165	62	with	with	ADP
ecj-12463	165	63	persistently	persistently	ADV
ecj-12463	165	64	elevated	elevated	ADJ
ecj-12463	165	65	sst2	sst2	NOUN
ecj-12463	165	66	concentrations	concentration	NOUN
ecj-12463	165	67	postacs	postac	NOUN
ecj-12463	165	68	have	have	VERB
ecj-12463	165	69	a	a	DET
ecj-12463	165	70	higher	high	ADJ
ecj-12463	165	71	risk	risk	NOUN
ecj-12463	165	72	of	of	ADP
ecj-12463	165	73	recurrence	recurrence	NOUN
ecj-12463	165	74	or	or	CCONJ
ecj-12463	165	75	death	death	NOUN
ecj-12463	165	76	during	during	ADP
ecj-12463	165	77	one	one	NUM
ecj-12463	165	78	year	year	NOUN
ecj-12463	165	79	after	after	SCONJ
ecj-12463	165	80	the	the	DET
ecj-12463	165	81	event.40	event.40	PROPN
ecj-12463	165	82	other	other	ADJ
ecj-12463	165	83	studies	study	NOUN
ecj-12463	165	84	analyzed	analyze	VERB
ecj-12463	165	85	are	be	AUX
ecj-12463	165	86	listed	list	VERB
ecj-12463	165	87	in	in	ADP
ecj-12463	165	88	supplementary	supplementary	ADJ
ecj-12463	165	89	table	table	NOUN
ecj-12463	165	90	1	1	NUM
ecj-12463	165	91	.	.	PUNCT
ecj-12463	166	1	therefore	therefore	ADV
ecj-12463	166	2	,	,	PUNCT
ecj-12463	166	3	supar	supar	PROPN
ecj-12463	166	4	is	be	AUX
ecj-12463	166	5	another	another	DET
ecj-12463	166	6	biomarker	biomarker	NOUN
ecj-12463	166	7	on	on	ADP
ecj-12463	166	8	which	which	PRON
ecj-12463	166	9	authors	author	NOUN
ecj-12463	166	10	have	have	AUX
ecj-12463	166	11	shown	show	VERB
ecj-12463	166	12	great	great	ADJ
ecj-12463	166	13	interest	interest	NOUN
ecj-12463	166	14	in	in	ADP
ecj-12463	166	15	recent	recent	ADJ
ecj-12463	166	16	years	year	NOUN
ecj-12463	166	17	.	.	PUNCT
ecj-12463	167	1	it	it	PRON
ecj-12463	167	2	is	be	AUX
ecj-12463	167	3	the	the	DET
ecj-12463	167	4	soluble	soluble	ADJ
ecj-12463	167	5	form	form	NOUN
ecj-12463	167	6	of	of	ADP
ecj-12463	167	7	the	the	DET
ecj-12463	167	8	urokinase	urokinase	NOUN
ecj-12463	167	9	plasminogen	plasminogen	NOUN
ecj-12463	167	10	activator	activator	NOUN
ecj-12463	167	11	receptor	receptor	NOUN
ecj-12463	167	12	(	(	PUNCT
ecj-12463	167	13	upar	upar	NOUN
ecj-12463	167	14	)	)	PUNCT
ecj-12463	167	15	,	,	PUNCT
ecj-12463	167	16	bound	bind	VERB
ecj-12463	167	17	to	to	PART
ecj-12463	167	18	differ	differ	VERB
ecj-12463	167	19	review	review	NOUN
ecj-12463	167	20	[	[	X
ecj-12463	167	21	emergency	emergency	NOUN
ecj-12463	167	22	care	care	NOUN
ecj-12463	167	23	journal	journal	PROPN
ecj-12463	167	24	2024	2024	NUM
ecj-12463	167	25	;	;	PUNCT
ecj-12463	167	26	20:12463	20:12463	NUM
ecj-12463	167	27	]	]	X
ecj-12463	168	1	[	[	X
ecj-12463	168	2	page	page	NOUN
ecj-12463	168	3	54	54	NUM
ecj-12463	168	4	]	]	SYM
ecj-12463	168	5	non	non	ADJ
ecj-12463	168	6	-co	-co	PROPN
ecj-12463	168	7	mmerc	mmerc	PROPN
ecj-12463	168	8	ial	ial	PROPN
ecj-12463	168	9	us	us	PROPN
ecj-12463	168	10	e	e	NOUN
ecj-12463	168	11	o	o	PROPN
ecj-12463	168	12	nly	nly	ADV
ecj-12463	168	13	ent	ent	NOUN
ecj-12463	168	14	cell	cell	NOUN
ecj-12463	168	15	membranes	membrane	NOUN
ecj-12463	168	16	and	and	CCONJ
ecj-12463	168	17	it	it	PRON
ecj-12463	168	18	is	be	AUX
ecj-12463	168	19	involved	involve	VERB
ecj-12463	168	20	in	in	ADP
ecj-12463	168	21	several	several	ADJ
ecj-12463	168	22	pathophysiological	pathophysiological	ADJ
ecj-12463	168	23	pathways.4,50,51	pathways.4,50,51	NOUN
ecj-12463	168	24	commonly	commonly	ADV
ecj-12463	168	25	,	,	PUNCT
ecj-12463	168	26	values	value	NOUN
ecj-12463	168	27	<	<	X
ecj-12463	168	28	3	3	NUM
ecj-12463	168	29	ng	ng	PROPN
ecj-12463	168	30	/	/	SYM
ecj-12463	168	31	ml	ml	NOUN
ecj-12463	168	32	are	be	AUX
ecj-12463	168	33	considered	consider	VERB
ecj-12463	168	34	normal	normal	ADJ
ecj-12463	168	35	,	,	PUNCT
ecj-12463	168	36	but	but	CCONJ
ecj-12463	168	37	literature	literature	NOUN
ecj-12463	168	38	reports	report	VERB
ecj-12463	168	39	variations	variation	NOUN
ecj-12463	168	40	in	in	ADP
ecj-12463	168	41	supar	supar	PROPN
ecj-12463	168	42	threshold	threshold	NOUN
ecj-12463	168	43	in	in	ADP
ecj-12463	168	44	relation	relation	NOUN
ecj-12463	168	45	to	to	PART
ecj-12463	168	46	socio	socio	VERB
ecj-12463	168	47	-	-	PUNCT
ecj-12463	168	48	biological	biological	ADJ
ecj-12463	168	49	factors.44,48,50	factors.44,48,50	NOUN
ecj-12463	168	50	some	some	DET
ecj-12463	168	51	studies	study	NOUN
ecj-12463	168	52	showed	show	VERB
ecj-12463	168	53	a	a	DET
ecj-12463	168	54	relationship	relationship	NOUN
ecj-12463	168	55	between	between	ADP
ecj-12463	168	56	supar	supar	NOUN
ecj-12463	168	57	plasma	plasma	NOUN
ecj-12463	168	58	levels	level	NOUN
ecj-12463	168	59	and	and	CCONJ
ecj-12463	168	60	endothelial	endothelial	ADJ
ecj-12463	168	61	dysfunction	dysfunction	NOUN
ecj-12463	168	62	,	,	PUNCT
ecj-12463	168	63	explaining	explain	VERB
ecj-12463	168	64	its	its	PRON
ecj-12463	168	65	relationship	relationship	NOUN
ecj-12463	168	66	with	with	ADP
ecj-12463	168	67	cardiovascular	cardiovascular	ADJ
ecj-12463	168	68	risk	risk	NOUN
ecj-12463	168	69	factors	factor	NOUN
ecj-12463	168	70	,	,	PUNCT
ecj-12463	168	71	since	since	SCONJ
ecj-12463	168	72	it	it	PRON
ecj-12463	168	73	correlates	correlate	VERB
ecj-12463	168	74	with	with	ADP
ecj-12463	168	75	the	the	DET
ecj-12463	168	76	release	release	NOUN
ecj-12463	168	77	of	of	ADP
ecj-12463	168	78	proinflammatory	proinflammatory	ADJ
ecj-12463	168	79	cytokines	cytokine	NOUN
ecj-12463	168	80	,	,	PUNCT
ecj-12463	168	81	which	which	PRON
ecj-12463	168	82	may	may	AUX
ecj-12463	168	83	be	be	AUX
ecj-12463	168	84	linked	link	VERB
ecj-12463	168	85	to	to	ADP
ecj-12463	168	86	the	the	DET
ecj-12463	168	87	susceptibility	susceptibility	NOUN
ecj-12463	168	88	of	of	ADP
ecj-12463	168	89	the	the	DET
ecj-12463	168	90	atherosclerotic	atherosclerotic	ADJ
ecj-12463	168	91	plaque.4,45,49,50	plaque.4,45,49,50	NOUN
ecj-12463	168	92	a	a	DET
ecj-12463	168	93	statistically	statistically	ADV
ecj-12463	168	94	significant	significant	ADJ
ecj-12463	168	95	relationship	relationship	NOUN
ecj-12463	168	96	between	between	ADP
ecj-12463	168	97	acs	acs	PROPN
ecj-12463	168	98	and	and	CCONJ
ecj-12463	168	99	supar	supar	PROPN
ecj-12463	168	100	levels	level	NOUN
ecj-12463	168	101	is	be	AUX
ecj-12463	168	102	demonstrated	demonstrate	VERB
ecj-12463	168	103	in	in	ADP
ecj-12463	168	104	different	different	ADJ
ecj-12463	168	105	studies.47,58	studies.47,58	NOUN
ecj-12463	168	106	in	in	ADP
ecj-12463	168	107	researches	research	NOUN
ecj-12463	168	108	performed	perform	VERB
ecj-12463	168	109	in	in	ADP
ecj-12463	168	110	the	the	DET
ecj-12463	168	111	emergency	emergency	NOUN
ecj-12463	168	112	setting	setting	NOUN
ecj-12463	168	113	,	,	PUNCT
ecj-12463	168	114	supar	supar	NOUN
ecj-12463	168	115	levels	level	NOUN
ecj-12463	168	116	correlated	correlate	VERB
ecj-12463	168	117	positively	positively	ADV
ecj-12463	168	118	with	with	ADP
ecj-12463	168	119	suspected	suspect	VERB
ecj-12463	168	120	ami	ami	NOUN
ecj-12463	168	121	and	and	CCONJ
ecj-12463	168	122	assessed	assess	VERB
ecj-12463	168	123	oneyear	oneyear	NOUN
ecj-12463	168	124	mortality	mortality	NOUN
ecj-12463	168	125	,	,	PUNCT
ecj-12463	168	126	resulting	result	VERB
ecj-12463	168	127	higher	higher	ADV
ecj-12463	168	128	in	in	ADP
ecj-12463	168	129	patients	patient	NOUN
ecj-12463	168	130	who	who	PRON
ecj-12463	168	131	were	be	AUX
ecj-12463	168	132	diagnosed	diagnose	VERB
ecj-12463	168	133	with	with	ADP
ecj-12463	168	134	ami	ami	NOUN
ecj-12463	168	135	than	than	ADP
ecj-12463	168	136	in	in	ADP
ecj-12463	168	137	the	the	DET
ecj-12463	168	138	non	non	ADJ
ecj-12463	168	139	-	-	ADJ
ecj-12463	168	140	ami	ami	ADJ
ecj-12463	168	141	patients	patient	NOUN
ecj-12463	168	142	.	.	PUNCT
ecj-12463	169	1	it	it	PRON
ecj-12463	169	2	correlates	correlate	VERB
ecj-12463	169	3	also	also	ADV
ecj-12463	169	4	with	with	ADP
ecj-12463	169	5	post	post	ADJ
ecj-12463	169	6	-	-	ADJ
ecj-12463	169	7	discharge	discharge	ADJ
ecj-12463	169	8	mortality.3,51	mortality.3,51	NOUN
ecj-12463	169	9	for	for	ADP
ecj-12463	169	10	these	these	DET
ecj-12463	169	11	reasons	reason	NOUN
ecj-12463	169	12	,	,	PUNCT
ecj-12463	169	13	supar	supar	NOUN
ecj-12463	169	14	may	may	AUX
ecj-12463	169	15	be	be	AUX
ecj-12463	169	16	a	a	DET
ecj-12463	169	17	promising	promising	ADJ
ecj-12463	169	18	addition	addition	NOUN
ecj-12463	169	19	to	to	ADP
ecj-12463	169	20	the	the	DET
ecj-12463	169	21	consolidated	consolidated	ADJ
ecj-12463	169	22	biomarkers	biomarker	NOUN
ecj-12463	169	23	for	for	ADP
ecj-12463	169	24	the	the	DET
ecj-12463	169	25	management	management	NOUN
ecj-12463	169	26	of	of	ADP
ecj-12463	169	27	patients	patient	NOUN
ecj-12463	169	28	in	in	ADP
ecj-12463	169	29	the	the	DET
ecj-12463	169	30	ed	ed	NOUN
ecj-12463	169	31	and	and	CCONJ
ecj-12463	169	32	for	for	ADP
ecj-12463	169	33	their	their	PRON
ecj-12463	169	34	risk	risk	NOUN
ecj-12463	169	35	stratification	stratification	NOUN
ecj-12463	169	36	.	.	PUNCT
ecj-12463	170	1	however	however	ADV
ecj-12463	170	2	,	,	PUNCT
ecj-12463	170	3	further	further	ADJ
ecj-12463	170	4	evidence	evidence	NOUN
ecj-12463	170	5	is	be	AUX
ecj-12463	170	6	needed	need	VERB
ecj-12463	170	7	.	.	PUNCT
ecj-12463	171	1	furthermore	furthermore	ADV
ecj-12463	171	2	,	,	PUNCT
ecj-12463	171	3	other	other	ADJ
ecj-12463	171	4	molecules	molecule	NOUN
ecj-12463	171	5	which	which	PRON
ecj-12463	171	6	have	have	AUX
ecj-12463	171	7	attracted	attract	VERB
ecj-12463	171	8	greater	great	ADJ
ecj-12463	171	9	interest	interest	NOUN
ecj-12463	171	10	in	in	ADP
ecj-12463	171	11	the	the	DET
ecj-12463	171	12	field	field	NOUN
ecj-12463	171	13	of	of	ADP
ecj-12463	171	14	cardiovascular	cardiovascular	ADJ
ecj-12463	171	15	disease	disease	NOUN
ecj-12463	171	16	have	have	AUX
ecj-12463	171	17	been	be	AUX
ecj-12463	171	18	taken	take	VERB
ecj-12463	171	19	into	into	ADP
ecj-12463	171	20	account	account	NOUN
ecj-12463	171	21	and	and	CCONJ
ecj-12463	171	22	their	their	PRON
ecj-12463	171	23	possible	possible	ADJ
ecj-12463	171	24	use	use	NOUN
ecj-12463	171	25	in	in	ADP
ecj-12463	171	26	clinical	clinical	ADJ
ecj-12463	171	27	practice	practice	NOUN
ecj-12463	171	28	is	be	AUX
ecj-12463	171	29	summarized	summarize	VERB
ecj-12463	171	30	below	below	ADP
ecj-12463	171	31	.	.	PUNCT
ecj-12463	172	1	for	for	ADP
ecj-12463	172	2	instance	instance	NOUN
ecj-12463	172	3	,	,	PUNCT
ecj-12463	172	4	copeptin	copeptin	PROPN
ecj-12463	172	5	has	have	AUX
ecj-12463	172	6	gained	gain	VERB
ecj-12463	172	7	attention	attention	NOUN
ecj-12463	172	8	as	as	ADP
ecj-12463	172	9	part	part	NOUN
ecj-12463	172	10	of	of	ADP
ecj-12463	172	11	a	a	DET
ecj-12463	172	12	dual	dual	ADJ
ecj-12463	172	13	marker	marker	NOUN
ecj-12463	172	14	approach	approach	NOUN
ecj-12463	172	15	,	,	PUNCT
ecj-12463	172	16	in	in	ADP
ecj-12463	172	17	combination	combination	NOUN
ecj-12463	172	18	with	with	ADP
ecj-12463	172	19	cardiac	cardiac	ADJ
ecj-12463	172	20	troponin	troponin	ADJ
ecj-12463	172	21	(	(	PUNCT
ecj-12463	172	22	ctn	ctn	NOUN
ecj-12463	172	23	)	)	PUNCT
ecj-12463	172	24	,	,	PUNCT
ecj-12463	172	25	in	in	ADP
ecj-12463	172	26	promptly	promptly	ADV
ecj-12463	172	27	ruling	rule	VERB
ecj-12463	172	28	out	out	ADP
ecj-12463	172	29	acute	acute	ADJ
ecj-12463	172	30	myocardial	myocardial	ADJ
ecj-12463	172	31	infarction	infarction	NOUN
ecj-12463	172	32	(	(	PUNCT
ecj-12463	172	33	ami	ami	NOUN
ecj-12463	172	34	)	)	PUNCT
ecj-12463	172	35	when	when	SCONJ
ecj-12463	172	36	patients	patient	NOUN
ecj-12463	172	37	present	present	VERB
ecj-12463	172	38	with	with	ADP
ecj-12463	172	39	chest	chest	NOUN
ecj-12463	172	40	pain.63	pain.63	NOUN
ecj-12463	172	41	indeed	indeed	ADV
ecj-12463	172	42	,	,	PUNCT
ecj-12463	172	43	copeptin	copeptin	NOUN
ecj-12463	172	44	rises	rise	VERB
ecj-12463	172	45	to	to	ADP
ecj-12463	172	46	peak	peak	VERB
ecj-12463	172	47	values	value	NOUN
ecj-12463	172	48	within	within	ADP
ecj-12463	172	49	30	30	NUM
ecj-12463	172	50	min	min	NOUN
ecj-12463	172	51	after	after	ADP
ecj-12463	172	52	the	the	DET
ecj-12463	172	53	onset	onset	NOUN
ecj-12463	172	54	of	of	ADP
ecj-12463	172	55	chest	chest	NOUN
ecj-12463	172	56	pain	pain	NOUN
ecj-12463	172	57	in	in	ADP
ecj-12463	172	58	patients	patient	NOUN
ecj-12463	172	59	with	with	ADP
ecj-12463	172	60	acute	acute	PROPN
ecj-12463	172	61	mi	mi	PROPN
ecj-12463	172	62	,	,	PUNCT
ecj-12463	172	63	unlike	unlike	ADP
ecj-12463	172	64	troponin	troponin	NOUN
ecj-12463	172	65	whose	whose	DET
ecj-12463	172	66	levels	level	NOUN
ecj-12463	172	67	may	may	AUX
ecj-12463	172	68	still	still	ADV
ecj-12463	172	69	be	be	AUX
ecj-12463	172	70	undetectable	undetectable	ADJ
ecj-12463	172	71	in	in	ADP
ecj-12463	172	72	the	the	DET
ecj-12463	172	73	early	early	ADJ
ecj-12463	172	74	hours	hour	NOUN
ecj-12463	172	75	;	;	PUNCT
ecj-12463	172	76	for	for	ADP
ecj-12463	172	77	this	this	DET
ecj-12463	172	78	reason	reason	NOUN
ecj-12463	172	79	copeptin	copeptin	NOUN
ecj-12463	172	80	could	could	AUX
ecj-12463	172	81	allow	allow	VERB
ecj-12463	172	82	a	a	DET
ecj-12463	172	83	timely	timely	ADJ
ecj-12463	172	84	diagnosis	diagnosis	NOUN
ecj-12463	172	85	even	even	ADV
ecj-12463	172	86	before	before	ADP
ecj-12463	172	87	the	the	DET
ecj-12463	172	88	troponin	troponin	PROPN
ecj-12463	172	89	rise.66,69	rise.66,69	NOUN
ecj-12463	172	90	-	-	PUNCT
ecj-12463	172	91	72also	72also	PRON
ecj-12463	172	92	the	the	DET
ecj-12463	172	93	latest	late	ADJ
ecj-12463	172	94	2023	2023	NUM
ecj-12463	172	95	esc	esc	NOUN
ecj-12463	172	96	guidelines	guideline	NOUN
ecj-12463	172	97	indicate	indicate	VERB
ecj-12463	172	98	a	a	DET
ecj-12463	172	99	possible	possible	ADJ
ecj-12463	172	100	value	value	NOUN
ecj-12463	172	101	of	of	ADP
ecj-12463	172	102	copeptin	copeptin	NOUN
ecj-12463	172	103	as	as	ADP
ecj-12463	172	104	an	an	DET
ecj-12463	172	105	additional	additional	ADJ
ecj-12463	172	106	biomarker	biomarker	NOUN
ecj-12463	172	107	to	to	ADP
ecj-12463	172	108	high	high	ADJ
ecj-12463	172	109	-	-	PUNCT
ecj-12463	172	110	sensitivity	sensitivity	NOUN
ecj-12463	172	111	ctn	ctn	NOUN
ecj-12463	172	112	in	in	ADP
ecj-12463	172	113	patients	patient	NOUN
ecj-12463	172	114	without	without	ADP
ecj-12463	172	115	persistent	persistent	ADJ
ecj-12463	172	116	stsegment	stsegment	NOUN
ecj-12463	172	117	elevation	elevation	NOUN
ecj-12463	172	118	states.14	states.14	NOUN
ecj-12463	172	119	moreover	moreover	ADV
ecj-12463	172	120	,	,	PUNCT
ecj-12463	172	121	copeptin	copeptin	PROPN
ecj-12463	172	122	appears	appear	VERB
ecj-12463	172	123	to	to	PART
ecj-12463	172	124	be	be	AUX
ecj-12463	172	125	associated	associate	VERB
ecj-12463	172	126	with	with	ADP
ecj-12463	172	127	1	1	NUM
ecj-12463	172	128	-	-	PUNCT
ecj-12463	172	129	year	year	NOUN
ecj-12463	172	130	mortality	mortality	NOUN
ecj-12463	172	131	and	and	CCONJ
ecj-12463	172	132	adverse	adverse	ADJ
ecj-12463	172	133	cardiovascular	cardiovascular	ADJ
ecj-12463	172	134	outcomes.64	outcomes.64	NOUN
ecj-12463	172	135	-	-	PUNCT
ecj-12463	172	136	67	67	NUM
ecj-12463	172	137	in	in	ADP
ecj-12463	172	138	addition	addition	NOUN
ecj-12463	172	139	,	,	PUNCT
ecj-12463	172	140	ilfamily	ilfamily	NOUN
ecj-12463	172	141	molecules	molecule	NOUN
ecj-12463	172	142	seem	seem	VERB
ecj-12463	172	143	to	to	PART
ecj-12463	172	144	be	be	AUX
ecj-12463	172	145	involved	involve	VERB
ecj-12463	172	146	in	in	ADP
ecj-12463	172	147	the	the	DET
ecj-12463	172	148	inflammatory	inflammatory	ADJ
ecj-12463	172	149	mechanism	mechanism	NOUN
ecj-12463	172	150	underlying	underlie	VERB
ecj-12463	172	151	the	the	DET
ecj-12463	172	152	complication	complication	NOUN
ecj-12463	172	153	of	of	ADP
ecj-12463	172	154	atherosclerotic	atherosclerotic	ADJ
ecj-12463	172	155	plaque	plaque	NOUN
ecj-12463	172	156	;	;	PUNCT
ecj-12463	172	157	in	in	ADP
ecj-12463	172	158	fact	fact	NOUN
ecj-12463	172	159	molecules	molecule	NOUN
ecj-12463	172	160	such	such	ADJ
ecj-12463	172	161	as	as	ADP
ecj-12463	172	162	il-17	il-17	NUM
ecj-12463	172	163	and	and	CCONJ
ecj-12463	172	164	inflammatory	inflammatory	ADJ
ecj-12463	172	165	cytokines	cytokine	NOUN
ecj-12463	172	166	like	like	ADP
ecj-12463	172	167	il-1β	il-1β	PROPN
ecj-12463	172	168	and	and	CCONJ
ecj-12463	172	169	il-6	il-6	NOUN
ecj-12463	172	170	correlate	correlate	VERB
ecj-12463	172	171	with	with	ADP
ecj-12463	172	172	the	the	DET
ecj-12463	172	173	development	development	NOUN
ecj-12463	172	174	of	of	ADP
ecj-12463	172	175	cad.2,62	cad.2,62	ADJ
ecj-12463	172	176	adhesion	adhesion	NOUN
ecj-12463	172	177	molecules	molecule	NOUN
ecj-12463	172	178	like	like	ADP
ecj-12463	172	179	vcam-1	vcam-1	NUM
ecj-12463	172	180	and	and	CCONJ
ecj-12463	172	181	icam-1	icam-1	PRON
ecj-12463	172	182	also	also	ADV
ecj-12463	172	183	have	have	VERB
ecj-12463	172	184	a	a	DET
ecj-12463	172	185	role	role	NOUN
ecj-12463	172	186	in	in	ADP
ecj-12463	172	187	drawing	draw	VERB
ecj-12463	172	188	leukocytes	leukocyte	NOUN
ecj-12463	172	189	to	to	ADP
ecj-12463	172	190	the	the	DET
ecj-12463	172	191	endothelium	endothelium	NOUN
ecj-12463	172	192	during	during	ADP
ecj-12463	172	193	inflammation	inflammation	NOUN
ecj-12463	172	194	and	and	CCONJ
ecj-12463	172	195	sustaining	sustain	VERB
ecj-12463	172	196	the	the	DET
ecj-12463	172	197	inflammatory	inflammatory	ADJ
ecj-12463	172	198	response	response	NOUN
ecj-12463	172	199	;	;	PUNCT
ecj-12463	172	200	for	for	ADP
ecj-12463	172	201	this	this	DET
ecj-12463	172	202	reason	reason	NOUN
ecj-12463	172	203	they	they	PRON
ecj-12463	172	204	have	have	AUX
ecj-12463	172	205	shown	show	VERB
ecj-12463	172	206	a	a	DET
ecj-12463	172	207	role	role	NOUN
ecj-12463	172	208	in	in	ADP
ecj-12463	172	209	the	the	DET
ecj-12463	172	210	atheromatous	atheromatous	ADJ
ecj-12463	172	211	plaques	plaque	NOUN
ecj-12463	172	212	creation	creation	NOUN
ecj-12463	172	213	and	and	CCONJ
ecj-12463	172	214	complication	complication	NOUN
ecj-12463	172	215	which	which	PRON
ecj-12463	172	216	raises	raise	VERB
ecj-12463	172	217	the	the	DET
ecj-12463	172	218	risk	risk	NOUN
ecj-12463	172	219	of	of	ADP
ecj-12463	172	220	cvd	cvd	PROPN
ecj-12463	172	221	and	and	CCONJ
ecj-12463	172	222	acs.2	acs.2	PROPN
ecj-12463	172	223	mirs	mir	NOUN
ecj-12463	172	224	,	,	PUNCT
ecj-12463	172	225	such	such	ADJ
ecj-12463	172	226	as	as	ADP
ecj-12463	172	227	mir-146a	mir-146a	ADJ
ecj-12463	172	228	,	,	PUNCT
ecj-12463	172	229	mir-26a	mir-26a	NOUN
ecj-12463	172	230	,	,	PUNCT
ecj-12463	172	231	mir-499	mir-499	NOUN
ecj-12463	172	232	,	,	PUNCT
ecj-12463	172	233	mir-133b	mir-133b	PROPN
ecj-12463	172	234	and	and	CCONJ
ecj-12463	172	235	mir21	mir21	PROPN
ecj-12463	172	236	,	,	PUNCT
ecj-12463	172	237	could	could	AUX
ecj-12463	172	238	be	be	AUX
ecj-12463	172	239	involved	involve	VERB
ecj-12463	172	240	in	in	ADP
ecj-12463	172	241	atherosclerosis	atherosclerosis	NOUN
ecj-12463	172	242	and	and	CCONJ
ecj-12463	172	243	cvd	cvd	PROPN
ecj-12463	172	244	.	.	PUNCT
ecj-12463	173	1	of	of	ADP
ecj-12463	173	2	these	these	PRON
ecj-12463	173	3	,	,	PUNCT
ecj-12463	173	4	mir146a	mir146a	PROPN
ecj-12463	173	5	seems	seem	VERB
ecj-12463	173	6	to	to	PART
ecj-12463	173	7	be	be	AUX
ecj-12463	173	8	more	more	ADV
ecj-12463	173	9	implicated	implicated	ADJ
ecj-12463	173	10	in	in	ADP
ecj-12463	173	11	development	development	NOUN
ecj-12463	173	12	of	of	ADP
ecj-12463	173	13	chd.2,72	chd.2,72	PROPN
ecj-12463	173	14	gdf-15	gdf-15	X
ecj-12463	173	15	has	have	AUX
ecj-12463	173	16	been	be	AUX
ecj-12463	173	17	largely	largely	ADV
ecj-12463	173	18	studied	study	VERB
ecj-12463	173	19	in	in	ADP
ecj-12463	173	20	the	the	DET
ecj-12463	173	21	context	context	NOUN
ecj-12463	173	22	of	of	ADP
ecj-12463	173	23	acute	acute	ADJ
ecj-12463	173	24	and	and	CCONJ
ecj-12463	173	25	chronic	chronic	ADJ
ecj-12463	173	26	heart	heart	NOUN
ecj-12463	173	27	failure	failure	NOUN
ecj-12463	173	28	.	.	PUNCT
ecj-12463	174	1	based	base	VERB
ecj-12463	174	2	on	on	ADP
ecj-12463	174	3	the	the	DET
ecj-12463	174	4	current	current	ADJ
ecj-12463	174	5	evidence	evidence	NOUN
ecj-12463	174	6	,	,	PUNCT
ecj-12463	174	7	high	high	ADJ
ecj-12463	174	8	levels	level	NOUN
ecj-12463	174	9	of	of	ADP
ecj-12463	174	10	gdf15	gdf15	PROPN
ecj-12463	174	11	are	be	AUX
ecj-12463	174	12	associated	associate	VERB
ecj-12463	174	13	with	with	ADP
ecj-12463	174	14	a	a	DET
ecj-12463	174	15	poor	poor	ADJ
ecj-12463	174	16	prognosis.62	prognosis.62	NOUN
ecj-12463	174	17	likewise	likewise	ADV
ecj-12463	174	18	mr	mr	PROPN
ecj-12463	174	19	-	-	PUNCT
ecj-12463	174	20	proadm	proadm	PROPN
ecj-12463	174	21	plays	play	VERB
ecj-12463	174	22	an	an	DET
ecj-12463	174	23	important	important	ADJ
ecj-12463	174	24	role	role	NOUN
ecj-12463	174	25	in	in	ADP
ecj-12463	174	26	the	the	DET
ecj-12463	174	27	course	course	NOUN
ecj-12463	174	28	of	of	ADP
ecj-12463	174	29	cardiovascular	cardiovascular	ADJ
ecj-12463	174	30	disease	disease	NOUN
ecj-12463	174	31	.	.	PUNCT
ecj-12463	175	1	an	an	DET
ecj-12463	175	2	increased	increase	VERB
ecj-12463	175	3	value	value	NOUN
ecj-12463	175	4	has	have	AUX
ecj-12463	175	5	been	be	AUX
ecj-12463	175	6	found	find	VERB
ecj-12463	175	7	in	in	ADP
ecj-12463	175	8	both	both	CCONJ
ecj-12463	175	9	chronic	chronic	ADJ
ecj-12463	175	10	and	and	CCONJ
ecj-12463	175	11	acute	acute	ADJ
ecj-12463	175	12	cardiovascular	cardiovascular	ADJ
ecj-12463	175	13	disease	disease	NOUN
ecj-12463	175	14	too	too	ADV
ecj-12463	175	15	.	.	PUNCT
ecj-12463	176	1	an	an	DET
ecj-12463	176	2	interesting	interesting	ADJ
ecj-12463	176	3	study	study	NOUN
ecj-12463	176	4	has	have	AUX
ecj-12463	176	5	shown	show	VERB
ecj-12463	176	6	that	that	SCONJ
ecj-12463	176	7	elevated	elevated	ADJ
ecj-12463	176	8	levels	level	NOUN
ecj-12463	176	9	of	of	ADP
ecj-12463	176	10	mr	mr	PROPN
ecj-12463	176	11	-	-	PUNCT
ecj-12463	176	12	proadm	proadm	PROPN
ecj-12463	176	13	were	be	AUX
ecj-12463	176	14	a	a	DET
ecj-12463	176	15	strong	strong	ADJ
ecj-12463	176	16	predictor	predictor	NOUN
ecj-12463	176	17	of	of	ADP
ecj-12463	176	18	short	short	ADJ
ecj-12463	176	19	and	and	CCONJ
ecj-12463	176	20	longterm	longterm	ADJ
ecj-12463	176	21	mortality	mortality	NOUN
ecj-12463	176	22	and	and	CCONJ
ecj-12463	176	23	hospital	hospital	NOUN
ecj-12463	176	24	admission	admission	NOUN
ecj-12463	176	25	for	for	ADP
ecj-12463	176	26	hf	hf	NOUN
ecj-12463	176	27	after	after	SCONJ
ecj-12463	176	28	ami.62,76	ami.62,76	PROPN
ecj-12463	176	29	galectin-3	galectin-3	PROPN
ecj-12463	176	30	,	,	PUNCT
ecj-12463	176	31	a	a	DET
ecj-12463	176	32	protein	protein	NOUN
ecj-12463	176	33	expressed	express	VERB
ecj-12463	176	34	in	in	ADP
ecj-12463	176	35	myocardial	myocardial	ADJ
ecj-12463	176	36	cells	cell	NOUN
ecj-12463	176	37	and	and	CCONJ
ecj-12463	176	38	released	release	VERB
ecj-12463	176	39	from	from	ADP
ecj-12463	176	40	activated	activate	VERB
ecj-12463	176	41	macrophages	macrophage	NOUN
ecj-12463	176	42	,	,	PUNCT
ecj-12463	176	43	had	have	AUX
ecj-12463	176	44	been	be	AUX
ecj-12463	176	45	investigated	investigate	VERB
ecj-12463	176	46	as	as	ADP
ecj-12463	176	47	a	a	DET
ecj-12463	176	48	biomarker	biomarker	NOUN
ecj-12463	176	49	of	of	ADP
ecj-12463	176	50	inflammation	inflammation	NOUN
ecj-12463	176	51	with	with	ADP
ecj-12463	176	52	a	a	DET
ecj-12463	176	53	promising	promising	ADJ
ecj-12463	176	54	predictive	predictive	ADJ
ecj-12463	176	55	value	value	NOUN
ecj-12463	176	56	for	for	ADP
ecj-12463	176	57	heart	heart	NOUN
ecj-12463	176	58	failure	failure	NOUN
ecj-12463	176	59	and	and	CCONJ
ecj-12463	176	60	cardiovascular	cardiovascular	ADJ
ecj-12463	176	61	events	event	NOUN
ecj-12463	176	62	.	.	PUNCT
ecj-12463	177	1	increased	increase	VERB
ecj-12463	177	2	galectin-3	galectin-3	PROPN
ecj-12463	177	3	levels	level	NOUN
ecj-12463	177	4	in	in	ADP
ecj-12463	177	5	patients	patient	NOUN
ecj-12463	177	6	with	with	ADP
ecj-12463	177	7	hf	hf	PROPN
ecj-12463	177	8	were	be	AUX
ecj-12463	177	9	an	an	DET
ecj-12463	177	10	independent	independent	ADJ
ecj-12463	177	11	predictor	predictor	NOUN
ecj-12463	177	12	of	of	ADP
ecj-12463	177	13	all	all	DET
ecj-12463	177	14	-	-	PUNCT
ecj-12463	177	15	cause	cause	NOUN
ecj-12463	177	16	mortality	mortality	NOUN
ecj-12463	177	17	and	and	CCONJ
ecj-12463	177	18	rehospitalization	rehospitalization	NOUN
ecj-12463	177	19	within	within	ADP
ecj-12463	177	20	a	a	DET
ecj-12463	177	21	12	12	NUM
ecj-12463	177	22	-	-	PUNCT
ecj-12463	177	23	month	month	NOUN
ecj-12463	177	24	follow	follow	NOUN
ecj-12463	177	25	-	-	PUNCT
ecj-12463	177	26	up	up	ADP
ecj-12463	177	27	period.63,77,78	period.63,77,78	PROPN
ecj-12463	177	28	elevated	elevated	ADJ
ecj-12463	177	29	levels	level	NOUN
ecj-12463	177	30	of	of	ADP
ecj-12463	177	31	galectin-3	galectin-3	PROPN
ecj-12463	177	32	were	be	AUX
ecj-12463	177	33	also	also	ADV
ecj-12463	177	34	found	find	VERB
ecj-12463	177	35	in	in	ADP
ecj-12463	177	36	patients	patient	NOUN
ecj-12463	177	37	with	with	ADP
ecj-12463	177	38	adverse	adverse	ADJ
ecj-12463	177	39	cardiac	cardiac	ADJ
ecj-12463	177	40	remodeling	remodeling	NOUN
ecj-12463	177	41	,	,	PUNCT
ecj-12463	177	42	but	but	CCONJ
ecj-12463	177	43	sst2	sst2	NOUN
ecj-12463	177	44	seems	seem	VERB
ecj-12463	177	45	to	to	PART
ecj-12463	177	46	be	be	AUX
ecj-12463	177	47	superior	superior	ADJ
ecj-12463	177	48	in	in	ADP
ecj-12463	177	49	longterm	longterm	ADJ
ecj-12463	177	50	risk	risk	NOUN
ecj-12463	177	51	stratification	stratification	NOUN
ecj-12463	177	52	in	in	ADP
ecj-12463	177	53	hf.62	hf.62	NOUN
ecj-12463	177	54	a	a	DET
ecj-12463	177	55	high	high	ADJ
ecj-12463	177	56	concentration	concentration	NOUN
ecj-12463	177	57	of	of	ADP
ecj-12463	177	58	galectin-3	galectin-3	PROPN
ecj-12463	177	59	observed	observe	VERB
ecj-12463	177	60	on	on	ADP
ecj-12463	177	61	admission	admission	NOUN
ecj-12463	177	62	may	may	AUX
ecj-12463	177	63	also	also	ADV
ecj-12463	177	64	identify	identify	VERB
ecj-12463	177	65	patients	patient	NOUN
ecj-12463	177	66	at	at	ADP
ecj-12463	177	67	high	high	ADJ
ecj-12463	177	68	risk	risk	NOUN
ecj-12463	177	69	of	of	ADP
ecj-12463	177	70	late	late	ADJ
ecj-12463	177	71	mace.78	mace.78	PROPN
ecj-12463	177	72	h	h	NOUN
ecj-12463	177	73	-	-	PUNCT
ecj-12463	177	74	fabp	fabp	PROPN
ecj-12463	177	75	is	be	AUX
ecj-12463	177	76	a	a	DET
ecj-12463	177	77	protein	protein	NOUN
ecj-12463	177	78	expressed	express	VERB
ecj-12463	177	79	in	in	ADP
ecj-12463	177	80	cardiomyocytes	cardiomyocyte	NOUN
ecj-12463	177	81	and	and	CCONJ
ecj-12463	177	82	released	release	VERB
ecj-12463	177	83	when	when	SCONJ
ecj-12463	177	84	myocardial	myocardial	ADJ
ecj-12463	177	85	damage	damage	NOUN
ecj-12463	177	86	has	have	AUX
ecj-12463	177	87	occurred	occur	VERB
ecj-12463	177	88	,	,	PUNCT
ecj-12463	177	89	which	which	PRON
ecj-12463	177	90	seems	seem	VERB
ecj-12463	177	91	to	to	PART
ecj-12463	177	92	be	be	AUX
ecj-12463	177	93	decisive	decisive	ADJ
ecj-12463	177	94	in	in	ADP
ecj-12463	177	95	the	the	DET
ecj-12463	177	96	differential	differential	ADJ
ecj-12463	177	97	diagnoses	diagnosis	NOUN
ecj-12463	177	98	of	of	ADP
ecj-12463	177	99	some	some	DET
ecj-12463	177	100	conditions.79	conditions.79	NOUN
ecj-12463	177	101	finally	finally	ADV
ecj-12463	177	102	,	,	PUNCT
ecj-12463	177	103	renalase	renalase	VERB
ecj-12463	177	104	,	,	PUNCT
ecj-12463	177	105	a	a	DET
ecj-12463	177	106	new	new	ADJ
ecj-12463	177	107	class	class	NOUN
ecj-12463	177	108	of	of	ADP
ecj-12463	177	109	maos	maos	PROPN
ecj-12463	177	110	,	,	PUNCT
ecj-12463	177	111	are	be	AUX
ecj-12463	177	112	involved	involve	VERB
ecj-12463	177	113	in	in	ADP
ecj-12463	177	114	numerous	numerous	ADJ
ecj-12463	177	115	cardiovascular	cardiovascular	ADJ
ecj-12463	177	116	diseases	disease	NOUN
ecj-12463	177	117	,	,	PUNCT
ecj-12463	177	118	such	such	ADJ
ecj-12463	177	119	as	as	ADP
ecj-12463	177	120	hf	hf	PROPN
ecj-12463	177	121	,	,	PUNCT
ecj-12463	177	122	cad	cad	PROPN
ecj-12463	177	123	,	,	PUNCT
ecj-12463	177	124	hypertension	hypertension	NOUN
ecj-12463	177	125	,	,	PUNCT
ecj-12463	177	126	diabetes	diabetes	NOUN
ecj-12463	177	127	mellitus	mellitus	NOUN
ecj-12463	177	128	.	.	PUNCT
ecj-12463	178	1	elevated	elevated	ADJ
ecj-12463	178	2	plasma	plasma	NOUN
ecj-12463	178	3	renalase	renalase	NOUN
ecj-12463	178	4	concentration	concentration	NOUN
ecj-12463	178	5	had	have	AUX
ecj-12463	178	6	been	be	AUX
ecj-12463	178	7	found	find	VERB
ecj-12463	178	8	in	in	ADP
ecj-12463	178	9	chronic	chronic	ADJ
ecj-12463	178	10	hf	hf	X
ecj-12463	178	11	patients.80	patients.80	NOUN
ecj-12463	178	12	in	in	ADP
ecj-12463	178	13	summary	summary	NOUN
ecj-12463	178	14	,	,	PUNCT
ecj-12463	178	15	several	several	ADJ
ecj-12463	178	16	recent	recent	ADJ
ecj-12463	178	17	studies	study	NOUN
ecj-12463	178	18	have	have	AUX
ecj-12463	178	19	addressed	address	VERB
ecj-12463	178	20	these	these	DET
ecj-12463	178	21	molecules	molecule	NOUN
ecj-12463	178	22	as	as	ADP
ecj-12463	178	23	possible	possible	ADJ
ecj-12463	178	24	biomarkers	biomarker	NOUN
ecj-12463	178	25	of	of	ADP
ecj-12463	178	26	cardiac	cardiac	ADJ
ecj-12463	178	27	damage	damage	NOUN
ecj-12463	178	28	and	and	CCONJ
ecj-12463	178	29	predictors	predictor	NOUN
ecj-12463	178	30	of	of	ADP
ecj-12463	178	31	cardiovascular	cardiovascular	ADJ
ecj-12463	178	32	risk	risk	NOUN
ecj-12463	178	33	;	;	PUNCT
ecj-12463	178	34	however	however	ADV
ecj-12463	178	35	,	,	PUNCT
ecj-12463	178	36	larger	large	ADJ
ecj-12463	178	37	further	further	ADJ
ecj-12463	178	38	investigations	investigation	NOUN
ecj-12463	178	39	are	be	AUX
ecj-12463	178	40	needed	need	VERB
ecj-12463	178	41	to	to	PART
ecj-12463	178	42	better	well	ADV
ecj-12463	178	43	understand	understand	VERB
ecj-12463	178	44	the	the	DET
ecj-12463	178	45	correlation	correlation	NOUN
ecj-12463	178	46	between	between	ADP
ecj-12463	178	47	these	these	DET
ecj-12463	178	48	molecule	molecule	NOUN
ecj-12463	178	49	levels	level	NOUN
ecj-12463	178	50	and	and	CCONJ
ecj-12463	178	51	acs	acs	PROPN
ecj-12463	178	52	risk	risk	NOUN
ecj-12463	178	53	,	,	PUNCT
ecj-12463	178	54	to	to	PART
ecj-12463	178	55	allow	allow	VERB
ecj-12463	178	56	prompt	prompt	ADJ
ecj-12463	178	57	diagnosis	diagnosis	NOUN
ecj-12463	178	58	and	and	CCONJ
ecj-12463	178	59	facilitate	facilitate	NOUN
ecj-12463	178	60	patients	patient	NOUN
ecj-12463	178	61	’	'	PUNCT
ecj-12463	178	62	management	management	NOUN
ecj-12463	178	63	in	in	ADP
ecj-12463	178	64	the	the	DET
ecj-12463	178	65	ed	ed	NOUN
ecj-12463	178	66	.	.	PUNCT
ecj-12463	179	1	conclusions	conclusion	NOUN
ecj-12463	179	2	biomarkers	biomarker	NOUN
ecj-12463	179	3	play	play	VERB
ecj-12463	179	4	a	a	DET
ecj-12463	179	5	key	key	ADJ
ecj-12463	179	6	role	role	NOUN
ecj-12463	179	7	in	in	ADP
ecj-12463	179	8	risk	risk	NOUN
ecj-12463	179	9	stratification	stratification	NOUN
ecj-12463	179	10	,	,	PUNCT
ecj-12463	179	11	diagnosis	diagnosis	NOUN
ecj-12463	179	12	and	and	CCONJ
ecj-12463	179	13	prognosis	prognosis	NOUN
ecj-12463	179	14	assessment	assessment	NOUN
ecj-12463	179	15	of	of	ADP
ecj-12463	179	16	patients	patient	NOUN
ecj-12463	179	17	with	with	ADP
ecj-12463	179	18	suspected	suspect	VERB
ecj-12463	179	19	acs	ac	NOUN
ecj-12463	179	20	;	;	PUNCT
ecj-12463	179	21	indeed	indeed	ADV
ecj-12463	179	22	,	,	PUNCT
ecj-12463	179	23	some	some	DET
ecj-12463	179	24	circulating	circulate	VERB
ecj-12463	179	25	biomarkers	biomarker	NOUN
ecj-12463	179	26	may	may	AUX
ecj-12463	179	27	reflect	reflect	VERB
ecj-12463	179	28	pathophysiological	pathophysiological	ADJ
ecj-12463	179	29	pathways	pathway	NOUN
ecj-12463	179	30	involved	involve	VERB
ecj-12463	179	31	in	in	ADP
ecj-12463	179	32	acs	acs	PROPN
ecj-12463	179	33	.	.	PUNCT
ecj-12463	180	1	sst2	sst2	PROPN
ecj-12463	180	2	and	and	CCONJ
ecj-12463	180	3	supar	supar	PROPN
ecj-12463	180	4	are	be	AUX
ecj-12463	180	5	promising	promise	VERB
ecj-12463	180	6	biomarkers	biomarker	NOUN
ecj-12463	180	7	that	that	SCONJ
ecj-12463	180	8	,	,	PUNCT
ecj-12463	180	9	given	give	VERB
ecj-12463	180	10	the	the	DET
ecj-12463	180	11	limitations	limitation	NOUN
ecj-12463	180	12	of	of	ADP
ecj-12463	180	13	troponin	troponin	NOUN
ecj-12463	180	14	,	,	PUNCT
ecj-12463	180	15	could	could	AUX
ecj-12463	180	16	help	help	VERB
ecj-12463	180	17	in	in	ADP
ecj-12463	180	18	the	the	DET
ecj-12463	180	19	management	management	NOUN
ecj-12463	180	20	of	of	ADP
ecj-12463	180	21	patients	patient	NOUN
ecj-12463	180	22	with	with	ADP
ecj-12463	180	23	chest	chest	NOUN
ecj-12463	180	24	pain	pain	NOUN
ecj-12463	180	25	in	in	ADP
ecj-12463	180	26	the	the	DET
ecj-12463	180	27	ed	ed	NOUN
ecj-12463	180	28	.	.	PUNCT
ecj-12463	181	1	further	further	ADJ
ecj-12463	181	2	studies	study	NOUN
ecj-12463	181	3	are	be	AUX
ecj-12463	181	4	needed	need	VERB
ecj-12463	181	5	to	to	PART
ecj-12463	181	6	validate	validate	VERB
ecj-12463	181	7	their	their	PRON
ecj-12463	181	8	role	role	NOUN
ecj-12463	181	9	in	in	ADP
ecj-12463	181	10	management	management	NOUN
ecj-12463	181	11	of	of	ADP
ecj-12463	181	12	acs	acs	PROPN
ecj-12463	181	13	in	in	ADP
ecj-12463	181	14	this	this	DET
ecj-12463	181	15	specific	specific	ADJ
ecj-12463	181	16	setting	setting	NOUN
ecj-12463	181	17	.	.	PUNCT
ecj-12463	182	1	therefore	therefore	ADV
ecj-12463	182	2	,	,	PUNCT
ecj-12463	182	3	further	further	ADJ
ecj-12463	182	4	evaluation	evaluation	NOUN
ecj-12463	182	5	to	to	PART
ecj-12463	182	6	establish	establish	VERB
ecj-12463	182	7	the	the	DET
ecj-12463	182	8	diagnostic	diagnostic	ADJ
ecj-12463	182	9	and	and	CCONJ
ecj-12463	182	10	prognostic	prognostic	ADJ
ecj-12463	182	11	value	value	NOUN
ecj-12463	182	12	of	of	ADP
ecj-12463	182	13	these	these	DET
ecj-12463	182	14	biomarkers	biomarker	NOUN
ecj-12463	182	15	is	be	AUX
ecj-12463	182	16	warranted	warrant	VERB
ecj-12463	182	17	.	.	PUNCT
ecj-12463	183	1	additional	additional	ADJ
ecj-12463	183	2	future	future	ADJ
ecj-12463	183	3	research	research	NOUN
ecj-12463	183	4	should	should	AUX
ecj-12463	183	5	also	also	ADV
ecj-12463	183	6	compare	compare	VERB
ecj-12463	183	7	the	the	DET
ecj-12463	183	8	accuracy	accuracy	NOUN
ecj-12463	183	9	of	of	ADP
ecj-12463	183	10	these	these	DET
ecj-12463	183	11	tools	tool	NOUN
ecj-12463	183	12	with	with	ADP
ecj-12463	183	13	the	the	DET
ecj-12463	183	14	traditional	traditional	ADJ
ecj-12463	183	15	approved	approve	VERB
ecj-12463	183	16	biomarkers	biomarker	NOUN
ecj-12463	183	17	in	in	ADP
ecj-12463	183	18	the	the	DET
ecj-12463	183	19	ed	ed	NOUN
ecj-12463	183	20	and	and	CCONJ
ecj-12463	183	21	to	to	PART
ecj-12463	183	22	evaluate	evaluate	VERB
ecj-12463	183	23	their	their	PRON
ecj-12463	183	24	introduction	introduction	NOUN
ecj-12463	183	25	in	in	ADP
ecj-12463	183	26	clinical	clinical	ADJ
ecj-12463	183	27	practice	practice	NOUN
ecj-12463	183	28	.	.	PUNCT
ecj-12463	184	1	references	reference	NOUN
ecj-12463	184	2	1	1	NUM
ecj-12463	184	3	.	.	PUNCT
ecj-12463	184	4	timmis	timmis	PROPN
ecj-12463	184	5	a	a	PRON
ecj-12463	184	6	,	,	PUNCT
ecj-12463	184	7	vardas	vardas	PROPN
ecj-12463	184	8	p	p	X
ecj-12463	184	9	,	,	PUNCT
ecj-12463	184	10	townsend	townsend	PROPN
ecj-12463	184	11	n	n	CCONJ
ecj-12463	184	12	,	,	PUNCT
ecj-12463	184	13	et	et	PROPN
ecj-12463	184	14	al	al	PROPN
ecj-12463	184	15	.	.	PUNCT
ecj-12463	185	1	european	european	PROPN
ecj-12463	185	2	society	society	PROPN
ecj-12463	185	3	of	of	ADP
ecj-12463	185	4	cardiology	cardiology	NOUN
ecj-12463	185	5	:	:	PUNCT
ecj-12463	185	6	cardiovascular	cardiovascular	ADJ
ecj-12463	185	7	disease	disease	NOUN
ecj-12463	185	8	statistics	statistic	NOUN
ecj-12463	185	9	2021	2021	NUM
ecj-12463	185	10	.	.	PUNCT
ecj-12463	186	1	eur	eur	PROPN
ecj-12463	186	2	heart	heart	NOUN
ecj-12463	186	3	j	j	PROPN
ecj-12463	186	4	2022;43:716	2022;43:716	PROPN
ecj-12463	186	5	-	-	SYM
ecj-12463	186	6	99	99	NUM
ecj-12463	186	7	.	.	PUNCT
ecj-12463	187	1	erratum	erratum	PROPN
ecj-12463	187	2	in	in	ADP
ecj-12463	187	3	:	:	PUNCT
ecj-12463	187	4	eur	eur	ADJ
ecj-12463	187	5	heart	heart	NOUN
ecj-12463	187	6	j	j	PROPN
ecj-12463	187	7	2022;43:799	2022;43:799	NUM
ecj-12463	187	8	.	.	PROPN
ecj-12463	188	1	2	2	NUM
ecj-12463	188	2	.	.	X
ecj-12463	188	3	piccioni	piccioni	PROPN
ecj-12463	188	4	a	a	PRON
ecj-12463	188	5	,	,	PUNCT
ecj-12463	188	6	valletta	valletta	PROPN
ecj-12463	188	7	f	f	PROPN
ecj-12463	188	8	,	,	PUNCT
ecj-12463	188	9	zanza	zanza	PROPN
ecj-12463	188	10	c	c	PROPN
ecj-12463	188	11	,	,	PUNCT
ecj-12463	188	12	et	et	PROPN
ecj-12463	188	13	al	al	PROPN
ecj-12463	188	14	.	.	PROPN
ecj-12463	189	1	novel	novel	ADJ
ecj-12463	189	2	biomarkers	biomarker	NOUN
ecj-12463	189	3	to	to	PART
ecj-12463	189	4	assess	assess	VERB
ecj-12463	189	5	the	the	DET
ecj-12463	189	6	risk	risk	NOUN
ecj-12463	189	7	for	for	ADP
ecj-12463	189	8	acute	acute	ADJ
ecj-12463	189	9	coronary	coronary	ADJ
ecj-12463	189	10	syndrome	syndrome	NOUN
ecj-12463	189	11	:	:	PUNCT
ecj-12463	189	12	beyond	beyond	ADP
ecj-12463	189	13	troponins	troponin	NOUN
ecj-12463	189	14	.	.	PUNCT
ecj-12463	190	1	internal	internal	ADJ
ecj-12463	190	2	emerg	emerg	PROPN
ecj-12463	190	3	med	med	PROPN
ecj-12463	190	4	2020;15:1193–9	2020;15:1193–9	PROPN
ecj-12463	190	5	.	.	PUNCT
ecj-12463	191	1	3	3	X
ecj-12463	191	2	.	.	X
ecj-12463	191	3	rehan	rehan	PROPN
ecj-12463	191	4	st	st	PROPN
ecj-12463	191	5	,	,	PUNCT
ecj-12463	191	6	hussain	hussain	PROPN
ecj-12463	191	7	hu	hu	PROPN
ecj-12463	191	8	,	,	PUNCT
ecj-12463	191	9	ali	ali	PROPN
ecj-12463	191	10	e	e	PROPN
ecj-12463	191	11	,	,	PUNCT
ecj-12463	191	12	et	et	PROPN
ecj-12463	191	13	al	al	PROPN
ecj-12463	191	14	.	.	PUNCT
ecj-12463	191	15	role	role	NOUN
ecj-12463	191	16	of	of	ADP
ecj-12463	191	17	soluble	soluble	ADJ
ecj-12463	191	18	urokinase	urokinase	NOUN
ecj-12463	191	19	type	type	NOUN
ecj-12463	191	20	plasminogen	plasminogen	NOUN
ecj-12463	191	21	activator	activator	NOUN
ecj-12463	191	22	receptor	receptor	NOUN
ecj-12463	191	23	(	(	PUNCT
ecj-12463	191	24	supar	supar	NOUN
ecj-12463	191	25	)	)	PUNCT
ecj-12463	191	26	in	in	ADP
ecj-12463	191	27	predicting	predict	VERB
ecj-12463	191	28	mortality	mortality	NOUN
ecj-12463	191	29	,	,	PUNCT
ecj-12463	191	30	readmission	readmission	NOUN
ecj-12463	191	31	,	,	PUNCT
ecj-12463	191	32	length	length	NOUN
ecj-12463	191	33	of	of	ADP
ecj-12463	191	34	stay	stay	NOUN
ecj-12463	191	35	and	and	CCONJ
ecj-12463	191	36	discharge	discharge	VERB
ecj-12463	191	37	in	in	ADP
ecj-12463	191	38	emergency	emergency	NOUN
ecj-12463	191	39	patients	patient	NOUN
ecj-12463	191	40	:	:	PUNCT
ecj-12463	191	41	a	a	DET
ecj-12463	191	42	systematic	systematic	ADJ
ecj-12463	191	43	review	review	NOUN
ecj-12463	191	44	and	and	CCONJ
ecj-12463	191	45	meta	meta	VERB
ecj-12463	191	46	analysis	analysis	NOUN
ecj-12463	191	47	.	.	PUNCT
ecj-12463	192	1	medicine	medicine	NOUN
ecj-12463	192	2	2023;102:45	2023;102:45	NUM
ecj-12463	192	3	.	.	PUNCT
ecj-12463	193	1	4	4	NUM
ecj-12463	193	2	.	.	X
ecj-12463	193	3	yang	yang	PROPN
ecj-12463	193	4	l	l	PROPN
ecj-12463	193	5	,	,	PUNCT
ecj-12463	193	6	yaqun	yaqun	X
ecj-12463	193	7	d	d	NOUN
ecj-12463	193	8	,	,	PUNCT
ecj-12463	193	9	yinjie	yinjie	PROPN
ecj-12463	193	10	z	z	PROPN
ecj-12463	193	11	,	,	PUNCT
ecj-12463	193	12	et	et	PROPN
ecj-12463	193	13	al	al	PROPN
ecj-12463	193	14	.	.	PUNCT
ecj-12463	194	1	prognostic	prognostic	ADJ
ecj-12463	194	2	value	value	NOUN
ecj-12463	194	3	of	of	ADP
ecj-12463	194	4	soluble	soluble	ADJ
ecj-12463	194	5	urokinase	urokinase	NOUN
ecj-12463	194	6	-	-	PUNCT
ecj-12463	194	7	type	type	NOUN
ecj-12463	194	8	plasminogen	plasminogen	NOUN
ecj-12463	194	9	activator	activator	NOUN
ecj-12463	194	10	receptor	receptor	NOUN
ecj-12463	194	11	in	in	ADP
ecj-12463	194	12	coronary	coronary	ADJ
ecj-12463	194	13	artery	artery	NOUN
ecj-12463	194	14	disease	disease	NOUN
ecj-12463	194	15	:	:	PUNCT
ecj-12463	194	16	a	a	DET
ecj-12463	194	17	meta-analysis.eur	meta-analysis.eur	NOUN
ecj-12463	194	18	j	j	PROPN
ecj-12463	194	19	clin	clin	PROPN
ecj-12463	194	20	invest	invest	VERB
ecj-12463	194	21	2022;52	2022;52	NUM
ecj-12463	194	22	:	:	PUNCT
ecj-12463	194	23	e13867	e13867	PRON
ecj-12463	194	24	.	.	PUNCT
ecj-12463	195	1	5	5	X
ecj-12463	195	2	.	.	X
ecj-12463	195	3	holstein	holstein	PROPN
ecj-12463	195	4	rm	rm	PROPN
ecj-12463	195	5	,	,	PUNCT
ecj-12463	195	6	mäkinen	mäkinen	PROPN
ecj-12463	195	7	mt	mt	PROPN
ecj-12463	195	8	,	,	PUNCT
ecj-12463	195	9	castrén	castrén	PROPN
ecj-12463	195	10	mk	mk	PROPN
ecj-12463	195	11	,	,	PUNCT
ecj-12463	195	12	kaartinen	kaartinen	PROPN
ecj-12463	195	13	jm	jm	PROPN
ecj-12463	195	14	.	.	PROPN
ecj-12463	195	15	utilization	utilization	NOUN
ecj-12463	195	16	of	of	ADP
ecj-12463	195	17	prognostic	prognostic	ADJ
ecj-12463	195	18	biomarker	biomarker	NOUN
ecj-12463	195	19	soluble	soluble	ADJ
ecj-12463	195	20	urokinase	urokinase	NOUN
ecj-12463	195	21	plasminogen	plasminogen	NOUN
ecj-12463	195	22	activator	activator	NOUN
ecj-12463	195	23	receptor	receptor	NOUN
ecj-12463	195	24	in	in	ADP
ecj-12463	195	25	the	the	DET
ecj-12463	195	26	emergency	emergency	NOUN
ecj-12463	195	27	department	department	NOUN
ecj-12463	195	28	:	:	PUNCT
ecj-12463	195	29	a	a	DET
ecj-12463	195	30	tool	tool	NOUN
ecj-12463	195	31	for	for	ADP
ecj-12463	195	32	safe	safe	ADJ
ecj-12463	195	33	and	and	CCONJ
ecj-12463	195	34	more	more	ADV
ecj-12463	195	35	efficient	efficient	ADJ
ecj-12463	195	36	decision	decision	NOUN
ecj-12463	195	37	-	-	PUNCT
ecj-12463	195	38	making	making	NOUN
ecj-12463	195	39	.	.	PUNCT
ecj-12463	196	1	biomarker	biomarker	NOUN
ecj-12463	196	2	insights	insight	NOUN
ecj-12463	196	3	2022;17	2022;17	NUM
ecj-12463	196	4	:	:	PUNCT
ecj-12463	196	5	1–7	1–7	NUM
ecj-12463	196	6	.	.	NOUN
ecj-12463	196	7	6	6	NUM
ecj-12463	196	8	.	.	X
ecj-12463	196	9	holstei	holstei	PROPN
ecj-12463	196	10	rm	rm	PROPN
ecj-12463	196	11	,	,	PUNCT
ecj-12463	196	12	seppälä	seppälä	PROPN
ecj-12463	196	13	s	s	PROPN
ecj-12463	196	14	,	,	PUNCT
ecj-12463	196	15	kaartinen	kaartinen	PROPN
ecj-12463	196	16	j	j	PROPN
ecj-12463	196	17	,	,	PUNCT
ecj-12463	196	18	et	et	PROPN
ecj-12463	196	19	al	al	PROPN
ecj-12463	196	20	.	.	PROPN
ecj-12463	196	21	soluble	soluble	ADJ
ecj-12463	196	22	urokinase	urokinase	NOUN
ecj-12463	196	23	plasminogen	plasminogen	NOUN
ecj-12463	196	24	activator	activator	NOUN
ecj-12463	196	25	receptor	receptor	NOUN
ecj-12463	196	26	(	(	PUNCT
ecj-12463	196	27	supar	supar	NOUN
ecj-12463	196	28	)	)	PUNCT
ecj-12463	196	29	in	in	ADP
ecj-12463	196	30	the	the	DET
ecj-12463	196	31	emergency	emergency	NOUN
ecj-12463	196	32	department	department	NOUN
ecj-12463	196	33	(	(	PUNCT
ecj-12463	196	34	ed	ed	NOUN
ecj-12463	196	35	):	):	PUNCT
ecj-12463	196	36	a	a	DET
ecj-12463	196	37	tool	tool	NOUN
ecj-12463	196	38	for	for	ADP
ecj-12463	196	39	the	the	DET
ecj-12463	196	40	assessment	assessment	NOUN
ecj-12463	196	41	of	of	ADP
ecj-12463	196	42	elderly	elderly	ADJ
ecj-12463	196	43	patients	patient	NOUN
ecj-12463	196	44	.	.	PUNCT
ecj-12463	197	1	j	j	PROPN
ecj-12463	197	2	clin	clin	PROPN
ecj-12463	197	3	med	med	PROPN
ecj-12463	197	4	2022;11:3283	2022;11:3283	NUM
ecj-12463	197	5	.	.	PROPN
ecj-12463	198	1	7	7	X
ecj-12463	198	2	.	.	PUNCT
ecj-12463	198	3	lazar	lazar	PROPN
ecj-12463	198	4	dr	dr	PROPN
ecj-12463	198	5	,	,	PUNCT
ecj-12463	198	6	lazar	lazar	PROPN
ecj-12463	198	7	fl	fl	PROPN
ecj-12463	198	8	,	,	PUNCT
ecj-12463	198	9	homorodean	homorodean	PROPN
ecj-12463	198	10	c	c	NOUN
ecj-12463	198	11	,	,	PUNCT
ecj-12463	198	12	et	et	PROPN
ecj-12463	198	13	al	al	PROPN
ecj-12463	198	14	.	.	PROPN
ecj-12463	198	15	high	high	ADJ
ecj-12463	198	16	-	-	PUNCT
ecj-12463	198	17	sensitivity	sensitivity	NOUN
ecj-12463	198	18	review	review	NOUN
ecj-12463	198	19	[	[	X
ecj-12463	198	20	page	page	NOUN
ecj-12463	198	21	55	55	NUM
ecj-12463	198	22	]	]	PUNCT
ecj-12463	199	1	[	[	X
ecj-12463	199	2	emergency	emergency	NOUN
ecj-12463	199	3	care	care	NOUN
ecj-12463	199	4	journal	journal	PROPN
ecj-12463	199	5	2024	2024	NUM
ecj-12463	199	6	;	;	PUNCT
ecj-12463	199	7	20:12463	20:12463	NUM
ecj-12463	199	8	]	]	X
ecj-12463	199	9	non	non	ADJ
ecj-12463	199	10	-co	-co	PROPN
ecj-12463	199	11	mmerc	mmerc	PROPN
ecj-12463	199	12	ial	ial	PROPN
ecj-12463	199	13	us	us	PROPN
ecj-12463	199	14	e	e	NOUN
ecj-12463	199	15	o	o	X
ecj-12463	199	16	nly	nly	ADV
ecj-12463	199	17	troponin	troponin	ADJ
ecj-12463	199	18	:	:	PUNCT
ecj-12463	199	19	a	a	DET
ecj-12463	199	20	review	review	NOUN
ecj-12463	199	21	on	on	ADP
ecj-12463	199	22	characteristics	characteristic	NOUN
ecj-12463	199	23	,	,	PUNCT
ecj-12463	199	24	assessment	assessment	NOUN
ecj-12463	199	25	,	,	PUNCT
ecj-12463	199	26	and	and	CCONJ
ecj-12463	199	27	clinical	clinical	ADJ
ecj-12463	199	28	implications	implication	NOUN
ecj-12463	199	29	.	.	PUNCT
ecj-12463	200	1	hindawi	hindawi	ADJ
ecj-12463	200	2	disease	disease	NOUN
ecj-12463	200	3	markers	marker	NOUN
ecj-12463	200	4	2022;9713326	2022;9713326	NOUN
ecj-12463	200	5	.	.	PUNCT
ecj-12463	201	1	8	8	NUM
ecj-12463	201	2	.	.	PUNCT
ecj-12463	202	1	boone	boone	PROPN
ecj-12463	202	2	s	s	PROPN
ecj-12463	202	3	,	,	PUNCT
ecj-12463	202	4	peacock	peacock	NOUN
ecj-12463	202	5	wf	wf	PROPN
ecj-12463	202	6	.	.	PUNCT
ecj-12463	203	1	contemporary	contemporary	ADJ
ecj-12463	203	2	biomarker	biomarker	NOUN
ecj-12463	203	3	strategies	strategy	NOUN
ecj-12463	203	4	for	for	ADP
ecj-12463	203	5	patients	patient	NOUN
ecj-12463	203	6	with	with	ADP
ecj-12463	203	7	chest	chest	NOUN
ecj-12463	203	8	pain	pain	NOUN
ecj-12463	203	9	.	.	PUNCT
ecj-12463	204	1	rev	rev	AUX
ecj-12463	204	2	cardiovasc	cardiovasc	PROPN
ecj-12463	204	3	med	me	VERB
ecj-12463	204	4	2022;23:157	2022;23:157	PROPN
ecj-12463	204	5	.	.	PUNCT
ecj-12463	205	1	9	9	X
ecj-12463	205	2	.	.	X
ecj-12463	205	3	chuang	chuang	PROPN
ecj-12463	205	4	am	be	AUX
ecj-12463	205	5	,	,	PUNCT
ecj-12463	205	6	nguyen	nguyen	PROPN
ecj-12463	205	7	mt	mt	PROPN
ecj-12463	205	8	,	,	PUNCT
ecj-12463	205	9	kung	kung	PROPN
ecj-12463	205	10	wm	wm	PROPN
ecj-12463	205	11	,	,	PUNCT
ecj-12463	205	12	et	et	PROPN
ecj-12463	205	13	al	al	PROPN
ecj-12463	205	14	.	.	PROPN
ecj-12463	205	15	high	high	ADJ
ecj-12463	205	16	-	-	PUNCT
ecj-12463	205	17	sensitivity	sensitivity	NOUN
ecj-12463	205	18	troponin	troponin	ADJ
ecj-12463	205	19	in	in	ADP
ecj-12463	205	20	chronic	chronic	ADJ
ecj-12463	205	21	kidney	kidney	NOUN
ecj-12463	205	22	disease	disease	NOUN
ecj-12463	205	23	:	:	PUNCT
ecj-12463	205	24	considerations	consideration	NOUN
ecj-12463	205	25	in	in	ADP
ecj-12463	205	26	myocardial	myocardial	ADJ
ecj-12463	205	27	infarction	infarction	NOUN
ecj-12463	205	28	and	and	CCONJ
ecj-12463	205	29	beyond	beyond	ADP
ecj-12463	205	30	.	.	PUNCT
ecj-12463	206	1	rev	rev	VERB
ecj-12463	206	2	cardio	cardio	NOUN
ecj-12463	206	3	-	-	PUNCT
ecj-12463	206	4	vasc	vasc	X
ecj-12463	206	5	med	med	PROPN
ecj-12463	206	6	2020;21	2020;21	PROPN
ecj-12463	206	7	:	:	PUNCT
ecj-12463	206	8	191–203	191–203	NUM
ecj-12463	206	9	.	.	PUNCT
ecj-12463	207	1	10	10	NUM
ecj-12463	207	2	.	.	PUNCT
ecj-12463	208	1	long	long	PROPN
ecj-12463	208	2	b	b	NOUN
ecj-12463	208	3	,	,	PUNCT
ecj-12463	208	4	long	long	ADJ
ecj-12463	208	5	da	da	PROPN
ecj-12463	208	6	,	,	PUNCT
ecj-12463	208	7	tannenbaum	tannenbaum	PROPN
ecj-12463	208	8	l	l	PROPN
ecj-12463	208	9	,	,	PUNCT
ecj-12463	208	10	koyfman	koyfman	PROPN
ecj-12463	208	11	a.	a.	NOUN
ecj-12463	208	12	an	an	DET
ecj-12463	208	13	emergency	emergency	NOUN
ecj-12463	208	14	medicine	medicine	NOUN
ecj-12463	208	15	approach	approach	NOUN
ecj-12463	208	16	to	to	ADP
ecj-12463	208	17	troponin	troponin	ADJ
ecj-12463	208	18	elevation	elevation	NOUN
ecj-12463	208	19	due	due	ADP
ecj-12463	208	20	to	to	ADP
ecj-12463	208	21	causes	cause	VERB
ecj-12463	208	22	other	other	ADJ
ecj-12463	208	23	than	than	ADP
ecj-12463	208	24	occlusion	occlusion	NOUN
ecj-12463	208	25	myocardial	myocardial	ADJ
ecj-12463	208	26	infarction	infarction	NOUN
ecj-12463	208	27	.	.	PUNCT
ecj-12463	209	1	am	be	AUX
ecj-12463	209	2	j	j	PROPN
ecj-12463	209	3	emerg	emerg	PROPN
ecj-12463	209	4	med	med	PROPN
ecj-12463	209	5	2020;38:998	2020;38:998	PROPN
ecj-12463	209	6	-	-	SYM
ecj-12463	209	7	1006	1006	NUM
ecj-12463	209	8	.	.	PUNCT
ecj-12463	210	1	11	11	NUM
ecj-12463	210	2	.	.	X
ecj-12463	210	3	januzzi	januzzi	PROPN
ecj-12463	210	4	jl	jl	PROPN
ecj-12463	210	5	,	,	PUNCT
ecj-12463	210	6	mahler	mahler	PROPN
ecj-12463	210	7	sa	sa	PROPN
ecj-12463	210	8	,	,	PUNCT
ecj-12463	210	9	christenson	christenson	PROPN
ecj-12463	210	10	rh	rh	PROPN
ecj-12463	210	11	,	,	PUNCT
ecj-12463	210	12	et	et	PROPN
ecj-12463	210	13	al	al	PROPN
ecj-12463	210	14	.	.	PUNCT
ecj-12463	210	15	recommendations	recommendation	NOUN
ecj-12463	210	16	for	for	ADP
ecj-12463	210	17	institutions	institution	NOUN
ecj-12463	210	18	transitioning	transition	VERB
ecj-12463	210	19	to	to	ADP
ecj-12463	210	20	highsensitivity	highsensitivity	NOUN
ecj-12463	210	21	troponin	troponin	ADJ
ecj-12463	210	22	testing	testing	NOUN
ecj-12463	210	23	:	:	PUNCT
ecj-12463	210	24	jacc	jacc	VERB
ecj-12463	210	25	scientific	scientific	ADJ
ecj-12463	210	26	expert	expert	NOUN
ecj-12463	210	27	panel	panel	NOUN
ecj-12463	210	28	.	.	PUNCT
ecj-12463	211	1	j	j	PROPN
ecj-12463	211	2	am	be	AUX
ecj-12463	211	3	coll	coll	PROPN
ecj-12463	211	4	cardiol	cardiol	NOUN
ecj-12463	211	5	2019;73:1059–77	2019;73:1059–77	NUM
ecj-12463	211	6	.	.	PUNCT
ecj-12463	212	1	12	12	NUM
ecj-12463	212	2	.	.	PUNCT
ecj-12463	213	1	januzzi	januzzi	PROPN
ecj-12463	213	2	jl	jl	PROPN
ecj-12463	213	3	,	,	PUNCT
ecj-12463	213	4	mccarthy	mccarthy	PROPN
ecj-12463	213	5	cp	cp	PROPN
ecj-12463	213	6	.	.	PUNCT
ecj-12463	213	7	cardiac	cardiac	ADJ
ecj-12463	213	8	troponin	troponin	PROPN
ecj-12463	213	9	and	and	CCONJ
ecj-12463	213	10	the	the	DET
ecj-12463	213	11	true	true	ADJ
ecj-12463	213	12	false	false	ADJ
ecj-12463	213	13	positive	positive	NOUN
ecj-12463	213	14	.	.	PUNCT
ecj-12463	214	1	jacc	jacc	ADJ
ecj-12463	214	2	:	:	PUNCT
ecj-12463	214	3	case	case	NOUN
ecj-12463	214	4	reports	report	VERB
ecj-12463	214	5	2020;2:461–463	2020;2:461–463	PROPN
ecj-12463	214	6	.	.	PROPN
ecj-12463	214	7	13	13	NUM
ecj-12463	214	8	.	.	PUNCT
ecj-12463	215	1	sandoval	sandoval	PROPN
ecj-12463	215	2	y	y	PROPN
ecj-12463	215	3	,	,	PUNCT
ecj-12463	215	4	apple	apple	PROPN
ecj-12463	215	5	fs	fs	PROPN
ecj-12463	215	6	,	,	PUNCT
ecj-12463	215	7	mahle	mahle	ADJ
ecj-12463	215	8	sa	sa	PROPN
ecj-12463	215	9	,	,	PUNCT
ecj-12463	215	10	et	et	PROPN
ecj-12463	215	11	al	al	PROPN
ecj-12463	215	12	.	.	PROPN
ecj-12463	215	13	high	high	ADJ
ecj-12463	215	14	-	-	PUNCT
ecj-12463	215	15	sensitivity	sensitivity	NOUN
ecj-12463	215	16	cardiac	cardiac	ADJ
ecj-12463	215	17	troponin	troponin	ADJ
ecj-12463	215	18	and	and	CCONJ
ecj-12463	215	19	the	the	DET
ecj-12463	215	20	2021aha	2021aha	PROPN
ecj-12463	215	21	/	/	SYM
ecj-12463	215	22	acc	acc	PROPN
ecj-12463	215	23	/	/	SYM
ecj-12463	215	24	ase	ase	NOUN
ecj-12463	215	25	/	/	SYM
ecj-12463	215	26	chest	chest	NOUN
ecj-12463	215	27	/	/	SYM
ecj-12463	215	28	saem/	saem/	NUM
ecj-12463	215	29	scct	scct	NOUN
ecj-12463	215	30	/	/	SYM
ecj-12463	215	31	scmr	scmr	NOUN
ecj-12463	215	32	guidelines	guideline	NOUN
ecj-12463	215	33	for	for	ADP
ecj-12463	215	34	the	the	DET
ecj-12463	215	35	evaluation	evaluation	NOUN
ecj-12463	215	36	and	and	CCONJ
ecj-12463	215	37	diagnosis	diagnosis	NOUN
ecj-12463	215	38	of	of	ADP
ecj-12463	215	39	acute	acute	ADJ
ecj-12463	215	40	chest	chest	NOUN
ecj-12463	215	41	pain	pain	NOUN
ecj-12463	215	42	.	.	PUNCT
ecj-12463	216	1	circulation	circulation	NOUN
ecj-12463	216	2	2022;146:569–81	2022;146:569–81	NUM
ecj-12463	216	3	.	.	PUNCT
ecj-12463	216	4	14	14	NUM
ecj-12463	216	5	.	.	PUNCT
ecj-12463	217	1	byrne	byrne	PROPN
ecj-12463	217	2	ra	ra	PROPN
ecj-12463	217	3	,	,	PUNCT
ecj-12463	217	4	rossello	rossello	PROPN
ecj-12463	217	5	x	x	X
ecj-12463	217	6	,	,	PUNCT
ecj-12463	217	7	coughlan	coughlan	PROPN
ecj-12463	217	8	jj	jj	PROPN
ecj-12463	217	9	,	,	PUNCT
ecj-12463	217	10	et	et	PROPN
ecj-12463	217	11	al	al	PROPN
ecj-12463	217	12	.	.	PROPN
ecj-12463	218	1	2023	2023	NUM
ecj-12463	218	2	esc	esc	NOUN
ecj-12463	218	3	guidelines	guideline	NOUN
ecj-12463	218	4	for	for	ADP
ecj-12463	218	5	the	the	DET
ecj-12463	218	6	management	management	NOUN
ecj-12463	218	7	of	of	ADP
ecj-12463	218	8	acute	acute	ADJ
ecj-12463	218	9	coronary	coronary	ADJ
ecj-12463	218	10	syndromes	syndrome	NOUN
ecj-12463	218	11	developed	develop	VERB
ecj-12463	218	12	by	by	ADP
ecj-12463	218	13	the	the	DET
ecj-12463	218	14	task	task	NOUN
ecj-12463	218	15	force	force	NOUN
ecj-12463	218	16	on	on	ADP
ecj-12463	218	17	the	the	DET
ecj-12463	218	18	management	management	NOUN
ecj-12463	218	19	of	of	ADP
ecj-12463	218	20	acute	acute	ADJ
ecj-12463	218	21	coronary	coronary	ADJ
ecj-12463	218	22	syndromes	syndrome	NOUN
ecj-12463	218	23	of	of	ADP
ecj-12463	218	24	the	the	DET
ecj-12463	218	25	european	european	ADJ
ecj-12463	218	26	society	society	PROPN
ecj-12463	218	27	of	of	ADP
ecj-12463	218	28	cardiology	cardiology	NOUN
ecj-12463	218	29	(	(	PUNCT
ecj-12463	218	30	esc	esc	NOUN
ecj-12463	218	31	)	)	PUNCT
ecj-12463	218	32	.	.	PUNCT
ecj-12463	219	1	eur	eur	PROPN
ecj-12463	219	2	heart	heart	NOUN
ecj-12463	219	3	j	j	PROPN
ecj-12463	219	4	2023;44;3720–826	2023;44;3720–826	PROPN
ecj-12463	219	5	.	.	PROPN
ecj-12463	219	6	15	15	NUM
ecj-12463	219	7	.	.	PUNCT
ecj-12463	220	1	chesnaye	chesnaye	PROPN
ecj-12463	220	2	nc	nc	PROPN
ecj-12463	220	3	,	,	PUNCT
ecj-12463	220	4	szummer	szummer	PROPN
ecj-12463	220	5	k	k	PROPN
ecj-12463	220	6	,	,	PUNCT
ecj-12463	220	7	bárány	bárány	PROPN
ecj-12463	220	8	p	p	X
ecj-12463	220	9	,	,	PUNCT
ecj-12463	220	10	et	et	PROPN
ecj-12463	220	11	al	al	PROPN
ecj-12463	220	12	.	.	PROPN
ecj-12463	220	13	association	association	PROPN
ecj-12463	220	14	between	between	ADP
ecj-12463	220	15	renal	renal	ADJ
ecj-12463	220	16	function	function	NOUN
ecj-12463	220	17	and	and	CCONJ
ecj-12463	220	18	troponin	troponin	PROPN
ecj-12463	220	19	t	t	NOUN
ecj-12463	220	20	over	over	ADP
ecj-12463	220	21	time	time	NOUN
ecj-12463	220	22	in	in	ADP
ecj-12463	220	23	stable	stable	ADJ
ecj-12463	220	24	chronic	chronic	ADJ
ecj-12463	220	25	kidney	kidney	NOUN
ecj-12463	220	26	disease	disease	NOUN
ecj-12463	220	27	patients	patient	NOUN
ecj-12463	220	28	.	.	PUNCT
ecj-12463	221	1	j	j	PROPN
ecj-12463	221	2	am	be	AUX
ecj-12463	221	3	heart	heart	NOUN
ecj-12463	221	4	assoc	assoc	PROPN
ecj-12463	221	5	2019;8	2019;8	PROPN
ecj-12463	221	6	:	:	PUNCT
ecj-12463	221	7	e013091	e013091	PROPN
ecj-12463	221	8	.	.	PROPN
ecj-12463	221	9	16	16	NUM
ecj-12463	221	10	.	.	PUNCT
ecj-12463	222	1	bhatia	bhatia	PROPN
ecj-12463	222	2	pm	pm	PROPN
ecj-12463	222	3	,	,	PUNCT
ecj-12463	222	4	daniels	daniels	PROPN
ecj-12463	222	5	lb	lb	PROPN
ecj-12463	222	6	.	.	PUNCT
ecj-12463	223	1	highly	highly	ADV
ecj-12463	223	2	sensitive	sensitive	ADJ
ecj-12463	223	3	cardiac	cardiac	ADJ
ecj-12463	223	4	troponins	troponin	NOUN
ecj-12463	223	5	:	:	PUNCT
ecj-12463	223	6	the	the	DET
ecj-12463	223	7	evidence	evidence	NOUN
ecj-12463	223	8	behind	behind	ADP
ecj-12463	223	9	sex	sex	NOUN
ecj-12463	223	10	-	-	PUNCT
ecj-12463	223	11	specific	specific	ADJ
ecj-12463	223	12	cutoffs	cutoff	NOUN
ecj-12463	223	13	.	.	PUNCT
ecj-12463	224	1	j	j	PROPN
ecj-12463	224	2	am	be	AUX
ecj-12463	224	3	heart	heart	NOUN
ecj-12463	224	4	assoc	assoc	PROPN
ecj-12463	224	5	2020;9	2020;9	NOUN
ecj-12463	224	6	:	:	PUNCT
ecj-12463	224	7	e015272	e015272	PROPN
ecj-12463	224	8	.	.	PROPN
ecj-12463	224	9	17	17	NUM
ecj-12463	224	10	.	.	PUNCT
ecj-12463	225	1	karády	karády	PROPN
ecj-12463	225	2	j	j	PROPN
ecj-12463	225	3	,	,	PUNCT
ecj-12463	225	4	mayrhofer	mayrhofer	PROPN
ecj-12463	225	5	t	t	PROPN
ecj-12463	225	6	,	,	PUNCT
ecj-12463	225	7	ferencik	ferencik	VERB
ecj-12463	225	8	m	m	PROPN
ecj-12463	225	9	,	,	PUNCT
ecj-12463	225	10	et	et	PROPN
ecj-12463	225	11	al	al	PROPN
ecj-12463	225	12	.	.	PROPN
ecj-12463	225	13	discordance	discordance	NOUN
ecj-12463	225	14	of	of	ADP
ecj-12463	225	15	highsensitivity	highsensitivity	NOUN
ecj-12463	225	16	troponin	troponin	ADJ
ecj-12463	225	17	assays	assay	NOUN
ecj-12463	225	18	in	in	ADP
ecj-12463	225	19	patients	patient	NOUN
ecj-12463	225	20	with	with	ADP
ecj-12463	225	21	suspected	suspect	VERB
ecj-12463	225	22	acute	acute	ADJ
ecj-12463	225	23	coronary	coronary	ADJ
ecj-12463	225	24	syndromes	syndrome	NOUN
ecj-12463	225	25	.	.	PUNCT
ecj-12463	226	1	j	j	PROPN
ecj-12463	226	2	am	be	AUX
ecj-12463	226	3	coll	coll	PROPN
ecj-12463	226	4	cardiol	cardiol	NOUN
ecj-12463	226	5	2021;77:1487–99	2021;77:1487–99	NUM
ecj-12463	226	6	.	.	PUNCT
ecj-12463	227	1	18	18	NUM
ecj-12463	227	2	.	.	PUNCT
ecj-12463	228	1	u.s	u.s	PROPN
ecj-12463	228	2	.	.	PROPN
ecj-12463	228	3	food	food	PROPN
ecj-12463	228	4	and	and	CCONJ
ecj-12463	228	5	drug	drug	PROPN
ecj-12463	228	6	administration	administration	PROPN
ecj-12463	228	7	(	(	PUNCT
ecj-12463	228	8	fda	fda	PROPN
ecj-12463	228	9	)	)	PUNCT
ecj-12463	228	10	safety	safety	NOUN
ecj-12463	228	11	communication	communication	NOUN
ecj-12463	228	12	.	.	PUNCT
ecj-12463	229	1	biotin	biotin	NOUN
ecj-12463	229	2	interference	interference	NOUN
ecj-12463	229	3	with	with	ADP
ecj-12463	229	4	troponin	troponin	ADJ
ecj-12463	229	5	lab	lab	NOUN
ecj-12463	229	6	tests	test	NOUN
ecj-12463	229	7	assays	assay	NOUN
ecj-12463	229	8	subject	subject	ADJ
ecj-12463	229	9	to	to	ADP
ecj-12463	229	10	biotin	biotin	NOUN
ecj-12463	229	11	interference	interference	NOUN
ecj-12463	229	12	.	.	PUNCT
ecj-12463	230	1	2019	2019	NUM
ecj-12463	230	2	.	.	PUNCT
ecj-12463	231	1	available	available	ADJ
ecj-12463	231	2	at	at	ADP
ecj-12463	231	3	:	:	PUNCT
ecj-12463	231	4	https	https	NOUN
ecj-12463	231	5	:	:	PUNCT
ecj-12463	231	6	//www.fda.gov	//www.fda.gov	PUNCT
ecj-12463	231	7	/	/	SYM
ecj-12463	231	8	medical	medical	ADJ
ecj-12463	231	9	-	-	PUNCT
ecj-12463	231	10	devices	device	NOUN
ecj-12463	231	11	/	/	SYM
ecj-12463	231	12	in	in	ADP
ecj-12463	231	13	-	-	PUNCT
ecj-12463	231	14	vitro	vitro	NOUN
ecj-12463	231	15	-	-	PUNCT
ecj-12463	231	16	diagnostics	diagnostic	NOUN
ecj-12463	231	17	/	/	SYM
ecj-12463	231	18	biotininterference	biotininterference	NOUN
ecj-12463	231	19	-	-	PUNCT
ecj-12463	231	20	troponin	troponin	ADJ
ecj-12463	231	21	-	-	PUNCT
ecj-12463	231	22	lab	lab	NOUN
ecj-12463	231	23	-	-	PUNCT
ecj-12463	231	24	tests	test	NOUN
ecj-12463	231	25	-	-	PUNCT
ecj-12463	231	26	assays	assay	NOUN
ecj-12463	231	27	-	-	PUNCT
ecj-12463	231	28	subject	subject	NOUN
ecj-12463	231	29	-	-	PUNCT
ecj-12463	231	30	biotin	biotin	NOUN
ecj-12463	231	31	-	-	PUNCT
ecj-12463	231	32	interference	interference	NOUN
ecj-12463	231	33	19	19	NUM
ecj-12463	231	34	.	.	PUNCT
ecj-12463	232	1	mumma	mumma	PROPN
ecj-12463	232	2	b	b	PROPN
ecj-12463	232	3	,	,	PUNCT
ecj-12463	232	4	diercks	diercks	PROPN
ecj-12463	232	5	d	d	PROPN
ecj-12463	232	6	,	,	PUNCT
ecj-12463	232	7	twerenbold	twerenbold	ADJ
ecj-12463	232	8	r	r	NOUN
ecj-12463	232	9	,	,	PUNCT
ecj-12463	232	10	et	et	PROPN
ecj-12463	232	11	al	al	PROPN
ecj-12463	232	12	.	.	PUNCT
ecj-12463	233	1	clinical	clinical	ADJ
ecj-12463	233	2	risk	risk	NOUN
ecj-12463	233	3	assessment	assessment	NOUN
ecj-12463	233	4	of	of	ADP
ecj-12463	233	5	biotin	biotin	NOUN
ecj-12463	233	6	interference	interference	NOUN
ecj-12463	233	7	with	with	ADP
ecj-12463	233	8	a	a	DET
ecj-12463	233	9	high	high	ADJ
ecj-12463	233	10	-	-	PUNCT
ecj-12463	233	11	sensitivity	sensitivity	NOUN
ecj-12463	233	12	cardiac	cardiac	ADJ
ecj-12463	233	13	troponin	troponin	PROPN
ecj-12463	233	14	t	t	PROPN
ecj-12463	233	15	assay	assay	PROPN
ecj-12463	233	16	.	.	PUNCT
ecj-12463	234	1	clin	clin	PROPN
ecj-12463	234	2	chem	chem	NOUN
ecj-12463	234	3	lab	lab	NOUN
ecj-12463	234	4	med	med	PROPN
ecj-12463	234	5	2020;58:1931–40	2020;58:1931–40	NUM
ecj-12463	234	6	.	.	PROPN
ecj-12463	235	1	20	20	NUM
ecj-12463	235	2	.	.	X
ecj-12463	235	3	santos	santos	PROPN
ecj-12463	235	4	lg	lg	PROPN
ecj-12463	235	5	,	,	PUNCT
ecj-12463	235	6	carvalho	carvalho	PROPN
ecj-12463	235	7	rr	rr	PROPN
ecj-12463	235	8	,	,	PUNCT
ecj-12463	235	9	sá	sá	PROPN
ecj-12463	235	10	fm	fm	PROPN
ecj-12463	235	11	,	,	PUNCT
ecj-12463	235	12	et	et	PROPN
ecj-12463	235	13	al	al	PROPN
ecj-12463	235	14	.	.	PUNCT
ecj-12463	236	1	circulating	circulate	VERB
ecj-12463	236	2	heterophile	heterophile	PROPN
ecj-12463	236	3	antibodies	antibodie	VERB
ecj-12463	236	4	causing	cause	VERB
ecj-12463	236	5	cardiac	cardiac	ADJ
ecj-12463	236	6	troponin	troponin	ADJ
ecj-12463	236	7	elevation	elevation	NOUN
ecj-12463	236	8	:	:	PUNCT
ecj-12463	236	9	an	an	DET
ecj-12463	236	10	unusual	unusual	ADJ
ecj-12463	236	11	differential	differential	ADJ
ecj-12463	236	12	diagnosis	diagnosis	NOUN
ecj-12463	236	13	of	of	ADP
ecj-12463	236	14	myocardial	myocardial	ADJ
ecj-12463	236	15	disease	disease	NOUN
ecj-12463	236	16	.	.	PUNCT
ecj-12463	237	1	j	j	PROPN
ecj-12463	237	2	am	be	AUX
ecj-12463	237	3	coll	coll	PROPN
ecj-12463	237	4	cardiol	cardiol	NOUN
ecj-12463	237	5	case	case	NOUN
ecj-12463	237	6	rep	rep	PROPN
ecj-12463	237	7	2020;2:456–60	2020;2:456–60	PROPN
ecj-12463	237	8	.	.	PROPN
ecj-12463	238	1	21	21	NUM
ecj-12463	238	2	.	.	PUNCT
ecj-12463	239	1	dudek	dudek	PROPN
ecj-12463	239	2	m	m	PROPN
ecj-12463	239	3	,	,	PUNCT
ecj-12463	239	4	kałużna	kałużna	NOUN
ecj-12463	239	5	-	-	PUNCT
ecj-12463	239	6	oleksy	oleksy	PROPN
ecj-12463	239	7	m	m	PROPN
ecj-12463	239	8	,	,	PUNCT
ecj-12463	239	9	migaj	migaj	PROPN
ecj-12463	239	10	j	j	PROPN
ecj-12463	239	11	,	,	PUNCT
ecj-12463	239	12	straburzyńska	straburzyńska	NOUN
ecj-12463	239	13	-	-	PUNCT
ecj-12463	239	14	migaj	migaj	NOUN
ecj-12463	239	15	e.	e.	PROPN
ecj-12463	239	16	clinical	clinical	PROPN
ecj-12463	239	17	value	value	NOUN
ecj-12463	239	18	of	of	ADP
ecj-12463	239	19	soluble	soluble	ADJ
ecj-12463	239	20	st2	st2	NOUN
ecj-12463	239	21	in	in	ADP
ecj-12463	239	22	cardiology	cardiology	NOUN
ecj-12463	239	23	.	.	PUNCT
ecj-12463	240	1	adv	adv	PROPN
ecj-12463	240	2	clin	clin	PROPN
ecj-12463	240	3	exp	exp	NOUN
ecj-12463	240	4	med	med	PROPN
ecj-12463	240	5	2020;29:1205–10	2020;29:1205–10	NUM
ecj-12463	240	6	.	.	PROPN
ecj-12463	241	1	22	22	NUM
ecj-12463	241	2	.	.	PUNCT
ecj-12463	242	1	aleksova	aleksova	PROPN
ecj-12463	242	2	a	a	PRON
ecj-12463	242	3	,	,	PUNCT
ecj-12463	242	4	paldino	paldino	NOUN
ecj-12463	242	5	a	a	PRON
ecj-12463	242	6	,	,	PUNCT
ecj-12463	242	7	beltrami	beltrami	PROPN
ecj-12463	242	8	ap	ap	PROPN
ecj-12463	242	9	,	,	PUNCT
ecj-12463	242	10	et	et	PROPN
ecj-12463	242	11	al	al	PROPN
ecj-12463	242	12	.	.	PUNCT
ecj-12463	243	1	cardiac	cardiac	ADJ
ecj-12463	243	2	biomarkers	biomarker	NOUN
ecj-12463	243	3	in	in	ADP
ecj-12463	243	4	the	the	DET
ecj-12463	243	5	emergency	emergency	NOUN
ecj-12463	243	6	department	department	NOUN
ecj-12463	243	7	:	:	PUNCT
ecj-12463	243	8	the	the	DET
ecj-12463	243	9	role	role	NOUN
ecj-12463	243	10	of	of	ADP
ecj-12463	243	11	soluble	soluble	ADJ
ecj-12463	243	12	st2	st2	NOUN
ecj-12463	243	13	(	(	PUNCT
ecj-12463	243	14	sst2	sst2	NOUN
ecj-12463	243	15	)	)	PUNCT
ecj-12463	243	16	in	in	ADP
ecj-12463	243	17	acute	acute	ADJ
ecj-12463	243	18	heart	heart	NOUN
ecj-12463	243	19	failure	failure	NOUN
ecj-12463	243	20	and	and	CCONJ
ecj-12463	243	21	acute	acute	ADJ
ecj-12463	243	22	coronary	coronary	ADJ
ecj-12463	243	23	syndrome	syndrome	NOUN
ecj-12463	243	24	—	—	PUNCT
ecj-12463	243	25	there	there	PRON
ecj-12463	243	26	is	be	VERB
ecj-12463	243	27	meat	meat	NOUN
ecj-12463	243	28	on	on	ADP
ecj-12463	243	29	the	the	DET
ecj-12463	243	30	bone	bone	NOUN
ecj-12463	243	31	.	.	PUNCT
ecj-12463	244	1	j	j	PROPN
ecj-12463	244	2	clin	clin	PROPN
ecj-12463	244	3	med	med	PROPN
ecj-12463	244	4	2019;8:270	2019;8:270	NUM
ecj-12463	244	5	.	.	PROPN
ecj-12463	245	1	23	23	NUM
ecj-12463	245	2	.	.	PUNCT
ecj-12463	246	1	liu	liu	PROPN
ecj-12463	246	2	r	r	PROPN
ecj-12463	246	3	,	,	PUNCT
ecj-12463	246	4	liu	liu	PROPN
ecj-12463	246	5	l	l	PROPN
ecj-12463	246	6	,	,	PUNCT
ecj-12463	246	7	wei	wei	PROPN
ecj-12463	246	8	c	c	PROPN
ecj-12463	246	9	,	,	PUNCT
ecj-12463	246	10	li	li	PROPN
ecj-12463	246	11	d.	d.	PROPN
ecj-12463	246	12	il-33	il-33	PROPN
ecj-12463	246	13	/	/	SYM
ecj-12463	246	14	st2	st2	NOUN
ecj-12463	246	15	immunobiology	immunobiology	NOUN
ecj-12463	246	16	in	in	ADP
ecj-12463	246	17	coronary	coronary	ADJ
ecj-12463	246	18	artery	artery	NOUN
ecj-12463	246	19	disease	disease	NOUN
ecj-12463	246	20	:	:	PUNCT
ecj-12463	246	21	a	a	DET
ecj-12463	246	22	systematic	systematic	ADJ
ecj-12463	246	23	review	review	NOUN
ecj-12463	246	24	and	and	CCONJ
ecj-12463	246	25	meta	meta	ADJ
ecj-12463	246	26	-	-	PUNCT
ecj-12463	246	27	analysis	analysis	NOUN
ecj-12463	246	28	.	.	PUNCT
ecj-12463	247	1	front	front	PROPN
ecj-12463	247	2	cardiovasc	cardiovasc	PROPN
ecj-12463	247	3	med	me	VERB
ecj-12463	247	4	2022;9:990007	2022;9:990007	NOUN
ecj-12463	247	5	.	.	PUNCT
ecj-12463	248	1	24	24	NUM
ecj-12463	248	2	.	.	PUNCT
ecj-12463	249	1	liu	liu	PROPN
ecj-12463	249	2	l	l	PROPN
ecj-12463	249	3	,	,	PUNCT
ecj-12463	249	4	li	li	PROPN
ecj-12463	249	5	s	s	PROPN
ecj-12463	249	6	,	,	PUNCT
ecj-12463	249	7	ding	ding	NOUN
ecj-12463	249	8	x	x	SYM
ecj-12463	249	9	,	,	PUNCT
ecj-12463	249	10	et	et	PROPN
ecj-12463	249	11	al	al	PROPN
ecj-12463	249	12	.	.	PUNCT
ecj-12463	249	13	dynamic	dynamic	ADJ
ecj-12463	249	14	changes	change	NOUN
ecj-12463	249	15	in	in	ADP
ecj-12463	249	16	soluble	soluble	ADJ
ecj-12463	249	17	suppression	suppression	NOUN
ecj-12463	249	18	of	of	ADP
ecj-12463	249	19	tumorigenicity	tumorigenicity	NOUN
ecj-12463	249	20	2	2	NUM
ecj-12463	249	21	levels	level	NOUN
ecj-12463	249	22	predict	predict	VERB
ecj-12463	249	23	major	major	ADJ
ecj-12463	249	24	adverse	adverse	ADJ
ecj-12463	249	25	cardiovascular	cardiovascular	ADJ
ecj-12463	249	26	events	event	NOUN
ecj-12463	249	27	in	in	ADP
ecj-12463	249	28	patients	patient	NOUN
ecj-12463	249	29	with	with	ADP
ecj-12463	249	30	st	st	PROPN
ecj-12463	249	31	-	-	PUNCT
ecj-12463	249	32	segment	segment	NOUN
ecj-12463	249	33	elevation	elevation	NOUN
ecj-12463	249	34	myocardial	myocardial	ADJ
ecj-12463	249	35	infarction	infarction	NOUN
ecj-12463	249	36	.	.	PUNCT
ecj-12463	250	1	pol	pol	PROPN
ecj-12463	250	2	arch	arch	PROPN
ecj-12463	250	3	intern	intern	NOUN
ecj-12463	250	4	med	me	VERB
ecj-12463	250	5	2022;132:16317	2022;132:16317	NUM
ecj-12463	250	6	.	.	PUNCT
ecj-12463	251	1	25	25	NUM
ecj-12463	251	2	.	.	PUNCT
ecj-12463	252	1	sun	sun	PROPN
ecj-12463	252	2	y	y	PROPN
ecj-12463	252	3	,	,	PUNCT
ecj-12463	252	4	pavey	pavey	ADJ
ecj-12463	252	5	h	h	NOUN
ecj-12463	252	6	,	,	PUNCT
ecj-12463	252	7	wilkinson	wilkinson	PROPN
ecj-12463	252	8	i	i	PROPN
ecj-12463	252	9	,	,	PUNCT
ecj-12463	252	10	fisk	fisk	PROPN
ecj-12463	252	11	m.	m.	NOUN
ecj-12463	252	12	role	role	NOUN
ecj-12463	252	13	of	of	ADP
ecj-12463	252	14	the	the	DET
ecj-12463	252	15	il-33	il-33	PRON
ecj-12463	252	16	/	/	SYM
ecj-12463	252	17	st2	st2	NOUN
ecj-12463	252	18	axis	axis	NOUN
ecj-12463	252	19	in	in	ADP
ecj-12463	252	20	cardiovascular	cardiovascular	ADJ
ecj-12463	252	21	disease	disease	NOUN
ecj-12463	252	22	:	:	PUNCT
ecj-12463	252	23	a	a	DET
ecj-12463	252	24	systematic	systematic	ADJ
ecj-12463	252	25	review	review	NOUN
ecj-12463	252	26	and	and	CCONJ
ecj-12463	252	27	metaanalysis	metaanalysis	NOUN
ecj-12463	252	28	.	.	PUNCT
ecj-12463	253	1	plos	plos	PROPN
ecj-12463	253	2	one	one	NUM
ecj-12463	253	3	2021;16	2021;16	NUM
ecj-12463	253	4	:	:	PUNCT
ecj-12463	253	5	e0259026	e0259026	PROPN
ecj-12463	253	6	.	.	PUNCT
ecj-12463	253	7	26	26	NUM
ecj-12463	253	8	.	.	PUNCT
ecj-12463	254	1	pascual	pascual	ADJ
ecj-12463	254	2	-	-	ADJ
ecj-12463	254	3	figal	figal	ADJ
ecj-12463	254	4	da	da	NOUN
ecj-12463	254	5	,	,	PUNCT
ecj-12463	254	6	bayes	bayes	NOUN
ecj-12463	254	7	-	-	PUNCT
ecj-12463	254	8	genis	genis	PROPN
ecj-12463	254	9	a	a	DET
ecj-12463	254	10	,	,	PUNCT
ecj-12463	254	11	asensio	asensio	ADJ
ecj-12463	254	12	-	-	PUNCT
ecj-12463	254	13	lopez	lopez	PROPN
ecj-12463	254	14	mc	mc	PROPN
ecj-12463	254	15	,	,	PUNCT
ecj-12463	254	16	et	et	PROPN
ecj-12463	254	17	al	al	PROPN
ecj-12463	254	18	.	.	PUNCT
ecj-12463	255	1	the	the	DET
ecj-12463	255	2	interleukin-1	interleukin-1	NUM
ecj-12463	255	3	axis	axis	NOUN
ecj-12463	255	4	and	and	CCONJ
ecj-12463	255	5	risk	risk	NOUN
ecj-12463	255	6	of	of	ADP
ecj-12463	255	7	death	death	NOUN
ecj-12463	255	8	in	in	ADP
ecj-12463	255	9	patients	patient	NOUN
ecj-12463	255	10	with	with	ADP
ecj-12463	255	11	acutely	acutely	ADV
ecj-12463	255	12	decompensated	decompensate	VERB
ecj-12463	255	13	heart	heart	NOUN
ecj-12463	255	14	failure	failure	NOUN
ecj-12463	255	15	.	.	PUNCT
ecj-12463	256	1	jacc	jacc	VERB
ecj-12463	256	2	2019;73:1016	2019;73:1016	NUM
ecj-12463	256	3	-	-	SYM
ecj-12463	256	4	25	25	NUM
ecj-12463	256	5	27	27	NUM
ecj-12463	256	6	.	.	PUNCT
ecj-12463	257	1	meijers	meijers	PROPN
ecj-12463	257	2	wc	wc	PROPN
ecj-12463	257	3	,	,	PUNCT
ecj-12463	257	4	bayes	bayes	PROPN
ecj-12463	257	5	-	-	PUNCT
ecj-12463	257	6	genis	genis	PROPN
ecj-12463	257	7	a	a	PRON
ecj-12463	257	8	,	,	PUNCT
ecj-12463	257	9	mebazaa	mebazaa	NOUN
ecj-12463	257	10	,	,	PUNCT
ecj-12463	257	11	et	et	PROPN
ecj-12463	257	12	al	al	PROPN
ecj-12463	257	13	.	.	PROPN
ecj-12463	258	1	circulating	circulate	VERB
ecj-12463	258	2	heart	heart	NOUN
ecj-12463	258	3	failure	failure	NOUN
ecj-12463	258	4	biomarkers	biomarker	NOUN
ecj-12463	258	5	beyond	beyond	ADP
ecj-12463	258	6	natriuretic	natriuretic	ADJ
ecj-12463	258	7	peptides	peptide	NOUN
ecj-12463	258	8	:	:	PUNCT
ecj-12463	258	9	review	review	NOUN
ecj-12463	258	10	from	from	ADP
ecj-12463	258	11	the	the	DET
ecj-12463	258	12	biomarker	biomarker	NOUN
ecj-12463	258	13	study	study	NOUN
ecj-12463	258	14	group	group	NOUN
ecj-12463	258	15	of	of	ADP
ecj-12463	258	16	the	the	DET
ecj-12463	258	17	heart	heart	NOUN
ecj-12463	258	18	failure	failure	NOUN
ecj-12463	258	19	association	association	NOUN
ecj-12463	258	20	(	(	PUNCT
ecj-12463	258	21	hfa	hfa	PROPN
ecj-12463	258	22	)	)	PUNCT
ecj-12463	258	23	,	,	PUNCT
ecj-12463	258	24	european	european	ADJ
ecj-12463	258	25	society	society	NOUN
ecj-12463	258	26	of	of	ADP
ecj-12463	258	27	cardiology	cardiology	NOUN
ecj-12463	258	28	(	(	PUNCT
ecj-12463	258	29	esc	esc	NOUN
ecj-12463	258	30	)	)	PUNCT
ecj-12463	258	31	.	.	PUNCT
ecj-12463	259	1	eur	eur	PROPN
ecj-12463	259	2	j	j	PROPN
ecj-12463	259	3	heart	heart	NOUN
ecj-12463	259	4	failure	failure	NOUN
ecj-12463	259	5	2021;23:1610–32	2021;23:1610–32	NUM
ecj-12463	259	6	.	.	PUNCT
ecj-12463	259	7	28	28	NUM
ecj-12463	259	8	.	.	PUNCT
ecj-12463	260	1	aimo	aimo	PROPN
ecj-12463	260	2	a	a	PRON
ecj-12463	260	3	,	,	PUNCT
ecj-12463	260	4	januzzi	januzzi	ADJ
ecj-12463	260	5	jl	jl	PROPN
ecj-12463	260	6	,	,	PUNCT
ecj-12463	260	7	bayes	bayes	NOUN
ecj-12463	260	8	-	-	PUNCT
ecj-12463	260	9	genis	genis	PROPN
ecj-12463	260	10	a	a	PRON
ecj-12463	260	11	,	,	PUNCT
ecj-12463	260	12	et	et	PROPN
ecj-12463	260	13	al	al	PROPN
ecj-12463	260	14	.	.	PROPN
ecj-12463	261	1	clinical	clinical	ADJ
ecj-12463	261	2	and	and	CCONJ
ecj-12463	261	3	prognostic	prognostic	ADJ
ecj-12463	261	4	significance	significance	NOUN
ecj-12463	261	5	of	of	ADP
ecj-12463	261	6	sst2	sst2	NOUN
ecj-12463	261	7	in	in	ADP
ecj-12463	261	8	heart	heart	NOUN
ecj-12463	261	9	failure	failure	NOUN
ecj-12463	261	10	.	.	PUNCT
ecj-12463	262	1	jacc	jacc	VERB
ecj-12463	262	2	2019;74:2193	2019;74:2193	NUM
ecj-12463	262	3	-	-	SYM
ecj-12463	262	4	203	203	NUM
ecj-12463	262	5	.	.	PUNCT
ecj-12463	263	1	29	29	NUM
ecj-12463	263	2	.	.	PUNCT
ecj-12463	264	1	ip	ip	PROPN
ecj-12463	265	1	c	c	NOUN
ecj-12463	265	2	,	,	PUNCT
ecj-12463	265	3	luk	luk	PROPN
ecj-12463	265	4	ks	ks	PROPN
ecj-12463	265	5	,	,	PUNCT
ecj-12463	265	6	yuen	yuen	PROPN
ecj-12463	265	7	vlc	vlc	PROPN
ecj-12463	265	8	,	,	PUNCT
ecj-12463	265	9	et	et	PROPN
ecj-12463	265	10	al	al	PROPN
ecj-12463	265	11	.	.	PROPN
ecj-12463	265	12	soluble	soluble	ADJ
ecj-12463	265	13	suppression	suppression	NOUN
ecj-12463	265	14	of	of	ADP
ecj-12463	265	15	tumorigenicity	tumorigenicity	NOUN
ecj-12463	265	16	2	2	NUM
ecj-12463	265	17	(	(	PUNCT
ecj-12463	265	18	sst2	sst2	NOUN
ecj-12463	265	19	)	)	PUNCT
ecj-12463	265	20	for	for	ADP
ecj-12463	265	21	predicting	predict	VERB
ecj-12463	265	22	disease	disease	NOUN
ecj-12463	265	23	severity	severity	NOUN
ecj-12463	265	24	or	or	CCONJ
ecj-12463	265	25	mortality	mortality	NOUN
ecj-12463	265	26	outcomes	outcome	NOUN
ecj-12463	265	27	in	in	ADP
ecj-12463	265	28	cardiovascular	cardiovascular	ADJ
ecj-12463	265	29	diseases	disease	NOUN
ecj-12463	265	30	:	:	PUNCT
ecj-12463	265	31	a	a	DET
ecj-12463	265	32	systematic	systematic	ADJ
ecj-12463	265	33	review	review	NOUN
ecj-12463	265	34	and	and	CCONJ
ecj-12463	265	35	meta	meta	ADJ
ecj-12463	265	36	-	-	PUNCT
ecj-12463	265	37	analysis	analysis	NOUN
ecj-12463	265	38	.	.	PUNCT
ecj-12463	266	1	ijc	ijc	PROPN
ecj-12463	266	2	heart	heart	NOUN
ecj-12463	266	3	&	&	CCONJ
ecj-12463	266	4	vasculature	vasculature	NOUN
ecj-12463	266	5	2021;37:100887	2021;37:100887	NUM
ecj-12463	266	6	.	.	PUNCT
ecj-12463	266	7	30	30	NUM
ecj-12463	266	8	.	.	PUNCT
ecj-12463	267	1	zhang	zhang	PROPN
ecj-12463	267	2	j	j	PROPN
ecj-12463	267	3	,	,	PUNCT
ecj-12463	267	4	chen	chen	PROPN
ecj-12463	267	5	z	z	PROPN
ecj-12463	267	6	,	,	PUNCT
ecj-12463	267	7	ma	ma	PROPN
ecj-12463	267	8	m	m	PROPN
ecj-12463	267	9	,	,	PUNCT
ecj-12463	267	10	he	he	PRON
ecj-12463	267	11	y.	y.	NOUN
ecj-12463	267	12	soluble	soluble	ADJ
ecj-12463	267	13	st2	st2	NOUN
ecj-12463	267	14	in	in	ADP
ecj-12463	267	15	coronary	coronary	ADJ
ecj-12463	267	16	artery	artery	NOUN
ecj-12463	267	17	disease	disease	NOUN
ecj-12463	267	18	:	:	PUNCT
ecj-12463	267	19	clinical	clinical	ADJ
ecj-12463	267	20	biomarkers	biomarker	NOUN
ecj-12463	267	21	and	and	CCONJ
ecj-12463	267	22	treatment	treatment	NOUN
ecj-12463	267	23	guidance	guidance	NOUN
ecj-12463	267	24	.	.	PUNCT
ecj-12463	268	1	front	front	PROPN
ecj-12463	268	2	cardiovasc	cardiovasc	PROPN
ecj-12463	268	3	med	med	PROPN
ecj-12463	268	4	2022;9:924461	2022;9:924461	NUM
ecj-12463	268	5	.	.	PUNCT
ecj-12463	269	1	31	31	NUM
ecj-12463	269	2	.	.	PUNCT
ecj-12463	270	1	clemente	clemente	PROPN
ecj-12463	270	2	g	g	PROPN
ecj-12463	270	3	,	,	PUNCT
ecj-12463	270	4	soldano	soldano	NOUN
ecj-12463	270	5	js	js	PROPN
ecj-12463	270	6	,	,	PUNCT
ecj-12463	270	7	tuttolomondo	tuttolomondo	NOUN
ecj-12463	270	8	a.	a.	NOUN
ecj-12463	270	9	heart	heart	PROPN
ecj-12463	270	10	failure	failure	NOUN
ecj-12463	270	11	:	:	PUNCT
ecj-12463	270	12	is	be	AUX
ecj-12463	270	13	there	there	PRON
ecj-12463	270	14	an	an	DET
ecj-12463	270	15	ideal	ideal	ADJ
ecj-12463	270	16	biomarker	biomarker	NOUN
ecj-12463	270	17	?	?	PUNCT
ecj-12463	271	1	rev	rev	AUX
ecj-12463	271	2	cardiovasc	cardiovasc	PROPN
ecj-12463	271	3	med	med	PROPN
ecj-12463	271	4	2023;24:310	2023;24:310	NUM
ecj-12463	271	5	.	.	PUNCT
ecj-12463	272	1	32	32	NUM
ecj-12463	272	2	.	.	PUNCT
ecj-12463	273	1	wang	wang	PROPN
ecj-12463	273	2	z	z	PROPN
ecj-12463	273	3	,	,	PUNCT
ecj-12463	273	4	pan	pan	PROPN
ecj-12463	273	5	x	x	PROPN
ecj-12463	273	6	,	,	PUNCT
ecj-12463	273	7	xu	xu	PROPN
ecj-12463	274	1	h	h	PROPN
ecj-12463	274	2	,	,	PUNCT
ecj-12463	274	3	et	et	PROPN
ecj-12463	274	4	al	al	PROPN
ecj-12463	274	5	.	.	PROPN
ecj-12463	275	1	serum	serum	PROPN
ecj-12463	275	2	soluble	soluble	ADJ
ecj-12463	275	3	st2	st2	NOUN
ecj-12463	275	4	is	be	AUX
ecj-12463	275	5	a	a	DET
ecj-12463	275	6	valuable	valuable	ADJ
ecj-12463	275	7	prognostic	prognostic	ADJ
ecj-12463	275	8	biomarker	biomarker	NOUN
ecj-12463	275	9	in	in	ADP
ecj-12463	275	10	patients	patient	NOUN
ecj-12463	275	11	with	with	ADP
ecj-12463	275	12	acute	acute	ADJ
ecj-12463	275	13	heart	heart	NOUN
ecj-12463	275	14	failure	failure	NOUN
ecj-12463	275	15	.	.	PUNCT
ecj-12463	276	1	front	front	PROPN
ecj-12463	276	2	cardiovasc	cardiovasc	PROPN
ecj-12463	276	3	med	me	VERB
ecj-12463	276	4	2022;9:812654	2022;9:812654	PROPN
ecj-12463	276	5	.	.	PUNCT
ecj-12463	277	1	33	33	NUM
ecj-12463	277	2	.	.	PUNCT
ecj-12463	278	1	rezar	rezar	PROPN
ecj-12463	278	2	r	r	PROPN
ecj-12463	278	3	,	,	PUNCT
ecj-12463	278	4	paar	paar	NOUN
ecj-12463	278	5	v	v	NOUN
ecj-12463	278	6	,	,	PUNCT
ecj-12463	278	7	seelmaier	seelmaier	NOUN
ecj-12463	278	8	c	c	NOUN
ecj-12463	278	9	,	,	PUNCT
ecj-12463	278	10	et	et	PROPN
ecj-12463	278	11	al	al	PROPN
ecj-12463	278	12	.	.	PROPN
ecj-12463	278	13	soluble	soluble	ADJ
ecj-12463	278	14	suppression	suppression	NOUN
ecj-12463	278	15	of	of	ADP
ecj-12463	278	16	tumorigenicity	tumorigenicity	NOUN
ecj-12463	278	17	2	2	NUM
ecj-12463	278	18	as	as	ADP
ecj-12463	278	19	outcome	outcome	NOUN
ecj-12463	278	20	predictor	predictor	NOUN
ecj-12463	278	21	after	after	ADP
ecj-12463	278	22	cardiopulmonary	cardiopulmonary	ADJ
ecj-12463	278	23	resuscitation	resuscitation	NOUN
ecj-12463	278	24	:	:	PUNCT
ecj-12463	278	25	an	an	DET
ecj-12463	278	26	observational	observational	ADJ
ecj-12463	278	27	prospective	prospective	ADJ
ecj-12463	278	28	study	study	NOUN
ecj-12463	278	29	.	.	PUNCT
ecj-12463	279	1	sci	sci	PROPN
ecj-12463	279	2	rep	rep	PROPN
ecj-12463	279	3	2021;11:21756	2021;11:21756	PROPN
ecj-12463	279	4	.	.	PUNCT
ecj-12463	280	1	34	34	NUM
ecj-12463	280	2	.	.	PUNCT
ecj-12463	281	1	huet	huet	PROPN
ecj-12463	281	2	f	f	PROPN
ecj-12463	281	3	,	,	PUNCT
ecj-12463	281	4	dupuy	dupuy	PROPN
ecj-12463	281	5	am	am	PROPN
ecj-12463	281	6	,	,	PUNCT
ecj-12463	281	7	duflos	duflos	PROPN
ecj-12463	281	8	c	c	PROPN
ecj-12463	281	9	,	,	PUNCT
ecj-12463	281	10	et	et	PROPN
ecj-12463	281	11	al	al	PROPN
ecj-12463	281	12	.	.	PROPN
ecj-12463	281	13	soluble	soluble	ADJ
ecj-12463	281	14	urokinase	urokinase	NOUN
ecj-12463	281	15	-	-	PUNCT
ecj-12463	281	16	type	type	NOUN
ecj-12463	281	17	plasminogen	plasminogen	NOUN
ecj-12463	281	18	activator	activator	NOUN
ecj-12463	281	19	receptor	receptor	NOUN
ecj-12463	281	20	strongly	strongly	ADV
ecj-12463	281	21	predicts	predict	VERB
ecj-12463	281	22	global	global	ADJ
ecj-12463	281	23	mortality	mortality	NOUN
ecj-12463	281	24	in	in	ADP
ecj-12463	281	25	acute	acute	ADJ
ecj-12463	281	26	heart	heart	NOUN
ecj-12463	281	27	failure	failure	NOUN
ecj-12463	281	28	patients	patient	NOUN
ecj-12463	281	29	:	:	PUNCT
ecj-12463	281	30	insight	insight	NOUN
ecj-12463	281	31	from	from	ADP
ecj-12463	281	32	the	the	DET
ecj-12463	281	33	stadehf	stadehf	ADJ
ecj-12463	281	34	registry	registry	NOUN
ecj-12463	281	35	”	"	PUNCT
ecj-12463	281	36	.	.	PUNCT
ecj-12463	282	1	future	future	ADJ
ecj-12463	282	2	sci	sci	PROPN
ecj-12463	282	3	oa	oa	PROPN
ecj-12463	282	4	2021;fso697	2021;fso697	PROPN
ecj-12463	282	5	.	.	PUNCT
ecj-12463	283	1	35	35	NUM
ecj-12463	283	2	.	.	PUNCT
ecj-12463	284	1	huet	huet	PROPN
ecj-12463	284	2	f	f	PROPN
ecj-12463	284	3	,	,	PUNCT
ecj-12463	284	4	nicoleau	nicoleau	PROPN
ecj-12463	284	5	j	j	PROPN
ecj-12463	284	6	,	,	PUNCT
ecj-12463	284	7	dupuy	dupuy	PROPN
ecj-12463	284	8	am	am	PROPN
ecj-12463	284	9	,	,	PUNCT
ecj-12463	284	10	et	et	PROPN
ecj-12463	284	11	al	al	PROPN
ecj-12463	284	12	.	.	PROPN
ecj-12463	284	13	stade	stade	PROPN
ecj-12463	284	14	-	-	NOUN
ecj-12463	284	15	hf	hf	NOUN
ecj-12463	284	16	(	(	PUNCT
ecj-12463	284	17	sst2as	sst2as	VERB
ecj-12463	284	18	a	a	DET
ecj-12463	284	19	help	help	NOUN
ecj-12463	284	20	for	for	ADP
ecj-12463	284	21	management	management	NOUN
ecj-12463	284	22	of	of	ADP
ecj-12463	284	23	hf	hf	NOUN
ecj-12463	284	24	):	):	PUNCT
ecj-12463	284	25	a	a	DET
ecj-12463	284	26	pilot	pilot	NOUN
ecj-12463	284	27	study	study	NOUN
ecj-12463	284	28	.	.	PUNCT
ecj-12463	285	1	esc	esc	NOUN
ecj-12463	285	2	heart	heart	NOUN
ecj-12463	285	3	failure	failure	NOUN
ecj-12463	285	4	2020;7:774–8	2020;7:774–8	NOUN
ecj-12463	285	5	.	.	PUNCT
ecj-12463	286	1	36	36	NUM
ecj-12463	286	2	.	.	PUNCT
ecj-12463	286	3	berezin	berezin	PROPN
ecj-12463	286	4	ae	ae	PROPN
ecj-12463	286	5	,	,	PUNCT
ecj-12463	286	6	berezin	berezin	PROPN
ecj-12463	286	7	aa	aa	PROPN
ecj-12463	286	8	.	.	PUNCT
ecj-12463	287	1	biomarkers	biomarker	NOUN
ecj-12463	287	2	in	in	ADP
ecj-12463	287	3	heart	heart	NOUN
ecj-12463	287	4	failure	failure	NOUN
ecj-12463	287	5	:	:	PUNCT
ecj-12463	287	6	from	from	ADP
ecj-12463	287	7	research	research	NOUN
ecj-12463	287	8	to	to	ADP
ecj-12463	287	9	clinical	clinical	ADJ
ecj-12463	287	10	practice	practice	NOUN
ecj-12463	287	11	.	.	PUNCT
ecj-12463	288	1	ann	ann	PROPN
ecj-12463	288	2	lab	lab	PROPN
ecj-12463	288	3	med	med	PROPN
ecj-12463	288	4	2023;43:225	2023;43:225	PROPN
ecj-12463	288	5	-	-	SYM
ecj-12463	288	6	36	36	NUM
ecj-12463	288	7	.	.	PUNCT
ecj-12463	288	8	37	37	NUM
ecj-12463	288	9	.	.	PUNCT
ecj-12463	289	1	timothy	timothy	PROPN
ecj-12463	289	2	sd	sd	PROPN
ecj-12463	289	3	,	,	PUNCT
ecj-12463	289	4	hartopo	hartopo	PROPN
ecj-12463	289	5	ab	ab	PROPN
ecj-12463	289	6	,	,	PUNCT
ecj-12463	289	7	anggraeni	anggraeni	PROPN
ecj-12463	289	8	vy	vy	NOUN
ecj-12463	289	9	,	,	PUNCT
ecj-12463	289	10	makrufardi	makrufardi	PROPN
ecj-12463	289	11	f.	f.	PROPN
ecj-12463	289	12	association	association	PROPN
ecj-12463	289	13	of	of	ADP
ecj-12463	289	14	soluble	soluble	ADJ
ecj-12463	289	15	st2	st2	NOUN
ecj-12463	289	16	and	and	CCONJ
ecj-12463	289	17	infarct	infarct	NOUN
ecj-12463	289	18	location	location	NOUN
ecj-12463	289	19	within	within	ADP
ecj-12463	289	20	12–24	12–24	NUM
ecj-12463	289	21	h	h	PROPN
ecj-12463	289	22	in	in	ADP
ecj-12463	289	23	stemi	stemi	PROPN
ecj-12463	289	24	:	:	PUNCT
ecj-12463	289	25	a	a	DET
ecj-12463	289	26	cross	cross	ADJ
ecj-12463	289	27	-	-	ADJ
ecj-12463	289	28	sectional	sectional	ADJ
ecj-12463	289	29	study	study	NOUN
ecj-12463	289	30	.	.	PUNCT
ecj-12463	290	1	ann	ann	PROPN
ecj-12463	290	2	med	med	PROPN
ecj-12463	290	3	surgery	surgery	NOUN
ecj-12463	290	4	2021;70:102844	2021;70:102844	NUM
ecj-12463	290	5	.	.	PROPN
ecj-12463	290	6	38	38	NUM
ecj-12463	290	7	.	.	PUNCT
ecj-12463	291	1	zhang	zhang	PROPN
ecj-12463	291	2	y	y	PROPN
ecj-12463	291	3	,	,	PUNCT
ecj-12463	291	4	fan	fan	PROPN
ecj-12463	291	5	z	z	PROPN
ecj-12463	291	6	,	,	PUNCT
ecj-12463	291	7	liu	liu	PROPN
ecj-12463	291	8	h	h	PROPN
ecj-12463	291	9	,	,	PUNCT
ecj-12463	291	10	et	et	PROPN
ecj-12463	291	11	al	al	PROPN
ecj-12463	291	12	.	.	PUNCT
ecj-12463	291	13	correlation	correlation	NOUN
ecj-12463	291	14	of	of	ADP
ecj-12463	291	15	plasma	plasma	NOUN
ecj-12463	291	16	soluble	soluble	ADJ
ecj-12463	291	17	suppression	suppression	NOUN
ecj-12463	291	18	of	of	ADP
ecj-12463	291	19	tumorigenicity-2	tumorigenicity-2	NOUN
ecj-12463	291	20	level	level	NOUN
ecj-12463	291	21	with	with	ADP
ecj-12463	291	22	the	the	DET
ecj-12463	291	23	severity	severity	NOUN
ecj-12463	291	24	and	and	CCONJ
ecj-12463	291	25	stability	stability	NOUN
ecj-12463	291	26	of	of	ADP
ecj-12463	291	27	coronary	coronary	ADJ
ecj-12463	291	28	atherosclerosis	atherosclerosis	NOUN
ecj-12463	291	29	.	.	PUNCT
ecj-12463	292	1	coron	coron	NOUN
ecj-12463	292	2	artery	artery	NOUN
ecj-12463	292	3	dis	dis	PROPN
ecj-12463	292	4	2020;31:628	2020;31:628	PROPN
ecj-12463	292	5	-	-	SYM
ecj-12463	292	6	35	35	NUM
ecj-12463	292	7	.	.	PUNCT
ecj-12463	292	8	39	39	NUM
ecj-12463	292	9	.	.	PUNCT
ecj-12463	293	1	luo	luo	PROPN
ecj-12463	293	2	g	g	PROPN
ecj-12463	293	3	,	,	PUNCT
ecj-12463	293	4	qian	qian	PROPN
ecj-12463	293	5	y	y	PROPN
ecj-12463	293	6	,	,	PUNCT
ecj-12463	293	7	sheng	sheng	PROPN
ecj-12463	293	8	x	x	PROPN
ecj-12463	293	9	,	,	PUNCT
ecj-12463	293	10	et	et	PROPN
ecj-12463	293	11	al	al	PROPN
ecj-12463	293	12	.	.	PROPN
ecj-12463	293	13	elevated	elevate	VERB
ecj-12463	293	14	serum	serum	NOUN
ecj-12463	293	15	levels	level	NOUN
ecj-12463	293	16	of	of	ADP
ecj-12463	293	17	soluble	soluble	ADJ
ecj-12463	293	18	st2	st2	NOUN
ecj-12463	293	19	are	be	AUX
ecj-12463	293	20	associated	associate	VERB
ecj-12463	293	21	with	with	ADP
ecj-12463	293	22	plaque	plaque	NOUN
ecj-12463	293	23	vulnerability	vulnerability	NOUN
ecj-12463	293	24	in	in	ADP
ecj-12463	293	25	patients	patient	NOUN
ecj-12463	293	26	with	with	ADP
ecj-12463	293	27	non	non	ADJ
ecj-12463	293	28	-	-	ADJ
ecj-12463	293	29	st	st	ADJ
ecj-12463	293	30	-	-	PUNCT
ecj-12463	293	31	elevation	elevation	NOUN
ecj-12463	293	32	acute	acute	ADJ
ecj-12463	293	33	coronary	coronary	ADJ
ecj-12463	293	34	syndrome	syndrome	NOUN
ecj-12463	293	35	.	.	PUNCT
ecj-12463	294	1	front	front	PROPN
ecj-12463	294	2	cardiovasc	cardiovasc	PROPN
ecj-12463	294	3	med	med	PROPN
ecj-12463	294	4	2021;8:688522	2021;8:688522	PROPN
ecj-12463	294	5	.	.	PUNCT
ecj-12463	295	1	40	40	NUM
ecj-12463	295	2	.	.	PUNCT
ecj-12463	296	1	van	van	PROPN
ecj-12463	296	2	den	den	PROPN
ecj-12463	296	3	berg	berg	PROPN
ecj-12463	296	4	vj	vj	PROPN
ecj-12463	296	5	,	,	PUNCT
ecj-12463	296	6	vroegindewey	vroegindewey	PROPN
ecj-12463	296	7	mm	mm	PROPN
ecj-12463	296	8	,	,	PUNCT
ecj-12463	296	9	umans	umans	PROPN
ecj-12463	296	10	va	va	PROPN
ecj-12463	296	11	,	,	PUNCT
ecj-12463	296	12	et	et	PROPN
ecj-12463	296	13	al	al	PROPN
ecj-12463	296	14	.	.	PUNCT
ecj-12463	297	1	persistently	persistently	ADV
ecj-12463	297	2	elevated	elevate	VERB
ecj-12463	297	3	levels	level	NOUN
ecj-12463	297	4	of	of	ADP
ecj-12463	297	5	sst2	sst2	NOUN
ecj-12463	297	6	after	after	SCONJ
ecj-12463	297	7	acute	acute	ADJ
ecj-12463	297	8	coronary	coronary	ADJ
ecj-12463	297	9	syndrome	syndrome	NOUN
ecj-12463	297	10	are	be	AUX
ecj-12463	297	11	associated	associate	VERB
ecj-12463	297	12	with	with	ADP
ecj-12463	297	13	recurrent	recurrent	ADJ
ecj-12463	297	14	cardiac	cardiac	ADJ
ecj-12463	297	15	events	event	NOUN
ecj-12463	297	16	.	.	PUNCT
ecj-12463	298	1	biomarkers	biomarker	NOUN
ecj-12463	298	2	2022;27:264	2022;27:264	NOUN
ecj-12463	298	3	-	-	SYM
ecj-12463	298	4	9	9	NUM
ecj-12463	298	5	.	.	NOUN
ecj-12463	298	6	41	41	NUM
ecj-12463	298	7	.	.	PUNCT
ecj-12463	299	1	liu	liu	PROPN
ecj-12463	299	2	n	n	PROPN
ecj-12463	299	3	,	,	PUNCT
ecj-12463	299	4	hang	hang	PROPN
ecj-12463	299	5	t	t	PROPN
ecj-12463	299	6	,	,	PUNCT
ecj-12463	299	7	gao	gao	PROPN
ecj-12463	299	8	x	x	PROPN
ecj-12463	299	9	,	,	PUNCT
ecj-12463	299	10	et	et	PROPN
ecj-12463	299	11	al	al	PROPN
ecj-12463	299	12	.	.	PUNCT
ecj-12463	300	1	the	the	DET
ecj-12463	300	2	association	association	NOUN
ecj-12463	300	3	between	between	ADP
ecj-12463	300	4	soluble	soluble	ADJ
ecj-12463	300	5	suppression	suppression	NOUN
ecj-12463	300	6	of	of	ADP
ecj-12463	300	7	tumorigenicity-2	tumorigenicity-2	NOUN
ecj-12463	300	8	and	and	CCONJ
ecj-12463	300	9	long	long	ADJ
ecj-12463	300	10	term	term	NOUN
ecj-12463	300	11	prognosis	prognosis	NOUN
ecj-12463	300	12	in	in	ADP
ecj-12463	300	13	patients	patient	NOUN
ecj-12463	300	14	with	with	ADP
ecj-12463	300	15	coronary	coronary	ADJ
ecj-12463	300	16	artery	artery	NOUN
ecj-12463	300	17	disease	disease	NOUN
ecj-12463	300	18	:	:	PUNCT
ecj-12463	300	19	a	a	DET
ecj-12463	300	20	meta	meta	ADJ
ecj-12463	300	21	-	-	PUNCT
ecj-12463	300	22	analysis	analysis	NOUN
ecj-12463	300	23	.	.	PUNCT
ecj-12463	301	1	plos	plos	PROPN
ecj-12463	301	2	one	one	NUM
ecj-12463	301	3	2020;15	2020;15	NUM
ecj-12463	301	4	:	:	PUNCT
ecj-12463	301	5	e0238775	e0238775	NOUN
ecj-12463	301	6	.	.	PUNCT
ecj-12463	302	1	42	42	NUM
ecj-12463	302	2	.	.	PUNCT
ecj-12463	303	1	kim	kim	PROPN
ecj-12463	303	2	hl	hl	PROPN
ecj-12463	303	3	,	,	PUNCT
ecj-12463	303	4	lee	lee	PROPN
ecj-12463	303	5	jp	jp	PROPN
ecj-12463	303	6	,	,	PUNCT
ecj-12463	303	7	wong	wong	PROPN
ecj-12463	303	8	n	n	CCONJ
ecj-12463	303	9	,	,	PUNCT
ecj-12463	303	10	et	et	PROPN
ecj-12463	303	11	al	al	PROPN
ecj-12463	303	12	.	.	PROPN
ecj-12463	304	1	prognostic	prognostic	ADJ
ecj-12463	304	2	value	value	NOUN
ecj-12463	304	3	of	of	ADP
ecj-12463	304	4	serum	serum	NOUN
ecj-12463	304	5	soluble	soluble	ADJ
ecj-12463	304	6	st2	st2	NOUN
ecj-12463	304	7	in	in	ADP
ecj-12463	304	8	stable	stable	ADJ
ecj-12463	304	9	coronary	coronary	ADJ
ecj-12463	304	10	artery	artery	NOUN
ecj-12463	304	11	disease	disease	NOUN
ecj-12463	304	12	:	:	PUNCT
ecj-12463	304	13	a	a	DET
ecj-12463	304	14	prospective	prospective	ADJ
ecj-12463	304	15	observational	observational	ADJ
ecj-12463	304	16	study	study	NOUN
ecj-12463	304	17	.	.	PUNCT
ecj-12463	305	1	sci	sci	PROPN
ecj-12463	305	2	rep	rep	PROPN
ecj-12463	305	3	2021;11:15203	2021;11:15203	PROPN
ecj-12463	305	4	.	.	PUNCT
ecj-12463	306	1	review	review	NOUN
ecj-12463	306	2	[	[	X
ecj-12463	306	3	emergency	emergency	NOUN
ecj-12463	306	4	care	care	NOUN
ecj-12463	306	5	journal	journal	PROPN
ecj-12463	306	6	2024	2024	NUM
ecj-12463	306	7	;	;	PUNCT
ecj-12463	306	8	20:12463	20:12463	NUM
ecj-12463	306	9	]	]	X
ecj-12463	307	1	[	[	X
ecj-12463	307	2	page	page	NOUN
ecj-12463	307	3	56	56	NUM
ecj-12463	307	4	]	]	X
ecj-12463	307	5	non	non	ADJ
ecj-12463	307	6	-co	-co	PROPN
ecj-12463	307	7	mmerc	mmerc	PROPN
ecj-12463	307	8	ial	ial	PROPN
ecj-12463	307	9	us	us	PROPN
ecj-12463	307	10	e	e	NOUN
ecj-12463	307	11	o	o	NOUN
ecj-12463	307	12	nly	nly	ADV
ecj-12463	307	13	43	43	NUM
ecj-12463	307	14	.	.	PUNCT
ecj-12463	308	1	chen	chen	PROPN
ecj-12463	308	2	d	d	PROPN
ecj-12463	308	3	,	,	PUNCT
ecj-12463	308	4	untaru	untaru	PROPN
ecj-12463	308	5	r	r	NOUN
ecj-12463	308	6	,	,	PUNCT
ecj-12463	308	7	stavropoulou	stavropoulou	ADJ
ecj-12463	308	8	g	g	PROPN
ecj-12463	308	9	,	,	PUNCT
ecj-12463	308	10	et	et	PROPN
ecj-12463	308	11	al	al	PROPN
ecj-12463	308	12	.	.	PROPN
ecj-12463	308	13	elevated	elevate	VERB
ecj-12463	308	14	soluble	soluble	ADJ
ecj-12463	308	15	suppressor	suppressor	NOUN
ecj-12463	308	16	of	of	ADP
ecj-12463	308	17	tumorigenicity	tumorigenicity	NOUN
ecj-12463	308	18	2	2	NUM
ecj-12463	308	19	predict	predict	VERB
ecj-12463	308	20	hospital	hospital	NOUN
ecj-12463	308	21	admissions	admission	NOUN
ecj-12463	308	22	due	due	ADJ
ecj-12463	308	23	to	to	ADP
ecj-12463	308	24	major	major	ADJ
ecj-12463	308	25	adverse	adverse	ADJ
ecj-12463	308	26	cardiovascular	cardiovascular	ADJ
ecj-12463	308	27	events	event	NOUN
ecj-12463	308	28	(	(	PUNCT
ecj-12463	308	29	mace	mace	NOUN
ecj-12463	308	30	)	)	PUNCT
ecj-12463	308	31	.	.	PUNCT
ecj-12463	309	1	j	j	PROPN
ecj-12463	309	2	clin	clin	PROPN
ecj-12463	309	3	med	me	VERB
ecj-12463	309	4	2023;12:2790	2023;12:2790	NUM
ecj-12463	309	5	.	.	PROPN
ecj-12463	309	6	44	44	NUM
ecj-12463	309	7	.	.	PUNCT
ecj-12463	310	1	velissaris	velissaris	PROPN
ecj-12463	310	2	d	d	NOUN
ecj-12463	310	3	,	,	PUNCT
ecj-12463	310	4	zareifopoulos	zareifopoulo	NOUN
ecj-12463	310	5	n	n	CCONJ
ecj-12463	310	6	,	,	PUNCT
ecj-12463	310	7	koniari	koniari	PROPN
ecj-12463	310	8	i	i	PROPN
ecj-12463	310	9	,	,	PUNCT
ecj-12463	310	10	et	et	PROPN
ecj-12463	310	11	al	al	PROPN
ecj-12463	310	12	.	.	PROPN
ecj-12463	310	13	soluble	soluble	ADJ
ecj-12463	310	14	urokinase	urokinase	NOUN
ecj-12463	310	15	plasminogen	plasminogen	NOUN
ecj-12463	310	16	activator	activator	NOUN
ecj-12463	310	17	receptor	receptor	NOUN
ecj-12463	310	18	as	as	ADP
ecj-12463	310	19	a	a	DET
ecj-12463	310	20	diagnostic	diagnostic	ADJ
ecj-12463	310	21	and	and	CCONJ
ecj-12463	310	22	prognostic	prognostic	ADJ
ecj-12463	310	23	biomarker	biomarker	NOUN
ecj-12463	310	24	in	in	ADP
ecj-12463	310	25	cardiac	cardiac	ADJ
ecj-12463	310	26	disease	disease	NOUN
ecj-12463	310	27	.	.	PUNCT
ecj-12463	311	1	j	j	PROPN
ecj-12463	311	2	clin	clin	PROPN
ecj-12463	311	3	med	med	PROPN
ecj-12463	311	4	res	re	NOUN
ecj-12463	311	5	2021;13:133	2021;13:133	PROPN
ecj-12463	311	6	-	-	SYM
ecj-12463	311	7	42	42	NUM
ecj-12463	311	8	.	.	PUNCT
ecj-12463	312	1	45	45	NUM
ecj-12463	312	2	.	.	PUNCT
ecj-12463	312	3	rasmussen	rasmussen	PROPN
ecj-12463	312	4	ljh	ljh	PROPN
ecj-12463	312	5	,	,	PUNCT
ecj-12463	312	6	petersen	petersen	PROPN
ecj-12463	312	7	jev	jev	PROPN
ecj-12463	312	8	,	,	PUNCT
ecj-12463	312	9	eugen	eugen	PROPN
ecj-12463	312	10	-	-	PUNCT
ecj-12463	312	11	olsen	olsen	PROPN
ecj-12463	312	12	j.	j.	PROPN
ecj-12463	312	13	soluble	soluble	ADJ
ecj-12463	312	14	urokinase	urokinase	NOUN
ecj-12463	312	15	plasminogen	plasminogen	NOUN
ecj-12463	312	16	activator	activator	NOUN
ecj-12463	312	17	receptor	receptor	NOUN
ecj-12463	312	18	(	(	PUNCT
ecj-12463	312	19	supar	supar	NOUN
ecj-12463	312	20	)	)	PUNCT
ecj-12463	312	21	as	as	ADP
ecj-12463	312	22	a	a	DET
ecj-12463	312	23	biomarker	biomarker	NOUN
ecj-12463	312	24	of	of	ADP
ecj-12463	312	25	systemic	systemic	ADJ
ecj-12463	312	26	chronic	chronic	ADJ
ecj-12463	312	27	inflammation	inflammation	NOUN
ecj-12463	312	28	.	.	PUNCT
ecj-12463	313	1	front	front	ADJ
ecj-12463	313	2	immunol	immunol	NOUN
ecj-12463	313	3	2021;12	2021;12	PROPN
ecj-12463	313	4	:	:	PUNCT
ecj-12463	313	5	780641	780641	NUM
ecj-12463	313	6	.	.	PUNCT
ecj-12463	314	1	46	46	NUM
ecj-12463	314	2	.	.	PUNCT
ecj-12463	315	1	goodchild	goodchild	PROPN
ecj-12463	315	2	tt	tt	PROPN
ecj-12463	315	3	,	,	PUNCT
ecj-12463	315	4	li	li	PROPN
ecj-12463	315	5	z	z	PROPN
ecj-12463	315	6	,	,	PUNCT
ecj-12463	315	7	lefer	lefer	NOUN
ecj-12463	315	8	dj	dj	NOUN
ecj-12463	315	9	.	.	PUNCT
ecj-12463	315	10	soluble	soluble	ADJ
ecj-12463	315	11	urokinase	urokinase	NOUN
ecj-12463	315	12	plasminogen	plasminogen	NOUN
ecj-12463	315	13	activator	activator	NOUN
ecj-12463	315	14	receptor	receptor	NOUN
ecj-12463	315	15	:	:	PUNCT
ecj-12463	315	16	from	from	ADP
ecj-12463	315	17	biomarker	biomarker	NOUN
ecj-12463	315	18	to	to	ADP
ecj-12463	315	19	active	active	ADJ
ecj-12463	315	20	participant	participant	NOUN
ecj-12463	315	21	in	in	ADP
ecj-12463	315	22	atherosclerosis	atherosclerosis	NOUN
ecj-12463	315	23	and	and	CCONJ
ecj-12463	315	24	cardiovascular	cardiovascular	ADJ
ecj-12463	315	25	disease	disease	NOUN
ecj-12463	315	26	.	.	PUNCT
ecj-12463	316	1	j	j	PROPN
ecj-12463	316	2	clin	clin	PROPN
ecj-12463	316	3	invest	invest	VERB
ecj-12463	316	4	2022;132	2022;132	NUM
ecj-12463	316	5	:	:	PUNCT
ecj-12463	316	6	e165868	e165868	VERB
ecj-12463	316	7	.	.	PROPN
ecj-12463	316	8	47	47	NUM
ecj-12463	316	9	.	.	PUNCT
ecj-12463	317	1	pruc	pruc	PROPN
ecj-12463	317	2	m	m	PROPN
ecj-12463	317	3	,	,	PUNCT
ecj-12463	317	4	jannasz	jannasz	VERB
ecj-12463	317	5	i	i	PRON
ecj-12463	317	6	,	,	PUNCT
ecj-12463	317	7	swieczkowski	swieczkowski	PROPN
ecj-12463	317	8	d	d	PROPN
ecj-12463	317	9	,	,	PUNCT
ecj-12463	317	10	et	et	PROPN
ecj-12463	317	11	al	al	PROPN
ecj-12463	317	12	.	.	PUNCT
ecj-12463	318	1	diagnostic	diagnostic	ADJ
ecj-12463	318	2	value	value	NOUN
ecj-12463	318	3	of	of	ADP
ecj-12463	318	4	soluble	soluble	ADJ
ecj-12463	318	5	urokinase	urokinase	NOUN
ecj-12463	318	6	-	-	PUNCT
ecj-12463	318	7	type	type	NOUN
ecj-12463	318	8	plasminogen	plasminogen	NOUN
ecj-12463	318	9	activator	activator	NOUN
ecj-12463	318	10	receptor	receptor	NOUN
ecj-12463	318	11	in	in	ADP
ecj-12463	318	12	patients	patient	NOUN
ecj-12463	318	13	with	with	ADP
ecj-12463	318	14	acute	acute	ADJ
ecj-12463	318	15	coronary	coronary	ADJ
ecj-12463	318	16	syndrome	syndrome	NOUN
ecj-12463	318	17	:	:	PUNCT
ecj-12463	318	18	a	a	DET
ecj-12463	318	19	systematic	systematic	ADJ
ecj-12463	318	20	review	review	NOUN
ecj-12463	318	21	and	and	CCONJ
ecj-12463	318	22	meta	meta	ADJ
ecj-12463	318	23	-	-	PUNCT
ecj-12463	318	24	analysis	analysis	NOUN
ecj-12463	318	25	.	.	PUNCT
ecj-12463	319	1	cardiol	cardiol	PROPN
ecj-12463	319	2	j	j	PROPN
ecj-12463	319	3	2023;30:335	2023;30:335	PROPN
ecj-12463	319	4	-	-	SYM
ecj-12463	319	5	6	6	NUM
ecj-12463	319	6	.	.	NOUN
ecj-12463	319	7	48	48	NUM
ecj-12463	319	8	.	.	PUNCT
ecj-12463	320	1	velissaris	velissaris	NOUN
ecj-12463	320	2	d	d	NOUN
ecj-12463	320	3	,	,	PUNCT
ecj-12463	320	4	zareifopoulos	zareifopoulo	NOUN
ecj-12463	320	5	n	n	CCONJ
ecj-12463	320	6	,	,	PUNCT
ecj-12463	320	7	karamouzos	karamouzos	PROPN
ecj-12463	320	8	v	v	PROPN
ecj-12463	320	9	,	,	PUNCT
ecj-12463	320	10	et	et	PROPN
ecj-12463	320	11	al	al	PROPN
ecj-12463	320	12	.	.	PROPN
ecj-12463	320	13	soluble	soluble	ADJ
ecj-12463	320	14	urokinase	urokinase	NOUN
ecj-12463	320	15	plasminogen	plasminogen	NOUN
ecj-12463	320	16	activator	activator	NOUN
ecj-12463	320	17	receptor	receptor	NOUN
ecj-12463	320	18	(	(	PUNCT
ecj-12463	320	19	supar	supar	NOUN
ecj-12463	320	20	)	)	PUNCT
ecj-12463	320	21	in	in	ADP
ecj-12463	320	22	the	the	DET
ecj-12463	320	23	emergency	emergency	NOUN
ecj-12463	320	24	department	department	NOUN
ecj-12463	320	25	:	:	PUNCT
ecj-12463	320	26	an	an	DET
ecj-12463	320	27	update	update	NOUN
ecj-12463	320	28	.	.	PUNCT
ecj-12463	321	1	caspian	caspian	PROPN
ecj-12463	321	2	j	j	PROPN
ecj-12463	321	3	intern	intern	PROPN
ecj-12463	321	4	med	med	PROPN
ecj-12463	321	5	2022;13:650	2022;13:650	PROPN
ecj-12463	321	6	-	-	SYM
ecj-12463	321	7	65	65	NUM
ecj-12463	321	8	.	.	PUNCT
ecj-12463	321	9	49	49	NUM
ecj-12463	321	10	.	.	PUNCT
ecj-12463	322	1	wohlwend	wohlwend	PROPN
ecj-12463	322	2	nf	nf	PROPN
ecj-12463	322	3	,	,	PUNCT
ecj-12463	322	4	grossmann	grossmann	PROPN
ecj-12463	322	5	k	k	PROPN
ecj-12463	322	6	,	,	PUNCT
ecj-12463	322	7	aeschbacher	aeschbacher	PROPN
ecj-12463	322	8	s	s	PROPN
ecj-12463	322	9	,	,	PUNCT
ecj-12463	322	10	et	et	PROPN
ecj-12463	322	11	al	al	PROPN
ecj-12463	322	12	.	.	PUNCT
ecj-12463	323	1	the	the	DET
ecj-12463	323	2	association	association	PROPN
ecj-12463	323	3	of	of	ADP
ecj-12463	323	4	supar	supar	PROPN
ecj-12463	323	5	with	with	ADP
ecj-12463	323	6	cardiovascular	cardiovascular	ADJ
ecj-12463	323	7	risk	risk	NOUN
ecj-12463	323	8	factors	factor	NOUN
ecj-12463	323	9	in	in	ADP
ecj-12463	323	10	young	young	ADJ
ecj-12463	323	11	and	and	CCONJ
ecj-12463	323	12	healthy	healthy	ADJ
ecj-12463	323	13	adults	adult	NOUN
ecj-12463	323	14	.	.	PUNCT
ecj-12463	324	1	diagnostics	diagnostic	NOUN
ecj-12463	324	2	2023;13:2938	2023;13:2938	NUM
ecj-12463	324	3	.	.	PROPN
ecj-12463	324	4	50	50	NUM
ecj-12463	324	5	.	.	PUNCT
ecj-12463	325	1	hindy	hindy	PROPN
ecj-12463	325	2	g	g	PROPN
ecj-12463	325	3	,	,	PUNCT
ecj-12463	325	4	tyrrell	tyrrell	PROPN
ecj-12463	325	5	dj	dj	PROPN
ecj-12463	325	6	,	,	PUNCT
ecj-12463	325	7	vasbinder	vasbinder	VERB
ecj-12463	325	8	a	a	PRON
ecj-12463	325	9	,	,	PUNCT
ecj-12463	325	10	et	et	PROPN
ecj-12463	325	11	al	al	PROPN
ecj-12463	325	12	.	.	PROPN
ecj-12463	325	13	increased	increase	VERB
ecj-12463	325	14	soluble	soluble	ADJ
ecj-12463	325	15	urokinase	urokinase	NOUN
ecj-12463	325	16	plasminogen	plasminogen	NOUN
ecj-12463	325	17	activator	activator	NOUN
ecj-12463	325	18	levels	level	NOUN
ecj-12463	325	19	modulate	modulate	VERB
ecj-12463	325	20	monocyte	monocyte	NOUN
ecj-12463	325	21	function	function	NOUN
ecj-12463	325	22	to	to	PART
ecj-12463	325	23	promote	promote	VERB
ecj-12463	325	24	atherosclerosis	atherosclerosis	NOUN
ecj-12463	325	25	.	.	PUNCT
ecj-12463	326	1	j	j	PROPN
ecj-12463	326	2	clin	clin	PROPN
ecj-12463	326	3	invest	invest	VERB
ecj-12463	326	4	2022;132	2022;132	NUM
ecj-12463	326	5	:	:	PUNCT
ecj-12463	326	6	e158788	e158788	NOUN
ecj-12463	326	7	.	.	NOUN
ecj-12463	326	8	51	51	NUM
ecj-12463	326	9	.	.	PUNCT
ecj-12463	327	1	sörensen	sörensen	PROPN
ecj-12463	327	2	na	na	NOUN
ecj-12463	327	3	,	,	PUNCT
ecj-12463	327	4	nikorowitsch	nikorowitsch	PROPN
ecj-12463	327	5	j	j	PROPN
ecj-12463	327	6	,	,	PUNCT
ecj-12463	327	7	neumann	neumann	PROPN
ecj-12463	327	8	jt	jt	PROPN
ecj-12463	327	9	,	,	PUNCT
ecj-12463	327	10	et	et	PROPN
ecj-12463	327	11	al	al	PROPN
ecj-12463	327	12	.	.	PROPN
ecj-12463	327	13	predictive	predictive	ADJ
ecj-12463	327	14	value	value	NOUN
ecj-12463	327	15	of	of	ADP
ecj-12463	327	16	soluble	soluble	ADJ
ecj-12463	327	17	urokinase	urokinase	NOUN
ecj-12463	327	18	-	-	PUNCT
ecj-12463	327	19	type	type	NOUN
ecj-12463	327	20	plasminogen	plasminogen	NOUN
ecj-12463	327	21	activator	activator	NOUN
ecj-12463	327	22	receptor	receptor	NOUN
ecj-12463	327	23	for	for	ADP
ecj-12463	327	24	mortality	mortality	NOUN
ecj-12463	327	25	in	in	ADP
ecj-12463	327	26	patients	patient	NOUN
ecj-12463	327	27	with	with	ADP
ecj-12463	327	28	suspected	suspect	VERB
ecj-12463	327	29	myocardial	myocardial	ADJ
ecj-12463	327	30	infarction	infarction	NOUN
ecj-12463	327	31	.	.	PUNCT
ecj-12463	328	1	clin	clin	PROPN
ecj-12463	328	2	res	res	PROPN
ecj-12463	328	3	cardiol	cardiol	NOUN
ecj-12463	328	4	2019;108:1386	2019;108:1386	NUM
ecj-12463	328	5	-	-	SYM
ecj-12463	328	6	93	93	NUM
ecj-12463	328	7	.	.	PUNCT
ecj-12463	329	1	52	52	NUM
ecj-12463	329	2	.	.	PUNCT
ecj-12463	330	1	chenevier	chenevier	NOUN
ecj-12463	330	2	-	-	PUNCT
ecj-12463	330	3	gobeaux	gobeaux	NOUN
ecj-12463	330	4	c	c	NOUN
ecj-12463	330	5	,	,	PUNCT
ecj-12463	330	6	lemarechal	lemarechal	ADJ
ecj-12463	330	7	h	h	NOUN
ecj-12463	330	8	,	,	PUNCT
ecj-12463	330	9	doumenc	doumenc	PROPN
ecj-12463	330	10	b	b	PROPN
ecj-12463	330	11	,	,	PUNCT
ecj-12463	330	12	et	et	PROPN
ecj-12463	330	13	al	al	PROPN
ecj-12463	330	14	.	.	PROPN
ecj-12463	330	15	prognostic	prognostic	ADJ
ecj-12463	330	16	value	value	NOUN
ecj-12463	330	17	of	of	ADP
ecj-12463	330	18	soluble	soluble	ADJ
ecj-12463	330	19	urokinase	urokinase	NOUN
ecj-12463	330	20	plasminogen	plasminogen	NOUN
ecj-12463	330	21	activator	activator	NOUN
ecj-12463	330	22	receptor	receptor	NOUN
ecj-12463	330	23	in	in	ADP
ecj-12463	330	24	patients	patient	NOUN
ecj-12463	330	25	presenting	present	VERB
ecj-12463	330	26	to	to	ADP
ecj-12463	330	27	the	the	DET
ecj-12463	330	28	emergency	emergency	NOUN
ecj-12463	330	29	department	department	NOUN
ecj-12463	330	30	with	with	ADP
ecj-12463	330	31	chest	chest	NOUN
ecj-12463	330	32	pain	pain	NOUN
ecj-12463	330	33	suggestive	suggestive	ADJ
ecj-12463	330	34	of	of	ADP
ecj-12463	330	35	acute	acute	ADJ
ecj-12463	330	36	coronary	coronary	ADJ
ecj-12463	330	37	syndrome	syndrome	NOUN
ecj-12463	330	38	.	.	PUNCT
ecj-12463	331	1	clin	clin	PROPN
ecj-12463	331	2	biochem	biochem	PROPN
ecj-12463	331	3	2021;92:19	2021;92:19	NUM
ecj-12463	331	4	-	-	SYM
ecj-12463	331	5	24	24	NUM
ecj-12463	331	6	.	.	PUNCT
ecj-12463	332	1	53	53	NUM
ecj-12463	332	2	.	.	PUNCT
ecj-12463	333	1	santeri	santeri	PROPN
ecj-12463	333	2	s	s	PROPN
ecj-12463	333	3	,	,	PUNCT
ecj-12463	333	4	andersen	andersen	PROPN
ecj-12463	333	5	ap	ap	PROPN
ecj-12463	333	6	,	,	PUNCT
ecj-12463	333	7	nyyssönen	nyyssönen	PROPN
ecj-12463	333	8	k	k	PROPN
ecj-12463	333	9	,	,	PUNCT
ecj-12463	333	10	et	et	PROPN
ecj-12463	333	11	al	al	PROPN
ecj-12463	333	12	.	.	PROPN
ecj-12463	334	1	supar	supar	PROPN
ecj-12463	334	2	cut	cut	NOUN
ecj-12463	334	3	-	-	PUNCT
ecj-12463	334	4	offs	off	NOUN
ecj-12463	334	5	for	for	ADP
ecj-12463	334	6	stratification	stratification	NOUN
ecj-12463	334	7	of	of	ADP
ecj-12463	334	8	low	low	ADJ
ecj-12463	334	9	,	,	PUNCT
ecj-12463	334	10	medium	medium	ADJ
ecj-12463	334	11	,	,	PUNCT
ecj-12463	334	12	and	and	CCONJ
ecj-12463	334	13	high	high	ADJ
ecj-12463	334	14	-	-	PUNCT
ecj-12463	334	15	risk	risk	NOUN
ecj-12463	334	16	acute	acute	NOUN
ecj-12463	334	17	medical	medical	ADJ
ecj-12463	334	18	patients	patient	NOUN
ecj-12463	334	19	in	in	ADP
ecj-12463	334	20	the	the	DET
ecj-12463	334	21	emergency	emergency	NOUN
ecj-12463	334	22	department	department	NOUN
ecj-12463	334	23	.	.	PUNCT
ecj-12463	335	1	bmc	bmc	PROPN
ecj-12463	335	2	emerg	emerg	PROPN
ecj-12463	335	3	med	med	PROPN
ecj-12463	335	4	2021;21:149	2021;21:149	NOUN
ecj-12463	335	5	.	.	PUNCT
ecj-12463	336	1	54	54	NUM
ecj-12463	336	2	.	.	PUNCT
ecj-12463	337	1	velissaris	velissaris	NOUN
ecj-12463	337	2	d	d	NOUN
ecj-12463	337	3	,	,	PUNCT
ecj-12463	337	4	zareifopoulosb	zareifopoulosb	PROPN
ecj-12463	337	5	n	n	CCONJ
ecj-12463	337	6	,	,	PUNCT
ecj-12463	337	7	koniaric	koniaric	PROPN
ecj-12463	337	8	i	i	PROPN
ecj-12463	337	9	,	,	PUNCT
ecj-12463	337	10	et	et	PROPN
ecj-12463	337	11	al	al	PROPN
ecj-12463	337	12	.	.	PROPN
ecj-12463	337	13	soluble	soluble	ADJ
ecj-12463	337	14	urokinase	urokinase	NOUN
ecj-12463	337	15	plasminogen	plasminogen	NOUN
ecj-12463	337	16	activator	activator	NOUN
ecj-12463	337	17	receptor	receptor	NOUN
ecj-12463	337	18	as	as	ADP
ecj-12463	337	19	a	a	DET
ecj-12463	337	20	diagnostic	diagnostic	ADJ
ecj-12463	337	21	and	and	CCONJ
ecj-12463	337	22	prognostic	prognostic	ADJ
ecj-12463	337	23	biomarker	biomarker	NOUN
ecj-12463	337	24	in	in	ADP
ecj-12463	337	25	cardiac	cardiac	ADJ
ecj-12463	337	26	disease	disease	NOUN
ecj-12463	337	27	.	.	PUNCT
ecj-12463	338	1	j	j	PROPN
ecj-12463	338	2	clin	clin	PROPN
ecj-12463	338	3	med	med	PROPN
ecj-12463	338	4	res	re	NOUN
ecj-12463	338	5	2021;13:133	2021;13:133	PROPN
ecj-12463	338	6	-	-	SYM
ecj-12463	338	7	42	42	NUM
ecj-12463	338	8	.	.	PUNCT
ecj-12463	339	1	55	55	NUM
ecj-12463	339	2	.	.	PUNCT
ecj-12463	339	3	bengaard	bengaard	PROPN
ecj-12463	339	4	ak	ak	PROPN
ecj-12463	339	5	,	,	PUNCT
ecj-12463	339	6	versen	versen	NOUN
ecj-12463	339	7	e	e	NOUN
ecj-12463	339	8	,	,	PUNCT
ecj-12463	339	9	kallemose	kallemose	PROPN
ecj-12463	339	10	t	t	PROPN
ecj-12463	339	11	,	,	PUNCT
ecj-12463	339	12	et	et	PROPN
ecj-12463	339	13	al	al	PROPN
ecj-12463	339	14	.	.	PUNCT
ecj-12463	340	1	using	use	VERB
ecj-12463	340	2	soluble	soluble	ADJ
ecj-12463	340	3	urokinase	urokinase	NOUN
ecj-12463	340	4	plasminogen	plasminogen	NOUN
ecj-12463	340	5	activator	activator	NOUN
ecj-12463	340	6	receptor	receptor	NOUN
ecj-12463	340	7	to	to	PART
ecj-12463	340	8	stratify	stratify	VERB
ecj-12463	340	9	patients	patient	NOUN
ecj-12463	340	10	for	for	ADP
ecj-12463	340	11	medication	medication	NOUN
ecj-12463	340	12	review	review	NOUN
ecj-12463	340	13	in	in	ADP
ecj-12463	340	14	the	the	DET
ecj-12463	340	15	emergency	emergency	NOUN
ecj-12463	340	16	department	department	NOUN
ecj-12463	340	17	.	.	PUNCT
ecj-12463	341	1	br	br	PROPN
ecj-12463	342	1	j	j	PROPN
ecj-12463	342	2	clin	clin	PROPN
ecj-12463	342	3	pharmacol	pharmacol	PROPN
ecj-12463	342	4	2022;88:1679	2022;88:1679	PROPN
ecj-12463	342	5	-	-	SYM
ecj-12463	342	6	90	90	NUM
ecj-12463	342	7	.	.	PUNCT
ecj-12463	342	8	56	56	NUM
ecj-12463	342	9	.	.	PUNCT
ecj-12463	343	1	al	al	PROPN
ecj-12463	343	2	-	-	PUNCT
ecj-12463	343	3	badri	badri	PROPN
ecj-12463	343	4	a	a	DET
ecj-12463	343	5	,	,	PUNCT
ecj-12463	343	6	tahhan	tahhan	NOUN
ecj-12463	343	7	as	as	ADP
ecj-12463	343	8	,	,	PUNCT
ecj-12463	343	9	sabbak	sabbak	ADJ
ecj-12463	343	10	n	n	CCONJ
ecj-12463	343	11	,	,	PUNCT
ecj-12463	343	12	et	et	PROPN
ecj-12463	343	13	al	al	PROPN
ecj-12463	343	14	.	.	PROPN
ecj-12463	343	15	soluble	soluble	ADJ
ecj-12463	343	16	urokinasetype	urokinasetype	NOUN
ecj-12463	343	17	plasminogen	plasminogen	NOUN
ecj-12463	343	18	activator	activator	NOUN
ecj-12463	343	19	receptor	receptor	NOUN
ecj-12463	343	20	and	and	CCONJ
ecj-12463	343	21	high	high	ADJ
ecj-12463	343	22	-	-	PUNCT
ecj-12463	343	23	sensitivity	sensitivity	NOUN
ecj-12463	343	24	troponin	troponin	ADJ
ecj-12463	343	25	levels	level	NOUN
ecj-12463	343	26	predict	predict	VERB
ecj-12463	343	27	outcomes	outcome	NOUN
ecj-12463	343	28	in	in	ADP
ecj-12463	343	29	nonobstructive	nonobstructive	ADJ
ecj-12463	343	30	coronary	coronary	ADJ
ecj-12463	343	31	artery	artery	NOUN
ecj-12463	343	32	disease	disease	NOUN
ecj-12463	343	33	.	.	PUNCT
ecj-12463	344	1	j	j	PROPN
ecj-12463	344	2	am	be	AUX
ecj-12463	344	3	heart	heart	NOUN
ecj-12463	344	4	assoc	assoc	PROPN
ecj-12463	344	5	2020;9	2020;9	NOUN
ecj-12463	344	6	:	:	PUNCT
ecj-12463	344	7	e015515	e015515	NUM
ecj-12463	344	8	.	.	NOUN
ecj-12463	344	9	57	57	NUM
ecj-12463	344	10	.	.	PUNCT
ecj-12463	345	1	frarya	frarya	PROPN
ecj-12463	345	2	ce	ce	PROPN
ecj-12463	345	3	,	,	PUNCT
ecj-12463	345	4	biering	biere	VERB
ecj-12463	345	5	-	-	PUNCT
ecj-12463	345	6	sørensenc	sørensenc	NOUN
ecj-12463	345	7	t	t	PROPN
ecj-12463	345	8	,	,	PUNCT
ecj-12463	345	9	nochiokad	nochiokad	PROPN
ecj-12463	346	1	k	k	PROPN
ecj-12463	346	2	,	,	PUNCT
ecj-12463	346	3	et	et	PROPN
ecj-12463	346	4	al	al	PROPN
ecj-12463	346	5	.	.	PROPN
ecj-12463	347	1	sexand	sexand	PROPN
ecj-12463	347	2	age	age	NOUN
ecj-12463	347	3	-	-	PUNCT
ecj-12463	347	4	related	relate	VERB
ecj-12463	347	5	differences	difference	NOUN
ecj-12463	347	6	in	in	ADP
ecj-12463	347	7	the	the	DET
ecj-12463	347	8	predictive	predictive	ADJ
ecj-12463	347	9	capability	capability	NOUN
ecj-12463	347	10	of	of	ADP
ecj-12463	347	11	circulating	circulate	VERB
ecj-12463	347	12	biomarkers	biomarker	NOUN
ecj-12463	347	13	:	:	PUNCT
ecj-12463	347	14	from	from	ADP
ecj-12463	347	15	the	the	DET
ecj-12463	347	16	monica	monica	PROPN
ecj-12463	347	17	10	10	NUM
ecj-12463	347	18	cohort	cohort	NOUN
ecj-12463	347	19	.	.	PUNCT
ecj-12463	348	1	scand	scand	PROPN
ecj-12463	348	2	cardiovasc	cardiovasc	PROPN
ecj-12463	348	3	j	j	PROPN
ecj-12463	348	4	2021;55:65–72	2021;55:65–72	PROPN
ecj-12463	348	5	.	.	PUNCT
ecj-12463	349	1	58	58	NUM
ecj-12463	349	2	.	.	PUNCT
ecj-12463	350	1	hodges	hodges	PROPN
ecj-12463	350	2	g	g	PROPN
ecj-12463	350	3	,	,	PUNCT
ecj-12463	350	4	lyngbæk	lyngbæk	PROPN
ecj-12463	350	5	s	s	PROPN
ecj-12463	350	6	,	,	PUNCT
ecj-12463	350	7	selmer	selmer	PROPN
ecj-12463	350	8	c	c	AUX
ecj-12463	350	9	,	,	PUNCT
ecj-12463	350	10	et	et	PROPN
ecj-12463	350	11	al	al	PROPN
ecj-12463	350	12	.	.	PROPN
ecj-12463	350	13	supar	supar	PROPN
ecj-12463	350	14	is	be	AUX
ecj-12463	350	15	associated	associate	VERB
ecj-12463	350	16	with	with	ADP
ecj-12463	350	17	death	death	NOUN
ecj-12463	350	18	and	and	CCONJ
ecj-12463	350	19	adverse	adverse	ADJ
ecj-12463	350	20	cardiovascular	cardiovascular	ADJ
ecj-12463	350	21	outcomes	outcome	NOUN
ecj-12463	350	22	in	in	ADP
ecj-12463	350	23	patients	patient	NOUN
ecj-12463	350	24	with	with	ADP
ecj-12463	350	25	suspected	suspect	VERB
ecj-12463	350	26	coronary	coronary	ADJ
ecj-12463	350	27	artery	artery	NOUN
ecj-12463	350	28	disease	disease	NOUN
ecj-12463	350	29	.	.	PUNCT
ecj-12463	351	1	scand	scand	PROPN
ecj-12463	351	2	cardiovasc	cardiovasc	PROPN
ecj-12463	351	3	j	j	PROPN
ecj-12463	352	1	2020;54:339–45	2020;54:339–45	NUM
ecj-12463	352	2	.	.	PROPN
ecj-12463	352	3	59	59	NUM
ecj-12463	352	4	.	.	PUNCT
ecj-12463	352	5	sarlo	sarlo	PROPN
ecj-12463	352	6	f	f	PROPN
ecj-12463	352	7	,	,	PUNCT
ecj-12463	352	8	urbani	urbani	PROPN
ecj-12463	352	9	a	a	DET
ecj-12463	352	10	,	,	PUNCT
ecj-12463	352	11	baroni	baroni	PROPN
ecj-12463	352	12	s.	s.	PROPN
ecj-12463	352	13	urokinase	urokinase	PROPN
ecj-12463	352	14	-	-	PUNCT
ecj-12463	352	15	type	type	NOUN
ecj-12463	352	16	plasminogen	plasminogen	NOUN
ecj-12463	352	17	activator	activator	NOUN
ecj-12463	352	18	soluble	soluble	ADJ
ecj-12463	352	19	receptor	receptor	NOUN
ecj-12463	352	20	(	(	PUNCT
ecj-12463	352	21	supar	supar	NOUN
ecj-12463	352	22	)	)	PUNCT
ecj-12463	352	23	assay	assay	VERB
ecj-12463	352	24	in	in	ADP
ecj-12463	352	25	clinical	clinical	ADJ
ecj-12463	352	26	routine	routine	NOUN
ecj-12463	352	27	:	:	PUNCT
ecj-12463	352	28	evaluation	evaluation	NOUN
ecj-12463	352	29	one	one	NUM
ecj-12463	352	30	year	year	NOUN
ecj-12463	352	31	after	after	ADP
ecj-12463	352	32	its	its	PRON
ecj-12463	352	33	introduction	introduction	NOUN
ecj-12463	352	34	in	in	ADP
ecj-12463	352	35	the	the	DET
ecj-12463	352	36	high	high	ADJ
ecj-12463	352	37	automation	automation	NOUN
ecj-12463	352	38	corelab	corelab	NOUN
ecj-12463	352	39	of	of	ADP
ecj-12463	352	40	the	the	DET
ecj-12463	352	41	a.	a.	NOUN
ecj-12463	352	42	gemelli	gemelli	PROPN
ecj-12463	352	43	hospital	hospital	NOUN
ecj-12463	352	44	.	.	PUNCT
ecj-12463	353	1	clin	clin	PROPN
ecj-12463	353	2	chem	chem	NOUN
ecj-12463	353	3	lab	lab	NOUN
ecj-12463	353	4	med	med	PROPN
ecj-12463	353	5	2023;61	2023;61	NUM
ecj-12463	353	6	:	:	PUNCT
ecj-12463	353	7	e33–5	e33–5	NOUN
ecj-12463	353	8	.	.	PUNCT
ecj-12463	354	1	60	60	NUM
ecj-12463	354	2	.	.	PUNCT
ecj-12463	355	1	abdelmageed	abdelmageed	PROPN
ecj-12463	355	2	m	m	PROPN
ecj-12463	355	3	,	,	PUNCT
ecj-12463	355	4	güzelgül	güzelgül	PROPN
ecj-12463	355	5	f.	f.	PROPN
ecj-12463	355	6	copeptin	copeptin	PROPN
ecj-12463	355	7	:	:	PUNCT
ecj-12463	355	8	up	up	ADP
ecj-12463	355	9	-	-	PUNCT
ecj-12463	355	10	to	to	ADP
ecj-12463	355	11	-	-	PUNCT
ecj-12463	355	12	date	date	NOUN
ecj-12463	355	13	diagnostic	diagnostic	ADJ
ecj-12463	355	14	and	and	CCONJ
ecj-12463	355	15	prognostic	prognostic	ADJ
ecj-12463	355	16	role	role	NOUN
ecj-12463	355	17	highlight	highlight	VERB
ecj-12463	355	18	.	.	PUNCT
ecj-12463	356	1	anal	anal	ADJ
ecj-12463	356	2	biochem	biochem	PROPN
ecj-12463	356	3	2023;15:115181	2023;15:115181	NUM
ecj-12463	356	4	.	.	PROPN
ecj-12463	356	5	61	61	NUM
ecj-12463	356	6	.	.	PUNCT
ecj-12463	357	1	mu	mu	PROPN
ecj-12463	357	2	d	d	PROPN
ecj-12463	357	3	,	,	PUNCT
ecj-12463	357	4	zhong	zhong	PROPN
ecj-12463	357	5	j	j	PROPN
ecj-12463	357	6	,	,	PUNCT
ecj-12463	357	7	li	li	PROPN
ecj-12463	357	8	l	l	PROPN
ecj-12463	357	9	,	,	PUNCT
ecj-12463	357	10	et	et	PROPN
ecj-12463	357	11	al	al	PROPN
ecj-12463	357	12	.	.	PROPN
ecj-12463	357	13	copeptin	copeptin	PROPN
ecj-12463	357	14	with	with	ADP
ecj-12463	357	15	high	high	ADJ
ecj-12463	357	16	-	-	PUNCT
ecj-12463	357	17	sensitivity	sensitivity	NOUN
ecj-12463	357	18	cardiac	cardiac	ADJ
ecj-12463	357	19	troponin	troponin	ADJ
ecj-12463	357	20	to	to	PART
ecj-12463	357	21	rule	rule	VERB
ecj-12463	357	22	out	out	ADP
ecj-12463	357	23	non	non	ADJ
ecj-12463	357	24	-	-	ADJ
ecj-12463	357	25	st	st	ADJ
ecj-12463	357	26	-	-	PUNCT
ecj-12463	357	27	elevation	elevation	NOUN
ecj-12463	357	28	myocardial	myocardial	ADJ
ecj-12463	357	29	infarction	infarction	NOUN
ecj-12463	357	30	early	early	ADV
ecj-12463	357	31	on	on	ADP
ecj-12463	357	32	:	:	PUNCT
ecj-12463	357	33	a	a	DET
ecj-12463	357	34	systematic	systematic	ADJ
ecj-12463	357	35	review	review	NOUN
ecj-12463	357	36	and	and	CCONJ
ecj-12463	357	37	meta	meta	ADJ
ecj-12463	357	38	-	-	PUNCT
ecj-12463	357	39	analysis	analysis	NOUN
ecj-12463	357	40	.	.	PUNCT
ecj-12463	358	1	clin	clin	PROPN
ecj-12463	358	2	biochem	biochem	PROPN
ecj-12463	358	3	2023;112:24	2023;112:24	NUM
ecj-12463	358	4	-	-	SYM
ecj-12463	358	5	32	32	NUM
ecj-12463	358	6	.	.	PUNCT
ecj-12463	359	1	62	62	NUM
ecj-12463	359	2	.	.	PUNCT
ecj-12463	359	3	berezin	berezin	PROPN
ecj-12463	359	4	ae	ae	PROPN
ecj-12463	359	5	,	,	PUNCT
ecj-12463	359	6	berezin	berezin	PROPN
ecj-12463	360	1	aa	aa	PROPN
ecj-12463	360	2	.	.	PUNCT
ecj-12463	361	1	adverse	adverse	ADJ
ecj-12463	361	2	cardiac	cardiac	ADJ
ecj-12463	361	3	remodelling	remodelling	NOUN
ecj-12463	361	4	after	after	ADP
ecj-12463	361	5	acute	acute	ADJ
ecj-12463	361	6	myocardial	myocardial	ADJ
ecj-12463	361	7	infarction	infarction	NOUN
ecj-12463	361	8	:	:	PUNCT
ecj-12463	361	9	old	old	ADJ
ecj-12463	361	10	and	and	CCONJ
ecj-12463	361	11	new	new	ADJ
ecj-12463	361	12	biomarkers	biomarker	NOUN
ecj-12463	361	13	.	.	PUNCT
ecj-12463	362	1	disease	disease	NOUN
ecj-12463	362	2	markers	marker	NOUN
ecj-12463	362	3	volume	volume	NOUN
ecj-12463	362	4	2020;121580	2020;121580	NUM
ecj-12463	362	5	.	.	PROPN
ecj-12463	362	6	63	63	NUM
ecj-12463	362	7	.	.	PUNCT
ecj-12463	363	1	katsioupa	katsioupa	PROPN
ecj-12463	363	2	m	m	PROPN
ecj-12463	363	3	,	,	PUNCT
ecj-12463	363	4	kourampi	kourampi	PROPN
ecj-12463	363	5	i	i	PRON
ecj-12463	363	6	,	,	PUNCT
ecj-12463	363	7	oikonomou	oikonomou	PROPN
ecj-12463	363	8	e	e	NOUN
ecj-12463	363	9	,	,	PUNCT
ecj-12463	363	10	et	et	PROPN
ecj-12463	363	11	al	al	PROPN
ecj-12463	363	12	.	.	PROPN
ecj-12463	363	13	novel	novel	ADJ
ecj-12463	363	14	biomarkers	biomarker	NOUN
ecj-12463	363	15	and	and	CCONJ
ecj-12463	363	16	their	their	PRON
ecj-12463	363	17	role	role	NOUN
ecj-12463	363	18	in	in	ADP
ecj-12463	363	19	the	the	DET
ecj-12463	363	20	diagnosis	diagnosis	NOUN
ecj-12463	363	21	and	and	CCONJ
ecj-12463	363	22	prognosis	prognosis	NOUN
ecj-12463	363	23	of	of	ADP
ecj-12463	363	24	acute	acute	ADJ
ecj-12463	363	25	coronary	coronary	ADJ
ecj-12463	363	26	syndrome	syndrome	NOUN
ecj-12463	363	27	.	.	PUNCT
ecj-12463	364	1	life	life	NOUN
ecj-12463	364	2	2023;13:1992	2023;13:1992	NUM
ecj-12463	364	3	.	.	PROPN
ecj-12463	364	4	64	64	NUM
ecj-12463	364	5	.	.	PUNCT
ecj-12463	364	6	ion	ion	NOUN
ecj-12463	364	7	a	a	NOUN
ecj-12463	364	8	,	,	PUNCT
ecj-12463	364	9	stafie	stafie	PROPN
ecj-12463	364	10	c	c	NOUN
ecj-12463	364	11	,	,	PUNCT
ecj-12463	364	12	mitu	mitu	ADJ
ecj-12463	364	13	o	o	NOUN
ecj-12463	364	14	,	,	PUNCT
ecj-12463	364	15	et	et	PROPN
ecj-12463	364	16	al	al	PROPN
ecj-12463	364	17	.	.	PUNCT
ecj-12463	365	1	biomarkers	biomarker	NOUN
ecj-12463	365	2	utility	utility	NOUN
ecj-12463	365	3	:	:	PUNCT
ecj-12463	365	4	at	at	ADP
ecj-12463	365	5	the	the	DET
ecj-12463	365	6	borderline	borderline	NOUN
ecj-12463	365	7	between	between	ADP
ecj-12463	365	8	cardiology	cardiology	NOUN
ecj-12463	365	9	and	and	CCONJ
ecj-12463	365	10	neurology	neurology	NOUN
ecj-12463	365	11	.	.	PUNCT
ecj-12463	366	1	j	j	PROPN
ecj-12463	366	2	cardiovasc	cardiovasc	PROPN
ecj-12463	366	3	dev	dev	PROPN
ecj-12463	366	4	dis	dis	PROPN
ecj-12463	366	5	2021;8:139	2021;8:139	NUM
ecj-12463	366	6	.	.	PUNCT
ecj-12463	367	1	65	65	NUM
ecj-12463	367	2	.	.	PUNCT
ecj-12463	368	1	maisel	maisel	PROPN
ecj-12463	368	2	a	a	NOUN
ecj-12463	368	3	,	,	PUNCT
ecj-12463	368	4	mueller	mueller	PROPN
ecj-12463	368	5	c	c	PROPN
ecj-12463	368	6	,	,	PUNCT
ecj-12463	368	7	neath	neath	NOUN
ecj-12463	368	8	sx	sx	PROPN
ecj-12463	368	9	,	,	PUNCT
ecj-12463	368	10	et	et	PROPN
ecj-12463	368	11	al	al	PROPN
ecj-12463	368	12	.	.	PROPN
ecj-12463	368	13	copeptin	copeptin	PROPN
ecj-12463	368	14	helps	help	VERB
ecj-12463	368	15	in	in	ADP
ecj-12463	368	16	the	the	DET
ecj-12463	368	17	early	early	ADJ
ecj-12463	368	18	detection	detection	NOUN
ecj-12463	368	19	of	of	ADP
ecj-12463	368	20	patients	patient	NOUN
ecj-12463	368	21	with	with	ADP
ecj-12463	368	22	acute	acute	ADJ
ecj-12463	368	23	myocardial	myocardial	ADJ
ecj-12463	368	24	infarction	infarction	NOUN
ecj-12463	368	25	:	:	PUNCT
ecj-12463	368	26	primary	primary	ADJ
ecj-12463	368	27	results	result	NOUN
ecj-12463	368	28	of	of	ADP
ecj-12463	368	29	the	the	DET
ecj-12463	368	30	chopin	chopin	PROPN
ecj-12463	368	31	trial	trial	NOUN
ecj-12463	368	32	(	(	PUNCT
ecj-12463	368	33	copeptin	copeptin	NOUN
ecj-12463	368	34	helps	help	VERB
ecj-12463	368	35	in	in	ADP
ecj-12463	368	36	the	the	DET
ecj-12463	368	37	early	early	ADJ
ecj-12463	368	38	detection	detection	NOUN
ecj-12463	368	39	of	of	ADP
ecj-12463	368	40	patients	patient	NOUN
ecj-12463	368	41	with	with	ADP
ecj-12463	368	42	acute	acute	ADJ
ecj-12463	368	43	myocardial	myocardial	ADJ
ecj-12463	368	44	infarction	infarction	NOUN
ecj-12463	368	45	)	)	PUNCT
ecj-12463	368	46	.	.	PUNCT
ecj-12463	369	1	j	j	PROPN
ecj-12463	369	2	am	be	AUX
ecj-12463	369	3	coll	coll	PROPN
ecj-12463	369	4	cardiol	cardiol	NOUN
ecj-12463	369	5	2013;62:150	2013;62:150	PROPN
ecj-12463	369	6	-	-	SYM
ecj-12463	369	7	60	60	NUM
ecj-12463	369	8	.	.	PUNCT
ecj-12463	370	1	66	66	NUM
ecj-12463	370	2	.	.	PUNCT
ecj-12463	371	1	jeong	jeong	PROPN
ecj-12463	371	2	jh	jh	PROPN
ecj-12463	371	3	,	,	PUNCT
ecj-12463	371	4	seo	seo	PROPN
ecj-12463	371	5	yh	yh	PROPN
ecj-12463	371	6	,	,	PUNCT
ecj-12463	371	7	ahn	ahn	PROPN
ecj-12463	371	8	jy	jy	PROPN
ecj-12463	371	9	,	,	PUNCT
ecj-12463	371	10	et	et	PROPN
ecj-12463	371	11	al	al	PROPN
ecj-12463	371	12	.	.	PUNCT
ecj-12463	371	13	performance	performance	NOUN
ecj-12463	371	14	of	of	ADP
ecj-12463	371	15	copeptin	copeptin	NOUN
ecj-12463	371	16	for	for	ADP
ecj-12463	371	17	early	early	ADJ
ecj-12463	371	18	diagnosis	diagnosis	NOUN
ecj-12463	371	19	of	of	ADP
ecj-12463	371	20	acute	acute	ADJ
ecj-12463	371	21	myocardial	myocardial	ADJ
ecj-12463	371	22	infarction	infarction	NOUN
ecj-12463	371	23	in	in	ADP
ecj-12463	371	24	an	an	DET
ecj-12463	371	25	emergency	emergency	NOUN
ecj-12463	371	26	department	department	NOUN
ecj-12463	371	27	setting	setting	NOUN
ecj-12463	371	28	.	.	PUNCT
ecj-12463	372	1	ann	ann	PROPN
ecj-12463	372	2	lab	lab	PROPN
ecj-12463	372	3	med	med	PROPN
ecj-12463	372	4	2020;40:7	2020;40:7	PROPN
ecj-12463	372	5	-	-	SYM
ecj-12463	372	6	14	14	NUM
ecj-12463	372	7	.	.	PUNCT
ecj-12463	373	1	67	67	NUM
ecj-12463	373	2	.	.	PUNCT
ecj-12463	374	1	waldsperger	waldsperger	PROPN
ecj-12463	374	2	h	h	PROPN
ecj-12463	374	3	,	,	PUNCT
ecj-12463	374	4	biener	biener	NOUN
ecj-12463	374	5	m	m	PROPN
ecj-12463	374	6	,	,	PUNCT
ecj-12463	374	7	stoyanov	stoyanov	PROPN
ecj-12463	374	8	km	km	PROPN
ecj-12463	374	9	,	,	PUNCT
ecj-12463	374	10	et	et	PROPN
ecj-12463	374	11	al	al	PROPN
ecj-12463	374	12	.	.	PROPN
ecj-12463	375	1	prognostic	prognostic	ADJ
ecj-12463	375	2	value	value	NOUN
ecj-12463	375	3	of	of	ADP
ecj-12463	375	4	elevated	elevated	ADJ
ecj-12463	375	5	copeptin	copeptin	NOUN
ecj-12463	375	6	and	and	CCONJ
ecj-12463	375	7	high	high	ADJ
ecj-12463	375	8	-	-	PUNCT
ecj-12463	375	9	sensitivity	sensitivity	NOUN
ecj-12463	375	10	cardiac	cardiac	ADJ
ecj-12463	375	11	troponin	troponin	PROPN
ecj-12463	375	12	t	t	PROPN
ecj-12463	375	13	in	in	ADP
ecj-12463	375	14	patients	patient	NOUN
ecj-12463	375	15	with	with	ADP
ecj-12463	375	16	and	and	CCONJ
ecj-12463	375	17	without	without	ADP
ecj-12463	375	18	acute	acute	ADJ
ecj-12463	375	19	coronary	coronary	ADJ
ecj-12463	375	20	syndrome	syndrome	NOUN
ecj-12463	375	21	:	:	PUNCT
ecj-12463	375	22	the	the	DET
ecj-12463	375	23	contracs	contrac	NOUN
ecj-12463	375	24	study	study	VERB
ecj-12463	375	25	.	.	PUNCT
ecj-12463	376	1	j	j	PROPN
ecj-12463	376	2	clin	clin	PROPN
ecj-12463	376	3	med	med	PROPN
ecj-12463	376	4	2020;9:3627	2020;9:3627	PROPN
ecj-12463	376	5	.	.	PUNCT
ecj-12463	377	1	68	68	NUM
ecj-12463	377	2	.	.	PUNCT
ecj-12463	378	1	mueller	mueller	PROPN
ecj-12463	378	2	-	-	PUNCT
ecj-12463	378	3	hennessen	hennessen	PROPN
ecj-12463	378	4	m	m	PROPN
ecj-12463	378	5	,	,	PUNCT
ecj-12463	378	6	lindahl	lindahl	PROPN
ecj-12463	378	7	b	b	PROPN
ecj-12463	378	8	,	,	PUNCT
ecj-12463	378	9	giannitsis	giannitsis	NOUN
ecj-12463	378	10	e	e	NOUN
ecj-12463	378	11	,	,	PUNCT
ecj-12463	378	12	et	et	PROPN
ecj-12463	378	13	al	al	PROPN
ecj-12463	378	14	.	.	PROPN
ecj-12463	378	15	combined	combine	VERB
ecj-12463	378	16	testing	testing	NOUN
ecj-12463	378	17	of	of	ADP
ecj-12463	378	18	copeptin	copeptin	NOUN
ecj-12463	378	19	and	and	CCONJ
ecj-12463	378	20	high	high	ADJ
ecj-12463	378	21	-	-	PUNCT
ecj-12463	378	22	sensitivity	sensitivity	NOUN
ecj-12463	378	23	cardiac	cardiac	ADJ
ecj-12463	378	24	troponin	troponin	PROPN
ecj-12463	378	25	t	t	PROPN
ecj-12463	378	26	at	at	ADP
ecj-12463	378	27	presentation	presentation	NOUN
ecj-12463	378	28	in	in	ADP
ecj-12463	378	29	comparison	comparison	NOUN
ecj-12463	378	30	to	to	ADP
ecj-12463	378	31	other	other	ADJ
ecj-12463	378	32	algorithms	algorithm	NOUN
ecj-12463	378	33	for	for	ADP
ecj-12463	378	34	rapid	rapid	ADJ
ecj-12463	378	35	rule	rule	NOUN
ecj-12463	378	36	-	-	PUNCT
ecj-12463	378	37	out	out	NOUN
ecj-12463	378	38	of	of	ADP
ecj-12463	378	39	acute	acute	ADJ
ecj-12463	378	40	myocardial	myocardial	ADJ
ecj-12463	378	41	infarction	infarction	NOUN
ecj-12463	378	42	.	.	PUNCT
ecj-12463	379	1	int	int	NOUN
ecj-12463	379	2	j	j	PROPN
ecj-12463	379	3	cardiol	cardiol	NOUN
ecj-12463	379	4	2019;276:261	2019;276:261	NUM
ecj-12463	379	5	-	-	SYM
ecj-12463	379	6	7	7	NUM
ecj-12463	379	7	69	69	NUM
ecj-12463	379	8	.	.	PUNCT
ecj-12463	380	1	giannitsis	giannitsis	PROPN
ecj-12463	380	2	e	e	NOUN
ecj-12463	380	3	,	,	PUNCT
ecj-12463	380	4	slagman	slagman	NOUN
ecj-12463	380	5	a	a	PRON
ecj-12463	380	6	,	,	PUNCT
ecj-12463	380	7	hamm	hamm	PROPN
ecj-12463	380	8	cw	cw	PROPN
ecj-12463	380	9	,	,	PUNCT
ecj-12463	380	10	et	et	PROPN
ecj-12463	380	11	al	al	PROPN
ecj-12463	380	12	.	.	PROPN
ecj-12463	380	13	copeptin	copeptin	PROPN
ecj-12463	380	14	combined	combine	VERB
ecj-12463	380	15	with	with	ADP
ecj-12463	380	16	either	either	CCONJ
ecj-12463	380	17	non	non	ADJ
ecj-12463	380	18	-	-	ADJ
ecj-12463	380	19	high	high	ADJ
ecj-12463	380	20	sensitivity	sensitivity	NOUN
ecj-12463	380	21	or	or	CCONJ
ecj-12463	380	22	high	high	ADJ
ecj-12463	380	23	sensitivity	sensitivity	NOUN
ecj-12463	380	24	cardiac	cardiac	ADJ
ecj-12463	380	25	troponin	troponin	ADJ
ecj-12463	380	26	for	for	ADP
ecj-12463	380	27	instant	instant	ADJ
ecj-12463	380	28	rule	rule	NOUN
ecj-12463	380	29	-	-	PUNCT
ecj-12463	380	30	out	out	NOUN
ecj-12463	380	31	of	of	ADP
ecj-12463	380	32	suspected	suspect	VERB
ecj-12463	380	33	non	non	ADJ
ecj-12463	380	34	-	-	ADJ
ecj-12463	380	35	st	st	ADJ
ecj-12463	380	36	segment	segment	NOUN
ecj-12463	380	37	elevation	elevation	NOUN
ecj-12463	380	38	myocardial	myocardial	ADJ
ecj-12463	380	39	infarction	infarction	NOUN
ecj-12463	380	40	.	.	PUNCT
ecj-12463	381	1	biomarkers	biomarker	NOUN
ecj-12463	381	2	2020;25:649	2020;25:649	NOUN
ecj-12463	381	3	-	-	NOUN
ecj-12463	381	4	58	58	NUM
ecj-12463	381	5	.	.	PUNCT
ecj-12463	382	1	70	70	NUM
ecj-12463	382	2	.	.	PUNCT
ecj-12463	383	1	lattuca	lattuca	PROPN
ecj-12463	383	2	b	b	X
ecj-12463	383	3	,	,	PUNCT
ecj-12463	383	4	sy	sy	PROPN
ecj-12463	383	5	v	v	NOUN
ecj-12463	383	6	,	,	PUNCT
ecj-12463	383	7	nguyen	nguyen	PROPN
ecj-12463	383	8	ls	ls	PROPN
ecj-12463	383	9	,	,	PUNCT
ecj-12463	383	10	et	et	PROPN
ecj-12463	383	11	al	al	PROPN
ecj-12463	383	12	.	.	PROPN
ecj-12463	383	13	copeptin	copeptin	PROPN
ecj-12463	383	14	as	as	ADP
ecj-12463	383	15	a	a	DET
ecj-12463	383	16	prognostic	prognostic	ADJ
ecj-12463	383	17	biomarker	biomarker	NOUN
ecj-12463	383	18	in	in	ADP
ecj-12463	383	19	acute	acute	ADJ
ecj-12463	383	20	myocardial	myocardial	ADJ
ecj-12463	383	21	infarction	infarction	NOUN
ecj-12463	383	22	.	.	PUNCT
ecj-12463	384	1	int	int	NOUN
ecj-12463	384	2	j	j	PROPN
ecj-12463	384	3	cardiol	cardiol	NOUN
ecj-12463	384	4	2019;274:337	2019;274:337	NUM
ecj-12463	384	5	-	-	SYM
ecj-12463	384	6	41	41	NUM
ecj-12463	384	7	.	.	PUNCT
ecj-12463	385	1	71	71	NUM
ecj-12463	385	2	.	.	PUNCT
ecj-12463	386	1	ahmed	ahmed	PROPN
ecj-12463	386	2	tan	tan	PROPN
ecj-12463	386	3	,	,	PUNCT
ecj-12463	386	4	johny	johny	PROPN
ecj-12463	386	5	js	js	PROPN
ecj-12463	386	6	,	,	PUNCT
ecj-12463	386	7	abdel	abdel	PROPN
ecj-12463	386	8	-	-	PUNCT
ecj-12463	386	9	malek	malek	PROPN
ecj-12463	386	10	my	my	PRON
ecj-12463	386	11	,	,	PUNCT
ecj-12463	386	12	fouad	fouad	PROPN
ecj-12463	386	13	da	da	PROPN
ecj-12463	386	14	.	.	PUNCT
ecj-12463	387	1	the	the	DET
ecj-12463	387	2	additive	additive	ADJ
ecj-12463	387	3	value	value	NOUN
ecj-12463	387	4	of	of	ADP
ecj-12463	387	5	copeptin	copeptin	NOUN
ecj-12463	387	6	for	for	ADP
ecj-12463	387	7	early	early	ADJ
ecj-12463	387	8	diagnosis	diagnosis	NOUN
ecj-12463	387	9	and	and	CCONJ
ecj-12463	387	10	prognosis	prognosis	NOUN
ecj-12463	387	11	of	of	ADP
ecj-12463	387	12	acute	acute	ADJ
ecj-12463	387	13	coronary	coronary	ADJ
ecj-12463	387	14	syndromes	syndrome	NOUN
ecj-12463	387	15	.	.	PUNCT
ecj-12463	387	16	am	be	AUX
ecj-12463	387	17	j	j	PROPN
ecj-12463	387	18	emerg	emerg	PROPN
ecj-12463	387	19	med	med	PROPN
ecj-12463	387	20	2021;50:413	2021;50:413	PROPN
ecj-12463	387	21	-	-	PROPN
ecj-12463	387	22	21	21	NUM
ecj-12463	387	23	72	72	NUM
ecj-12463	387	24	.	.	PUNCT
ecj-12463	388	1	szarpak	szarpak	PROPN
ecj-12463	388	2	l	l	NOUN
ecj-12463	388	3	,	,	PUNCT
ecj-12463	388	4	lapinski	lapinski	NOUN
ecj-12463	388	5	m	m	PROPN
ecj-12463	388	6	,	,	PUNCT
ecj-12463	388	7	gasecka	gasecka	PROPN
ecj-12463	388	8	a	a	X
ecj-12463	388	9	,	,	PUNCT
ecj-12463	388	10	et	et	PROPN
ecj-12463	388	11	al	al	PROPN
ecj-12463	388	12	.	.	PUNCT
ecj-12463	388	13	performance	performance	NOUN
ecj-12463	388	14	of	of	ADP
ecj-12463	388	15	copeptin	copeptin	NOUN
ecj-12463	388	16	for	for	ADP
ecj-12463	388	17	early	early	ADJ
ecj-12463	388	18	diagnosis	diagnosis	NOUN
ecj-12463	388	19	of	of	ADP
ecj-12463	388	20	acute	acute	ADJ
ecj-12463	388	21	coronary	coronary	ADJ
ecj-12463	388	22	syndromes	syndrome	NOUN
ecj-12463	388	23	:	:	PUNCT
ecj-12463	388	24	a	a	DET
ecj-12463	388	25	systematic	systematic	ADJ
ecj-12463	388	26	review	review	NOUN
ecj-12463	388	27	and	and	CCONJ
ecj-12463	388	28	meta	meta	NOUN
ecj-12463	388	29	-	-	PUNCT
ecj-12463	388	30	analysis	analysis	NOUN
ecj-12463	388	31	of	of	ADP
ecj-12463	388	32	14,139	14,139	NUM
ecj-12463	388	33	patients	patient	NOUN
ecj-12463	388	34	.	.	PUNCT
ecj-12463	389	1	j	j	PROPN
ecj-12463	389	2	cardiovasc	cardiovasc	PROPN
ecj-12463	389	3	dev	dev	PROPN
ecj-12463	389	4	dis	dis	PROPN
ecj-12463	389	5	2021;9:6	2021;9:6	NUM
ecj-12463	389	6	.	.	PUNCT
ecj-12463	390	1	73	73	NUM
ecj-12463	390	2	.	.	PUNCT
ecj-12463	391	1	pedersen	pedersen	PROPN
ecj-12463	391	2	ck	ck	PROPN
ecj-12463	391	3	,	,	PUNCT
ecj-12463	391	4	stengaard	stengaard	NOUN
ecj-12463	391	5	c	c	PROPN
ecj-12463	391	6	,	,	PUNCT
ecj-12463	391	7	bøtker	bøtker	PROPN
ecj-12463	391	8	mt	mt	PROPN
ecj-12463	391	9	,	,	PUNCT
ecj-12463	391	10	et	et	PROPN
ecj-12463	391	11	al	al	PROPN
ecj-12463	391	12	.	.	PROPN
ecj-12463	391	13	accelerated	accelerate	VERB
ecj-12463	391	14	rule	rule	NOUN
ecj-12463	391	15	-	-	PUNCT
ecj-12463	391	16	out	out	NOUN
ecj-12463	391	17	of	of	ADP
ecj-12463	391	18	acute	acute	ADJ
ecj-12463	391	19	myocardial	myocardial	ADJ
ecj-12463	391	20	infarction	infarction	NOUN
ecj-12463	391	21	using	use	VERB
ecj-12463	391	22	prehospital	prehospital	ADJ
ecj-12463	391	23	copeptin	copeptin	NOUN
ecj-12463	391	24	and	and	CCONJ
ecj-12463	391	25	in	in	ADP
ecj-12463	391	26	-	-	PUNCT
ecj-12463	391	27	hospital	hospital	NOUN
ecj-12463	391	28	troponin	troponin	NOUN
ecj-12463	391	29	:	:	PUNCT
ecj-12463	391	30	the	the	DET
ecj-12463	391	31	aromi	aromi	ADJ
ecj-12463	391	32	study	study	NOUN
ecj-12463	391	33	.	.	PUNCT
ecj-12463	392	1	eur	eur	PROPN
ecj-12463	392	2	heart	heart	NOUN
ecj-12463	392	3	j	j	PROPN
ecj-12463	392	4	2023;44:3875	2023;44:3875	NUM
ecj-12463	392	5	-	-	SYM
ecj-12463	392	6	88	88	NUM
ecj-12463	392	7	.	.	PUNCT
ecj-12463	393	1	74	74	NUM
ecj-12463	393	2	.	.	PUNCT
ecj-12463	394	1	xue	xue	PROPN
ecj-12463	394	2	s	s	PROPN
ecj-12463	394	3	,	,	PUNCT
ecj-12463	394	4	zhu	zhu	PROPN
ecj-12463	394	5	w	w	PROPN
ecj-12463	394	6	,	,	PUNCT
ecj-12463	394	7	liu	liu	PROPN
ecj-12463	394	8	d	d	PROPN
ecj-12463	394	9	,	,	PUNCT
ecj-12463	394	10	et	et	PROPN
ecj-12463	394	11	al	al	PROPN
ecj-12463	394	12	.	.	PUNCT
ecj-12463	395	1	circulating	circulate	VERB
ecj-12463	395	2	mir-26a-1	mir-26a-1	PROPN
ecj-12463	395	3	,	,	PUNCT
ecj-12463	395	4	mir-146a	mir-146a	NOUN
ecj-12463	395	5	and	and	CCONJ
ecj-12463	395	6	mir199a-1	mir199a-1	NOUN
ecj-12463	395	7	are	be	AUX
ecj-12463	395	8	potential	potential	ADJ
ecj-12463	395	9	candidate	candidate	NOUN
ecj-12463	395	10	biomarkers	biomarker	NOUN
ecj-12463	395	11	for	for	ADP
ecj-12463	395	12	acute	acute	ADJ
ecj-12463	395	13	myocardial	myocardial	ADJ
ecj-12463	395	14	infrction	infrction	NOUN
ecj-12463	395	15	.	.	PUNCT
ecj-12463	396	1	molec	molec	PROPN
ecj-12463	396	2	med	me	VERB
ecj-12463	396	3	2019;25:18	2019;25:18	NUM
ecj-12463	396	4	.	.	PUNCT
ecj-12463	397	1	75	75	NUM
ecj-12463	397	2	.	.	PUNCT
ecj-12463	397	3	topf	topf	VERB
ecj-12463	397	4	a	a	PRON
ecj-12463	397	5	,	,	PUNCT
ecj-12463	397	6	mirna	mirna	PROPN
ecj-12463	397	7	m	m	PROPN
ecj-12463	397	8	,	,	PUNCT
ecj-12463	397	9	paar	paar	PROPN
ecj-12463	397	10	v	v	NOUN
ecj-12463	397	11	,	,	PUNCT
ecj-12463	397	12	et	et	PROPN
ecj-12463	397	13	al	al	PROPN
ecj-12463	397	14	.	.	PUNCT
ecj-12463	398	1	the	the	DET
ecj-12463	398	2	differential	differential	ADJ
ecj-12463	398	3	diagnostic	diagnostic	ADJ
ecj-12463	398	4	value	value	NOUN
ecj-12463	398	5	of	of	ADP
ecj-12463	398	6	selected	select	VERB
ecj-12463	398	7	cardiovascular	cardiovascular	ADJ
ecj-12463	398	8	biomarkers	biomarker	NOUN
ecj-12463	398	9	in	in	ADP
ecj-12463	398	10	takotsubo	takotsubo	NOUN
ecj-12463	398	11	syndrome	syndrome	PROPN
ecj-12463	398	12	.	.	PUNCT
ecj-12463	399	1	clin	clin	PROPN
ecj-12463	399	2	res	res	PROPN
ecj-12463	399	3	cardiol	cardiol	NOUN
ecj-12463	399	4	2022;111:197–206	2022;111:197–206	NUM
ecj-12463	399	5	.	.	PUNCT
ecj-12463	400	1	76	76	NUM
ecj-12463	400	2	.	.	PUNCT
ecj-12463	401	1	castiglione	castiglione	NOUN
ecj-12463	401	2	v	v	NOUN
ecj-12463	401	3	,	,	PUNCT
ecj-12463	401	4	aimo	aimo	PROPN
ecj-12463	401	5	a	a	PRON
ecj-12463	401	6	,	,	PUNCT
ecj-12463	401	7	vergaro	vergaro	NOUN
ecj-12463	401	8	g	g	NOUN
ecj-12463	401	9	,	,	PUNCT
ecj-12463	401	10	et	et	PROPN
ecj-12463	401	11	al	al	PROPN
ecj-12463	401	12	.	.	PUNCT
ecj-12463	401	13	biomarkers	biomarker	NOUN
ecj-12463	401	14	for	for	ADP
ecj-12463	401	15	the	the	DET
ecj-12463	401	16	review	review	NOUN
ecj-12463	401	17	[	[	X
ecj-12463	401	18	page	page	NOUN
ecj-12463	401	19	57	57	NUM
ecj-12463	401	20	]	]	PUNCT
ecj-12463	402	1	[	[	X
ecj-12463	402	2	emergency	emergency	NOUN
ecj-12463	402	3	care	care	NOUN
ecj-12463	402	4	journal	journal	PROPN
ecj-12463	402	5	2024	2024	NUM
ecj-12463	402	6	;	;	PUNCT
ecj-12463	402	7	20:12463	20:12463	NUM
ecj-12463	402	8	]	]	X
ecj-12463	402	9	non	non	ADJ
ecj-12463	402	10	-co	-co	PROPN
ecj-12463	402	11	mmerc	mmerc	PROPN
ecj-12463	402	12	ial	ial	PROPN
ecj-12463	402	13	us	us	PROPN
ecj-12463	402	14	e	e	NOUN
ecj-12463	402	15	o	o	NOUN
ecj-12463	402	16	nly	nly	ADV
ecj-12463	402	17	diagnosis	diagnosis	NOUN
ecj-12463	402	18	and	and	CCONJ
ecj-12463	402	19	management	management	NOUN
ecj-12463	402	20	of	of	ADP
ecj-12463	402	21	heart	heart	NOUN
ecj-12463	402	22	failure	failure	NOUN
ecj-12463	402	23	.	.	PUNCT
ecj-12463	403	1	heart	heart	NOUN
ecj-12463	403	2	failure	failure	NOUN
ecj-12463	403	3	reviews	review	VERB
ecj-12463	403	4	2022;27:625–43	2022;27:625–43	NUM
ecj-12463	403	5	.	.	PUNCT
ecj-12463	404	1	77	77	NUM
ecj-12463	404	2	.	.	PUNCT
ecj-12463	405	1	paul	paul	PROPN
ecj-12463	405	2	s	s	PROPN
ecj-12463	405	3	,	,	PUNCT
ecj-12463	405	4	harshaw	harshaw	PROPN
ecj-12463	405	5	-	-	PUNCT
ecj-12463	405	6	ellis	ellis	PROPN
ecj-12463	405	7	k.	k.	PROPN
ecj-12463	405	8	evolving	evolve	VERB
ecj-12463	405	9	use	use	NOUN
ecj-12463	405	10	of	of	ADP
ecj-12463	405	11	biomarkers	biomarker	NOUN
ecj-12463	405	12	in	in	ADP
ecj-12463	405	13	the	the	DET
ecj-12463	405	14	management	management	NOUN
ecj-12463	405	15	of	of	ADP
ecj-12463	405	16	heart	heart	NOUN
ecj-12463	405	17	failure	failure	NOUN
ecj-12463	405	18	.	.	PUNCT
ecj-12463	406	1	cardiol	cardiol	NOUN
ecj-12463	406	2	rev	rev	VERB
ecj-12463	406	3	2019;27:153–9	2019;27:153–9	NUM
ecj-12463	406	4	.	.	PUNCT
ecj-12463	407	1	78	78	NUM
ecj-12463	407	2	.	.	PUNCT
ecj-12463	407	3	idzikowska	idzikowska	PROPN
ecj-12463	407	4	k	k	PROPN
ecj-12463	407	5	,	,	PUNCT
ecj-12463	407	6	kacprzak	kacprzak	PROPN
ecj-12463	407	7	m	m	PROPN
ecj-12463	407	8	,	,	PUNCT
ecj-12463	407	9	zielinska	zielinska	PROPN
ecj-12463	407	10	m.	m.	VERB
ecj-12463	407	11	the	the	DET
ecj-12463	407	12	prognostic	prognostic	ADJ
ecj-12463	407	13	value	value	NOUN
ecj-12463	407	14	of	of	ADP
ecj-12463	407	15	cardiac	cardiac	ADJ
ecj-12463	407	16	biomarkers	biomarker	NOUN
ecj-12463	407	17	in	in	ADP
ecj-12463	407	18	patients	patient	NOUN
ecj-12463	407	19	with	with	ADP
ecj-12463	407	20	acute	acute	ADJ
ecj-12463	407	21	myocardial	myocardial	ADJ
ecj-12463	407	22	infarction	infarction	NOUN
ecj-12463	407	23	during	during	ADP
ecj-12463	407	24	and	and	CCONJ
ecj-12463	407	25	after	after	ADP
ecj-12463	407	26	hospitalization	hospitalization	NOUN
ecj-12463	407	27	.	.	PUNCT
ecj-12463	408	1	rev	rev	AUX
ecj-12463	408	2	cardiovasc	cardiovasc	PROPN
ecj-12463	408	3	med	med	PROPN
ecj-12463	408	4	2022;23:320	2022;23:320	PROPN
ecj-12463	408	5	.	.	PROPN
ecj-12463	408	6	79	79	NUM
ecj-12463	408	7	.	.	PUNCT
ecj-12463	409	1	topf	topf	VERB
ecj-12463	409	2	a	a	PRON
ecj-12463	409	3	,	,	PUNCT
ecj-12463	409	4	mirna	mirna	PROPN
ecj-12463	409	5	m	m	PROPN
ecj-12463	409	6	,	,	PUNCT
ecj-12463	409	7	bacher	bacher	PROPN
ecj-12463	409	8	n	n	CCONJ
ecj-12463	409	9	,	,	PUNCT
ecj-12463	409	10	et	et	PROPN
ecj-12463	409	11	al	al	PROPN
ecj-12463	409	12	.	.	PUNCT
ecj-12463	410	1	analysis	analysis	NOUN
ecj-12463	410	2	of	of	ADP
ecj-12463	410	3	selected	select	VERB
ecj-12463	410	4	cardiovascular	cardiovascular	ADJ
ecj-12463	410	5	biomarkers	biomarker	NOUN
ecj-12463	410	6	in	in	ADP
ecj-12463	410	7	takotsubo	takotsubo	NOUN
ecj-12463	410	8	cardiomyopathy	cardiomyopathy	ADJ
ecj-12463	410	9	and	and	CCONJ
ecj-12463	410	10	the	the	DET
ecj-12463	410	11	most	most	ADV
ecj-12463	410	12	frequent	frequent	ADJ
ecj-12463	410	13	cardiomyopathies	cardiomyopathy	NOUN
ecj-12463	410	14	.	.	PUNCT
ecj-12463	411	1	front	front	PROPN
ecj-12463	411	2	cardiovasc	cardiovasc	PROPN
ecj-12463	411	3	med	med	PROPN
ecj-12463	411	4	2021;8:700169	2021;8:700169	PROPN
ecj-12463	411	5	.	.	PUNCT
ecj-12463	412	1	80	80	NUM
ecj-12463	412	2	.	.	PUNCT
ecj-12463	413	1	stojanovic	stojanovic	ADJ
ecj-12463	413	2	d	d	PROPN
ecj-12463	413	3	,	,	PUNCT
ecj-12463	413	4	mitic	mitic	ADJ
ecj-12463	413	5	v	v	NOUN
ecj-12463	413	6	,	,	PUNCT
ecj-12463	413	7	stojanovic	stojanovic	ADJ
ecj-12463	413	8	m	m	PROPN
ecj-12463	413	9	,	,	PUNCT
ecj-12463	413	10	et	et	PROPN
ecj-12463	413	11	al	al	PROPN
ecj-12463	413	12	.	.	PUNCT
ecj-12463	414	1	the	the	DET
ecj-12463	414	2	discriminatory	discriminatory	ADJ
ecj-12463	414	3	ability	ability	NOUN
ecj-12463	414	4	of	of	ADP
ecj-12463	414	5	renalase	renalase	NOUN
ecj-12463	414	6	and	and	CCONJ
ecj-12463	414	7	biomarkers	biomarker	NOUN
ecj-12463	414	8	of	of	ADP
ecj-12463	414	9	cardiac	cardiac	ADJ
ecj-12463	414	10	remodeling	remodeling	NOUN
ecj-12463	414	11	for	for	ADP
ecj-12463	414	12	the	the	DET
ecj-12463	414	13	prediction	prediction	NOUN
ecj-12463	414	14	of	of	ADP
ecj-12463	414	15	ischemia	ischemia	NOUN
ecj-12463	414	16	in	in	ADP
ecj-12463	414	17	chronic	chronic	ADJ
ecj-12463	414	18	heart	heart	NOUN
ecj-12463	414	19	failure	failure	NOUN
ecj-12463	414	20	patients	patient	NOUN
ecj-12463	414	21	with	with	ADP
ecj-12463	414	22	the	the	DET
ecj-12463	414	23	regard	regard	NOUN
ecj-12463	414	24	to	to	ADP
ecj-12463	414	25	the	the	DET
ecj-12463	414	26	ejection	ejection	NOUN
ecj-12463	414	27	fraction	fraction	NOUN
ecj-12463	414	28	.	.	PUNCT
ecj-12463	415	1	front	front	PROPN
ecj-12463	415	2	cardiovasc	cardiovasc	PROPN
ecj-12463	415	3	med	med	PROPN
ecj-12463	415	4	2021;8:691513	2021;8:691513	PROPN
ecj-12463	415	5	.	.	PUNCT
ecj-12463	416	1	review	review	NOUN
ecj-12463	417	1	[	[	X
ecj-12463	417	2	emergency	emergency	NOUN
ecj-12463	417	3	care	care	NOUN
ecj-12463	417	4	journal	journal	PROPN
ecj-12463	417	5	2024	2024	NUM
ecj-12463	417	6	;	;	PUNCT
ecj-12463	417	7	20:12463	20:12463	NUM
ecj-12463	417	8	]	]	X
ecj-12463	418	1	[	[	X
ecj-12463	418	2	page	page	NOUN
ecj-12463	418	3	58	58	NUM
ecj-12463	418	4	]	]	PUNCT
ecj-12463	418	5	online	online	PROPN
ecj-12463	418	6	supplementary	supplementary	ADJ
ecj-12463	418	7	materials	material	NOUN
ecj-12463	418	8	table	table	NOUN
ecj-12463	418	9	1	1	NUM
ecj-12463	418	10	.	.	PUNCT
ecj-12463	418	11	brief	brief	ADJ
ecj-12463	418	12	summary	summary	NOUN
ecj-12463	418	13	of	of	ADP
ecj-12463	418	14	all	all	DET
ecj-12463	418	15	studies	study	NOUN
ecj-12463	418	16	performed	perform	VERB
ecj-12463	418	17	on	on	ADP
ecj-12463	418	18	sst2	sst2	NOUN
ecj-12463	418	19	in	in	ADP
ecj-12463	418	20	relation	relation	NOUN
ecj-12463	418	21	to	to	ADP
ecj-12463	418	22	cvd	cvd	PROPN
ecj-12463	418	23	.	.	PUNCT
ecj-12463	419	1	table	table	NOUN
ecj-12463	419	2	2	2	NUM
ecj-12463	419	3	.	.	PUNCT
ecj-12463	419	4	brief	brief	ADJ
ecj-12463	419	5	summary	summary	NOUN
ecj-12463	419	6	of	of	ADP
ecj-12463	419	7	all	all	DET
ecj-12463	419	8	studies	study	NOUN
ecj-12463	419	9	performed	perform	VERB
ecj-12463	419	10	on	on	ADP
ecj-12463	419	11	supar	supar	NOUN
ecj-12463	419	12	in	in	ADP
ecj-12463	419	13	relation	relation	NOUN
ecj-12463	419	14	to	to	ADP
ecj-12463	419	15	cvd	cvd	PROPN
ecj-12463	419	16	.	.	PUNCT
ecj-12463	420	1	non	non	PROPN
ecj-12463	420	2	-co	-co	PROPN
ecj-12463	420	3	mmerc	mmerc	PROPN
ecj-12463	420	4	ial	ial	PROPN
ecj-12463	420	5	us	us	PROPN
ecj-12463	420	6	e	e	NOUN
ecj-12463	420	7	o	o	NOUN
ecj-12463	420	8	nly	nly	ADV